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Background: Over 3 milion neonatal deaths occur annualy, mostly in developing 
countries. Neonatal massage with localy available vegetable oils is a low-cost 
intervention being explored to reduce neonatal morbidity and mortality. Although milions 
of infants in South Asia are massaged with mustard oil each year, it is unknown whether 
substituting sunflower seed oil changes any biological mechanisms that may improve 
neonatal health. 
Methods: This was a nested community-based cluster-randomized controled trial of 
1000 neonates (500 preterm (<37 weeks), 500 ful term) randomized to promotion of 
either mustard seed (traditional) or sunflower (improved) oil for ful body massage. Skin 
integrity was assessed using the folowing measurements: transepidermal water loss 
(TEWL), skin pH, skin condition (days 1, 3, 7, 14, and 28), and stratum corneum protein 
concentration (days 1, 7, 14, and 28). Nutritional status was assessed by weight (days 1, 
3, 7, 10, 14, 21, and 28) and length (days 1 and 28) measurements. Risk factors 
associated with skin integrity were evaluated using longitudinal mixed-efects models. 
Efects of oil group on skin integrity and nutritional status were assessed using 
longitudinal mixed-efects models, accounting for the clustered design. 
Results: Risk factors associated with skin integrity included: sex, birthweight, ethnicity, 
socioeconomic status, time between measurement and last (i.e. most frequent) 
massage, temperature, and humidity. In the sunflower oil group, skin pH and TEWL 
decreased at a faster rate during the neonatal period (0.006 pH units/day and 0.16 
g/m2/hr per day respectively) than in the mustard oil group. Preterm infants’ TEWL in the 
sunflower oil group decreased 0.47 g/m2/hr per day faster than those in the mustard oil 
group between days 4 and 28. There was no evidence that skin condition scores, protein 
concentration, or nutritional status was diferent between groups. 
 ii 
Conclusions: These data indicate neonatal ful body massage using sunflower oil may 
help to improve skin barrier integrity relative to mustard seed oil. Sunflower oil did not 
show an improved efect on nutritional status when compared to mustard seed oil. 
Further research on other possible biological mechanisms that may be related to 
improved health outcomes in infants massaged with emolients should be considered. 
Thesis Advisor: Dr. Luke Mulany 
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Chapter 1 Introduction 
Globaly, 3.1 milion neonatal (≤28 days) deaths occur each year, with 98% of these 
deaths occurring in developing countries. (Black, Cousens et al. 2010; Lawn, Kerber et 
al. 2010; Liu, Johnson et al. 2012) An increasing proportion of deaths in children under-
five occur during this neonatal period. (Lawn, Cousens et al. 2005; Oestergaard, Inoue 
et al. 2011; Liu, Johnson et al. 2012) The top three causes of death in these infants are 
complications from preterm birth (35%), infections (including sepsis, pneumonia, 
diarrhea, meningitis, and tetanus) (27%), and intrapartum related neonatal deaths, such 
as birth asphyxia (23%). (Liu, Johnson et al. 2012) Preterm complications also contribute 
to other causes of death, resulting in half of al neonatal deaths globaly as preterm. 
(Belizan, McClure et al. 2012) In Southeast Asia, 52% of child deaths occur during the 
neonatal period. (Liu, Johnson et al. 2012) 
 
In order to reach the Milennium Development Goal 4 (MDG4) of reducing child mortality 
by 2/3 by 2015, the current rate of reduction of under-five mortality must increase 13.5% 
per year between 2011 and 2015. (Lawn, Kinney et al. 2012) This goal cannot be 
achieved without a significant reduction in neonatal mortality. Preventing neonatal 
deaths has not been a traditional focus of child survival or safe motherhood programs.  
Child survival programs must continue to develop, looking for simple, cost-efective 
strategies to reduce neonatal mortality in community setings.  
 
One intervention being explored to reduce neonatal mortality is the practice of neonatal 
oil massage using localy available vegetable oils, which is practiced almost universaly 
throughout Southeast Asia. (Darmstadt and Saha 2002; Mulany, Darmstadt et al. 2005) 
 2 
In Africa, oil massage is not as commonly practiced as in South Asia however; it is stil 
commonly done in many communities and so could be acceptable as an intervention to 
improve neonatal mortality and morbidity. (Iweze 1983; Niang 2004; Darmstadt, Hussein 
et al. 2007; Mrisho, Schelenberg et al. 2008; Waiswa, Nyanzi et al. 2010; Dufy, 
Ferguson et al. 2012) 
 
Studies have shown that massage with oil is more beneficial than massage alone. (Field, 
Schanberg et al. 1996) Furthermore, hospital-based studies show that the application of 
sunflower oil reduces rates of invasive infection and mortality. A study in Egypt of 
preterm infants <34 weeks comparing the application of sunflower oil to controls showed 
a significant decrease in the incidence of nosocomial infections and an improvement in 
skin condition in infants receiving sunflower oil. (Darmstadt, Badrawi et al. 2004) Another 
study of preterm infants in Bangladesh comparing infants randomized to massage with 
sunflower oil, Aquaphor, or no emolient, found a 41% reduction in nosocomial infections 
(Darmstadt, Saha et al. 2005) and a 26% reduction in neonatal mortality rates in the 
sunflower oil group compared with controls. (Darmstadt, Saha et al. 2008) 
 
Although studies have shown that topical application of vegetable oil may be beneficial 
to neonates, the choice of oil may be important. A study done using a mouse model 
showed accelerated skin barrier recovery in mice one hour after application of sunflower 
oil, with a sustained efect up to five hours. (Darmstadt, Mao-Qiang et al. 2002) 
However, application of mustard, olive, or soybean oils showed delayed recovery of skin 
barrier function when compared to untreated or Aquaphor treated skin. Mustard seed oil 
showed the most detrimental efects, with sustained delay of barrier recovery for up to 
seven days. One possible reason for this delayed recovery is that mice treated with 
mustard seed oil showed structural changes in their epidermis, with flatened 
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keratinocytes, apoptotic nuclei and nuclear envelope hypertrophy, and condensed 
heterochromatin. (Darmstadt, Mao-Qiang et al. 2002) 
 
There are several ways in which emolient therapy with vegetable oil may improve the 
health of newborns. These include: improving skin integrity and barrier function, changes 
in the bacteriological profile of the skin, improving the immune response at the systemic 
and/or epidermal levels, and improving nutritional status through transcutaneous 
absorption of lipids. (Darmstadt and Dinulos 2000) Despite the interest in neonatal oil 
massage with localy available vegetable oils as a possible low-cost intervention for 
improvement of neonatal morbidity and mortality, there has been very litle research on 
the biological mechanisms through which sunflower oil massage may improve neonatal 
health. This research is important to alow for direct comparison of functional indicators 
across public health outcomes including neonatal skin infection, clinical signs of sepsis, 
and mortality. While a mouse model has provided some insights into these emolient-
dependent mechanisms, further research in human infants is essential for us to extend 
our understanding. (Expert Emolients Meeting, Bil and Melinda Gates Foundation, 
December 14, 2012)  
 
Study Objective: 
The objective of this study was to determine the possible mechanistic reasons for 
improved health outcomes in neonates receiving ful body massage using sunflower 
seed oil relative to mustard seed oil. These activities broadly relate to four domains: 
improved skin integrity and barrier function, nutritional status, microbial chalenge at the 





To determine if sunflower seed oil massage:  
1. improves skin integrity and barrier function. Specificaly, examine if (a) trans-
epidermal water loss is decreased, (b) skin pH more rapidly stabilizes during the first 
week of life, (c) there is a diference in stratum corneum protein content and amount 
and (d) skin condition scores for dryness, rash, and erythema are lower (improved) 
among infants in the sunflower oil group 
2. improves nutritional status. Specificaly, examine if (a) weight is higher at days 3, 
7, 10, 14, 21, 28, and 180 days after birth, (b) length is greater 28 and 180 days after 
birth, and (c) serum levels of essential faty acids are improved among infants in the 
sunflower oil group  
3. results in changes in bacteriological profile of the skin. Specificaly, examine if 
overal and organism-specific presence and density of colonization at the axila, 
inguinal, and periumbilical region difers between the groups 
4. results in changes in immune response at both the systemic and epidermal 
innate immunity levels. Specificaly, compare (a) salivary cytokine concentrations 
over the first two weeks of life using repeat salivary swabs, (b) serum cytokine 
concentrations on day 14 using heelprick blood samples and (c) epidermal 
biomarkers (keratin 1,10,11, involucrin, albumin) and cytokine levels (IL-1α, IL-1β, IL-
6, IL-8, TNF-α) using a non-invasive skin tape-strip sampling method  
 
This dissertation focuses on the first two specific aims relating to improvements in skin 
integrity and barrier function and nutritional status. In addition, the analyses presented 
here represent preliminary work conducted among a subset of the (eventual) sample 
size. There are six additional chapters included in this dissertation. Chapter 2 provides 
background information on neonatal massage with and without emolient therapy and its 
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relationship with skin barrier integrity, nutritional status, bacterial colonization, and 
immune response. Chapter 3 presents an overview of the methodology that was used to 
address specific aims 1 and 2. Chapter 4 discusses the epidemiology of the skin integrity 
measurements and the possible risk factors associated with them in this population. 
Chapter 5 addresses whether ful body oil massage using sunflower seed oil improves 
skin integrity and barrier function relative to massage with mustard seed oil. Chapter 6 
investigates whether massage with sunflower oil improves nutritional status when 
compared with massage using mustard seed oil. Chapter 7 is the final chapter and 
provides a discussion of the results presented in Chapters 4 through 6, strengths and 
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Chapter 2 Background 
Introduction 
Globaly, 3.1 milion neonatal (≤28 days) deaths occur each year, with 98% of these 
deaths occurring in developing countries based on estimates from the year 2010. (Black, 
Cousens et al. 2010; Lawn, Kerber et al. 2010; Liu, Johnson et al. 2012) This accounts 
for more than 40% of al deaths in children under-five years, an increase in the 
proportion of child deaths that occurred during the neonatal period according to year 
2000 estimates. (Lawn, Cousens et al. 2005; Oestergaard, Inoue et al. 2011; Liu, 
Johnson et al. 2012) The top three causes of death in these infants are complications 
from preterm birth (35%), infections (including sepsis, pneumonia, diarrhea, meningitis, 
and tetanus) (27%), and intrapartum related neonatal deaths, such as birth asphyxia 
(23%). (Liu, Johnson et al. 2012) However, in setings with high neonatal mortality 
(NMR), the proportion of deaths due to infections is about 50%. (Lawn, Cousens et al. 
2005; Blencowe and Cousens 2013) Preterm complications also contribute to other 
causes of death, resulting in half of al neonatal deaths globaly as preterm. (Belizan, 
McClure et al. 2012) Preterm infants have almost a seven-fold greater risk of neonatal 
mortality than term infants. (Katz, Lee et al. 2013) Sub-Saharan Africa and Southern 
Asia account for 52% of al live births, but 78% of neonatal deaths. (Oestergaard, Inoue 
et al. 2011) In addition, 60% of preterm births occur in Africa and South Asia. (WHO 
2012) 
 
At least half of al neonatal deaths occur in the first 24 hours and three-quarters of al 
neonatal deaths occur during the first week of life, with many of these deaths going 
unrecorded. (Lawn, Cousens et al. 2005; Belizan, McClure et al. 2012) Preventing 
neonatal deaths has not been a traditional focus of child survival or safe motherhood 
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programs. Child survival programs have mostly focused on interventions to combat 
diseases such as diarrhea, pneumonia, malaria, and vaccine preventable diseases that 
primarily afect children who are past their neonatal period. As a result, child mortality (2 
months to 5 years) saw a reduction of one-third from 1989-2000, while NMR only saw a 
one-fourth reduction. (Lawn, Cousens et al. 2005) The average annual rate of reduction 
of NMR from 2000 to 2010 accelerated 2.1% per year when compared with the 1990s, 
however this was slower than both child mortality and maternal mortality. (Hil, You et al. 
2012) Oficial development assistance for maternal, newborn, and child health doubled 
from 2003 to 2008, but by 2008 only 6% of aid mentioned newborns and only 0.1% 
exclusively targeted newborn care. (Lawn, Kinney et al. 2012) 
 
In Southeast Asia, 52% of child deaths occur during the neonatal period and in Nepal it 
is estimated that in 2010, there were 20,049 neonatal deaths, with 58% of under-five 
deaths occurring during the neonatal period. (Liu, Johnson et al. 2012) Poverty is 
associated with an increased risk of neonatal death and considerable income 
inequalities exist in Nepal, leading to large health disparities. For instance, Nepal would 
show a 43% reduction in NMR if the NMR for the entire population were the same as for 
the richest 20% of Nepalese. (Lawn, Cousens et al. 2005) The poorest quintile is 65% 
more likely to have a neonatal death than the wealthiest quintile. (Pradhan, Upreti et al. 
2012) These numbers are most likely underestimates, as studies have shown that in 
poor setings in Southeast Asia, neonatal deaths are greatly underestimated. (Bang, 
Reddy et al. 2002) However, between 2000 and 2010 the countries with the greatest 
overal reductions in NMR in Southern Asia were Iran, Bangladesh, and Nepal. (Lawn, 
Kinney et al. 2012) Nepal’s NMR has decreased from 50 per 1000 live births in 1996 to 
27 per 1000 live births in 2011. (Ban, Tuladhar et al. 2012; United Nations Children's 
Fund 2013) 
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In order to reach the Milennium Development Goal 4 (MDG4) of reducing child mortality 
by 2/3 by 2015, the current rate of reduction of under-five mortality must increase 13.5% 
per year between 2011 and 2015. (Lawn, Kinney et al. 2012) This goal cannot be 
achieved without a significant reduction in neonatal mortality. Child survival programs 
must continue to develop, looking for simple, cost-efective strategies to reduce neonatal 
mortality in community setings. While Nepal is one of the low-income countries on track 
to meet MDG4, many inequities exist. (Lozano, Wang et al. 2011) Urban children have 
beter chances of survival than rural children and ethnic groups such as the Dalits and 
Terai Madhesis have higher relative levels of neonatal mortality. (Nguyen, Jimenez-Soto 
et al. 2013) NMR is nearly double in rural and mountainous regions in Nepal and 
between 1996 and 2006 the inequity in NMR between advantaged and disadvantaged 
caste/ethnic groups increased. (Pradhan, Upreti et al. 2012) 
 
One intervention being explored to reduce neonatal mortality is the practice of neonatal 
oil massage using localy available vegetable oils, which is practiced almost universaly 
throughout Southeast Asia. A study in Bangladesh found that >96% of neonates 
regardless of socioeconomic factors or place of residence, received ful body massage, 
with mustard seed oil as the most commonly used oil. The perceived benefits from the 
mothers included preventing infections, keeping the infant warm, improving skin 
condition, and improving overal health. (Darmstadt and Saha 2002) Another study in 
Sarlahi district in rural Nepal, found that 99% of newborns received oil massage at least 
once in the first two weeks after birth, with mustard oil again as the oil of choice. This 
was practiced for al ethnicities, races, and cultures, and did not difer by socioeconomic 
status. The perceived benefits were similar to those cited by mothers in Bangladesh: the 
massage promotes strength, maintains health, and provides warmth. (Mulany, 
Darmstadt et al. 2005) 
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Studies done in Africa show that while oil massage is not as common a practice as in 
South Asia, it is stil commonly done in many communities and so could be acceptable 
as an intervention to improve neonatal mortality and morbidity. (Duffy, Ferguson et al. 
2012) In Nigeria after birth, infants are commonly rubbed with palm oil or kernel oil 
before their first bath in order to remove impurities and after the bath in order to increase 
limb strength. (Iweze 1983) In Tanzania, after birth, sesame or other cooking oil is often 
applied to the body to soften the skin and warm the infant. (Mrisho, Schelenberg et al. 
2008) Cooking oil is commonly applied to infants’ skin in Uganda in order to “make the 
skin strong” (Waiswa, Nyanzi et al. 2010) and in Senegal infants are often massaged 
soon after birth and then daily for the first one or two months with cooking oil in order to 
“massage al of the organs, move them in al directions, and give them shape”. (Niang 
2004) In addition, a study on neonatal home care in rural Egypt found that use of a skin 
care product was common, mostly in the first or second day of life and that most 
products were applied one to three times per day, with the most common reasons being 
to prevent skin infection and improve skin condition. Most mothers also said they would 
be wiling to apply a prescription skin oil or emolient to prevent infections. (Darmstadt, 
Hussein et al. 2007) 
 
Many studies have shown that massage with oil is more beneficial than massage alone. 
A study of infants massaged with Johnson and Johnson baby oil versus infants 
massaged without oil showed those massaged with oil to show fewer stress behaviors, 
lower salivary cortisol levels, and increased vagal activity. (Field, Schanberg et al. 1996) 
Another study of preterm neonates admited to a neonatal intensive care unit in Iran who 
were randomized to moderate pressure massage alone and the same massage using 
sunflower oil, showed greater mean weight gain at one and two months in neonates in 
the group massaged with sunflower oil. (Falah, Akhavan Karbasi et al. 2013) A study of 
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preterm neonates less than 1800g in a neonatal intensive care unit in India comparing 
infants massaged with sunflower oil with standard care to those only receiving standard 
care found those infants receiving oil massage to have greater weight gain at 28 days 
and less weight loss at seven days than those who were not receiving oil massage. 
(Kumar, Upadhyay et al. 2013) Another study in India with preterm neonates randomized 
to oil massage, massage without oil, and no massage, also showed oil massage may 
have the ability to improve weight gain in very low birthweight preterm infants. (Arora, 
Kumar et al. 2005) 
 
In addition, hospital-based studies have shown that the application of sunflower oil 
reduces rates of invasive infection and mortality. A study in Egypt of preterm infants <34 
weeks comparing the application of sunflower oil to controls showed a significant 
decrease in the incidence of nosocomial infections and an improvement in skin condition 
in infants receiving sunflower oil. (Darmstadt, Badrawi et al. 2004) Another study of 
preterm infants in Bangladesh comparing infants randomized to massage with sunflower 
oil, Aquaphor, or no emolient, found a 41% reduction in nosocomial infections 
(Darmstadt, Saha et al. 2005) and a 26% reduction in neonatal mortality rates in the 
sunflower oil group compared with controls. (Darmstadt, Saha et al. 2008) Many families 
from this same cohort perceived topical therapy with sunflower oil or Aquaphor to be 
beter than mustard oil. (Ahmed, Saha et al. 2007) 
 
Although studies have shown that topical application of vegetable oil may be beneficial 
to neonates, the choice of oil may be important. A study done using a mouse model 
showed accelerated skin barrier recovery in mice one hour after application of sunflower 
oil, with a sustained efect up to five hours. (Darmstadt, Mao-Qiang et al. 2002) 
However, application of mustard, olive, or soybean oils showed delayed recovery of skin 
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barrier function when compared to untreated or Aquaphor treated skin. Mustard seed oil 
showed the most detrimental efects, with sustained delay of barrier recovery for up to 
seven days. One possible reason for this delayed recovery is that mice treated with 
mustard seed oil showed structural changes in their epidermis, with flatened 
keratinocytes, apoptotic nuclei and nuclear envelope hypertrophy, and condensed 
heterochromatin. (Darmstadt, Mao-Qiang et al. 2002) In addition, a study looking at 
diferences in application of olive oil and sunflower oil on adult forearms found that after 
4 weeks, olive oil caused a significant reduction in skin integrity and induced mild 
erythema, whereas the sunflower oil preserved skin integrity and improved hydration. 
(Danby, AlEnezi et al. 2013) 
 
There are several ways in which emolient therapy with vegetable oil may improve the 
health of newborns. These include: improving skin barrier integrity and function, changes 
in the bacteriological profile of the skin, improving the immune response at the systemic 
and/or epidermal levels, and improving nutritional status through transcutaneous 
absorption of lipids. Table 2-1 describes some of the potential benefits of emolient 
therapy and the possible biological bases for those efects. 
 
Skin Structure and Function 
Newborn skin is an important organ in protecting the neonate. It serves as the first line of 
defense between the infant and the environment, the stratum corneum being where 
most of this important barrier function occurs. The skin is wel developed and fuly 
functional at birth in ful term infants, with a thick epidermis and wel-formed stratum 
corneum layers, despite being exposed to water and amniotic fluid for nine months. 
(Cunico, Maibach et al. 1977; Yosipovitch, Maayan-Metzger et al. 2000) 
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As an infant’s first line of defense, the skin serves many important functions. These 
include: moderating fluctuations in transepidermal water loss (TEWL) and maintaining 
electrolyte homeostasis, thermoregulation and minimizing caloric losses, antimicrobial 
defense, protection from environmental toxins, protection from ultraviolet (UV) radiation, 
and tactile stimulation. The stratum corneum contains the epidermal permeability barrier 
and is mainly composed of hydrophobic lipids (free faty acids, cholesterol, and 
ceramides). These three stratum corneum lipids are required for permeability 
homeostasis and a mixture of physiological lipids cholesterol, ceramide, palmitate and 
linoleate (ratio 3:1:1:1) was shown to be optimum for barrier repair. (Mao-Qiang, 
Feingold et al. 1996) 
 
This skin barrier is formed in utero during the third trimester, with the stratum corneum 
starting to develop at about 24 weeks gestation. After 24 weeks the number of epidermal 
cel layers and the epidermal thickness steadily increase and are wel developed at 
around 34 weeks. (Cartlidge 2000) Therefore, preterm infants before this time show 
immature barrier function, including: structural immaturity (i.e. the stratum corneum and 
epidermis are thinner leading to increased susceptibility to shear forces), an 
underdeveloped stratum corneum epidermal permeability barrier (leading to increased 
TEWL, loss of heat, increased caloric demands, an increase in potential for 
environmental toxin absorption, and compromised antimicrobial defense), slower 
formation of the antibacterial acid mantel, incomplete development of vernix (and 
subsequent efects), and increased UV susceptibility. (Evans and Ruter 1986; Cartlidge 
2000; Darmstadt and Dinulos 2000; Ruter 2000) Epidermal barrier properties such as 
increased hydration and water binding undergo progressive changes during a healthy 
ful term infant’s first month of life as it adapts to the dry extrauterine environment. 
(Visscher, Chaterjee et al. 2000) Neonatal skin is always adjusting to its extrauterine 
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environment when comparing parameters such as skin thickness, skin pH, TEWL, lipid 
content, and stratum corneum hydration to adult skin, which is in a steady state. This 
suggests that a balance between diferent parameters may be important for barrier 
function. (Chiou and Blume-Peytavi 2004; Fluhr, Darlenski et al. 2012; King, Balaji et al. 
2013) In addition, water handling behaviors and levels of stratum corneum water binding 
amino acids continue to develop during the first year of life. (Nikolovski, Stamatas et al. 
2008) 
 
The skin’s antimicrobial defense arises from factors inherent to the stratum corneum 
(xeric environment, acidic pH, antimicrobial lipids, and continued shedding of 
corneocytes), cationic antimicrobial peptides, cytokines (IL1-α, IL1-β, TNF-α, IL-10, and 
IL-12), granzyme B, Fas ligand, nitric oxide, and resident cutaneous flora. (Darmstadt 
and Dinulos 2000) Corneocytes and the extracelular matrix mediate this defense. 
Secreted hydrophobic lipids are organized into lamelar bilayers that are critical to 
permeability barrier and microbial function. (Elias 2007) The multiple functions of the 
stratum corneum and their relationships are shown in Figure 2-1. 
 
Neonates, especialy those who are preterm, are at high risk for infection. In preterm 
infants, 50% of neonatal mortality is caused by septicemia. (Bartlet, Paz de Bocaleti et 
al. 1991; Stol 1997) This high risk of infection could be due in part to their epidermal 
barrier immaturity (including fewer stratum corneum layers, poorly formed lipid layers, 
and increased permeability), developmental defects in the systemic immune function, 
and disordered cutaneous immunoregulatory function because of barrier distress or 
decreased cationic antimicrobial peptide expression. (Nickolof and Naidu 1994; 
Nishijima, Tokura et al. 1997) Three-fourths of al neonatal deaths occur during the first 
week of life when the epidermal barrier is least mature. (Lawn, Cousens et al. 2005) 
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Maturation of the skin barrier in premature infants is usualy complete in 2-4 weeks 
(Harpin and Ruter 1983), but may take as long as 9 weeks post neonatal age in very 
premature infants. (Harpin and Ruter 1983; Agren, Sjörs et al. 1998; Kalia, Nonato et al. 
1998; Nonato, Lund et al. 2000) In addition, the permeability of premature skin is much 
higher than that of adult skin, which can lead to absorption of foreign substances and 
pathogens. (Nachman and Esterly 1971; Harpin and Ruter 1983) 
 
Premature and low birthweight infants have increased skin permeability (Cartlidge and 
Ruter 1992) and are prone to skin breakdown. (Maloy and Perez-Woods 1991) The 
dermis is lacking in structural proteins, leading to poor mechanical properties. 
(Eichenfield and Hardaway 1999) Stress to the epidermal layer caused by handling or 
massage could exacerbate this breakdown. (Darmstadt and Dinulos 2000) Several 
studies have shown emolient therapy to improve overal skin condition in neonates. Very 
low birthweight infants treated with Aquaphor had improved skin scores when compared 
with untreated infants. (Pabst, Starr et al. 1999) Other studies of premature infants found 
infants treated with ointment had a decreased severity of dermatitis. (Lane and Drost 
1993; Nopper, Hori et al. 1996) 
 
Another important function of the skin barrier is to protect against transepidermal water 
loss (TEWL), a direct function of gestational age. (Hoath and Maibach 2003) TEWL in 
ful term infants is very low at birth, equal to or lower than adult values, which indicates a 
highly efective skin barrier. (Cunico, Maibach et al. 1977; Yosipovitch, Maayan-Metzger 
et al. 2000) There is an exponential relationship between TEWL and gestational age 
continuing during the four weeks after birth. (Hammarlund and Sedin 1979) Very low 
birthweight preterm infants have very high TEWL when measured at birth, ranging from 
50 to 70 g/m2/hr. (Hammarlund and Sedin 1979) A reference dataset of over 1000 term 
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neonates had a mean TEWL of 7.06 g/m2/hr. (Keleher, O'Carrol et al. 2013) This 
diference decreases with age of the infants and after two weeks, values of TEWL in 
preterm infants are similar to those in term infants. (Harpin and Ruter 1983) However, in 
very preterm infants (24-25 weeks gestational age) TEWL has been shown to remain 
higher after 4 weeks. (Agren, Sjörs et al. 1998) In addition to gestational age, TEWL is 
also dependent on the site of measurement, ambient humidity, temperature, activity, and 
nutritional status at birth. (Oberg, Hammarlund et al. 1981; Hammarlund, Sedin et al. 
1982; Hammarlund, Sedin et al. 1983) TEWL decreased at a slower rate in infants in an 
environment with a higher relative humidity, indicating that the level of relative humidity 
influences skin barrier development with more rapid barrier formation in infants at a 
lower relative humidity. (Agren, Sjörs et al. 2006) TEWL also increased when 
temperature was above 37.1°C. (Sedin, Hammarlund et al. 1983) This is important in an 
environment such as the Terai region of Nepal, which experiences very high 
temperatures and levels of humidity, particularly during monsoon season. Trauma of the 
skin can also cause an increase in transepidermal water loss. (Harpin and Ruter 1983) 
High transepidermal water loss can lead to problems in temperature control due to high 
evaporative heat, which may lead to hypothermia. (Ruter 1988) TEWL has been shown 
to decrease in infants treated with emolient therapy. A study of preterm very low 
birthweight infants randomized to topical coconut application versus no treatment 
showed a significantly lower TEWL at each point of measurement in the coconut oil 
group. TEWL was reduced by as much as 46%. (Nangia, Paul et al. 2008) 
 
The acidic pH of the skin is another mode of protection. This acidic surface of the skin is 
important in the formation and integrity of the stratum corneum. It alows the efective 
functioning of enzymes that are involved in lipid metabolism, bilayer structure, ceramide 
synthesis, and desquamatization. (Rippke, Schreiner et al. 2002; Schmid-Wendtner and 
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Korting 2006) Applying acidic treatments has been proposed for the treatment of 
inflammation and the normalization of stratum corneum structure and function. (Hachem, 
Roelandt et al. 2010) In order for the skin to maintain bacteriological, chemical and 
mechanical resistance the ‘acid mantle’ of the skin must have an optimal pH (Schmid-
Wendtner and Korting 2006). After birth, skin pH is elevated in ful term and preterm 
neonates compared with adults and older children and decreases in the first few weeks, 
most significantly during the first 4 days. (Green, Carol et al. 1968; Fluhr, Pfisterer et al. 
2000; Visscher, Chaterjee et al. 2000; Hoeger and Enzmann 2002) The mean skin pH 
value of ful term neonates within the first 10 hours after birth from six diferent body sites 
was 7.08 compared to a mean of 5.7 in adults. (Yosipovitch, Maayan-Metzger et al. 
2000; Hoeger and Enzmann 2002) At days 1, 2, and 3 after birth there was no diference 
in skin pH levels at diferent sites. (Yosipovitch, Maayan-Metzger et al. 2000) Some 
studies have suggested development of the acid mantle is not correlated with gestational 
age, with development in preterm neonates shown to be very close to that of ful term 
neonates. (Green, Carol et al. 1968) However, other studies have shown that for very 
preterm infants, skin pH tends to remain higher for a longer period of time. (Fox, Nelson 
et al. 1998) 
 
This optimal pH level is essential for epidermal barrier maturation and repair processes, 
since important enzymes such as beta-glucoerebroisdase and acidic sphingomyelinase 
that assist in the processing of lipids that make up the stratum corneum perform 
optimaly only at a certain pH level. (Mauro, Grayson et al. 1998) Degradation of these 
enzymes occurs as skin pH levels increase. (Hachem, Crumrine et al. 2003; Hachem, 
Man et al. 2005) A study looking at skin care practices in a Neonatal Intensive Care Unit 
(NICU) found that using skin wipes with emolient cleansers resulted in significantly 
lower skin pH levels compared with using a cloth and water. (Visscher, Odio et al. 2009) 
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Stratum corneum cohesion is reduced with delays in appropriate acidification of the skin, 
potentialy leading to increased risk of micro-injury from mechanical stress (i.e. 
massage). (Fluhr, Kao et al. 2001) Furthermore, acidic skin pH can enhance epidermal 
innate immune function by inhibiting colonization of some pathogens and maintaining 
bacterial homeostasis. (Puhvel, Reisner et al. 1975; Aly, Shirley et al. 1978; Fluhr, Kao 
et al. 2001; Elias 2007) In addition, if diferent emolients result in diferent pH levels of 
the skin, the changes in pH dynamics may influence the type and density of pathogens 
colonizing the skin. (Elias 2007) A hospital-based study in Bangladesh showed that 
preterm neonates treated with sunflower oil and Aquaphor had similar skin flora between 
groups, however in the neonates treated with sunflower oil, there were fewer pathogens 
in the blood. (Darmstadt, Saha et al. 2007) 
 
Bacterial Colonization 
Bacterial colonization occurs as soon as the infant enters the external world. Infants born 
by cesarean section are sterile if the amniotic membranes were not ruptured before 
labor, while infants born vaginaly become colonized during their passage through the 
birth canal. (Sarkany and Gaylarde 1967) 
 
Three types of skin flora have been described. The first is resident bacterial flora, which 
is relatively stable in number and composition. The second is transient flora. These are 
bacteria that are derived from exogenous sources and vary in types and amounts. (Price 
1938) A third type of skin flora that has been described are nomads or associate flora, 
which reside and multiply on the skin for only a short amount of time and depend on 
resident flora for their proliferation. (Brock 1966; Somervile-Milar and Noble 1974) 
Table 2-2 shows a list of common skin flora colonizing the newborn skin. 
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Staphylococcus epidermidis, the most common vaginal organism before birth, rapidly 
colonizes the skin, and is therefore the most common organism on the skin of most 
neonates. (Sarkany and Gaylarde 1967) After the first few weeks of life, under normal 
conditions, the skin flora of the infant is nearly the same as that of an adult. In infants 
who are not immune-compromised and have normal epidermal barriers, these skin-
colonizing flora are not virulent, are stable in number, and non-pathogenic. However, in 
very low birthweight infants whose skin and immune system are not fuly developed, 
Staphylococcus epidermidis is the most common cause of sepsis. (Sidbury and 
Darmstadt 2002) A hospital-based study looking at bacterial colonization of the skin in 
neonates in Nepal found coagulase-negative Staphylococci (42.1%) S. aureus (29.4%) 
and E. coli (24.0%) to be the most common organisms colonizing the skin. (Mulany, 
Khatry et al. 2008) Another study done in a neonatal unit in a tertiary care teaching 
hospital in North India found that out of the culture proven cases, the three most 
common pathogens were Pseudomonas (60%), S. aureus (13%) and E. coli (13%). 
They also found that 83.3%, 30.5%, and 80.6% of cases occurred in low birthweight, 
very low birthweight, and preterm infants respectively. (Chacko and Sohi 2005) Other 
studies investigating antibiotic susceptibility of pathogens causing neonatal sepsis have 
found frequent multi-drug resistance. (Talur, Kasturi et al. 2000; Jyothi, Basavaraj et al. 
2013) 
 
Stress to the stratum corneum, such as massage, may cause tiny fissures helping to 
introduce pathogenic bacteria into the blood stream. (Darmstadt, Saha et al. 2003) For 
instance, a break in the stratum corneum is required for streptococcal infection to occur. 
(Leyden, Stewart et al. 1980) In patients with dermatitis, S. aureus colonization is directly 
related to changes in the epidermis (Leyden, Marples et al. 1974; Nilsson, Henning et al. 
1986) and the presence of a single suture can increase the infectiousness of S. aureus 
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by a factor of 10,000. (Elek 1956) A study of the incidence and etiology of community 
acquired neonatal bacteremia in Bangladesh found S. aureus to be the most common 
pathogen (1/3 of al pathogens identified). (Darmstadt, Saha et al. 2009) A review of 
hospital-acquired neonatal infections in developing countries found that gram-negative 
bacteria and S. aureus are the major causes of neonatal sepsis. In South Asia gram-
negative bacteria and S. aureus accounted for 63.4% and 20.2% of neonatal sepsis 
respectively. This patern was observed even in early-onset sepsis (within the first 
week), which supports the hypothesis that in developing countries the majority of early-
onset infections in hospital-born infants may be hospital-acquired and not maternaly 
acquired. (Zaidi, Huskins et al. 2005) A review looking at the etiology of community-
acquired neonatal sepsis showed similar paterns of infection with 60.8% and 9.9% of 
infections in South Asia caused by gram-negative bacteria and S. aureus respectively. 
Again, these same pathogens are the main causes of sepsis during the first week of life, 
indicating that the infections may be environmentaly rather than maternaly acquired in 
this seting. (Zaidi, Thaver et al. 2009) Another review examining the etiology of 
community-acquired neonatal sepsis further supports this theory, finding a 
predominance of gram-negative organisms and a similar distribution of pathogens in 
neonates with early-onset and late-onset (8-59 days of life) sepsis. (Waters, Jawad et al. 
2011) Topical emolient therapy could help protect against environmentaly acquired 
infections as it has been shown to reduce bacterial colonization in premature infants 
(Nopper, Hori et al. 1996) and has been described as an area needed for further 
research for prevention of neonatal infections. (Osrin, Vergnano et al. 2004) 
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Structural and Immunological Biomarkers 
The stratum corneum is the outermost layer of the skin and is made of nuclear skin cels 
caled corneocytes, forming corneocyte envelopes. The cels of the stratum corneum are 
made up of many diferent proteins. Corneodesmosomes are macromolecular 
glycoprotein complexes within the corneocyte envelope that hold the cels in the stratum 
corneum together. (Serre, Mils et al. 1991) Smal proline-rich (SPRR) proteins help in the 
strength and flexibility of the corneocyte envelopes. (Cabral, Voskamp et al. 2001) 
 
Involucrin and keratin are structural proteins that help to make up the stratum corneum. 
Involucrin is a stratum corneum precursor and a component of the keratinocyte cross-
linked envelope. (Murphy, Flynn et al. 1984) In stratum corneum positive for involucrin, 
the cornified envelopes are fragile and have been linked with inflammation and weak 
barrier function. (Hirao, Terui et al. 2003) In addition, early expression of involucrin has 
been associated with barrier disruption. (Ekanayake-Mudiyanselage, Aschauer et al. 
1998) A reduction in keratin 1,10,11 has been linked with higher skin dryness and 
chronic hyperproliferation. (Engelke, Jensen et al. 1997) 
 
Albumin is the main protein found in plasma and binds unsaturated faty acids and 
calcium. It may also be involved in transport. (Hasse, Kothari et al. 2005) It helps to 
protect against H2O2 oxidation that may occur in the epidermis (Rokos, Moore et al. 
2004) and has a positive correlation with transepidermal water loss and a negative 
correlation with skin hydration. (Yamane, Moriyama et al. 2009) 
 
A study examining biomarkers of innate immunity found keratin 1,10,11 was decreased 
and involucrin was increased in al infants when compared with adult levels. Involucrin 
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was found to be higher in preterm than ful term infants and adults and to be higher in ful 
term infants when compared with adults. Albumin levels were also found to be higher in 
preterm infants than in ful term infants or adults. In addition when comparing epidermal 
cytokine levels, al infants had elevated IL1-α and reduced TNF-α compared with adults. 
Preterm infants also had significantly higher IL-6, IL-8, and albumin compared with ful 
term infants and adults. (Narendran, Visscher et al. 2010) Another study examining host 
defense proteins on neonatal skin compared to adults’ skin, found total protein was 2.8 
times higher in adults compared to newborns. However, host defense proteins lysozyme 
and lactoferrin were detected in al samples with lysozyme concentrations five-fold 
higher in neonates and lysozyme enzyme activity four-fold higher in neonates than in 
adults, demonstrating that newborn skin stratum corneum has classic host defense 
proteins. (Walker, Akinbi et al. 2008) These host defense proteins are also present in the 
vernix caseosa and amniotic fluid in addition to the skin of healthy newborns, indicating 
efective innate immunity during fetal and neonatal life. (Marchini, Lindow et al. 2002; 
Yoshio, Tolin et al. 2003; Akinbi, Narendran et al. 2004; Tolin, Bergsson et al. 2005; 
Walker, Akinbi et al. 2008) 
 
There are several suggested functions of antimicrobial peptides that reside on the skin, 
such as: 1) antimicrobial action, 2) recruitment of inflammatory cels, 3) wound repair, 4) 
apoptosis, and 5) stimulate release of pro- and anti-inflammatory factors (including 
cytokine release). Peptides HBD1 and HBD2 show bactericidal activity against gram-
negative bacteria and HBD3 is efective against gram-positive S. aureus. In addition, LL-
37 and HBD2 show bactericidal activity against Group B Streptococcus. (Yoshio, 
Lagercrantz et al. 2004) 
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Serum cytokine as wel as epidermal cytokine levels are associated with damage and 
stress to the stratum corneum, with changes in levels of pro-inflammatory cytokines such 
as IL1-α, IL1-β, IL-6, IL-8, and TNF-α. Cytokines are smal proteins that are released by 
cels in response to an activating stimulus. Cytokines such as IL1-α, IL1-β, IL-6, IL-8, 
and TNF-α are mainly produced by macrophages and promote inflammation and fever 
as wel as further activation of the immune response. (Murphy, Travers et al. 2008) 
 
Levels of IL-6 increase after stratum corneum barrier damage and application of IL-6 
increased barrier repair in animals. (Wang, Schunck et al. 2003) When barrier function is 
compromised, epidermal keratinocytes become activated quickly, resulting in increased 
keratinocyte proliferation and production of specific cytokines (TNF-α, IL-8, IL-10, INF-ϒ) 
and adhesion molecule mRNA and proteins from both the epidermis and dermis. 
(Nickolof and Naidu 1994) In addition, patients with certain chronic inflammatory 
diseases show elevated levels of IL1-β, TNF-α, and IL-10 in the skin, when compared 
with healthy controls. (van der Zee, de Ruiter et al. 2011) 
 
Preterm infants show higher levels of pro-inflammatory cytokines in both the serum 
(Skogstrand, Hougaard et al. 2008; Matoba, Yu et al. 2009) and the epidermal layer 
(Narendran, Visscher et al. 2010) and are at higher risk of infection than ful term infants 
as a consequence of this inflammatory process. (Yoon, Romero et al. 2000; Krueger, 
Nauck et al. 2001) A hospital-based study in Bangladesh showed that preterm neonates 
treated with sunflower oil applications to the skin reduced the number of pathogens in 
the blood, when compared with neonates treated with Aquaphor and untreated controls. 
(Darmstadt, Saha et al. 2007) These changes may be expressed by diferences between 
cytokine levels and profile over the first week of life in groups of infants massaged with 
sunflower oil compared with mustard seed oil. 
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Another medium in which to measure cytokine levels is saliva. Salivary measurements of 
immune markers have been internaly validated, however serum-saliva correlations are 
modest. (Granger, Granger et al. 2006) Taking cytokine measurements from several 
diferent sources (serum, saliva, the epidermis) is more likely to capture whether immune 
function is diferent in each group than taking measurements from only one source. 
 
Nutrition 
Improved nutritional status is another way topical emolient application may be beneficial 
to neonates. Nutritional deficiencies in infants can result from many sources such as 
inadequate diet, impaired absorption, high metabolic demands due to relatively large 
surface areas and rapid tissue growth, and defective metabolism of nutrients. Premature 
infants may be even more at risk because of a lack of nutrient stores. (Darmstadt 1998) 
 
Low birthweight infants (<2500g) account for 14% of al births and a disproportionate 
amount of neonatal deaths (60-80%). (Bang, Reddy et al. 2002) About half of the 18 
milion low birthweight births each year occur in South Asia. (United Nations Children's 
Fund 2009) This is a prevalent condition in Nepal, with 18% of al infants being low 
birthweight. (United Nations Children's Fund 2013) In our study location in Sarlahi, ~30% 
of infants are low birthweight. (Tielsch, Darmstadt et al. 2007) In addition, children grow 
up to be chronicaly malnourished with 16.2% of children under-five in Nepal having 
severe chronic malnutrition and 40.5% of children under-five having moderate or severe 
malnutrition in 2010. (Nepal Ministry of Health and Population 2011) 
 
Studies have demonstrated that application of vegetable oils to the skin may improve 
nutrition in neonates and increase rates of weight and length gain. In one study, infants 
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were randomly assigned to receive massage with herbal oil, sesame oil, mustard oil, or 
mineral oil for 4 weeks. Massage improved weight, length, mid-arm, and mid-leg 
circumference when compared with non-massaged in al groups, however sesame oil 
(high in linoleic acid) was the only oil that showed a significant diference. (Agarwal, 
Gupta et al. 2000) In another randomized controled trial, preterm and ful term neonates 
were assigned to receive massage with coconut oil, mineral oil, or a placebo. Coconut oil 
massage resulted in significantly higher weight gain velocity compared to infants 
massaged with mineral oil and controls in the preterm infant group and greater weight 
gain velocity compared to controls in the ful term infant group. The coconut oil group 
also had greater length gain velocity compared to controls in the preterm group. 
(Sankaranarayanan, Mondkar et al. 2005) A hospital-based study in Iran in neonates 
randomly assigned to massage with coconut oil, massage alone, and no massage, 
found a significant diference in weight gain between the oil massage and massage only 
group and between the oil massage and no massage group, but no diference between 
the massage only and no massage group. (Saeedi, Gholam et al. 2011) A study 
investigating the efects of cutaneous oil application on somatic growth and plasma 
linoleic and arachidonic acid levels in preterm newborns found the oil group had a 
greater increase in weight, length, arm circumference, and tricipital and subscapular skin 
folds compared to the group with no cutaneous treatment. However, an increase in 
linoleic acid and a decrease in arachidonic acid levels were seen in both groups. 
(Soriano, Martinez et al. 2000) 
 
This improvement of nutritional status could be the result of transcutaneous absorption 
of essential faty acids (EFA). Essential faty acids are important components of a 
healthy diet as fats in the n-3 and n-6 families cannot be synthesized by the body. 
Linoleic acid (LA) and α-linolenic acid (ALA) are the parent faty acids and must be 
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obtained from food. Both are converted to longer chain more highly unsaturated faty 
acids by enzymatic chain elongation and desaturation, which is required for barrier 
homeostasis. (Feingold 2007; Uauy and Dangour 2009) The pathway of EFA 
metabolism is shown in the Figure 2-2. 
 
Sunflower seed oil is high in linoleic acid (about 65%) and low in oleic acid (about 20%). 
(Campbel 1983) Linoleic and arachidonic acids are essential long-chain polyunsaturated 
faty acids, which may be deficient in infants. Deficiency can cause increased 
susceptibility to bacterial infections, failure to thrive, increased dermatitis, and 
thrombocytopenia. (Friedman, Shochat et al. 1976) Sunflower oil applications may vary 
the newborn's ability to mount a response to exposure due to a diference in systemic 
absorption of essential faty acids, which may modulate immune function. (Kinsela and 
Lokesh 1990) EFAs are precursors for the synthesis of eicosanoids, which are 
polyunsaturated faty acids that are precursors of prostaglandins and other enzymatic 
metabolites involved in the immune system. (Moncada and Vane 1978; Samuelsson, 
Dahlén et al. 1987) These mediators regulate many physiologic functions such as, 
inflammatory responses, thrombocyte aggregation, leukocyte migration, vasoconstriction 
and vasodilation, blood pressure, bronchial constriction, uterine contractibility, and 
apoptosis. (Uauy and Dangour 2009) Linoleic acid itself also has anti-inflammatory 
properties. (Schürer 2002) 
 
If linoleic acid is deficient, oleic acid is converted to 5,8,11-eicosatrienoic acid by 
enzymes that usualy produce arachidonic acid from linoleic acid. If linoleic acid 
deficiency occurs, it results in disordered lamelar bilayer structure and compromised 
epidermal barrier function. When oleic acid is substituted for linoleic acid, trienes derived 
from oleic acid may alter the fluidity and permeability of the cel. (Darmstadt 1998) The 
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body compensates for essential faty acid deficiency by converting faty acids to their 
derivatives and accumulating mono-unsaturated faty acids to maintain membrane 
fluidity. (Siguel, Chee et al. 1987) 
 
Deficiencies in essential faty acids can lead to changes in the skin and abnormalities in 
stratum corneum structure function. (Feingold 2007) Linoleic acid may be involved in the 
formation of the barrier layer of the stratum corneum, while arachidonic acid may prevent 
scaliness. (Protey 1977) Faty acids, particularly linoleic acid, increase the rate of barrier 
formation by activating peroxisome proliferator-activated receptor-α. (Darmstadt, Mao-
Qiang et al. 2002) EFA deficiency can lead to dryness, desquamatization, and thickening 
of the skin and growth faltering. (Hansen, Wiese et al. 1963) EFA deficiency is 
characterized by reduced amounts of linoleic and arachidonic acid and excessive 
amounts of 5,8,11-eicostraienoic acid in plasma lipids. (Mead 1968; Sprecher 1972) A 
diagnosis of essential faty acid deficiency is made using diferent clinical criteria such as 
a ratio of eicosatroenoic acid to arachidonic acid ≥0.4 (Darmstadt 1998), a ratio of Mead 
acid to arachidonic acid ≥0.025, or a ratio of total EFA to total non-EFA <0.6. (Siguel, 
Chee et al. 1987) 
 
The two sources of linoleic acid are dietary fat and adipose tissue stores. Infants who 
are premature or smal-for-gestational age have low body stores of essential nutrients 
and therefore are at greater risk for EFA deficiency. (Friedman, Shochat et al. 1976) The 
fat content of breastmilk is relatively constant at about 3-4% by weight with arachidonic 
acid being less variable than other faty acids on a worldwide basis. (Brenna and 
Lapilonne 2009) During a child’s first 6 months, dietary total fat intake should be 
between 40-60% of total caloric intake and 3-4.5% and 0.5% of total energy should be 
from linoleic acid and α-linolenic acid respectively. (Uauy and Dangour 2009) Most infant 
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formulas add a mix of vegetable oils in order to have an adequate amount of EFAs. 
(Uauy and Dangour 2009) Preterm infants are the most susceptible to essential faty 
acid and long chain polyunsaturated faty acid deficiencies because of their limited fat 
stores and greater nutrient demands. Preterm infants supplemented with long chain 
polyunsaturated faty acids (LCPUFAs) showed increases in growth. (Uauy and Dangour 
2009) In fetal life, LCPUFAs, not the EFA precursors, are transferred across the 
placenta, so DHA steadily accumulates in the fetus during gestation. After birth, there is 
a rapid fal in circulating plasma LCPUFAs and a rise in linoleic acid. This may be 
adequate in ful term infants however; preterm infants have minimal body fat stores in 
addition to dendritic and synaptic growth and development occurring. There is a high 
requirement of LCPUFAs and preterm newborn infants may not be able to elongate and 
desaturate EFAs at a fast enough rate. (Leaf 1996) 
 
There is litle knowledge of the prevalence of EFA deficiency in Nepal. A study 
completed on the nutritional status of rural Nepalese in southeast Nepal in the late 
1980s found the mean polyunsaturated faty acids (PUFA) and n-6 PUFA to be higher in 
males than in females, but both sexes had relatively low levels (30.4% and 31.6% of 
total faty acids in females and males respectively). (Hirai, Takagi et al. 1996) When 
compared to the percentage of PUFA in patients with intestinal fat malabsorption (26%) 
(Siguel, Chee et al. 1987), it may indicate EFA deficiency in the Nepalese population. In 
addition, the ratio of EFA/non-EFA in this population was 0.42 for females and 0.45 for 
males, which is below Siguel’s criteria of an EFA/non-EFA ratio >0.60 (Siguel, Chee et 
al. 1987), another indication of EFA deficiency in this population. (Hirai, Takagi et al. 
1996) 
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Animal studies of EFA deficiency show abnormal epidermal permeability and barrier 
function and diferentiation. These defects were corrected by both topical and systemic 
administration of linoleic acid or corn oil. Defects in barrier function were also reversed at 
the sites of the topical application of linoleic acid before the correction of the essential 
faty acid deficient state showing that barrier function in EFA deficiency can be corrected 
localy without first showing systemic reversal. Topical application of olive oil (low linoleic 
acid) or oleic acid demonstrated deteriorated barrier function. (Elias, Brown et al. 1980) 
The cutaneous application of saflower oil to EFA deficient rats also corrected the 
plasma and erythrocyte biochemical abnormalities of EFA deficiency. The linoleic and 
arachidonic acid content of both the plasma and the erythrocyte phospholipid increased 
and the eicosatroenoic acid of both decreased. In addition, the linoleic acid content of 
plasma triglyceride increased with the saflower oil treatment. (Böhles, Bieber et al. 
1976) 
 
Case studies on the correction of EFA deficiency in newborns using cutaneous 
application of sunflower oil showed biochemical and clinical response within three to five 
days, with an increase in both arachidonate and linoleic acid and a decrease in 5,8,11-
eicosatrienoic acid in plasma lipid levels. (Friedman, Shochat et al. 1976) Adults who 
acquired EFA deficiency after major intestinal resections had their deficiency corrected 
with only 2-3mg of linoleic acid per kilogram per day. (Press, Hartop et al. 1974) In 
patients with EFA deficiency, levels of epidermal lecithin increased, rates of 
transepidermal water loss decreased, and scaly lesions disappeared after 2 weeks of 
applying sunflower seed oil compared with no changes after application of olive oil. 
Control patients showed no changes after application with sunflower seed oil. (Protey, 
Hartop et al. 1975) More recent studies have also found that the application of vegetable 
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oils can improve serum faty acid profiles. (Fernandez, Geetha et al. 2005; Solanki, 
Matnani et al. 2005) 
 
Significance 
Emolient therapy research to improve neonatal survival is a global priority. (Lawn, 
Zupan et al. 2006) Although milions of infants in South Asia are massaged with mustard 
oil each year, it is unknown whether substituting sunflower seed oil changes any 
biological mechanisms that may improve neonatal health. As massage of neonates with 
mustard seed oil is almost universaly practiced in many communities in South Asia, 
neonates are routinely exposed to the efects of mustard oil massage. These efects 
could include increased risk of microfissures in the epidermal layer that might raise the 
likelihood of transcutaneous acquisition of invasive pathogens from the environment. 
(Darmstadt and Dinulos 2000; Darmstadt, Saha et al. 2003) Nutritional deficiencies 
could also cause compromised barrier function in these infants. Determining how and if 
certain biological mechanisms relating to skin barrier and integrity, microbial chalenge, 
nutritional status, and innate immune responses are diferent in infants massaged with 
sunflower oil wil help in the characterization of the modes through which sunflower oil 
massage may improve neonatal health, and alow for direct comparison of functional 
indicators across public health outcomes including neonatal skin infection, clinical signs 
of sepsis, and mortality. Such data are necessary to refine the timing, frequency, and 
mode of administration in future scaled up programmatic promotion of sunflower oil, a 
low cost (about $0.10 per massage) intervention with the potential to substantialy 
improve survival of newborns across South Asia. 
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Chapter 2 Tables and Figures 
Table 2-1: Potential Benefits of Topical Application of Emolients to the Newborn 
(Darmstadt and Dinulos 2000) 
Potential	  Benefits	  of	  Emoliation	  Therapy	   Possible	  Basis	  for	  Beneficial	  Efects	  
Reduced	  incidence	  of	  hypothermia	   Ability	  to	  intercalate	  within	  stratum	  corneum	  to	  
provide	  mechanical	  barrier	  to	  water	  loss	  
Improved	  nutrition	  through	  transcutaneous	  
absorption	  of	  lipids	  
Afect	  lipid	  metabolism,	  highly	  active	  lipid	  
metabolism	  in	  epidermis	  and	  the	  presence	  of	  a	  
fatty	  acid	  transporter	  on	  keratinocytes	  make	  
epidermis	  able	  to	  metabolize	  lipids	  from	  
emolients	  (Feingold	  1991;	  Schürer,	  Schliep	  et	  al.	  
1995)	  
Enhanced	  neurological	  development	  and	  
promotion	  of	  mother-­‐infant	  bonding	  through	  
tactile	  stimulation	  
Activation	  of	  superior	  coliculus,	  responsible	  for	  
organization	  of	  visual	  saccades	  (Vaivre-­‐Douret,	  
Oriot	  et	  al.	  2009)	  
Normalization	  of	  TEWL	   Ability	  to	  intercalate	  within	  stratum	  corneum	  to	  
provide	  mechanical	  barrier	  to	  water	  loss	  
Improvements	  in	  skin	  condition	  (including	  
hydration	  and	  surface	  lipid	  content)	  
Topical	  application	  of	  lipids	  directly	  provide	  
metabolic	  building	  blocks	  to	  form	  healthy	  layers	  
and	  repair	  damaged	  layers	  (Elias,	  Brown	  et	  al.	  
1980;	  Mao-­‐Qiang,	  Elias	  et	  al.	  1993)	  
Decrease	  of	  invasive	  infections	  in	  preterm	  infants	  
(Nopper,	  Hori	  et	  al.	  1996;	  Edwards,	  Connter	  et	  al.	  
2004;	  Darmstadt,	  Saha	  et	  al.	  2005)	  
Fewer	  portals	  of	  entry	  for	  invasive	  pathogens	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Staphylococcus	  saprophyticus	  (perineum)	  
Staphylococcus	  capitis	  (sebum-­‐rich	  areas)	  




Corynebacterium	  (most	  intertriginous	  areas)	  
Brevibacterium	  (toe	  webs)	  
Propionibacterium	  (hair	  folicles,	  sebaceous	  glands)	  
Gram-­‐negative	  rods	  
Acinetobacter	  (moist,	  intertriginous	  areas,	  perineum)	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Figure 2-1: Linkage Between Multiple Barrier Functions (Elias 2007) 
 
Figure 2-2: The Pathways to Convert LA to Arachidonic Acid (AA) and 
Docosapentaenoic Acid and ALA to Docosahexaenoic Acid (DHA) (Uauy and 
Dangour 2009) 
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Chapter 3 Methods 
This was a cluster-randomized community-based trial conducted by the Nepal Nutrition 
Intervention Project, Sarlahi (NNIPS) examining the biological mechanisms that may 
lead to improved health outcomes in neonates massaged with sunflower oil relative to 
mustard seed oil. It was nested within a larger parent trial on the Impact of Sunflower 
Seed Oil Massage on Neonatal Morbidity and Mortality in Nepal (NOMS), and hence the 
methods for the parent trial wil also be discussed. NOMS was a cluster-randomized, 
community-based trial. Newborn infants were randomized within clusters (sectors) to 
receive either promotion of ful body massage with sunflower seed oil or promotion of ful 
body massage with mustard seed oil, which is considered standard in these 
communities and is almost universaly practiced. The aims of the parent trial were to 
determine whether ful body sunflower seed oil massage in newborns reduced neonatal 
morbidity or mortality in Sarlahi District, Nepal. 
 
Study Population and Location 
In 2011, the NNIPS surveilance area consisted of 26 Vilage Development Commitees 
(VDCs) in Sarlahi District in rural Nepal. Each of these VDCs encompasses nine 
government defined geopolitical units (wards), which were further divided into sectors 
based on population. NNIPS has been conducting research in this area since 1989. 
Sarlahi is divided into a total of 96 VDCs and 2 municipalities, as defined by the 
government of Nepal, with NNIPS studies having been principaly involved in the 
northern third of the district. The entire district has a population of over 600,000.  
 
Sarlahi is a low, flat area in the Terai region of southern Nepal, lying along the border of 
Bihar State in Northern India. This study area’s population of around 250,000 lives in 
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rural farming communities comprised mainly of two ethnic groups, the Madeshi and the 
Pahadi. The Madeshi are from the southern plains and speak mainly Maithili and the 
Pahadi are from the hils and speak Nepali and other languages. Although the Pahadi 
are typicaly of a higher caste, the two groups have similar newborn care practices, with 
over 92% of births occurring in the home and more than 90% having no trained birth 
atendants at delivery. (Mulany, Darmstadt et al. 2006) This is considered a poor region 
of Nepal with a high rate of neonatal mortality (33 per 1000 live births) comprising more 
than two-thirds of al infant deaths. (Nepal Ministry of Health and Population 2011) The 
neonatal mortality rate measured in this area between 2002 and 2006 was 
approximately 38-40/1000 live births.  
 
Procedures for Parent Trial 
Sectors served as the clusters that were the unit of randomization for the NOMS study. 
The 9 wards in each of the 13 participating VDCs were divided into 1 or more sectors. 
On average, there were 1.6 sectors per ward and 14.4 sectors per VDC. Randomizing 
sectors rather than individuals helped to minimize crossovers or contamination of the 
intervention by providing each field worker only one type of oil to promote within her 
area. Previous sector level mortality estimates from prior research in this area were 
known for 9 of the 13 VDCs used in the NOMS trial and were used to perform restricted 
randomization in order to ensure balance of prior neonatal mortality risk. In the other 4 
VDCs, sectors (clusters) were randomized with a computerized quasi-random number 
generator, stratified on VDC using blocks of 4, ensuring a geographical balance of the 
types of oil across the study area. Sector assignment lists were maintained at study 
headquarters in Kathmandu and Sarlahi. This clustered-randomization approach has 
been used in six major field trials in Sarlahi over the past 20 years. (West, Pokhrel et al. 
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1991; West, Katz et al. 1999; Christian, Khatry et al. 2003; Mulany, Darmstadt et al. 
2006; Tielsch, Darmstadt et al. 2007; Tielsch, Khatry et al. 2007) A local resident 
woman, a “ward distributor” (WD), monitored each sector.  Al WDs worked within a 
defined sector (i.e. ward or subsection of a ward) and were responsible for identification, 
tracking, and folowing mothers and infants within their specific area. As such, any 
individual WD only promoted one type of oil and folowed consistent promotion of the 
alocated oil throughout the duration of the study. Blinding was not possible given some 
diferences in smel, texture, and taste between the two types of oils. While data 
colectors and higher-level supervisory staf were not directly aware of the sector-level 
alocations: it was not possible to fuly mask the intervention in the NOMS study. 
 
The nested mechanisms study took advantage of the randomization of the parent trial, 
using a subset of the VDCs in the original NOMS trial, which consisted of VDCs used in 
previous trials (sectors randomized using previous mortality estimates) and “new” VDCs 
(sectors randomized to achieve geographical balance). In the interests of eficiency and 
logistical constraints, VDCs were chosen that were closest to field headquarters, which 
facilitated eficient deployment of the biological mechanisms study field workers and 
more rapid return of the specimens to field headquarters, improving quality control of 
cold storage. Figure 3-1 shows the VDCs that participated in both the NOMS trial and 
the Biological (Oil) Mechanisms Sub-Study. 
 
Al households in the NOMS study area were mapped and entered into a population-
based database. The total population in the proposed VDCs for the NOMS trial was 
approximately 100,000 with an annual birth cohort of about 3000 infants. Al live born 
infants born in the study research area were eligible to participate in the NOMS trial. 
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Infants were enroled if the caretaker provided consent for participation in the study and 
the local worker met the infant alive at the time of their first visit to the household. 
 
For the NOMS trial, community-specific lists of married women of reproductive age were 
created. WDs carried out a combination of active and passive surveilance to identify 
pregnant women in the NOMS study area. Every five weeks, married women between 
15 and 40 years were visited and queried about timing of last menstrual period; if no 
period had occurred since the prior visit, the woman was ofered a pregnancy test. 
Other women who came into the area later in pregnancy to deliver (often at their 
maternal home, or maiti) were also eligible for enrolment. Regardless of mode of 
identification (i.e. active or passive), the WD explained the study and later returned with 
a “team leader interviewer” (TLI) to further explain the study and obtain consent. After a 
woman consented to be in the study, her pregnancy was tracked. Each consenting 
woman was given a set of common basic antenatal interventions including tetanus 
toxoid, a clean delivery kit, iron-folate supplements, chlorhexidine cleaning solution for 
disinfection of the umbilical cord, and basic educational messages. 
 
Intervention 
The worker visited the women in late pregnancy (~28-32 weeks) to promote the use of 
either the sunflower seed oil or mustard seed oil, and provide the mother or other 
caretaker with a 100ml botle of oil at that time, along with guidelines for the use of the 
oil and massage technique. Formative research has indicated that about 10ml of oil is 
needed for each massage. After birth, larger quantities of oil (500ml in recyclable PET 
botles and labeled with instructions) were provided at 3 intervals (usualy day 1, day 10, 
and day 21 after birth), for a total of 1.5 liters during the neonatal period. A smal finger 
bowl was also provided to each family. Each time the infant was massaged, a smal 
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amount of oil was transferred from the botle to the finger bowl. Enough oil was provided 
for a ful body massage of the infant 2-3 times per day for 28 days. Field workers visited 
homes every day during the first week of life to promote oil massage and address any 
questions or concerns of the mothers. Other possible caretakers including fathers and 
grandmothers were also given instructions on massage techniques.  
 
High quality oil for a variety of uses including eating, cooking, and topical therapy was 
purchased from Shiv Shakti in Jitpur, Nepal. The company provided a manufacturing 
date imprint on the individualy sealed packages and on large 20-liter containers and a 
recommended “use-by” date. Linoleic sunflower seed oil with high (about 65%) linoleic 
acid and low (about 20%) oleic acid was used. (Campbel 1983) The oil was purchased 
every 4 weeks and stored in sealed half-liter plastic packets at site headquarters at room 
temperature. 
 
The company was required to submit a sample for purity/quality to the Government of 
Nepal Food Inspection Laboratory in Hetauda, Makwanpur District, Nepal. A copy of this 
analysis was received from the Hetauda food lab for each distinct batch. Determination 
of the fatty-acid composition of the oils was done at Geo-Chem Laboratories PVT LTD 
(Mulund, Mumbai, India). This faty-acid profile analysis was repeated twice per year. 
These analyses consistently estimated the linoleic acid levels between 58%-67% and 
18%-22% in the sunflower and mustard oils, respectively.  
 
Data Colection 
Household data were colected for al individuals during the first visit of the parent trial 
when mothers were enroled, including socioeconomic status, education, household 
structure, maternal and paternal characteristics, and maternal health indicators such as 
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reproductive history. After the birth, the caretaker initiated the ful body massage using 
the provided oil folowing the guidelines provided by the WD. As soon as possible after 
birth or labor began, family members or neighbors notified the WD of the birth. The WD 
then visited the household for the next seven consecutive days to promote use of the 
provided oil and provide further guidance. At each of seven consecutive visits in the first 
week of life, the WD asked the number of times the infant was massaged since the 
previous visit and whether the oil provided by the project was used in order to measure 
compliance. A similar set of questions were asked by the TLI during their folow-up visits 
on days 1, 3, 7, 10, 14, 21, and 28. The TLIs also read and recorded the approximate 
volume of oil that was remaining in the botle. 
 
After conducting the first visit to the newborn, the WD recorded the location information, 
date and time of birth, and name of head of household on a form (“Birth Notification 
Form”) and delivered this form to one of the drop boxes monitored by her supervising 
TLI. After receiving the Birth Notification Form, the TLI conducted an initial birth 
assessment visit. Using a standardized Infant Birth Assessment Form (IBAF) and 
Maternal Birth Assessment Form (MBAF) the TLI recorded information related to the 
mother and newborn such as late pregnancy morbidity, labor and delivery 
characteristics, birth assistance and practices, length of labor, maternal temperature, 
date and time of birth, sex, length, and weight of infant, and immediate newborn practice 
(thermal care, cord practices, early bathing and massage, breastfeeding initiation, etc.).  
Weight and length of the infant were also recorded. 
 
After the initial birth assessment visit, the birth team member completed newborn folow-
up (NFF) visits on days 1, 3, 7, 10, 14, 21, and 28. Figure 3-2 shows the overal study 
design and flow of women and newborns through the parent trial. At each visit, infant’s 
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vital status, respiratory rate, axilary temperature, signs of cord infection, chest 
indrawing, jaundice, and skin infection were recorded. Any maternal or caregiver reports 
of signs of morbidity including dificulty breathing, diarrhea, convulsions, perceived fever, 
etc. were also recorded. In addition, newborn care practices since the prior visit were 
colected, including breastfeeding and other feeding practices, topical application to the 
cord, bathing, and massage. 
The underlying principles of scheduling these newborn folow-up visits were: 
1. Get to the birth as soon as possible after it occurs 
2. Maximize the number of visits where data were colected 
NFF visits were scheduled as calendar date of birth plus day of visit (e.g. visit 7 would be 
scheduled on calendar date of birth plus 7). NFF visits were always recorded up until the 
date of the next scheduled visit. For example, the folow-up visit would be considered 
visit 7 if it were conducted any time between calendar date of birth plus 7 and calendar 
date of birth plus 9, after which it would be considered folow-up visit 10. If infants were 
not met on the day they were scheduled, workers would return to their homes in order to 
complete that visit, up until the day the next visit was scheduled after which the infant 
would be considered not met for the previous visit. Infants not met at the initial atempt of 
the 28-day visit were considered not met for their 28-day visit; workers did not return to 
their household. The scheduling of newborn folow-up visits for the biological 
mechanisms study folowed these same guidelines. 
 
If death of a newborn was confirmed during any of the folow-up visits, the deaths were 
reported to the supervisors immediately. The supervisor conducted a confirmatory visit 
to the household with the local WD after the mourning period in order to conduct a verbal 
autopsy interview with the parents or other caretakers. The verbal autopsy form used 
was based on the standard WHO instrument and included confirmation of date and 
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approximate time of death, injuries, feeding and breathing paterns and dificulties prior 
to death, questions related to signs of tetanus, fever, diarrhea, dysentery, vomiting, cord 
and skin infections, and information on care-seeking paterns. Parents or other 
caretakers also provided an open description in their own words regarding the process 
of death for the infant. Verbal autopsies were reviewed independently by two Nepali 
physicians (co-investigators) familiar with the process. An immediate and one or more 
underlying causes of death were assigned. In the event of diferences between the 
reviewers, a joint adjudication process resolved any remaining diferences. 
 
Procedures for Biological Mechanisms Sub-Study 
This sub-study that is the focus of this dissertation included an extended set of 
measurements colected from a subset of infants participating in the main trial. The focus 
of data colection for this sub-study was on direct measurement of biological markers of 
infants built into a specific sub-study schedule (days 1, 3, 7, 14, and 28) of the parent 
trial visits, with an additional visit at 180-days. These biological measurements included: 
skin condition assessment, transepidermal water loss (TEWL), skin pH, and skin discs to 
evaluate skin integrity, skin swabs to examine bacterial colonization of the skin, salivary 
colection to assess immune status, serum colection to measure cytokines and faty 
acids in the blood, and weight and length to measure nutritional status. Measurements 
were colected using tiered sample sizes in a way that the most invasive and time-
consuming measures were done on the fewest number of infants (see Figure 3-3). For 
al infants enroled in the mechanisms study the worker performed the folowing 
procedures: skin condition score (visits 1, 3, 7, 14, and 28), TEWL measurement (visits 
1, 3, 7, 14, and 28), skin pH measurement (visits 1, 3, 7, 14, and 28), skin disc colection 
(visits 1, 7, 14, and 28), and salivary colection (visits 1, 7, and 14). In addition, in a 
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subset of infants (n=400), skin swabs were colected (visits 1, 3, and 7) and an additional 
subset (n=200) had a heelprick done at visit 14. Weight and length were also colected 
by birth team members at visits for the parent trial (weight on days 1, 3, 7, 10, 14, 21, 
and 28 and length on days 1 and 28) and at the 180-day visit for the complete sample 
size. Table 3-1 shows the timing of visits for measurements taken during folow-up visits 
and the sample size for each measurement for the biological mechanisms study. 
 
A subset of 7 VDCs of the 13 original VDCs in the NOMS trial was selected to participate 
in the mechanisms study, which began in July 2012. An 8th VDC was added after 5 
months and a 9th VDC was added in January 2013 (see Table 3-2 and Figure 3-1). 
Among infants participating in the main study, determination of eligibility to additionaly 
participate in the sub-study was done during the initial birth assessment visit, and was 
based on estimates of gestational age at birth. For this study, preterm infants (<37 
weeks gestational age) were oversampled, aiming for approximately 50% of the sample 
to be preterm. During the study period (July 2012 until September 2013), the gestational 
age was estimated directly by the field worker using the date of last menstrual period 
estimated by the woman at the time of initial enrolment. Each birth team member had a 
list of the date of the mother’s last menstrual period (LMP), which was used along with 
the date of birth to determine the gestational age of the infant. If the infant was born 
before week 37, one of the members of a specialy trained team of field workers focused 
on the implementation of the mechanisms sub-study, was contacted directly by mobile 
phone. Infants born on or after week 37 were listed by VDC in consecutive order (i.e. by 
birth date) on a pre-printed computer generated blank form of 20 rows, 4 of which had 
been randomly selected for shading. Infants listed on a randomly shaded row were 
eligible for inclusion in the mechanisms study, thus selecting 4 out of every 20 (20%) of 
the ful term infants for participation. Al preterm (<37 weeks) infants and every 5th ful 
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term infant born in the mechanisms study area were eligible for enrolment in the sub-
study. 
 
After the birth team member determined a newborn was eligible for inclusion in the 
biological mechanisms study, the mechanisms worker visited the home and initiated a 
process to obtain informed consent for the newborn’s participation. Eligible infants were 
enroled if the caretaker provided consent for participation, the birth team member met 
the infant alive, and the mechanisms team member was able to enrol the infant within 
the first 48 hours after birth. 
 
On the initial visit to the home by the biological mechanisms field worker, a consent form 
was read before colecting any information. The consent statement described the 
mechanisms study’s purpose and procedures that were carried out at each of the visits. 
It described that, in addition to the procedures for the main study, some additional 
measurements would be carried out on the infant that would help to explain more about 
the diferences between mustard oil and sunflower oil. There were additional 
explanations read if the visit was to include skin flora colection and/or blood. It also 
explained that there were no significant risks to being in the study, and that al 
information would be kept confidential. Voluntariness and who to contact was also 
explained. Each field worker had a laminated copy of the approved oral consent script in 
Nepali, and the process was documented on standardized data colection forms. The 
Nepal Health Research Council and the Commitee on Human Research of the Johns 
Hopkins Bloomberg School of Public Health approved this study. 
 
Once consent was granted, the mechanisms field worker continued with folow-up 
assessments scheduled for days 1, 3, 7, 14, and 28. Depending on the day of the folow-
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up visit, diferent measurements were taken as described above (see Table 3-1). At 
these visits the team member also asked additional interview questions about oil 
massage, feeding, and bathing practices.  
The sequence of measurements were as folows: 
1. Interview questions 
2. Skin Condition Assessment 
3. Skin Swab Colection (if scheduled) 
4. TEWL 
5. Skin pH 
6. Skin Disc Colection (if scheduled) 
7. Salivary Colection (if scheduled) 
8. Blood Colection (if scheduled) 
Al data were colected on standardized data colection forms.  
 
Birth team members colected the additional measurements of weight and length at 
folow-up visits for the parent trial. During the initial visit, this information was recorded 
on the IBAF and the birth team member initiated a new form for recording the weight and 
length for the subsequent visits (see Table 3-1). In order to schedule the 180-day folow-
up visit, a list by VDC of al infants who should receive a 180-day folow-up visit during 
each week was generated at the data center in Kathmandu. These lists were generated 
for a ful Nepali month on the 15th of the preceding Nepali month and provided to the 
birth team members. At the beginning of each week, the birth team members identified 
which infants were scheduled to receive their 180-day folow-up visit. If no one was met 
within four weeks of the scheduled visit week, the infant was considered not met for his 
or her 180-day visit. Vital status for the mother and infant were also recorded at this visit. 
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Measurement Methods 
Specific Aim 1: Skin Integrity and Barrier Function 
Four measurements were used to assess the relationship between the type of oil used 
for newborn massage and skin barrier function and integrity. These were: skin condition 
score, TEWL, skin pH, and stratum corneum protein content. Prior to the start of the 
study, measurement techniques for TEWL, skin pH, and skin disc colection were piloted 
on adult forearms in order to determine if skin should be wiped with any materials prior 
to measurements being taken. Both mustard oil and sunflower oil were tested on 
diferent arms measuring TEWL, skin pH and protein concentration after oil was applied 
without wiping and after wiping with gauze, alcohol swabs, and coton at 4 diferent 
locations on the arm. A decision was made based on the data not to wipe the skin as it 
might afect the skin barrier prior to measurement and to examine the efect of time since 
massage during analyses. 
 
1. Skin Condition Score: 
Field worker evaluation of skin condition was measured using a modified version of a 
scoring method described by Visscher et al. (Visscher, Odio et al. 2009) This team has 
experience extending these scores for patients in the United States. This study used an 
extended version of this more established scale for the measures of dryness, erythema, 
and rash (see Table 3-3), rating erythema severity on a scale from 0 to 3 and area 
afected on a scale from 0 to 4. Severity of rash and area afected by rash were 
evaluated on scales from 0 to 4 and 0 to 6 respectively. Dryness severity was evaluated 
on a scale from 0 to 5 and dryness area was evaluated on a scale from 0 to 3.  
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The first step of training in the use of the scales involved the field workers evaluating 
four sets of photos of infants in the population with varying degrees of skin condition. 
These photos were first evaluated and given a score for each skin condition component 
by an expert on skin condition evaluation. Each worker’s scores were then compared to 
this master key. After 4 days of training, percent agreement for each worker compared 
with the key was above 70%. Unfortunately this way of training was somewhat limited as 
the workers were viewing the photos on computers, with some photos being of poor 
quality and with non-ideal lighting conditions, making it sometimes dificult to judge the 
color of the skin. Additional training was then completed in the field with older infants 
prior to the start of the study. During the study, this author also evaluated skin condition 
at each supervised field visit. The percent agreement between field workers and this 
author during the study period was close to 95%. 
 
This assessment occurred on days 1, 3, 7, 14, and 28. Three areas of the body were 
chosen as areas to represent the infants’ skin condition. These areas were the mid-chest 
between the nipples, the entire left arm, and the entire right leg. The area inside a 4cm 
by 4cm template was evaluated for the chest area. The chest area was evaluated first, 
folowed by the arm, and then the leg. If the infant was crying or distressed, the workers 
waited until the infant was calm to complete the assessment. The infants’ skin 
assessment scores for severity and area for each component (erythema, rash, and 
dryness) were recorded separately on standardized data colection forms. 
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2. TEWL:  
TEWL was measured at visits on days 1, 3, 7, 14, and 28. Measurements were taken 
three times at the mid-chest nipple line. The exact location where measurements were 
taken was similar in al infants, through the measurement of anatomical markers. The 
location of the measurements was chosen, because it was easily accessible, an area 
that was massaged, and provided a reasonably flat surface area for placing the 
instrument. Measurement of transepidermal water loss was measured in g/m2/hr using a 
VapoMeter (Delfin Technologies, Ltd, Finland), a closed-chamber device containing 
sensors for relative humidity and temperature, using standardized procedures. (Rogeries 
and Group 2001; Nuutinen, Alanen et al. 2003; De Paepe, Houben et al. 2005) Once the 
VapoMeter contacts the skin, the relative humidity in the chamber begins increasing. 
The TEWL value is calculated from the information the instrument acquires based 
on this increase. Before each measurement the workers wiped the area of the 
VapoMeter that came in contact with the infant’s skin with an alcohol swab. The three 
measurements along with the temperature and relative humidity obtained from the 
VapoMeter were recorded on standardized data colection forms. 
 
3. Skin pH: 
Measurements of skin pH were performed with a flat electrode (SkincheckTM, Hanna 
Instruments, UK) calibrated daily to pH 4 and 7. (Parra and Paye 2003) These 
calibrations were done at field headquarters and were recorded each morning before the 
worker left to complete their house visits. Measurements were taken in the same 
location at the mid-nipple as for the TEWL measurements. Before each measurement 
was taken, the worker cleaned the electrode with an alcohol swab and rinsed it with 
distiled water before placing on the chest. Three measurements were taken and 
recorded on standardized data colection forms.  
	   61 
4. Stratum Corneum Protein Concentration: 
Using a technique described by Voeglei et al., protein content from the outermost 
stratum corneum was analyzed using samples colected with 380 mm2 D-Squame 
adhesive discs (CuDerm, TX) applied to the mid-chest with constant pressure for 2 
minutes. (Voegeli, Heiland et al. 2007) Diferent locations on the chest were used for the 
placement of the skin discs at each of the four visits (days 1, 7, 14, and 28) in order to 
colect discs from skin that had not been previously exposed to adhesive. These sites 
were diferent from those used for TEWL and skin pH measurements. Before handling 
the discs the workers put on a pair of powder free gloves. They then used tweezers to 
remove the disc from its backing and place it on the chest where they applied gentle 
pressure by rubbing the disc clockwise three times with their thumb. After two minutes, 
the worker used the tweezers to remove the disc from the chest and placed it in a 2ml 
microtube with the adhesive facing inward. These microtubes were labeled with a unique 
6-digit identification label, with an identical label placed on the data colection form. The 
microtubes were then transferred to field headquarters in cold boxes kept between 2° 
and 8°C. At field headquarters, the workers again put on powder free gloves and 
removed the skin discs from the microtubes using tweezers, placing them on a plate to 
determine the optical density. The optical density of the skin discs was determined using 
a spectrophotometer SquameScanTM 850A (Heiland electronic, Wetzlar, Germany) 
specificaly designed for the application of D-Squame discs. Before the optical densities 
of the discs were read, the spectrophotometer was calibrated to 0% and 36.2% optical 
densities (a daily calibration record was maintained throughout the entire study). Optical 
densities of the discs were recorded on standardized data colection forms. After they 
were recorded the discs were placed back in their microtubes and stored in liquid 
nitrogen for further processing relating to the measurement of epidermal cytokines (see 
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below). The folowing equation was used for quantification of protein concentration: 






Specific Aim 2: Nutritional Status 
There were three measurements used to assess the relationship between the types of 
oil used for newborn massage and a neonate’s nutritional status: weight at days 1, 3, 7, 
10, 14, 21, 28, and 180, length at days 1, 28, and 180, and serum faty acid levels 
colected at day 14. Questions regarding massage practices between months 1 and 6 
were also asked during the additional folow-up visit specific to the mechanisms study 
after 180 days. Although in these analyses only weight and length up to day 28 were 
analyzed, methods for serum faty acid colection wil also be discussed. 
 
5. Weight and Length  
The birth team member for the NOMS trial performed weight measurements at the 
homes during field visits at the initial birth assessment (day 1) and at folow-up visits on 
days 3, 7, 10, 21, 28 and 180 and length measurements at the birth assessment (day 1) 
and at folow-up visits 28 and 180. Weight measurements were taken without clothes 
using a Tanita portable digital infant scale (Tanita BD-585, Tokyo, Japan), with accuracy 
to ±10g. Length measurements were taken using a localy manufactured wooden length 
board. 
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6. Faty Acid Levels 
Field workers colected samples of serum in order to assess faty acid levels on day 14 
via heelprick using BD Quikheel lancets (BD QuikheelTM Lancets, Becton, Dickenson, 
and Company, Franklin Lakes, New Jersey). After puting on gloves, the workers rubbed 
the right heel gently for 30 seconds in order to warm the area and encourage blood flow. 
They then wiped the medial part of the right heel with alcohol alowing the alcohol to dry. 
The lancet was positioned against the medial part of the infant’s right heel (the area that 
was disinfected) at a 90-degree angle to the length of the foot. After pressing the trigger 
of the lancet firmly, pressure was applied so drops of blood would form, which were 
colected in a microtube placed at a 30- to 45-degree angle to the foot. If a complete 
microtube was filed, a second microtube was placed to colect the blood. After the blood 
was colected, the area was cleaned with sterile gauze, the foot was slightly elevated, 
and a smal bandage was placed over the incision. A unique 6-digit identification label 
was placed on each microtube, with a matching label placed on the standardized data 
colection form. The microtube(s) were inverted 10 times to disperse EDTA, an 
anticoagulant coated along the sides of the microtubes. The tube(s) were then placed in 
a cool box at 2° to 8°C for transport to field headquarters. 
 
The red blood cel pelet was separated from the plasma at field headquarters by trained 
laboratory technicians. Upon reaching field headquarters, each microtube of blood was 
centrifuged for 10 minutes at 1677 x g (5000 rpm). After centrifugation, the plasma was 
removed with a smal plastic transfer pipet to a 1.5ml cryovial. This cryovial was then 
given a unique 6-digit label, with its duplicate being placed on the data colection form. 
Using the same plastic transfer pipet, the bufy coat was removed and discarded into a 
10% bleach solution. If the sample of blood was too smal, the removal of the bufy coat 
was skipped. The red blood cels were then washed by adding 0.5ml of cold 0.01M 
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phosphate bufered saline, pH 7.4 with a clean micropipete tip and inverting the tube 4 
or 5 times to gently mix the solution with the red blood cels. The tubes were then 
centrifuged again for 10 minutes at 1677 x g (5000 rpm). Using a fresh plastic transfer 
pipet for each sample, the saline and remaining bufy coat was removed and discarded 
into the 10% bleach solution. The viscous washed red blood cel pelet was then 
transferred to a second 1.5ml cryovial. An identical label as was placed on the microtube 
in the field was then placed on the cryovial. Each sample yielded two cryovials, one 
containing plasma to be used in examining serum cytokine levels (discussed below) and 
one containing the red blood cels, which was used to examine serum faty acid levels. 
Both samples were stored at -15° to -20°C until shipped to colaborating laboratories at 
the Kennedy Krieger Institute (for faty acids) and Johns Hopkins Hospital (for cytokines) 
in Baltimore, Maryland for analysis. 
 
Specific Aim 3: Microbial Chalenge 
One measurement was used to assess the relationship between the type of oil used for 
newborn massage and microbial chalenge, skin swab colection to examine the density 
and types of bacterial colonization on the skin. These data were not analyzed as a part 
of this dissertation, however the methods for colection wil be discussed. 
 
7. Skin Colonization 
Specimens of resident cutaneous flora were colected from the axila, abdominal, and 
inguinal areas using surface swabs on visits 1, 3, and 7. Specimens were colected from 
a 4cm x 4cm area of skin, with the area to be swabbed indicated with a localy made, 
disposable template. The worker first colected skin swabs from the right axila area. The 
templates were sanitized with alcohol swabs and placed on the area to be swabbed. 
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After puting on gloves, the worker unwrapped a sterile swab from its package and 
dipped it into a tube filed with a phosphate-bufered saline (PBS) solution. Both the PBS 
solution and the STGG transport media (see below) were transferred from field 
headquarters to the house visits in cold boxes kept between 2° and 8°C. The swab was 
pressed against the wal of the tube to squeeze out any extra solution after which the 
worker rubbed the swab 5 times horizontaly and 5 times verticaly over the area within 
the template. Holding the swab with one hand, the other hand was used to open a 
specimen tube containing liquid transport media (skim milk, tryptone soya, glucose, 
glycerol [STGG]. (Gibson and Khoury 1986; O'Brien, Bronsdon et al. 2001) The swab 
was immersed in the media in the tube and the tube was placed in the same cold boxes 
kept between 2° and 8°C for transport back to field headquarters. Each tube was 
labeled with a unique 6-digit label number, with an identical label placed on the 
standardized data colection form. The same technique was repeated for the right 
inguinal and supra-umbilical areas. Samples were stored in liquid nitrogen at -20° to  
-80°C at field headquarters and were transported on a bi-weekly basis to our 
colaborating microbiology laboratory at the Institute of Medicine, Tribhuvan University in 
Kathmandu, which also prepared the PBS solution and STGG transport media that were 
sent bi-weekly from Kathmandu to field headquarters. 
  
Specimens were transported to Kathmandu in liquid nitrogen for processing and stored 
in liquid nitrogen at the laboratory in Kathmandu. When it was time for processing, 
specimens were removed from cold storage and the swabs were vortexed in a PBS 
bufer solution. Sheep blood and MacConkey agar plates were inoculated with 10µL of 
the neat specimen and three consecutive 10-fold dilutions and incubated overnight at 
37°C. Complete colony counts and bacterial identifications of sensitivity of isolates were 
done within 24 hours by standard biochemical and staining procedures. Colony count 
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=No.of	  colonies	  in	  10μL	  of	  PBS∗dilutions∗6.25 
 
Colony counts and types of bacteria identified were recorded on standardized data 
colection forms. 
	  
Specific Aim 4: Systemic and Epidermal Innate Immunity 
There were three measurements used to assess the relationship between the type of oil 
used for newborn massage and systemic and epidermal innate immunity in the neonate: 
levels of serum and salivary cytokines and levels of structural and immune biomarkers of 
the skin (including cytokines). The field workers colected salivary samples on days 1, 7, 
and 14, skin discs on days 1, 7, 14, and 28, and performed heelpricks to colect serum 
on day 14. These data were not analyzed as a part of this dissertation, however the 
methods for colection wil be discussed. 
 
8. Serum Cytokines 
Field workers colected samples of blood at homes in order to assess serum cytokines 
on day 14 via heelprick. These methods were discussed in the section on the colection 
of serum faty acid levels above. After shipment to our colaborating laboratory at Johns 
Hopkins Hospital in Baltimore, Maryland, samples wil be analyzed for the serum 
cytokines to be measured, which include IL-1α, IL-1β, IL-6, IL-8, TNF-α, by 
immunoassay. 
 
9. Salivary Cytokines 
Field workers colected samples of saliva at homes in order to assess salivary cytokines 
on days 1, 7, and 14 using Salimetrics Infant’s Swabs (Salimetrics LLC, State Colege, 
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PA), which can usualy recover a volume of saliva in the range of 200-1000µL. Tests 
using a similar microsponge have shown that the time to acquire a minimum sample test 
volume for a typical salivary assay of 25-50µL was 20-30 seconds. (Granger, Kivlighan 
et al. 2007) Salivary colection was done at least 20 minutes after the infant was last fed 
to avoid any contamination of cytokines present in the mouth from breastmilk. Before 
salivary colection, the workers put on gloves and removed a new swab from its 
packaging. The swab was folded in half and placed in the infant’s mouth, under the 
tongue, so both ends of the swab were inside the mouth and the worker was holding the 
folded middle portion. Swabs were left inside the mouth for 2 minutes in order to colect 
an adequate amount of saliva. After 2 minutes, the worker removed the swab and cut it 
in half, cuting of the middle portion that was dry where the worker was holding it. The 
worker then removed the needle of a 3cc syringe and placed the first half of the swab 
into the syringe. The syringe was then depressed, squeezing the saliva from the swab 
into a 2ml microtube. The swab with the saliva extracted was then removed from the 
syringe and placed in a second microtube. This method of saliva extraction was 
repeated for the second half of the swab. If less then 50µL (about 4 drops) of saliva was 
extracted, a second salivary sample was colected using the same process. Each 
microtube was labeled with a unique 6-digit identification number with an identical label 
placed on the data colection form. Immediately after colection, samples were placed in 
a cool box kept at 2° to 8°C for transport to field headquarters. The samples were then 
stored in liquid nitrogen at -20° to -80°C. Samples were shipped to the Center for 
Interdisciplinary Salivary Bioscience Research in Tempe, Arizona for analysis and wil be 
analyzed for the salivary cytokines to be measured, which include IL-1α, IL-1β, IL-6, IL-
8, TNF-α, by immunoassay. 
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10. Structural and Immune Biomarkers: 
Structural and immune biomarkers were measured from the outermost stratum corneum 
using the same noninvasive sampling method as discussed above for the colection of 
skin discs for measurement of stratum corneum protein concentration (via optical 
density) and described by Narendran et al. (Narendran, Visscher et al. 2010) The same 
skin discs were used that were colected for the stratum corneum protein concentration 
colection using 380 mm2 D-Squame tapes (CuDerm, TX) applied at the mid-nipple line 
with constant pressure. These clear polymer discs uniformly sample a fixed area of the 
skin surface, removing the stratum corneum in a reproducible way for analysis. After the 
field workers measured the optical density, the discs (placed in the microtubes) were 
stored in liquid nitrogen and shipped to a colaborating laboratory for further processing. 
 
Handling, Storage, and Transport of Specimens 
In order to preserve the integrity of the specimens that were colected during this study, 
while in the field specimens were kept in cold boxes at less than 8°C. LogTag 
temperature monitoring devices (LogTag TRID30-7, LogTag Recorders Limited, 
Auckland, New Zealand) were placed in each of the cold boxes to monitor the 
temperature throughout the day. Each morning the field worker recorded the date, time 
LogTag device was turned on and placed in cold box, device ID, and cold box ID.  After 
returning from the field, the time the LogTag devices were removed from the cold box 
and turned of was recorded. The devices checked the temperature of the cold boxes at 
2-minute intervals, storing the data, which was downloaded at the end of each workday 
to a central computer at field headquarters. 
 
Once specimens were brought to field headquarters and processed, each specimen was 
recorded in a log specific for specimen type (skin swabs, skin discs, plasma, saliva, 
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salivary swabs, and red blood cels). This log contained the label number of the 
specimen, specimen type, colection date, the bag number the specimen was stored in 
the liquid nitrogen tank, and also the route and shipment date (these were filed when 
the shipment was sent to Kathmandu). Each specimen storage bag only contained one 
type of specimen and contained a maximum of 45 specimen tubes. Celophane was 
wrapped around each label before the tubes were placed in the liquid nitrogen to ensure 
the label would not detach. When the shipper tanks were ready to be sent to 
Kathmandu, the route and shipment date were recorded on the logs and transmital lists 
of al specimens being sent were generated. These lists were checked for any potential 
problems (duplicate label numbers in current and previous shipments) and afterwards 
specimens were shipped to Kathmandu and then to their respective laboratories.  
 
Forms Management 
A NOMS Data Folder was initiated for every enroled pregnant woman upon completion 
of her Late Pregnancy Visit (LPV). The outside of the folder had the identification 
information of the enroled woman, her husband, her household, and her place of 
delivery. The outside also tracked the status and number of al the activities/forms 
completed for enroled women and their infants from LPV to the end of study 
participation. Al folders were held securely in the VDC ofice where the enroled woman 
and her infant(s) resided. At the end of study participation the outside of the data folder 
was completed to indicate which forms were not completed and the number of forms 
within.  
 
Forms from the mechanisms study were also added to these folders, however, during 
data colection for the neonatal period, the forms for the mechanisms study were kept at 
field headquarters. If an infant was enroled in the mechanisms study, the birth team 
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member placed a red sticker in the upper right hand corner of that NOMS folder. At the 
end of each day, the mechanisms workers brought the forms that were completed in the 
field back to field headquarters. Infants who were newly enroled were recorded in logs 
for numbers of preterm and ful term infants, depending on their gestational age. These 
forms kept a running list of how many infants were enroled in the study to monitor when 
the 500th infant was reached for each group. It also alowed monitoring of the number of 
infants who had received heelpricks and skin swabs, since these were only done in a 
subset of the study population.  
 
On the day of the first visit, each infant had a folder initiated at field headquarters with 
the identification information of the enroled woman, her household, and her child 
included. The status and number of al the activities/forms completed for the 
mechanisms study were also tracked on this folder. When the NOMS data folder arrived 
from the VDC ofice with a red sticker in the right hand corner, the forms from the 
mechanisms study folder were transferred to the NOMS data folder. The NOMS data 
folder was then sent to NNIPS Headquarters in Kathmandu for data entry. Completed 
forms recording information for the 180-day folow-up visit were kept in separate folders 
in each VDC ofice. Each week they were transferred to the NNIPS field headquarters 
and checked for completion. They were then sent to NNIPS Headquarters in Kathmandu 
for data entry. 
 
Oil Storage and Packing 
In order to preserve the integrity of the oil until the participating households received it, 
al study oil, until day of distribution to the field, was stored and botled in an air-
conditioned, temperature-monitored room. The optimal temperature range for oil storage 
is between 20-28°C (Rajendra Acharya, Hetauda Government Food Laboratory Chief, 
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personal communication). Therefore, the maximum and minimum temperature in the oil 
storage and packaging room over a 24-hour period in the room was recorded daily by oil 
handling personnel. In addition, the study oil botles, 500ml and 100ml, were filed on 
two, physicaly separated flat surfaces. Each oil type had its own necessary packaging 
equipment that was thoroughly cleaned between oil batch purchases. 
 
The labels afixed to each botle were sticky on one-side and pre-printed on water-
resistant paper. Printed on the label were the NOMS logo of a mother massaging her 
infant, the NNIPS logo, and the NNIPS organization name writen in Nepali. The 500ml 
botles used in the study were of the same size and al parts were made of plastic 
(botle, inner lid and cover). The Batch Number was also writen on the labels in 
waterproof marker according to the type of oil that would be poured into the botle and 
the current NNIPS week (e.g. mustard seed oil and NNIPS week 054: “M054”) left to 
right with M/S placed at the top of the label. Before the botle was filed, the cover and 
inner lid of the botle were removed and the botle was examined to ensure the inside of 
the botle was clean and dry.  The botle was placed on the packaging table with a funnel 
placed in the opening. One 500ml factory packet was used per botle, with the worker 
checking to make sure the oil in the packet matched the oil type of the Batch Number 
writen on the label. After the botle was filed, two circles of thin plastic were placed on 
the top of the botle, with the inner lid placed on top, and the cover was screwed on 
tightly. The number of 500ml botles filed each day were recorded in a daily log book. 
Similar procedures were used to fil the 100ml botles, however the oil from the 500ml 
factory packet was poured into a smal, plastic pitcher and the botles were filed from the 
pitcher. 
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Oil Tracking and Distribution 
In order ensure the oldest batches of oil were botled and distributed to households first 
and no excess oil was removed from the temperature-controled environment, a number 
of methods were employed. When a new oil purchase arrived at field headquarters, it 
was immediately placed in the oil storing and packaging room. At that time, the details of 
the purchase were recorded. Each week, oil was packaged and sent to the field to fulfil 
the study’s oil needs the folowing week. Al of the oil from one oil purchase was 
packaged before a new purchase arrived at the main study ofice so that no Botle Code 
was assigned to botled oil from two different purchases. Packaged oil was sent, the 
oldest packaged botles first according to their Botle Code, from field headquarters to 
the VDC ofices on Wednesday of every week. The VDC’s oil supply was distributed to 
households using the oldest packaged botles first. Pregnant women received 100ml of 
oil at the late pregnancy visit. One 500ml oil botle was provided per live birth on the first 
day of life, one on Day 10 NFF visit, and one on Day 21 NFF visit. If at any NFF visit the 
oil level in the 500ml botle was found below three centimeters, the TLI brought a new 
500ml botle of oil on the next NFF visit. This distribution design ensured the households 
a constant supply of oil.  
 
Quality Control 
The NNIPS study team used a supervisory structure that helped to ensure that quality 
data was colected in the field. A structural hierarchy was in place with checks and 
balances to ensure data quality. WDs who monitor the pregnancies and act as the 
primary contact between the mothers and newborns and the study staf, conducted the 
first level of data colection. Al of these women were literate and had more than 10 years 
of experience working on community trials. WDs identified and maintained a list of 
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pregnant women in each sector, provided the massage oil and oil promotion, and 
accompanied the team leaders (TLIs) and birth team members on folow-up visits.  
 
The team leaders supervised 8 to 14 WDs. These TLIs were men and women who had 
worked with the NNIPS team on previous studies and who showed good leadership and 
organizational skils. TLIs were directly responsible for enrolment, birth assessment, and 
the newborn folow-up visits at days 1, 3, 7, 10, 14, 28, and 180. They provided oversight 
in preparing the WDs schedules and distributed and maintained data colection forms at 
the VDC level. They reviewed al forms for missing or inconsistent data and revisited a 
subset of households to ensure the consistency of the WDs data. Every Thursday, they 
held a weekly meeting with al of their WDs to identify any problems in the field and to 
discuss field activities. 
 
Field supervisors, al of who had more than 15 years of experience with the organization 
and other large-scale health programs in rural Nepal, provided the highest level of 
supervision. They were in charge of managing any major problems that arose as wel as 
provided support and oversight to area coordinators. They were also responsible for 
assisting with the design, pretesting, and refinement of the data colection instruments 
and procedures and for organizing and conducting training programs for al field workers. 
In addition, this author assisted in supervisory visits to the field at least one day per 
week throughout the time of the mechanisms study period in which data for this 
dissertation is presented, observing each of the five biological mechanisms field workers 
at least once per month and ensuring standardized measurement procedures and data 
colection. 
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Once data were received at the central data processing unit, the forms were again 
checked for completeness and data entry operators entered the forms into the database 
on a series of networked client personal computers. Data entry screens displayed 
identification information on the screen to ensure that information was being entered for 
the correct individual. Data that were criticaly important were entered twice and 
confirmation was necessary before the database could be updated. Automated range 
and consistency checks were programmed into the database in order to ensure that the 
correct forms were linked to each participant. Data entry validation procedures were 
conducted at regular intervals to track the rate of data entry errors in order to identify the 
need for retraining. If problems were identified during data entry or data cleaning, those 
that could not be resolved by reviewing the form were returned to field supervisors who 
communicated with the workers in the field. The corrected forms were then returned to 
the central data processing unit for editing. Al problems identified were documented 
through an electronic audit trail. Those ongoing checks helped to improve data quality by 
keeping the database up to date and by alowing the identification of reoccurring 
problems that indicated a need to revise the data colection forms or procedures.  
 
Al data were backed up at the end of each workday on external storage devices and a 
backup server was used to protect against server failure. Both the primary and backup 
servers had mirrored drives to protect against drive failure. Al servers were located in 
field and project headquarters, which were locked and guarded at al times. Encrypted 
study databases were transferred to Baltimore on a regular basis and those files were 
kept on our server behind a local firewal. Al accounts and database files were password 
protected. 
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Sample Size and Power Calculations 
This nested biological mechanisms study included a subset of the sample size of 29,620 
infants required for the parent trial. Some measurements that were colected were fairly 
easy to obtain as they were noninvasive measures or procedures and as such did not 
impose a great burden on the mother or the infant (i.e. weight and length 
measurements). However, some measures were much more time consuming and 
invasive. Also, some measures were more exploratory and therefore it may not have 
been necessary or ethical to perform those measurements on a large number of infants 
(i.e. faty acid levels, and serum and epidermal cytokines). Therefore, we tiered the 
sample sizes in a way that the most invasive and time-consuming measures were done 
on the fewest number of infants (see Figure 3-3). As there was litle to no information 
available on these measurements in newborns, any information gathered wil make 
important contributions, as it wil help direct further research in determining whether 
larger studies should be conducted. It wil, however, be informative to have al of the 
measurements performed on the same set of infants, in order to determine how and if 
any of the biological mechanisms are related, as such, there were 200 infants who had 
al measurements taken (see Figure 3-3). 
 
We hypothesized that the outcome measures (and the moderating efect(s) of the 
diferent oils, if any) may be more important in preterm infants than ful term infants due 
to the immaturity of their skin, therefore, preterm infants were oversampled. A total 
sample size of 1000 infants was selected for Tier 1 measurements (see Figure 3-3), 
equally stratified by 500 preterm and 500 ful term infants. In doing so, the sample of this 
study did not reflect the actual preterm/ful-term ratio of the study population. 
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Al power calculations assumed a design efect of 1.5, a 5% loss to folow-up, and a 5% 
Type 1 error. A design efect of 1.5 was assumed without prior knowledge of the true 
extent of correlation of the diferent measurements within clusters. The analyses 
presented here represent a preliminary analysis of the first 63.7% of the anticipated 
enroled infants. 
 
Sample Size as Related to Specific Aims 
Specific Aim 1: Skin Integrity and Barrier Function 
Al measurements related to skin barrier integrity and function were located in Tier 1 with 
500 infants in each group (see Figure 3-3). Comparing diferences in mean TEWL, skin 
pH, protein concentration, or skin condition scores between groups at each visit we 
should have been able to detect even a smal diference in means with high power, 
however as can be seen in Table 3-4, as the standard deviation of the mean increases, 
the power to detect a diference decreases. 
 
At birth, the skin surface is relatively neutral (pH about 6.5) and gradualy becomes more 
acidic over the first few postnatal weeks. The acid mantle forms as a result of changes 
on the skin surface folowing birth (sweat, sebum, microorganisms) and lactic acid and 
free faty acids from metabolic processes within the stratum corneum. The skin pH fals 
to about 5.7, a level that is beneficial for antimicrobial defense by inhibiting the growth of 
pathogenic bacteria. (Yosipovitch, Maayan-Metzger et al. 2000; Hoeger and Enzmann 
2002) For this measurement we were interested in determining whether there was a 
diference in the time it took for a newborn’s skin to reach a beneficial pH level of 5.7. 
Assuming a hazard ratio of 0.8 and an equal proportion of infants in both groups, we had 
80% power to detect a diference in the survival curves. 
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Specific Aim 2: Nutritional Status 
There were three measurements related to determining diferences in the nutritional 
status between the two groups. Two of these measurements were Tier 1 measurements 
and one was a Tier 3 measurement (see Figure 3-3). 
 
The two measurements related to nutritional status that were Tier 1 sample size 
measurements were weight and length. For these measurements we were interested in 
comparing the proportion of infants who were less than 2 standard deviations below the 
normal mean weight-for-age (underweight) for each measurement point (girls: 3.2 kg, 
boys 3.4 kg at 28 days and girls: 5.7 kg, boys 6.4 kg at 180 days) and height-for-age 
(stunted) (girls: 49.8 cm, boys: 50.8 cm at 28 days and girls: 61.2 cm, boys 63.3 cm at 
180 days) according to the WHO (see Table 3-5). (WHO 2011) We were also interested 
in looking at the diferences in the mean weight and length measures for each visit 
comparing oil groups, which we would have the same power to detect with 1000 infants 
as we had for the skin integrity measures shown in Table 3-4.  
 
The third measurement related to nutritional status was the measurement of faty acid 
levels of the infants, which due to the invasive nature of the measurement and that it 
was more exploratory, was a Tier 3 measurement. The measurement of interest was 
whether there was a diference in the mean percentage of total faty acids that was 
linoleic acid. (Siguel, Chee et al. 1987) With a diference in mean percentage of faty 
acid of 5% we would have 81-100% power to detect a diference with this sample size if 
the standard deviation was between 5 and 10% (see Table 3-6). 
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Specific Aim 3: Microbial Chalenge 
The measurement of skin flora type and amount is related to microbial chalenge and 
was a Tier 2 measurement (see Figure 3-3). The measurement of interest was a 
diference in the mean amount of bacterium present on the skin when comparing infants 
massaged with mustard seed oil with those massaged with sunflower oil. The 
diferences in means were based on a study done by Pabst et al., comparing bacterial 
colonization of the skin of infants massaged with Aquaphor with a control group. This 
study was done in very low birthweight infants, so the diferences observed may be 
greater. (Pabst, Starr et al. 1999) However, even with a very low diference of 0.2 log10 
CFU/ml, if the standard deviation was low, there was high power to observe a diference 
(see Table 3-7). 
 
Specific Aim 4: Systemic and Epidermal Innate Immunity 
There were three measurements that related to systemic and epidermal innate immunity. 
One of these measurements was a Tier 1 measure and the other two were Tier 3 
measurements (see Figure 3-3).  
 
The colection of salivary samples was a Tier 1 measure, however, a ful analysis of the 
cytokines was only completed on a subset of 400 out of these 1000 infants. Of interest 
was the determination of a diference in the mean amount of certain salivary cytokines. 
As there was no information on amounts of cytokines measured in saliva for infants we 
used as our proxy to estimate the diferences in means and standard deviations a paper 
by Skogstrand et al. which measured cytokines present in serum in preterm and normal 
term infants (see Table 3-8). (Skogstrand, Hougaard et al. 2008) 
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Serum cytokine levels were a Tier 3 measurement. The measures of interest were the 
types and amounts of diferent cytokines and whether they were diferent between 
groups. In estimating the diferences of the means and the standard deviations we again 
used information from the Skogstrand study. (Skogstrand, Hougaard et al. 2008) With a 
diference in mean serum cytokine concentrations of 10 pg/ml we were able to detect a 
diference with between 81% and 100% power if the standard deviation was between 10 
and 20 pg/ml (see Table 3-9).  
 
Epidermal structural and immune biomarkers were also Tier 3 measures. The 
measurement of interest was whether there were diferences in the means of several 
diferent biomarkers between groups. In order to estimate the possible diferences in 
means and standard deviations, we used a study by Narendran et al. comparing the 
biomarkers of epidermal innate immunity in premature and ful term infants. (Narendran, 
Visscher et al. 2010) With a diference in mean epidermal cytokine concentrations 
between infants in each oil group of 1.5 pg/µg of protein we could detect a diference 
with between 81% and 100% power if the standard deviation ranged from 1-3 pg/µg of 
protein (see Table 3-10). We had 81-100% power to detect a diference of 10 pg/µg of 
protein in mean structural protein concentrations between infants massaged with 
sunflower oil versus mustard seed oil with standard deviations between 10 and 20 pg/µg 
of protein (see Table 3-11). 
 
Data Analysis 
Al analyses for these measurements were conducted using STATA v12 (Colege 
Station, TX). The first step in the analysis process was exploratory in order to examine 
the range of study variables and some of the possible relationships in order to beter 
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understand the data. This included tabulations, examination of the means, ploting the 
distributions, box plots, and scater plots. The comparability of the treatment groups in 
relation to their background characteristics was also assessed to determine if there were 
any confounding variables. The possible confounders that were investigated included: 
household demographics and socioeconomic status (SES), ethnic group, maternal and 
paternal education levels, maternal age, reproductive history, receipt of interventions, 
labor and delivery characteristics (place of birth, length and type of labor, type and 
practice of birth assistants), newborn characteristics and newborn care practices (sex, 
birthweight, gestational age, breastfeeding), and intervention exposure and compliance. 
Adjustment for any unbalanced variables occurred during analysis. Al statistics were 
evaluated at a significance level of p <0.05. Sub-group analyses were also conducted for 
preterm infants (<37 weeks) for each measurement. Al analyses folowed an intention-
to-treat approach for participating infants, regardless of the actual treatment provided. 
 
Specific Aim 1: Skin Integrity and Barrier Function 
Descriptive statistics of each outcome of interest were computed. These included 
means, standard deviations (within and between groups), minimums, and maximums for 
skin condition scores, TEWL, skin pH, and protein concentration. Outliers that were 
biologicaly impossible were removed from analyses on the basis that they were likely 
due to an instrument malfunction or measurement of another biological process (e.g. 
measurement of perspiration rather than TEWL). Skin pH values greater than 8 and less 
than 3 were removed (Marty Visscher, personal communication) as wel as TEWL values 
greater than 100 g/m2/hr. (Aki Immonen, personal communication) A total of 22 (<1%) 
skin pH measurements were removed, although due to using the mean of 3 
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measurements, this did not result in losing any observations. Thirty-nine (1.3%) TEWL 
observations were removed as a result of 133 (4%) measurements being out of range. 
 
In order to analyze diferences in skin pH, the diferences in the time it took for infants in 
each group to reach a beneficial skin pH level (<5.7) was assessed using Cox 
Regression Models. (Yosipovitch, Maayan-Metzger et al. 2000) For this survival 
analysis, infants were censored at the earliest of: skin pH = 5.7 (event), death, loss to 
folow-up, and after 28 days. 
 
In order to evaluate skin condition scores, the two scores that measured irritation of the 
skin (rash and erythema) were added together to get a total score. Due to the low 
presence of dryness in our study population (only 152 out of 3011 (5%) observations 
had chest dryness scores that were not zero), dryness scores were not included in our 
analyses. Individual scores were evaluated for each location (chest, left arm, and right 
leg). Evaluations were also done on each component of the skin condition score 
individualy for each body region. To examine whether there were diferences in mean 
skin condition scores, TEWL, skin pH, and protein concentration at diferent folow-up 
visit times for the diferent oil groups, mixed-efects regression analyses with random 
intercepts were performed. In al models, estimates of standard errors accounted for the 
clustered design. To determine if diferences in skin integrity measures were due to the 
efect of the diferent oils used, multi-level mixed-efects regression models with random 
intercepts accounting for the randomized clusters and repeated measures on each infant 
were performed for the entire neonatal period and stratified by early (<7 days) and late 
(≥7 days) neonatal periods. Multi-level models with an interaction between infant’s age 
and oil group were also used to explore whether the rate of change in skin pH, TEWL, or 
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protein concentration was diferent in the sunflower seed oil group during diferent 
periods of time. Linear splines were used to account for nonlinearity. 
 
In addition to evaluating whether oil group had an efect on skin integrity measures, 
further analyses were done to determine risk factors associated with skin barrier 
measures in this population. Possible risk factors related to the infant, mother, 
household and environment were evaluated. These included measures of household 
demographics and SES, ethnic group, maternal and paternal education levels, maternal 
age, reproductive history, labor and delivery characteristics (place of birth, length and 
type of labor, type and practice of birth assistants), newborn characteristics and newborn 
care practices (sex, birthweight, gestational age, breastfeeding, smal-for-gestational age 
(SGA) status), and temperature and humidity measures. 
 
A bivariate analysis was done for each potential risk factor using a mixed-methods 
approach with random intercepts, accounting for the repeated measures for each infant, 
to determine whether there was an association between any of the potential risk factors 
and any of the skin integrity measures. Additionaly, a multivariate model, accounting for 
multiple measures per infant, was constructed from risk factors that were statisticaly 
significantly associated with each skin integrity measure in the bivariate analyses and 
with variables that are believed to be associated with skin integrity in this population, but 
may not have been statisticaly significantly associated in the bivariate analyses. Mixed-
efects models were also used to assess the relationship between time and skin integrity 
measures. These analyses were done with linear splines where indicated to account for 
nonlinearity.  
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Specific Aim 2: Nutritional Status 
Descriptive statistics of each outcome of interest were computed. These included 
means, standard deviations (within and between groups), minimums, and maximums for 
weight at the birth assessment visit on day 1 and at folow-up visits on days 3, 7, 10, 14, 
21, and 28 and length at the birth assessment visit on day 1 and at folow-up visit 28. 
The mean change in weight and length between visits was also calculated. In addition, 
mean, range, and standard deviations of z-scores at visit 28 and numbers and 
proportions of infants who were <-2 z-scores weight-for-age and height-for-age were 
determined. Z-scores were calculated using WHO Anthro (version 3.2.2, January 2011). 
(WHO 2011) 
 
To examine whether there were diferences in mean weight, length, and z-scores for 
weight-for-age and height-for-age at diferent folow-up visit times between the diferent 
oil groups, mixed-efects regression models with random intercepts were performed, 
accounting for the clustered design in the standard error estimates. These mixed-efects 
models were also run to investigate diferences in the mean change in weight between 
visits using 1, 2, and 3 visit increments (e.g. diference between weight at the birth visit 
and folow-up visit on day 3, the birth visit and the folow-up visit on day 7, etc.) and 
diferences in the mean change in length between the birth visit and the folow-up visit on 
day 28 between the two oil groups. In addition, multi-level mixed-efects regression 
models with random intercepts, accounting for the clustered design and the repeated 
measures in the standard error estimates, were performed to determine if oil group had 
any efect on weight and length during the entire neonatal period and when stratified by 
early (<7 days, including the initial birth visit) and late (≥7 days) neonatal periods. Multi-
level models with an interaction between infant’s age and oil group were also used to 
explore whether the rate of change in weight or length was diferent in the sunflower 
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seed oil group during diferent time periods. Linear splines were used to account for 
nonlinearity. Mixed-efects logistic regression models with random-intercepts, accounting 
for the clustered design in the standard error estimates, were run to determine if there 
were diferences in the proportion of infants who were stunted or underweight (<2 z-
scores below normal) at 28 days of age. Sub-group analyses were conducted for 
preterm infants and SGA status for each measurement. 
 
Specific Aim 3: Microbial Chalenge and Specific Aim 4: Systemic and Epidermal 
Innate Immunity 
As the results of these specific aims are not reported in this dissertation, their statistical 
analyses are also not discussed. 
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Chapter 3 Tables and Figures 
Table 3-1: Scheduling of Visits and Associated Data Items Colected for 
Mechanisms Study 
Measure	   #	  of	  Infants	   1	   3	   7	   10	   14	   21	   28	   180	  
Activities	  for	  Birth	  Team	  Members	  
Sampling/LMP	   1000	   X	   	   	   	   	   	   	   	  
Birth	  Assessment	   1000	   X	   	   	   	   	   	   	   	  
Length	   1000	   X	   	   	   	   	   	   X	   X	  
Weight	   1000	   X	   X	   X	   X	   X	   X	   X	   X	  
Activities	  for	  Biological	  Mechanisms	  Team-­‐No	  Cold	  Chain	  Required	  
Consent	   1000	   X	   	   	   	   	   	   	   	  
Skin	  Condition	  Score	   1000	   X	   X	   X	   	   X	   	   X	   	  
TEWL	   1000	   X	   X	   X	   	   X	   	   X	   	  
Skin	  pH	   1000	   X	   X	   X	   	   X	   	   X	   	  
Activities	  for	  Biological	  Mechanisms	  Team-­‐Cold	  Chain	  Required	  
Skin	  Discs	   1000	   X	   	   X	   	   X	   	   X	   	  
Saliva	   1000	   X	   	   X	   	   X	   	   	   	  
Skin	  Flora	   400	   X	   X	   X	   	   	   	   	   	  
Heelprick	   200	   	   	   	   	   X	   	   	   	  
 
Table 3-2: VDCs Participating in NNIPS Oil Massage Study and Mechanisms Study 
VDC	  Number	   VDC	  Name	  
Participated	  in	  
Mechanisms	  Study	  
08	   Murtiya	   Yes	  
11	   Barahathawa	   Yes	  
12	   Laukat	   Yes	  
13	   Sundarpur	   Yes	  
14	   Manipur	   Yes	  
15	   Harkathawa	   No	  
16	   Bhawanipur	   No	  
17	   Dhankaul	   No	  
30	   Janakinagar	   Yes	  
31	   Mainathpur	   No	  
32	   Dhangada	   Yes	  
33	   Sahodawa	   Yes	  
43	   Sisautiya	   Yes	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Table 3-3: Skin Condition Score Scale 
	   Severity	   Area	  
Erythema	  Scale	  
0	   None	   None	  
1	   Faint	  or	  definite	  pink	   <2%	  
2	   Definite	  red	   2-­‐10%	  
3	   Very	  intense	  redness	   10-­‐50%	  
4	   NA	   >50%	  
Rash	  Scale	  
0	   None	   None	  
1	   Papules	   One	  
2	   Pustules	   2-­‐5	  
3	   Papules	  and	  pustules	   <10%	  
4	   Clear	  fluid-­‐filed	  vesicles	   10-­‐50%	  
5	   NA	   >50%	  
6	   NA	   Numerous	  and	  continuous/joining	  
Dryness	  Scale	  
0	   None	   None	  
1	   Slight	  powderiness	   <10%	  
2	   Early	  cracking	   10-­‐50%	  
3	   Moderate	  cracking	  &	  scales	   >50%	  
4	   High	  cracking	  &	  lifting	  scales	   NA	  
5	   Bleeding	  cracks	   NA	  
NA=Not applicable 
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Table 3-4: Power to Observe a Difference in Means of Skin Integrity Measures (500 
infants in each oil group) 
Standard	  Deviation	   Diference	  in	  means	  at	  each	  visit	  of	  infants	  massaged	  with	  sunflower	  oil	  
versus	  mustard	  seed	  oil	  
0.25	   0.5	   0.75	  
1.0	   88	   100	   100	  
1.5	   56	   99	   100	  
2.0	   35	   88	   100	  
2.5	   24	   71	   97	  
 
Table 3-5: Power to Observe a Difference in Proportion of Newborns Stunted or 
Underweight (500 infants in each oil group) 
Absolute	  
Diference	  
Proportion	  of	  infants	  massaged	  with	  mustard	  seed	  oil	  with	  <-­‐2	  SD	  below	  the	  
normal	  mean	  weight-­‐for-­‐age	  or	  height-­‐for-­‐age	  
.1	   .2	   .3	   .4	   .5	  
0.05	   61	   34	   26	   29	   22	  
0.10	   100	   93	   81	   73	   69	  
0.15	   100	   100	   99	   98	   96	  
0.20	   100	   100	   100	   100	   100	  
	  
Table 3-6: Power to Observe a Difference in Mean Percentage of Fatty Acids that is 
Linoleic Acid (100 infants in each oil group) 
Standard	  Deviation	  (%)	   Diference	  in	  mean	  percentage	  of	  fatty	  acids	  that	  is	  linoleic	  acid	  between	  
infants	  massaged	  with	  sunflower	  oil	  versus	  mustard	  seed	  oil	  (%)	  
5	   10	   15	  
5	   100	   100	   100	  
10	   81	   100	   100	  
15	   47	   97	   100	  
20	   29	   81	   99	  
	  
Table 3-7: Power to Observe a Difference in Mean Amounts of Skin Flora (200 




Diference	  in	  mean	  bacterial	  colonization	  of	  infants	  massaged	  with	  sunflower	  oil	  
versus	  mustard	  seed	  oil	  (log10CFU/ml)	  
0.1	   0.2	   0.3	   0.4	   0.5	  
0.5	   36	   89	   100	   100	   100	  
1.0	   12	   36	   67	   89	   98	  
1.5	   8	   19	   36	   57	   76	  
2.0	   6	   12	   22	   36	   51	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Table 3-8: Power to Observe a Difference in Mean Salivary Cytokine 
Concentrations (200 infants in each oil group) 
Standard	  Deviation	  
(pg/ml)	  
Diference	  in	  mean	  salivary	  cytokine	  concentrations	  in	  saliva	  between	  
infants	  massaged	  with	  sunflower	  oil	  versus	  mustard	  seed	  oil	  (pg/ml)	  
5	   10	   15	  
10	   98	   100	   100	  
15	   76	   100	   100	  
20	   51	   98	   100	  
25	   36	   89	   100	  
	  
Table 3-9: Power to Observe a Difference in Mean Serum Cytokine Concentrations 
(100 infants in each oil group) 
Standard	  Deviation	  
(pg/ml)	  
Diference	  in	  mean	  serum	  cytokine	  concentrations	  between	  infants	  
massaged	  with	  sunflower	  oil	  versus	  mustard	  seed	  oil	  (pg/ml)	  
5	   10	   15	  
10	   81	   100	   100	  
15	   47	   97	   100	  
20	   29	   81	   99	  
25	   21	   62	   92	  
	  
Table 3-10: Power to Observe a Difference in Mean Epidermal Cytokine 




Diference	  in	  mean	  epidermal	  cytokine	  concentrations	  between	  infants	  
massaged	  with	  sunflower	  oil	  versus	  mustard	  seed	  oil	  (pg/μg	  of	  protein)	  
0.5	   1	   1.5	   2	   2.5	  
1	   81	   100	   100	   100	   100	  
2	   29	   81	   99	   100	   100	  
3	   16	   47	   81	   97	   99	  
4	   11	   29	   56	   81	   94	  
 
Table 3-11: Power to Observe a Difference in Mean Structural Protein 
Concentrations (100 infants in each oil group) 
Standard	  Deviation	  
(pg/μg	  of	  protein)	  
Diference	  in	  mean	  structural	  protein	  concentrations	  between	  infants	  
massaged	  with	  sunflower	  oil	  versus	  mustard	  seed	  oil	  (pg/μg	  of	  protein)	  
5	   10	   15	  
10	   81	   100	   100	  
15	   47	   97	   100	  
20	   29	   81	   99	  
25	   21	   62	   92	  
 
	    
	   89 
Figure 3-1: NOMS and Oil Mechanisms Study VDCs 
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Figure 3-2: Flowchart of NOMS Trial Study Design  
Identify Pregnant Women
through regular pregnancy 
surveilance
Enrol/Consent Women
 - Colect baseline data
 - Deliver Common Interventions
 - regular monthly visits
Sectors (n=136) randomized to Sunflower Seed Oil or Standard (Mustard Oil) Massage
Sunflower Seed Oil Mustard Oil
Late Pregnancy Visit
 - Provision of alocated oil 
(mustard or sunflower seed oil) 
Post Birth Visit Schedule
Oil Promotion
 - Days 1,2,3,4,5,6,7
Morbidity, Vital Status, and Compliance Folow Up




Consent / Enrolment of 
Pregnant Women
Intervention Promotion 1
(prior to birth of baby)
N = 68 Sectors N = 68 Sectors
Intervention Promotion 2
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Chapter 4 Epidemiology and Risk Factors Associated with Skin 
Integrity and Barrier Function 
Background 
Newborn skin is an important organ protecting the neonate, serving as the first line of 
defense between the infant and the environment, the stratum corneum being where 
most of this important barrier function occurs. The skin serves many important functions 
including: moderating fluctuations in transepidermal water loss (TEWL) and maintaining 
electrolyte homeostasis, thermoregulation and minimizing caloric losses, antimicrobial 
defense, protection from environmental toxins, protection from ultraviolet (UV) radiation, 
and tactile stimulation. (Darmstadt and Dinulos 2000) 
 
The skin is wel developed and fuly functional at birth in ful term infants, with a thick 
epidermis and wel-formed stratum corneum layers, despite being exposed to water and 
amniotic fluid for nine months. (Cunico, Maibach et al. 1977; Yosipovitch, Maayan-
Metzger et al. 2000) Epidermal barrier properties such as increased hydration and water 
binding undergo progressive changes during a healthy ful term infant’s first month of life 
as it adapts to the dry extrauterine environment. (Visscher, Chaterjee et al. 2000) 
Neonatal skin is always adjusting to its extrauterine environment when comparing 
parameters such as skin thickness, skin pH, TEWL, lipid content, and stratum corneum 
hydration to adult skin, which is in a steady state, suggesting a balance between 
diferent parameters may be important for barrier function. (Chiou and Blume-Peytavi 
2004; Fluhr, Darlenski et al. 2012; King, Balaji et al. 2013) In addition, water handling 
behaviors and levels of stratum corneum water binding amino acids continue to develop 
during the first year of life. (Nikolovski, Stamatas et al. 2008) 
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Preterm infants show immature barrier function, including: structural immaturity (i.e. the 
stratum corneum and epidermis are thinner leading to increased susceptibility to shear 
forces), an underdeveloped stratum corneum epidermal permeability barrier (leading to 
increased TEWL, loss of heat, increased caloric demands, an increase in potential for 
environmental toxin absorption, and compromised antimicrobial defense), slower 
formation of the antibacterial acid mantel, incomplete development of vernix (and 
subsequent efects), and increased UV susceptibility. (Evans and Ruter 1986; Cartlidge 
2000; Darmstadt and Dinulos 2000; Ruter 2000) In addition, neonates, especialy those 
who are preterm, are at high risk for infection, which could be due in part to their 
epidermal barrier immaturity (including fewer stratum corneum layers, poorly formed lipid 
layers, and increased permeability). (Nickolof and Naidu 1994; Nishijima, Tokura et al. 
1997) 
 
An important function of the skin barrier is to protect against transepidermal water loss, a 
direct function of gestational age. (Hoath and Maibach 2003) TEWL measures in ful 
term infants are very low at birth, equal to or lower than adult values, indicating a highly 
efective skin barrier. (Cunico, Maibach et al. 1977; Yosipovitch, Maayan-Metzger et al. 
2000) A reference dataset of over 1000 term neonates had a mean TEWL of 7.06 
g/m2/hr. (Keleher, O'Carrol et al. 2013) In contrast, very low birthweight preterm infants 
have very high TEWL when measured at birth, ranging from 50 to 70 g/m2/hr. 
(Hammarlund and Sedin 1979) In addition to gestational age, TEWL is also dependent 
on the site of measurement, ambient humidity, temperature, activity, and nutritional 
status at birth. (Oberg, Hammarlund et al. 1981; Hammarlund, Sedin et al. 1982; 
Hammarlund, Sedin et al. 1983) 
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The acidic pH of the skin is another mode of protection. This acidic surface of the skin is 
important in the formation and integrity of the stratum corneum. It alows the efective 
functioning of enzymes that are involved in lipid metabolism, bilayer structure, ceramide 
synthesis, and desquamatization. (Rippke, Schreiner et al. 2002; Schmid-Wendtner and 
Korting 2006) After birth, skin pH is elevated in ful term neonates compared with adults 
and older children and decreases in the first few weeks, most significantly during the first 
4 days. (Green, Carol et al. 1968; Fluhr, Pfisterer et al. 2000; Visscher, Chaterjee et al. 
2000; Hoeger and Enzmann 2002). The mean skin pH of ful term neonates within the 
first 10 hours after birth from six diferent body sites was 7.08 compared to a mean of 5.7 
in adults. (Yosipovitch, Maayan-Metzger et al. 2000; Hoeger and Enzmann 2002) Some 
studies have suggested development of the acid mantle is not correlated with gestational 
age, with development in preterm neonates shown to be very close to that of ful term 
neonates. (Green, Carol et al. 1968) However, other studies have shown that for very 
preterm infants, skin pH tends to remain higher for a longer period of time. (Fox, Nelson 
et al. 1998) 
 
Recent observations of reductions in nosocomial infections and mortality among preterm 
infants receiving topical applications of sunflower seed oil (Darmstadt, Badrawi et al. 
2004; Darmstadt, Saha et al. 2005; Darmstadt, Saha et al. 2008) have been posited as 
possibly atributable to improvement in skin barrier function in the exposed infants. The 
epidemiological results have also prompted large-scale community based studies (such 
as ours) of the impact of substituting sunflower seed oil in place of the more commonly 
practiced application of mustard oil. However, while changes in skin barrier integrity and 
function could be one of the ways in which emolient therapy with vegetable oil may 
improve the health of newborns, litle is known about the risk factors associated with 
diferences in skin barrier integrity in many of the communities that routinely practice 
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neonatal oil massage with localy available vegetable oils. We aimed to determine 
possible risk factors associated with skin barrier integrity and skin condition, measured 
visualy as rash and erythema, and instrumentaly as skin pH, TEWL, and stratum 
corneum protein concentrations in such a population in rural Nepal. An examination of 
these risk factors wil be important in understanding how neonatal oil massage may 
influence skin barrier integrity and possibly contribute to improved health of newborns. 
 
Methods 
Settings and Population 
The data for this study were colected as part of a cluster-randomized community-based 
trial conducted by the Nepal Nutrition Intervention Project, Sarlahi (NNIPS). In 2011, the 
NNIPS surveilance area consisted of 26 Vilage Development Commitees (VDCs) each 
encompassing nine government defined geopolitical units (wards), which were further 
divided into sectors based on population. This trial was nested within a larger parent trial 
on the Impact of Sunflower Seed Oil Massage on Neonatal Morbidity and Mortality in 
Nepal (NOMS). The study population for the NOMS trial was al live born infants in 
households in 13 VDCs in Sarlahi District in rural Nepal. The Nepal Health Research 
Council and the Commitee on Human Research of the Johns Hopkins Bloomberg 
School of Public Health approved this study. 
 
Procedures and Design of the Parent Trial 
Previous sector level mortality estimates were known for 9 of the 13 VDCs from prior 
research in this community and were used to perform restricted randomization in order 
to ensure balance of prior neonatal mortality risk. In the other 4 VDCs, sectors (clusters) 
were randomized with a computerized quasi-random number generator, stratified on 
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VDC using blocks of 4, ensuring a geographical balance of the types of oil across the 
study area. Newborn infants were randomized within clusters (sectors) to receive either 
promotion of ful body massage with sunflower seed oil or promotion of ful body 
massage with mustard seed oil. A cluster-randomized design was chosen in order to 
minimize the chance of crossover or contamination of the intervention by providing each 
field worker with only one type of oil to promote in her area. It was not possible to blind 
field workers or mothers to the treatment, as mustard oil and sunflower oil have distinct 
colors and smels.  
 
Community-specific lists of married women of reproductive age were created. In order 
to rapidly identify new pregnancies, localy-resident female workers monitored the status 
of these women every 5 weeks, asking about menstruation in the prior month, and 
conducting pregnancy tests. A woman identified as pregnant was approached for 
recruitment and consent for her infant’s participation in the parent trial. Each woman 
participating in the study received a set of basic antenatal care interventions (e.g. 
tetanus toxoid, a clean delivery kit, iron-folate supplements, chlorhexidine cleaning 
solution for disinfecting the umbilical region, and deworming), along with basic 
educational messages on antenatal and newborn care. The worker visited the women in 
late pregnancy (~28-32 weeks) to promote the use of either the sunflower seed oil or 
mustard seed oil, and provide the mother or other caretaker with a 100ml botle of oil at 
that time. The mother or other caretaker initiated ful body massage folowing the field 
worker’s guidelines using the provided oil daily throughout the newborn period. During 
the first week of life, the local worker visited the homes daily to promote the continued 
use of the oil.  
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Immediately upon notification of the pregnancy, the local resident worker notified the 
supervisory staff and a birth assessment was conducted using standardized data 
colection forms recording information related to late pregnancy morbidity, labor and 
delivery characteristics, birth assistants and practices, length of labor, maternal 
temperature, date and time of birth, sex, length and weight of infants, and immediate 
newborn care practices (thermal care, cord practices, early bathing and massage, 
breastfeeding initiation, etc.). In addition to the individual data obtained, household level 
data were colected at the time of enrolment of the mothers. This included information 
on socioeconomic factors, such as ethnicity, caste, household assets, ownership of 
materials or livestock, water sources, and family members who may be working 
overseas. Data were also colected on parental literacy, education, and birth history. 
After the initial birth visit, the birth team member completed newborn folow-up visits 
(NFF) on days 3, 7, 10, 14, 21, and 28 (for a total of 7 visits), where signs of infant 
morbidity and newborn care practices since prior visit were recorded. A 500ml botle of 
oil was provided at the initial visit and on folow-up visits on days 10 and 21. The primary 
outcomes of NOMS are neonatal mortality and possible severe infections. 
 
Design of the Biological Mechanisms Sub-Study 
This biological mechanisms sub-study included an extended set of measurements 
colected from a subset of infants participating in the main trial. The focus of data 
colection for this sub-study was on direct measurement of biological markers of infants 
built into a specific sub-study schedule (days 1, 3, 7, 14, and 28) of the parent trial visits. 
The biological measurements used to assess skin integrity included: visual assessment 
of skin condition (erythema, rash), measurement of transepidermal water loss (TEWL), 
measurement of skin pH, and colection of skin discs in order to measure the stratum 
corneum cohesion and protein concentration via measurement of optical density. Al skin 
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integrity measures were taken at each of the five visits, apart from the skin disc 
colection, which was colected at visits 1, 7, 14, and 28. Table 4-1 shows the timing of 
measurement colections. 
 
A subset of 7 VDCs of the 13 original VDCs in the NOMS trial was selected to participate 
in the mechanisms study, which began in July 2012. An 8th VDC was added after 5 
months and a 9th VDC was added in January 2013. The cluster-randomization of the 
parent trial was conserved for the mechanisms study. Among infants participating in the 
main study, determination of eligibility to additionaly participate in the sub-study was 
done during the initial birth assessment visit, and was based on estimates of gestational 
age at birth. For this study, preterm infants (<37 weeks gestational age) were 
oversampled, aiming for approximately 50% of the sample to be preterm. During the 
study period (July 2012 until September 2013), the gestational age was estimated 
directly by the field worker using the date of last menstrual period estimated by the 
woman at the time of initial enrolment. Each birth team member had a list of the date of 
the mother’s last menstrual period (LMP), which was used along with the date of birth to 
determine the gestational age of the infant. If the infant was born before week 37, one of 
the members of a specialy trained team of field workers focused on the implementation 
of the mechanisms sub-study was contacted directly by mobile phone. Infants born on or 
after week 37 were listed by VDC in consecutive order (i.e. by birth date) on a pre-
printed computer generated blank form of 20 rows, 4 of which had been randomly 
selected for shading. Infants listed on a randomly shaded row were eligible for inclusion 
in the mechanisms study, thus selecting 4 out of every 20 (20%) of the ful term infants 
for participation. Al preterm (<37 weeks) infants and every 5th ful term infant born in the 
mechanisms study area were eligible for enrolment in the sub-study. Infants were 
enroled if consent was provided and the infant was met alive within 48 hours after birth. 
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Newborns enroled in the mechanisms study were visited in their homes 5 times, on 
days 1, 3, 7, 14, and 28. In addition, to performing the skin integrity measurements at 
these visits, the workers asked questions relating to newborn care practices since the 




Four measures were taken to evaluate skin integrity: skin condition scores, 
transepidermal water loss (TEWL), skin pH, and protein concentrations (via optical 
density). Field worker evaluation of skin condition was measured using a modified 
version of a scoring method described by Visscher et al. (Visscher, Odio et al. 2009) This 
team has experience extending these scores for patients in the United States. This study 
used an extended version of more established scales for the measure of irritation of the 
skin based on levels of erythema and rash, rating erythema severity on a scale from 0 to 
3 and area afected on a scale from 0 to 4. Severity of rash and area afected by rash 
were evaluated on scales from 0 to 4 and 0 to 6 respectively. Scores were based on the 
percent area of involvement and severity of skin compromised within the specified body 
region for each component. Each field worker was trained in the use of the scales. The 
severity of erythema and rash as wel as the area covered was recorded on 
standardized data colection instruments. Skin condition assessments were completed 
on the same 4cm by 4cm area of the chest, the entire left arm, and the entire right leg. 
 
Transepidermal water loss was measured in g/m2/hr using a VapoMeter (Delfin 
Technologies, Ltd, Finland), a closed-chamber device containing sensors for relative 
humidity and temperature, using standardized procedures. (Rogeries and Group 2001; 
Nuutinen, Alanen et al. 2003; De Paepe, Houben et al. 2005) TEWL measurements 
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were taken three times at the mid-chest nipple line. The mean value of these 
measurements was used for analyses. The exact location where measurements were 
taken was similar in al infants, through the measurement of anatomical markers. The 
location of the measurements was chosen because it was easily accessible, an area that 
was massaged, and provided a reasonably flat surface area for placing the VapoMeter. 
The three measurements along with the temperature and relative humidity obtained from 
the VapoMeter were recorded on standardized data colection forms. 
 
Measurements of skin pH were performed with a flat electrode (SkincheckTM, Hanna 
Instruments, UK) calibrated daily to pH 4 and 7. (Parra and Paye 2003) Measurements 
were taken in the same location at the mid-nipple as the TEWL measurements. The 
three measurements were recorded on standardized data colection forms and the mean 
skin pH of the three measurements was used for analyses. 
 
Using a technique described by Voeglei et al., protein content from the outermost 
stratum corneum was analyzed using samples colected using 380 mm2 D-Squame 
adhesive discs (CuDerm, TX) applied to the chest with constant pressure for 2 minutes. 
(Voegeli, Heiland et al. 2007) Diferent locations on the chest were used for the 
placement of the skin discs at each of the four visits in order to colect discs from skin 
that had not been previously exposed to adhesive. These locations were diferent from 
those used to measure TEWL and skin pH. After the discs were removed from the chest, 
they were placed in microtubes and transferred to field headquarters in cold boxes kept 
between 2° and 8°C. At field headquarters, optical absorption of the skin discs was 
determined using a spectrophotometer SquameScanTM 850A (Heiland electronic, 
Wetzlar, Germany) specificaly designed for the application of D-Squame discs. Before 
the optical absorptions of the discs were read, the spectrophotometer was calibrated to 
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0% and 36.2% optical absorption. Optical absorption of the discs was recorded on 
standardized data colection forms. The folowing equation was used for quantification of 







The nested biological mechanisms study included a subset of the sample size of 29,620 
infants required for the parent trial. Given that we hypothesized that the outcome 
measures may be more important in preterm infants than ful term infants due to the 
immaturity of their skin, preterm infants were oversampled. Due to the limited number of 
instruments (VapoMeters, pH meters) available for multiple field sites, a total sample 
size of 1000 infants was selected, equaly stratified by 500 preterm and 500 ful term 
infants, in order to obtain the power needed to detect any possible efects of the diferent 
oil groups on skin integrity measurements. The analyses presented here represent a 
preliminary analysis of the first 63.7% of the anticipated enroled infants. 
 
Al analyses for these measurements were conducted using STATA v12 (Colege 
Station, TX). Possible risk factors related to the infant, mother, household and 
environment that may be associated with skin integrity measures were evaluated. These 
included measures of household demographics and socioeconomic status (SES), ethnic 
group, maternal and paternal education levels, maternal age, reproductive history, labor 
and delivery characteristics (place of birth, length and type of labor, type and practice of 
birth assistants), newborn characteristics and newborn care practices (sex, birthweight, 
gestational age, breastfeeding, smal-for-gestational age (SGA) status), and temperature 
and humidity measures. Outliers that were biologicaly impossible were removed from 
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the analyses on the basis that they were likely due to an instrument malfunction or 
measurement of another biological process (e.g. measurement of perspiration rather 
than TEWL). Skin pH values greater than 8 and less than 3 were removed (Marty 
Visscher, personal communication) as wel as TEWL values greater than 100 g/m2/hr. 
(Aki Immonen, personal communication) A total of 22 (<1%) skin pH measurements 
were removed, although due to using the mean of 3 measurements, this did not result in 
any lost observations. Thirty-nine (1.3%) TEWL observations were removed as a result 
of 133 (4%) measurements being out of range. 
 
A bivariate analysis was done for each potential risk factor using a mixed-methods 
approach with random intercepts, accounting for the repeated measures on each infant 
in the estimates of standard errors, to determine whether there was an association 
between any of the potential risk factors and any of the skin integrity measures. 
Additionaly, a multivariate model, accounting for multiple measures per infant, was 
constructed from risk factors that were statisticaly significantly associated with each skin 
integrity measure in the bivariate analyses and with variables that are believed to be 
associated with skin integrity in this population, but may not have been statisticaly 
significantly associated in the bivariate analyses. Co-linear variables were not included 
in the multivariate model. Mixed-effects models were also used to assess the 
relationship between time and skin integrity measures. Linear splines for infant’s age at 
measurement were used where needed to account for nonlinearity, assessed through 
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Results 
Between July 23, 2012 and September 30, 2013, there were a total of 1,876 ful term 
and 409 preterm live born infants in the study area that were eligible for enrolment in the 
biological mechanisms study. Of these infants, 785 were selected for enrolment to date 
(Figure 4-1). Of those selected, 148 (18.9%) died or were not met by the mechanisms 
study field worker before 48 hours after birth and 5 (0.6%) mothers refused their infant’s 
participation in the study. A total of 632 newborns were enroled, with 533 (84.3%) 
completing 28 days of folow-up. A total of 13 (2%) neonatal deaths occurred and 86 
(13.6%) infants moved before the 28 days were competed, most likely because the 
mother was returning to her husband’s house after giving birth at her maternal home or 
maiti. 
 
Infants’ background characteristics are shown in Table 4-2. Sex was fairly balanced with 
51.6% of the study population male and 48.4% of the population female. The mean 
gestational age of infants in this study was 37.7 (±3.6) weeks, however preterm infants 
were oversampled, so this is not representative of births in the population. Mean weight 
at the initial visit was 2611.8g (±483.8). Infants in this population are massaged with oil 
quite frequently. The average number of massages infants received per day during the 
first week of life was 4.5 (±1.4). 
 
Socioeconomic, household, and maternal characteristics are shown in Table 4-3. The 
majority of infants in this population were of Madeshi ethnicity (92.8%), compared with 
only 7.2% Pahadi. The majority of mothers gave birth in the home (71.5%) and only 
32.4% of women had a skiled atendant at delivery. In addition, 29.2% of women did not 
receive any antenatal care during pregnancy. Most women in this population had not 
received any education (71.7%) and only 28.5% of mothers were literate. 
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Table 4-4 shows some of the environmental characteristics during this study period. 
Only 8.3% of visits took place when the relative humidity was <60%. The mean 
temperature at visits during the study period was 28.7°C (±4.2) and the average relative 
humidity was 77.8% (±11.7). The average heat index, which is a function of the 
temperature and relative humidity, was 35.9°C (±9.0), and heat index exceeded 35°C on 
56% of study days. 
 
Risk Factors Related to TEWL 
	  
There is an overal trend of increasing TEWL during the neonatal period for infants in this 
study, with the fastest rate of increase occurring between days 0 and 3 (Figure 4-2). At 
visit 1, infants have a mean TEWL of 34.8 g/m2/hr (±22.9) and by visit 28 the mean 
TEWL increased to 43.3 g/m2/hr (±23.2) (Table 4-5). Between days 0 and 3, infants’ 
TEWL increased an estimated 1.71 g/m2/hr (95% CI: 0.86-2.55) per day (Table 4-6). 
Between days 4 and 28 TEWL continued increasing, but at a slower rate of 0.22 g/m2/hr 
(95% CI: 0.13-0.30) per day. Table 4-6 shows the possible risk factors of infant 
characteristics that may be associated with TEWL in this population. These bivariate 
analyses indicate that in addition to age, sex and hours before breastfeeding initiation 
were statisticaly significantly associated with TEWL. The results estimate that females 
had a TEWL value 3.77 g/m2/hr (95% CI: 1.09-6.44) lower than males. The results also 
indicated that infants who were first breastfed 5 or more hours after birth had TEWL 
values 6.44 g/m2/hr (95% CI: 0.21-12.68) higher compared with infants who were first 
breastfed less than 1 hour after birth. In this population, gestational age was not 
statisticaly significantly associated with diferences in TEWL, however there was a trend 
of increasing TEWL with increasing gestational age. 
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The bivariate analyses of variables associated with the mother and the household are 
shown in Table 4-7. These results indicate maternal literacy, whether the household had 
electricity, and whether the mother received antenatal care were statisticaly significantly 
associated with changes in TEWL. The results estimate infants whose mother is literate 
have 3.40 g/m2/hr (95% CI: 0.43-6.37) higher values of TEWL than infants whose 
mothers are iliterate. In addition, infants whose household had electricity had 3.71 
g/m2/hr (95% CI: 0.96-6.47) higher values of TEWL when compared with infants whose 
households did not have electricity. Infants whose mothers atended antenatal care visits 
also had increased TEWL when compared with infants whose mothers did not receive 
any antenatal care, with infants whose mothers atended 1-2 antenatal care visits having 
estimated TEWL measures 5.49 g/m2/hr (95% CI: 2.18-8.80) higher and infants whose 
mothers attended 3 or more antenatal care visits having higher TEWL of 5.28 g/m2/hr 
(95% CI: 1.93-8.64). 
 
Table 4-8 shows the results of bivariate analyses of variables related to the environment 
and their impact on TEWL. These results indicate temperature, humidity, and heat index 
are al statisticaly significantly associated with TEWL, with humidity associated with 
increases in TEWL and temperature and heat index associated with decreases. For 
each 10°C increase in temperature, TEWL is estimated to decrease 10.62 g/m2/hr (95% 
CI: 10.38-10.86). Similarly, with each 10°C increase in heat index, TEWL is estimated to 
decrease 4.9 g/m2/hr (95% CI: 3.7-6.1). With each 10% increase in relative humidity, 
TEWL is estimated to increase 5.1 g/m2/hr (95% CI: 4.3-5.9). Comparing infants’ TEWL 
values where the relative humidity at the time of TEWL measure was >80% with infants’ 
TEWL values where the relative humidity at the time of TEWL measure was <40%, 
TEWL values were 13.95 g/m2/hr (95% CI: 6.28-21.62) higher. 
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A multivariate model, adjusted for multiple measures per infant, was constructed from 
variables that were statisticaly significantly associated with TEWL in the bivariate 
analyses and with variables that may not have been staticaly significantly associated in 
the bivariate models but are believed to be associated with TEWL in this population. This 
model is shown in Table 4-9. The variables that were included in the multivariate model 
were: preterm status, sex, ethnicity (whether they were Pahadi or Madeshi), maternal 
literacy, whether the household had electricity, antenatal care, time from birth to 
breastfeeding initiation, temperature, relative humidity, and infant’s age from days 0 to 3 
and 4 to 28 (using linear splines to account for nonlinearity). Unlike in the bivariate 
analyses, in the multivariate model, there were no statisticaly significant associations 
between maternal literacy or whether a household had electricity with TEWL. In addition, 
there were no statisticaly significant associations between ethnicity and term status on 
TEWL. In this model, female infants were estimated to have a TEWL 2.99 g/m2/hr (95% 
CI: 0.40-5.57) lower than male infants. Infants whose mothers atended 1-2 antenatal 
care visits had increased TEWL of 4.68 g/m2/hr (95% CI:	  1.42-7.94) when compared with 
infants whose mothers did not receive any antenatal care. Infants whose mothers 
atended 3 or more antenatal care visits had estimated TEWL measures 3.87 g/m2/hr 
(95% CI: 0.53-7.22) higher when compared with infants whose mothers received no 
antenatal care. Infants who had breastfeeding initiated 5 or more hours after birth had an 
estimated increase in TEWL measures of 5.89 g/m2/hr (95% CI: 0.29-11.49) compared 
with infants who had breastfeeding initiated within 1 hour. When controling for other 
variables in the model, for each increase in temperature of 10°C, TEWL was estimated 
to decrease 12.4 g/m2/hr (95% CI: 9.7-15.0) and with each increase of 10% relative 
humidity, TEWL was estimated to increase 3.6 g/m2/hr (95% CI: 2.8-4.5). In the 
multivariate model, TEWL increased an estimated 0.96 g/m2/hr (95% CI: 0.05-1.87) per 
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day between days 0 and 3 and 0.20 g/m2/hr (95% CI: 0.11-0.29) per day between days 4 
and 28. 
 
Risk Factors Related to Skin pH 
	  
The relationship of skin pH with age during the neonatal period is shown in Figure 4-3. 
There is a decrease in skin pH throughout the neonatal period, with a greater rate of 
decrease during the first 7 days of life (estimated to be 0.14 (95% CI: 0.13-0.14) per 
day), and a slower rate of decrease from days 8 to 28 (estimated to be 0.016 (95% CI: 
0.014-0.018) per day) (Table 4-10). Infants in this population have an estimated mean 
skin pH of 6.03 (±0.52) and 4.82 (±0.57) at visits 1 and 28 respectively (Table 4-5). 
Possible infant characteristics that may be associated with skin pH in this population are 
shown in Table 4-10. The results from the bivariate analyses indicate that along with 
age, both birthweight and time between folow-up visit and last massage were 
statisticaly significantly associated with skin pH. The results estimate that low 
birthweight infants (<2500g) had mean skin pH values 0.089 (95% CI: 0.032-0.15) 
higher than infants who were not low birthweight. For each 100g increase in first weight 
measurement at the initial birth assessment, infants’ skin pH values decreased an 
estimated 0.011 (95% CI: 0.005 -0.017). Infants who had a longer interval between the 
folow-up visit and time since last massaged tended to have lower skin pH values than 
infants who had a shorter interval. Infants who were last massaged between 120 and 
179 minutes before the folow-up visit had a mean skin pH 0.089 (95% CI: 0.0037-0.18) 
lower compared with infants who were massaged less than 30 minutes before the visit. 
Infants massaged more than 180 minutes before the folow-up visit had skin pH values 
0.23 (95% CI: 0.16-0.30) lower than infants massaged less than 30 minutes before the 
visit.  
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Table 4-11 shows the bivariate analyses results of variables associated with the mother 
and the household. These results indicate ethnicity (Madeshi or Pahadi), maternal and 
paternal literacy, maternal and paternal education, number of household assets, whether 
the household had electricity, facility delivery, and skiled atendant at delivery were 
statisticaly significantly associated with changes in skin pH. Infants whose family is 
Madeshi are estimated to have a skin pH 0.15 (95% CI: 0.043-0.26) higher compared 
with infants whose family is Pahadi. The results indicate that infants who have one or 
both parents who are educated or literate have lower skin pH values than infants whose 
parents are not. Infants whose mother is literate have 0.080 (95% CI: 0.017-0.14) lower 
values of skin pH than infants whose mothers are iliterate. Similarly, infants whose 
father is literate have estimated skin pH values 0.082 (95% CI: 0.025-0.14) lower than 
infants whose fathers are iliterate. In addition, infants whose mothers have between 1 
and 5 years of education have skin pH values 0.10 (95% CI: 0.0011-0.20) lower than 
infants whose mothers have no education and infants whose fathers have between 6 
and 10 years of education have skin pH values 0.11 (95% CI: 0.045-0.17) lower than 
infants whose fathers have no education. Infants whose households were of higher 
socioeconomic status (measured by number of household assets and whether the 
household had electricity) also tended to have lower skin pH values. Infants whose 
household had electricity had skin pH values 0.077 (95% CI: 0.019-0.13) lower 
compared with infants whose households did not have electricity. Similarly, infants 
whose families had between 6 and 10 household assets and more than 10 household 
assets had skin pH values 0.14 (95% CI: 0.026-0.26) and 0.28 (95% CI: 0.066-0.49) 
lower compared with infants whose households had 0 or 1 asset(s). Infants whose 
mothers delivered at a facility had estimated skin pH values 0.076 (95% CI: 0.013 -0.14) 
lower compared with infants whose mothers delivered at home and infants who had a 
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skiled atendant at delivery had estimated skin pH values 0.085 (95% CI: 0.025-0.15) 
lower compared with infants with no skiled atendant at delivery. 
 
Bivariate analyses showing results of variables related to the environment and their 
impact on skin pH are shown in Table 4-12. These results indicate that temperature, 
humidity, and heat index are al statisticaly significantly associated with skin pH, with 
increased humidity being associated with higher skin pH values and temperature and 
heat index being associated with lower skin pH values. For each 10°C increase in 
temperature, skin pH is estimated to decrease 0.19 (95% CI: 0.13-0.25). Similarly, with 
each 10°C increase in heat index, skin pH is estimated to decrease 0.05 (95% CI: 0.02-
0.08). With each 10% increase in relative humidity, skin pH is estimated to increase 
0.078 (95% CI: 0.056-0.10).  
 
A multivariate model was constructed from variables that were statisticaly significantly 
associated with skin pH in the bivariate analyses and with variables that may not have 
been statisticaly significantly associated in the bivariate analyses but are believed to be 
associated with skin pH in this population. The variables included in the multivariate 
model were: preterm status, sex, ethnicity, being low birthweight, maternal literacy, 
paternal literacy, whether the household had electricity, number of household assets, 
whether a skiled atendant was present during delivery, the time between the visit and 
the last massage, temperature, relative humidity, and infant’s age in days from day 0 to 
7 and from days 8 to 28 (using linear splines to account for nonlinearity). The results 
from this model are shown in Table 4-13. Mother’s and father’s education, facility 
delivery, and heat index were not included due to colinearity with other variables. Unlike 
in the bivariate analyses, in the multivariate model, there was no statisticaly significant 
association between maternal or paternal literacy, whether a household had electricity, 
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number of household assets, whether there was a skiled atendant at delivery, or time 
from last massage to folow-up visit with skin pH. In addition, there was no statisticaly 
significant association between whether an infant was preterm or sex on skin pH. After 
controling for other variables in the model, Madeshi infants’ skin pH was estimated to be 
0.13 (95% CI: 0.025-0.25) higher than Pahadi infants’ skin pH. In the multivariate model, 
infants who were of low birthweight had skin pH values 0.059 (95% CI: 0.0015-0.12) 
higher compared with infants who were 2500g or more. In this model, for each 10°C 
increase in temperature, skin pH was estimated to decrease 0.23 (95% CI: 0.17-0.29) 
and with each 10% increase in relative humidity, skin pH was estimated to increase 
0.057 (95% CI: 0.038-0.075). When controling for other variables in the model, between 
days 0 and 7, skin pH is estimated to decrease 0.14 (95% CI: 0.13-0.15) per day. When 
an infant is between 8 and 28 days old, skin pH is estimated to decrease 0.015 (95% CI: 
0.012-0.017) per day. 
 
Risk Factors Related to Stratum Corneum Protein Concentration 
	  
The relationship between stratum corneum protein concentration removed using skin 
discs during the neonatal period is shown in Figure 4-4, with lower stratum corneum 
protein concentrations removed per day during the first week (indicating an increasingly 
more cohesive and wel developed stratum corneum) folowed by a slight increase per 
day from days 8 to 28. Infants started with a high mean stratum corneum protein 
concentration of 16.4 µg/cm2 (±7.9) at visit 1, had decreasing protein concentration until 
visit 7 (12.9 µg/cm2 (±6.4)), and had an increased mean at visit 28 of 14.0 µg/cm2 (±6.1) 
(Table 4-5). During the first week of life, the estimated amount of protein removed 
decreased 0.58 µg/cm2 (95% CI: 0.46-0.70) per day, whereas after day 7 the estimated 
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amount of protein removed increased 0.06 µg/cm2 (95% CI: 0.02-0.10) per day (Table 4-
14).  
 
Additional risk factors of infant characteristics that may be associated with protein 
concentration in this population are shown in Table 4-14. The results from the bivariate 
analyses indicate that the only variable related to the infant apart from age that was 
statisticaly significantly associated with protein concentration was the time between the 
visit and the last time the infant was massaged, although smaler infants (preterm and 
lower birthweight) tended to have greater concentrations of protein removed. Infants 
with a greater amount of time since their last massage tended to have higher protein 
concentrations, with infants massaged between 60 and 119 minutes before the folow-up 
visit having an estimated 1.47 µg/cm2 (95% CI: 0.54-2.40) higher protein concentrations 
compared with infants massaged less than 30 minutes before the folow-up visit. In 
addition, infants massaged between 120 and 179 minutes and infants massaged more 
than 180 minutes before the folow-up visit had estimated protein concentrations 1.22 
µg/cm2 (95% CI: 0.15-2.30) and 1.78 µg/cm2 (95% CI: 0.88-2.68) higher respectively, 
when compared with infants massaged less than 30 minutes before the folow-up visit. 
 
Table 4-15 shows the results of bivariate analyses of variables associated with the 
mother and the household and stratum corneum protein concentration. These results 
indicate paternal literacy, paternal education, whether the household had electricity, 
whether the mother received antenatal care, and length of labor were statisticaly 
significantly associated with changes in protein concentration. Infants whose fathers 
were literate or educated tended to have lower amounts of protein concentrations than 
infants whose fathers were not. The results estimate infants whose fathers are literate 
have 0.92 µg/cm2 (95% CI: 0.23-1.60) lower protein concentrations than infants whose 
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father is iliterate and when compared to infants whose fathers received no education, 
infants whose fathers received between 6 and 10 years had 1.08 µg/cm2 (95% CI: 0.29-
1.87) lower protein concentrations. In addition, infants whose households had electricity 
had 0.85 µg/cm2 (95% CI: 0.15-1.55) lower protein concentrations when compared with 
infants whose households did not have electricity. When compared with infants whose 
mothers did not receive any antenatal care, infants whose mothers received antenatal 
care also tended to have lower protein concentrations, with infants whose mothers 
atended 1-2 antenatal care visits having protein concentrations 1.07 µg/cm2 (95% CI: 
0.22-1.93) lower. Infants whose mothers were in labor more than 5 hours tended to have 
lower protein concentrations as wel. Infants whose mothers were in labor between 5 
and 14 hours had protein concentrations 0.89 µg/cm2 (95% CI: 0.16-1.62) lower 
compared with infants whose mothers were in labor less than 5 hours.  
 
Bivariate analyses of variables related to the environment and their impact on protein 
concentrations, indicated that increasing temperature, humidity, and heat index were al 
statisticaly significantly associated with a decrease in protein concentration (Table 4-
16). For each 10°C increase in temperature, protein concentration decreased an 
estimated 2.0 µg/cm2 (95% CI: 1.3-2.7). Similarly, with each 10°C increase in heat index, 
protein concentration decreased an estimated 1.4 µg/cm2 (95% CI: 1.0-1.7). With each 
10% increase in relative humidity, a decrease of 0.6 µg/cm2 (95% CI: 0.4-0.9) in protein 
concentration is estimated. 
 
The results of a multivariate model constructed from variables that were statisticaly 
significantly associated with protein concentration in the bivariate analyses and with 
variables that may not have been statisticaly significantly associated in the bivariate 
analyses but are believed to be associated with stratum corneum protein concentration 
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in this population are shown in Table 4-17. The variables included in the multivariate 
model were: preterm status, sex, ethnicity, paternal literacy, whether the household had 
electricity, antenatal care received during pregnancy, length of labor, time between visit 
and last massage, temperature, relative humidity, and infant’s age from days 0 to 7 and 
days 8 to 28 (using splines to account for nonlinearity). Paternal education and heat 
index were not included due to colinearity with other variables. Unlike in the bivariate 
analyses, in the multivariate model, there was no statisticaly significant association 
between either number of antenatal care visits or whether a household had electricity 
with protein concentration. In addition, there was no statisticaly significant association 
between sex, ethnicity, or whether an infant was born preterm or ful term on stratum 
corneum protein concentrations. After controling for other variables in the model, infants 
whose mothers were in labor more than 5 hours tended to have lower protein 
concentrations, with infants whose mothers were in labor from 5 to 14 hours having 
protein concentrations 0.79 µg/cm2 (95% CI: 0.12-1.46) lower when compared with 
infants whose mothers were in labor for less than 5 hours. Infants whose fathers were 
literate had estimated protein concentrations 0.96 µg/cm2 (95% CI: 0.28-1.64) lower than 
infants whose fathers were iliterate. Increasing time from last massage continued to 
show a statisticaly significant trend of increasing protein concentration in the multivariate 
model. Infants who were massaged between 60 and 119 minutes before the folow-up 
visit had estimated protein concentrations 1.55 µg/cm2 (95% CI:  0.65-2.44) higher 
compared with infants who were massaged less than 30 minutes before the visit. Those 
infants who were massaged between 120 and 179 minutes and more than 180 minutes 
before the visit had protein concentrations 1.43 µg/cm2 (95% CI: 0.39-2.48) and 1.34 
µg/cm2 (95% CI: 1.46-3.22) higher respectively, when compared with infants massaged 
less than 30 minutes before the folow-up visit. When controling for other variables in the 
model, for each 10°C increase in temperature, protein concentration was estimated to 
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decrease 3.1 µg/cm2 (95% CI: 2.4-3.8) and with each 10% increase in relative humidity, 
protein concentration was estimated to decrease 0.84 µg/cm2 (95% CI: 0.58-1.1). After 
controling for other variables, the relationship between infants’ age and protein 
concentration persisted, with protein concentrations estimated to decrease 0.57 µg/cm2 
(95% CI: 0.45-0.69) per day between days 0 and 7 and estimated to increase 0.045 
µg/cm2 (95% CI: 0.0047- 0.085) per day between days 8 and 28. 
 
Risk Factors Related to Skin Condition 
	  
Figure 4-5 shows the relationships between erythema and rash skin condition scores 
measured on the chest region over the neonatal period. As an infant gets older, 
erythema scores tend to increase (become worse) from days 0 to 3, show no or very 
litle change over days 4 to 14, and then decrease (improve) from days 15 to 28. Infants 
in this population started with a mean skin erythema score of the chest region of 0.53 
(±0.67) at visit 1, which increased to 0.83 (±0.66) at visit 3. Visits 14 and 28 had the 
same mean skin erythema scores as visits 3 and 1 respectively (Table 4-5). Between 
days 0 and 3 erythema scores showed an estimated increase of 0.14 (95% CI: 0.11-
0.17) per day. During the period between days 4 and 14, there was no statisticaly 
significant change in erythema scores, however, from day 15 to 28, erythema scores 
showed an estimated decrease of 0.021 (0.017-0.025) per day (Table 4-18). 
 
In addition to age, Table 4-18 shows other possible risk factors of infant characteristics 
that may be associated with erythema in this population. The results from the bivariate 
analyses indicate that both birthweight and average number of massages per week 
during the first week of life were statisticaly significantly associated with erythema. For 
each 100g increase in birthweight, infants’ erythema scores in this region increased an 
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estimated 0.0084 (95% CI: 0.0017-0.015). For each additional massage received during 
the first week of life, infants’ erythema scores in the chest region decreased 0.023 (95% 
CI: 0.00035-0.046).  
 
Infants in this population tended to have increasing (worsening) rash scores in the chest 
region until day 14, with decreasing rash scores from day 14 to 28 (Figure 4-5). At visit 
1, infants started with an estimated mean rash score of 0.15 (±0.42), reached a high 
rash score of 1.01 (±0.80) at visit 14, before having a lower mean rash score at visit 28 
of 0.68 (±0.72) (Table 4-5). Between days 0 and 14, rash scores are estimated to 
increase 0.058 (95% CI: 0.052-0.063) per day. After day 14, rash scores are estimated 
to decrease 0.031 (95% CI: 0.025-0.036) per day (Table 4-19). Other characteristics that 
were statisticaly significantly associated with rash in the chest region in the bivariate 
models included: gestational age, birthweight, whether an infant was smal-for-
gestational age, average number of massages an infant received during the first week of 
life, and time from visit to last massage. Smaler infants (those who were preterm or of 
low birthweight) tended to have lower rash scores. Preterm infants had rash scores 
0.083 (95% CI: 0.015-0.15) lower than ful term infants. Infants who were between 32 
and 36 weeks gestational age had rash scores 0.077 (95% CI: 0.0058-0.15) lower than 
ful term infants. For each increase in week of gestational age, infants’ rash scores 
increased an estimated 0.014 (95% CI: 0.0041-0.023). Low birthweight infants had rash 
scores 0.16 (95% CI: 0.092-0.23) lower than infants weighing 2500g or more at the birth 
visit. For each increase in 100g of birthweight, infants’ rash scores increased 0.024 (95% 
CI: 0.017-0.031). In addition, infants who were smal-for-gestational age and in the 3rd 
percentile or lower had rash scores 0.087 (95% CI: 0.0046-0.17) lower compared to 
infants who were adequate-for-gestational age (AGA). For each increase in number of 
times massaged per week infants had a 0.042 (95% CI: 0.019-0.068) lower rash score. 
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Also, infants who were massaged more than 180 minutes before the folow-up visit had 
estimated rash scores 0.097 (95% CI: 0.015-0.18) higher than infants massaged <30 
minutes before the folow-up visit. 
 
Table 4-20 shows the results of bivariate analyses of variables associated with the 
mother and the household that may afect skin erythema. These results indicate that 
whether the household had electricity, maternal age, facility delivery, and skiled 
atendant at delivery were statisticaly significantly associated with erythema. Infants 
whose mothers were older than 18 years of age had higher erythema scores than those 
whose mothers were younger than 18 years of age. Infants whose mothers were 
between 18 and 24 years old were estimated to have 0.097 (95% CI: 0.0013-0.19) 
higher skin erythema scores compared with infants whose mothers were less than 18 
years old. Infants whose mothers were between 25 and 29 years old were estimated to 
have 0.11 (95% CI: 0.0016-0.22) higher erythema scores in the chest region compared 
with infants whose mothers were less than 18 years. Infants whose household had 
electricity had erythema values 0.094 (95% CI: 0.029-0.16) lower compared with infants 
whose households did not have electricity. Facility deliveries were associated with an 
estimated erythema score 0.13 (95% CI: 0.058-0.20) lower compared with home 
deliveries and infants who had a skiled atendant at delivery had estimated skin 
erythema scores 0.11 (95% CI: 0.038-0.17) lower compared with infants with no skiled 
atendant at delivery.  
	  
The bivariate analyses results of variables associated with the mother and the 
household that may afect skin rash scores are shown in Table 4-21. Ethnicity, maternal 
age, gravidity, and parity al showed a statisticaly significant association with skin rash 
scores. Madeshi infants had rash scores 0.17 (95% CI: 0.038-0.30) lower compared with 
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Pahadi infants. Increases in maternal age and numbers of previous pregnancies and 
deliveries were al associated with increases in rash scores. Mothers who were 18-24 
years old at the time of birth and mothers who were 25-29 years old at the time of birth 
had infants with rash scores 0.15 (95% CI: 0.050-0.26) and 0.18 (95% CI: 0.058-0.29) 
higher respectively compared with infants whose mothers were less than 18 years old. In 
addition, infants whose mothers were between 30 and 34 years old had rash scores 0.19 
(95% CI: 0.027-0.36) higher compared with infants whose mothers were less than 18 
years old. Infants whose mother had 1-2 or 3 or more previous pregnancies had rash 
scores 0.098 (95% CI: 0.016-0.18) and 0.14 (95% CI: 0.050-0.23) higher respectively 
compared with infants whose mother had no previous pregnancies. Likewise, infants 
whose mother had 1-2 or 3 or more previous deliveries had rash skin scores 0.090 (95% 
CI: 0.0085-0.17) and 0.15 (95% CI: 0.060-0.27) higher respectively compared with 
infants whose mother had no previous deliveries. 
 
The results of bivariate analyses of variables related to the environment and their impact 
on skin erythema scores are shown in Table 4-22. These results indicate that both 
temperature and heat index were statisticaly significantly associated with erythema. For 
each 10°C increase in temperature, skin erythema scores were estimated to decrease 
0.26 (95% CI: 0.19-0.32). Similarly, with each 10°C increase in heat index, erythema 
scores were estimated to decrease 0.12 (95% CI: 0.085-0.15). There was no statisticaly 
significant association with erythema scores and relative humidity.  
 
The results of bivariate analyses of variables related to the environment and their impact 
on skin rash scores for the chest region are shown in Table 4-23. Both relative humidity 
and heat index were statisticaly significantly associated with rash scores. For each 10% 
increase in relative humidity, rash scores increased 0.045 (95% CI: 0.019-0.07). For 
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each 10°C increase in heat index, rash scores increased 0.055 (95% CI: 0.02-0.09). 
Temperature was not statisticaly significantly associated with rash scores, however 
there was a trend of increasing rash scores as temperature increased. 
 
Table 4-24 shows the multivariate model constructed from variables that were 
statisticaly significantly associated with skin erythema in the bivariate analyses and with 
variables that may not have been statisticaly significantly associated with erythema in 
the bivariate analyses but are believed to be associated with erythema in this population. 
The variables included in the multivariate model were: preterm status, sex, ethnicity, 
birthweight, average number of massages per day during the first week of life, whether 
the household had electricity, maternal age, facility delivery, temperature, relative 
humidity, and infant’s age between days 0 and 3, 4 and 14, and 15 and 28 (using linear 
splines to account for nonlinearity). Whether there was a skiled birth atendant at 
delivery and heat index were not included due to colinearity with other variables. Unlike 
in the bivariate analyses, in the multivariate model, there was no statisticaly significant 
association between erythema and average number of massages during the first week 
of life. In addition, there was no statisticaly significant association between either an 
infant’s term status or sex on erythema. After controling for other variables in the model, 
Madeshi infants’ erythema scores were estimated to be 0.14 (95% CI: 0.017-0.27) lower 
than Pahadi infants’ erythema scores. In the multivariate model, for each 100g increase 
in birthweight infants had an increase in erythema scores of 0.0073 (95% CI: 0.0002-
0.014). Infants whose mothers were between 18 and 24 years old had erythema scores 
0.10 (95% CI: 0.0096-0.20) higher compared with infants whose mothers were less than 
18 years old. Whether a household had electricity was associated with a 0.088 (95% CI: 
0.025-0.15) lower skin erythema score and facility deliveries were associated with a 0.11 
(95% CI: 0.039-0.18) decrease in erythema scores. When controling for other variables 
	   121 
in the model, for each 10°C increase in temperature, erythema scores were estimated to 
decrease 0.25 (95% CI: 0.18-0.31). In the multivariate model throughout an infant’s first 
month of life, erythema scores increased an estimated 0.13 (95% CI: 0.11-0.16) per day 
between days 0 and 3, showed no statisticaly significant change between days 4 and 
14, and decreased an estimated of 0.022 (95% CI: 0.017-0.027) per day between days 
15 and 28. 
 
The multivariate model constructed from variables that were statisticaly significantly 
associated with skin rash in the bivariate analyses and with variables that may not have 
been statisticaly significantly associated with rash in the bivariate analyses but are 
believed to be associated with rash in this population is shown in Table 4-25. Variables 
included in the model were: preterm status, sex, ethnicity, birthweight, average number 
of massages received per day during the first week of life, time between folow-up visit 
and last massage, maternal age, parity, temperature, relative humidity, and infant’s age 
from days 0 to 14 and days 15 to 28 (using splines to account for nonlinearity). The 
multivariate model showed no statisticaly significant association between skin rash 
scores and preterm status, sex, average number of massages per day during the first 
week of life, time between folow-up visit and last massage, or maternal age. These 
results estimate that when controling for other variables in the model, Madeshi infants 
had rash scores 0.17 (95% CI: 0.032-0.31) lower compared with Pahadi infants. Also, 
infants with birthweight less than 2500g had rash scores 0.12 (95% CI: 0.044-0.19) 
lower than infants who weighed at least 2500g. Mothers with 3 or more prior deliveries 
had infants with rash scores 0.13 (95% CI: 0.017-0.25) higher compared with infants 
whose mothers had no prior deliveries. Although in the bivariate model there was not a 
statisticaly significant association between rash scores and temperature, in the 
multivariate model, for each 10°C increase in temperature, infants’ rash scores were 
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estimated to increase 0.13 (95% CI: 0.059-0.21). In addition, for each 10% increase in 
relative humidity, infants’ rash scores were estimated to increase 0.053 (95% CI: 0.028-
0.079). After controling for other variables in the model, when an infant was between 0 
and 14 days old, rash scores were estimated to increase 0.059 (95% CI: 0.053-0.064) 
per day. An infant’s rash score was estimated to decrease 0.030 (95% CI: 0.025-0.036) 
per day between days 15 and 28. 
 
Risk factor associations with skin erythema and rash were also examined for the left arm 
and the right leg. These regions showed very similar risk factor associations as the chest 
region with a few slight diferences (Appendix A). Erythema in the left arm region 
showed a statisticaly significant association with gestational age and SGA in the 
bivariate analyses with smaler infants having lower erythema scores, however these 
associations were not statisticaly significant in the multivariate analysis. In addition, the 
average number of massages per day during the first week of life was not statisticaly 
significantly associated with erythema in the bivariate analysis for the left arm, unlike for 
the chest. There remained a statisticaly significant association between rash and 
preterm status for the left arm region in the multivariate model, unlike with the chest 
region, with preterm infants having lower rash scores. 
 
When comparing the diferences in variables associated with erythema and rash in the 
right leg region to the chest region, SGA was statisticaly significantly associated with 
erythema and rash (with smaler infants having lower scores) in the right leg region in the 
bivariate model, which was not the case in the chest region. However, this was not 
statisticaly significant in the multivariate model. Also, average number of massages per 
day during the first week was not statisticaly significantly associated with erythema in 
the right leg region in the bivariate model, while it was in the chest region. In the 
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multivariate model for the right leg region, ethnicity was not statisticaly significantly 
associated with erythema, however it was statisticaly significant in the multivariate 
model for rash. Also, preterm status and time between folow-up visit and last massage 
were statisticaly significantly associated with skin rash in the right leg region in the 
multivariate model, with preterm infants having lower estimated rash scores and infants 
massaged more than 30 minutes before the folow-up visit having lower rash scores, 
with statisticaly significant diferences seen in infants massaged between 30 and 119 
minutes before the folow-up visit. 
 
Table 4-26 shows how select infant and environmental characteristics were associated 
with the skin integrity measurements in the multivariate models. Preterm status was not 
staticaly significantly associated with any of the skin integrity measures in the 
multivariate models. Low birthweight infants were statisticaly significantly associated 
with higher skin pH and lower erythema and rash scores. Female infants had lower 
TEWL scores than male infants. Increasing temperature was statisticaly significantly 
associated with a decrease in al of the skin integrity measures except rash, with which it 
was associated with increasing scores. Increasing relative humidity was statisticaly 
significantly associated with increasing TEWL, skin pH, and rash scores and decreasing 
protein concentration.  
 
Discussion 
This study examined some of the possible risk factors related to skin integrity measures 
of TEWL, skin pH, stratum corneum protein concentration, and skin condition in a 
population of neonates in rural Nepal. We found that in this population, TEWL measures 
increased over the entire neonatal period with the greatest rate of increase per day 
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occurring from days 0 to 3. This is in contrast to other studies that found TEWL 
measures in ful term infants to be lower than or equal to adults and to remain relatively 
stable during the first month of life, indicating a highly efective skin barrier. (Cunico, 
Maibach et al. 1977; Yosipovitch, Maayan-Metzger et al. 2000) TEWL measures in 
preterm infants have also been shown to decrease relatively quickly during the first few 
days and then level of during the first month of life. (Agren, Sjörs et al. 1998; Kalia, 
Nonato et al. 1998) These diferences in results could be explained by the diferences in 
study design between our study and previous studies, as previous studies were done at 
low relative humidity. In addition, in one study the reported TEWL was corrected to a 
relative humidity of 50% (Agren, Sjörs et al. 1998) and another study was done in very 
premature babies who were in incubators. (Kalia, Nonato et al. 1998) To our knowledge, 
this is the first time TEWL has been measured in this type of population and environment 
(i.e. a community seting with consistently high humidity), therefore an infant’s skin may 
not be undergoing the changes one would normaly expect when adapting from a warm, 
humid environment in utero, to a cool, dry extrauterine environment. Relative humidity 
was high in our study environment where the average relative humidity was 77.8% 
(±11.7). In addition, relative humidity was associated with increasing TEWL in this study. 
This relationship of increasing TEWL with increasing humidity is similar to that found in a 
study where infants were randomized to care in an environment with 50% relative 
humidity (RH) or 75% RH. TEWL decreased more slowly in the group randomized to 
75% RH during the first month of life and after 28 days the group at 75% RH had higher 
TEWL values, indicating delayed epidermal barrier maturation. (Agren, Sjörs et al. 2006) 
Our findings support this study, suggesting that the use of increasing relative humidity as 
a strategy for neonatal care in preterm infants should consider the impact this might 
have on delaying skin barrier maturation. (Fluhr, Darlenski et al. 2010) 
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In addition, although many studies have shown a relationship between TEWL and 
gestational age, with preterm infants having higher values of TEWL, we did not find a 
relationship between TEWL and gestational age in this population. (Hammarlund and 
Sedin 1979; Harpin and Ruter 1983) However, the most pronounced diferences in 
TEWL between ful term and preterm infants in these studies were found in infants with 
gestational ages less than 32 weeks, of which there were fewer than 40 in our study 
population, which may have made an association unable to be detected. Interestingly, 
being female in this population was associated with having lower TEWL measures 
compared with being male, whereas other studies have found no diferences in TEWL 
values between sexes. (Harpin and Ruter 1983; Yosipovitch, Maayan-Metzger et al. 
2000) Another interesting finding was that higher levels of measures of socioeconomic 
status, such as education and literacy, were associated with higher values of TEWL in 
this population. 
 
Infants in this study had decreasing skin pH values during the first month of life, with the 
greatest rate of decrease occurring during the first week, similar to findings of other 
studies. (Visscher, Chaterjee et al. 2000; Yosipovitch, Maayan-Metzger et al. 2000; 
Hoeger and Enzmann 2002) Being low birthweight was also associated with higher skin 
pH values, in contrast with other studies finding no association between birthweight and 
skin pH. (Green, Carol et al. 1968) In addition, temperature and humidity showed 
difering relationships with skin pH, with increasing temperature being associated with 
decreasing skin pH and increasing humidity being associated with increasing in skin pH. 
Humidity may have a more important influence on the sweat response in infants in this 
population, as sweat may be unable to evaporate at such high humidity levels. As such, 
this increase in skin pH with increasing humidity could be a result of measuring the pH of 
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sweat on the skin, which has been shown to result in higher skin pH measures. 
(Herrmann and Mandol 1955; Parra and Paye 2003) 
 
Throughout the first month of life, infants showed a trend of decreasing stratum corneum 
protein concentrations removed per day during the first week folowed by a slight 
increase in protein concentrations per day throughout the rest of the neonatal period. 
This indicates that during the first week of life, the stratum corneum is undergoing 
maturation as decreasing protein concentrations removed using the D-squame discs 
indicates increased cohesion of the stratum corneum. (Berthaud and Boncheva 2011; 
Myer and Maibach 2013) The slight increase in protein concentration per day after the 
first week of life could indicate the stratum corneum is starting to regenerate, causing old 
skin cels to shed and the stratum corneum to be less cohesive. (Chiou and Blume-
Peytavi 2004) Time between visit and last massage was also associated with changes in 
stratum corneum protein concentration, with infants with greater time since last massage 
tending to have higher levels of protein concentration removed. This could be due to the 
universal use of emolients for massage in infants in this population, which could prevent 
protein from being removed if it is colected sooner after the massage has taken place as 
the barrier of oil between the disc and the stratum corneum may prevent removal. In 
addition, increased measures of SES status were associated with a decrease in protein 
concentration, indicating that infants who are beter of may have beter barrier function 
than infants who are less wel of. Increases in temperature and humidity were also 
associated with a decrease in protein concentration. This again could be due to an 
increase in sweat that may be present, with the sweat acting as a barrier between the D-
squame disc and the skin, resulting in less protein being removed. (Foster, Hey et al. 
1969) 
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Erythema and rash are measures of irritation of the skin. The relationship between skin 
condition score and infant’s age in this population indicated a worsening in erythema 
during the first days of life (days 0-3), with a leveling of period of very litle to no change 
from days 4 to 14, and a period of improvement in the last two weeks. Rash scores 
tended to become worse during the first 2 weeks and to improve during the second 2 
weeks of life. Smaler infants, those who were preterm or of low birthweight, were 
associated with lower erythema and rash scores than larger infants. These are similar to 
findings from a study by Visscher et al., which found lower perineal irritation (erythema 
and rash) in premature infants. (Visscher, Taylor et al. 2013) However, these data 
examined diferences in a diapered region of the skin, which may not be comparable to 
data in our study. Higher measures of SES status were associated with improved 
erythema scores, however Madeshi infants, who are generaly of lower SES than Pahadi 
infants had lower erythema and rash scores than Pahadi infants. This diference may be 
related to diferent skin pigmentations. Interestingly, increases in temperature were 
associated with a decrease in erythema, however increases in temperature and humidity 
were both associated with increases in rash scores. This is most likely due to the 
presence of miliaria, a common rash in newborns caused by retention of sweat due to 
immaturity of eccrine structures. (Zuniga and Nguyen 2013) 
 
Although this study had many strengths including its large sample size and oversampling 
of preterm infants, it also had some limitations. Due to the fact that measurements were 
made at homes in this rural community it was sometimes dificult to folow the 
recommended measurement protocols for the instruments. For example, the standard 
TEWL measurement protocol normaly requires the skin to be bare and in a stil position 
for up to 30 minutes prior to measuring so that it acclimatizes to the environment. (Aki 
Immonen, personal communication) We were not able to do this in our study, which may 
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have resulted in higher measurements as infants usualy had their skin covered before 
and between measurements. In addition, it is recommended that TEWL measurements 
be taken in an environment that is less than 50% relative humidity and between 20-
22°C, which never occurred during our study period. (Rogeries and Group 2001) A 
similar temperature controled environment is recommended for skin pH measures. 
(Parra and Paye 2003) However, as temperature and humidity were controled for in our 
multivariate models, this should not have impacted the associations of the other possible 
risk factors in those models.  
 
In addition, a mother’s recaled date of last menstrual period (LMP) was used to 
determine gestational age (GA), which may have resulted in inaccurate estimates of GA 
in our study. A study done in a tertiary-care hospital in Bangladesh found that LMP 
underestimated GA by one day compared with estimation from ultrasound. (Rosenberg, 
Ahmed et al. 2009) Another study done at a hospital in Pakistan found that only 65% 
and 82% of estimated GA of reported LMP were within 7 and 14 days, respectively when 
compared to GA estimates using ultrasound. (Jehan, Zaidi et al. 2010) Despite the 
problems of the uncertainty of LMP date, in this community seting in rural Nepal, the 
low-cost and simple method of reported LMP is the best option for estimating GA. In 
addition, LMPs in our study were colected as soon as a pregnancy was identified 
(folowing-up women every 5 weeks) which would minimize the amount of recal bias. 
 
This study examined only some of the possible risk factors on skin barrier properties in 
this population. As neonatal oil massage is a nearly universal practice, we were not able 
to determine whether massage itself, diferent types of massage (i.e. vigorous vs. 
gentle), or massage with emolient were associated with skin integrity measurements. 
(Mulany, Darmstadt et al. 2005) However, we were able to examine the associations 
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between average number of massages per day during the first week of life and time 
since last massage, which showed no statisticaly significant associations in the 
multivariate models, apart from time since massage with stratum corneum protein 
concentrations. Further research should be conducted in this population investigating 
whether diferent massage practices are associated with skin integrity measurements. 
This type of study would be dificult to do in this community due to cultural behaviors; 
however, a smaler group of neonates in an urban area may be more wiling to accept 
behavioral change interventions relating to massage. Another possibility is to enrol older 
infants past the age when it is considered a cultural necessity to massage the infants, 
although this would not alow the measurement of skin maturity. Relationships between 
the diferent skin integrity measures should also be examined. 
 
Newborn skin is an infant’s first defense in protection against many environmental 
factors. If emolient therapy with vegetable oil is to be explored as a possible way of 
improving health in newborns, it is important to understand the risk factors associated 
with diferences in skin barrier integrity in the populations that routinely practice neonatal 
oil massage. These same risk factors could be applicable to similar populations in 
northern India, Pakistan, and northwestern Bangladesh, as wel as the Terai region in 
southern Nepal, as they share cultural, social, and economic characteristics. A beter 
understanding of the underlying mechanisms of how and why emolient therapy can 
improve neonatal health outcomes in low-resource setings is important, however, 
additional risk factors associated with these biological measures need to be explored in 
order to optimize any health benefits of the oils. Further research on possible efects of 
oil massage on skin integrity, immune function, nutritional status, and bacterial 
colonization, along with risk factors associated with these biological mechanisms should 
be considered. 
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Chapter 4 Tables and Figures 




Visit	  1 Visit	  3 Visit	  7 Visit	  14 Visit	  28 
Skin	  Condition	  Score	   1000	   X	   X	   X	   X	   X	  
TEWL	   1000	   X	   X	   X	   X	   X	  
Skin	  pH	   1000	   X	   X	   X	   X	   X	  
Skin	  Discs	  to	  Measure	  Protein	  
Concentration	  
1000	   X	   	   X	   X	   X	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Table 4-2: Baseline Newborn Care Characteristics 
Characteristic	   N	   (%)	  
Sex	  
	   	  
Male	   329	   51.6	  
Female	   308	   48.4	  
Gestational	  Age	  
	   	  
<32	  wks	   37	   5.9	  
32-­‐36	  wks	   230	   36.8	  
37-­‐41	  wks	   307	   49.1	  
>=42	  wks	   51	   8.2	  
Weight	  at	  initial	  visit	  
	   	  
<1500g	   12	   1.9	  
1500-­‐2499g	   219	   34.8	  
>2500g	   399	   63.3	  
SGA	  Status	  
	   	  
AGA	   363	   57.6	  
SGA	  3-­‐10%	   119	   18.9	  
SGA	  3%	   148	   23.5	  
Breastfed	  since	  birth	  
	   	  
No	   96	   15.1	  
Yes	   541	   84.9	  
Hours	  before	  breastfeeding	  
initiation	   	  
<1	  hr	   161	   30.1	  
1-­‐2	  hrs	   305	   57	  
3-­‐4	  hrs	   35	   6.5	  
>=5	  hrs	   34	   6.4	  
Infant	  received	  colostrum	  
	   	  
No	   57	   10.5	  
Yes	   483	   89.3	  
Time	  from	  visit	  to	  last	  massage	   	   	  
<30	  min	   615	   20.8	  
	  30-­‐59	  min	   505	   17.1	  
	  60-­‐119	  min	   681	   23.0	  
120-­‐179	  min	   398	   13.5	  
>180	  min	   759	   25.7	  
	  
MEAN	   SD	  
Gestational	  Age	  (N=625)	   37.7	   3.6	  
Birthweight	  (N=632)	   2611.8	   483.8	  
Avg	  #	  of	  massages	  per	  day	  during	  
first	  week	  of	  life	  
4.5	   1.4	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Table 4-3: Baseline Maternal, Socioeconomic, and Household Characteristics 
Characteristic	   N	   (%)	  
Ethnic	  Group	  
	   	  
Pahadi	   44	   7.2	  
Madeshi	   571	   92.8	  
Maternal	  literacy	  
	   	  
Not	  literate	   446	   71.5	  
Literate	   178	   28.5	  
Paternal	  literacy	  
	   	  
Not	  literate	   294	   47.1	  
Literate	   330	   52.9	  
Maternal	  Education	  
	   	  
None	   448	   71.7	  
1-­‐5	  yrs	   58	   9.3	  
6-­‐10	  yrs	   92	   14.7	  
>10	  yrs	   27	   4.3	  
Paternal	  Education	  
	   	  
None	   290	   46.4	  
1-­‐5	  yrs	   94	   15	  
6-­‐10	  yrs	   201	   32.2	  
>10	  yrs	   40	   6.4	  
Household	  Assets
§	  
	   	  
0	  or	  1	  asset(s)	   44	   7.2	  
2-­‐5	  assets	   276	   44.9	  
6-­‐10	  assets	   280	   45.5	  
>10	  assets	   15	   2.4	  
Electricity	  
	   	  
None	   252	   41	  
Yes	   363	   59	  
Maternal	  Age	  
	   	  
<18	  yrs	   83	   13.3	  
18-­‐24	  yrs	   353	   56.6	  
25-­‐29	  yrs	   135	   21.6	  
30-­‐34	  yrs	   35	   5.6	  
>=35	  yrs	   18	   2.9	  
Gravidity	  
	   	  
None	   167	   26.7	  
1-­‐2	   289	   46.2	  
3-­‐4	   155	   24.8	  
>5	   14	   2.2	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Table 4-3: Baseline Maternal, Socioeconomic, and Household Characteristics 
(continued) 
 
Characteristic	   N	   (%)	  
Parity	  
	   	  
None	   180	   28.8	  
1-­‐2	   265	   42.4	  
3-­‐4	   155	   24.8	  
>5	   25	   4	  
Antenatal	  Care	  Visits	  
	   	  
No	  ANC	   182	   29.2	  
1-­‐2	  ANC	  visits	   227	   36.4	  
3-­‐4	  ANC	  visits	   188	   30.1	  
>=5	  ANC	  visits	   27	   4.3	  
Delivery	  Location	  
	   	  
Home	   446	   71.5	  
Facility	   178	   28.5	  
Length	  of	  labor	  
	   	  
<5	  hrs	   293	   47	  
5-­‐14	  hrs	   259	   41.6	  
15-­‐19	  hrs	   27	   4.3	  
20-­‐24	  hrs	   24	   3.9	  
>24	  hrs	   20	   3.2	  
Complications	  during	  delivery	  
	  
No	   509	   81.8	  
Yes	   113	   18.2	  
Delivery	  Assistant	  
	   	  
Unskiled	   421	   67.6	  
Skiled	   202	   32.4	  
§:
 
HH assets were based on having at least one of the folowing: electricity, servants, 2nd floor, catle, goats, 
bulock carts, bicycles, clocks, radios, TVs, phones, plot of farmable land, plot of other land, family member 
living & working out of home.  
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Table 4-4: Baseline Environmental Characteristics 
Characteristic	   N	   (%)	  
Relative	  humidity	  (%)	   	   	  
<40%	   27	   0.9	  
40-­‐59%	   223	   7.4	  
60-­‐79%	   1,204	   40.1	  
>80%	   1,552	   51.6	  
	  
MEAN	   SD	  
Temperature	  (°C)	  (N=3003)	   28.7	   4.2	  
Relative	  humidity	  (%)	  (N=2991)	   77.8	   11.7	  
Heat	  index	  (°C)	  (N=2991)	   35.9	   9.0	  
 
 


















1	   34.8	  (22.9)	   6.03	  (0.52)	   16.4	  (7.9)	   0.53	  (0.67)	   0.15	  (0.42)	  
3	   37.7	  (24.4)	   5.59	  (0.49)	   N/A	   0.83	  (0.66)	   0.70	  (0.77)	  
7	   39.2	  (24.0)	   5.19	  (0.54)	   12.9	  (6.4)	   0.80	  (0.64)	   0.80	  (0.81)	  
14	   41.6	  (24.3)	   5.07	  (0.55)	   13.1	  (6.3)	   0.83	  (0.64)	   1.01	  (0.80)	  
28	   43.3	  (23.2)	   4.82	  (0.57)	   14.0	  (6.1)	   0.53	  (0.58)	   0.68	  (0.72)	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Table 4-6: TEWL and Infant Characteristics Bivariate Analyses 
Predictor	  Variable	  
Transepidermal	  Water	  Loss	  (g/m
2
/hr)	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   -­‐3.77	   1.36	   0.006	   -­‐6.44-­‐	  -­‐1.09	  
Preterm	  (<37	  wks)	   -­‐2.04	   1.39	   0.141	   -­‐4.76-­‐0.67	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   -­‐2.03	   1.45	   0.164	   -­‐4.88-­‐0.82	  
<32	  wks	   -­‐1.73	   2.96	   0.558	   -­‐7.54-­‐4.07	  
Gestational	  Age	  (cont.)	  (wks)	   0.17	   0.19	   0.388	   -­‐0.21-­‐0.54	  
Low	  birthweight	  (<2500g)
	  
-­‐0.29	   1.42	   0.837	   -­‐3.07-­‐2.48	  
Birthweight	  (g)	  (cont.)	   0.0006	   0.0014	   0.681	   -­‐0.0022-­‐0.0034	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   -­‐0.55	   1.81	   0.759	   -­‐4.10-­‐2.99	  
SGA	  3%	   1.64	   1.68	   0.330	   -­‐1.65-­‐4.92	  
Breastfed	  since	  birth	   -­‐1.24	   1.91	   0.518	   -­‐4.99	  -­‐2.51	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   0.049	   1.65	   0.976	   -­‐3.18-­‐3.28	  
3-­‐4	  hrs	   -­‐1.68	   3.13	   0.592	   -­‐7.83-­‐4.46	  
>=5	  hrs	   6.44	   3.18	   0.043	   0.21-­‐12.68	  
Infant	  received	  colostrum	   0.94	   2.40	   0.697	   -­‐3.77-­‐5.65	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
0.034	   5.02	   0.945	   -­‐0.95-­‐1.02	  




	   	   	   	  
30-­‐59	  min	   -­‐0.18	   1.25	   0.884	   -­‐2.62-­‐2.26	  
60-­‐119	  min	   -­‐0.52	   1.19	   0.664	   -­‐2.84-­‐1.81	  
120-­‐179	  min	   -­‐1.20	   1.37	   0.380	   -­‐3.89-­‐1.48	  
>180	  min	   1.01	   1.18	   0.394	   -­‐1.31-­‐3.32	  
Infant’s	  age	  days	  0	  to	  3	   1.71	   0.43	   <0.001	   0.86-­‐2.55	  
Infant’s	  age	  days	  4	  to	  28	   0.22	   0.04	   <0.001	   0.13-­‐	  0.30	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour 
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Table 4-7: TEWL and Maternal, Socioeconomic, and Household Characteristics 
Bivariate Analyses 
Predictor	  Variable	  
Transepidermal	  Water	  Loss	  (g/m
2
/hr)	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐4.55	   2.69	   0.090	   -­‐9.82-­‐0.72	  
Mother	  literate	   3.40	   1.52	   0.025	   0.43-­‐6.37	  
Father	  literate	   0.53	   1.38	   0.702	   -­‐2.17-­‐3.22	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   2.59	   2.39	   0.278	   -­‐2.09-­‐7.28	  
	  	  	  6-­‐10	  yrs	   3.08	   1.96	   0.117	   -­‐0.77-­‐6.93	  
	  	  	  >10	  yrs	   0.28	   3.39	   0.935	   -­‐6.37-­‐6.93	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.50	   2.03	   0.807	   -­‐3.48-­‐4.48	  
	  	  	  6-­‐10	  yrs	   0.40	   1.58	   0.802	   -­‐2.69-­‐3.48	  
	  	  	  >10	  yrs	   -­‐0.66	   2.91	   0.820	   -­‐6.37-­‐5.05	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.57	   2.82	   0.841	   -­‐6.11-­‐4.97	  
	  	  	  6-­‐10	  assets	   -­‐0.22	   2.83	   0.939	   -­‐5.76-­‐5.32	  
	  	  	  >10	  assets	   2.32	   5.17	   0.653	   -­‐7.81-­‐12.46	  
Household	  has	  electricity	   3.71	   1.41	   0.008	   0.96-­‐6.47	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.86	   2.10	   0.681	   -­‐3.25-­‐4.97	  
	  	  	  25-­‐29	  yrs	   2.12	   2.39	   0.376	   -­‐2.57-­‐6.81	  
	  	  	  30-­‐34	  yrs	   0.58	   3.45	   0.866	   -­‐6.17-­‐7.33	  
	  	  	  >=35	  yrs	   4.20	   4.45	   0.345	   -­‐4.52-­‐12.93	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   -­‐0.09	   1.67	   0.956	   -­‐3.36-­‐3.18	  
	  	  	  >=3	   -­‐0.58	   1.87	   0.758	   -­‐4.24-­‐3.09	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   -­‐0.03	   1.66	   0.986	   -­‐3.28-­‐3.22	  
	  	  	  >=3	   -­‐0.76	   1.81	   0.674	   -­‐4.31-­‐2.78	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   5.49	   1.69	   0.001	   2.18-­‐8.80	  
	  	  	  >=3	  ANC	  visits	   5.28	   1.71	   0.002	   1.93-­‐8.64	  
Delivery	  at	  facility	   -­‐1.18	   1.43	   0.438	   -­‐4.15-­‐1.80	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   -­‐2.32	   1.46	   0.113	   -­‐5.18-­‐0.54	  
	  	  >=15	  hrs	   1.08	   2.27	   0.632	   -­‐3.36-­‐5.53	  
Complications	  during	  delivery	   -­‐0.39	   1.77	   0.824	   -­‐3.88-­‐3.09	  
Skiled	  assistant	  at	  delivery	   -­‐1.70	   1.47	   0.248	   -­‐4.57-­‐1.18	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
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Table 4-8: TEWL and Environmental Characteristics Bivariate Analyses 
Predictor	  Variable	  
Transepidermal	  Water	  Loss	  (g/m
2
/hr)	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   -­‐1.62	   0.12	   <0.001	   -­‐1.86-­‐	  -­‐1.38	  
Relative	  humidity	  (cont.)	  (%)	   0.51	   0.039	   <0.001	   0.43-­‐0.59	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   -­‐4.03	   4.13	   0.328	   -­‐12.12-­‐4.05	  
60-­‐79%	   6.86	   3.91	   0.080	   -­‐0.81-­‐14.53	  
>80%	   13.95	   3.91	   <0.001	   6.28-­‐21.62	  
Heat	  index	  (°C)	   -­‐0.49	   0.061	   <0.001	   -­‐0.61-­‐	  -­‐0.37	  
a: Reference group, <40% 
 
 
Table 4-9: TEWL Multivariate Model 
Predictor	  Variable	  
Transepidermal	  Water	  Loss	  (g/m
2
/hr)	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  wks)	   1.45	   1.36	   0.296	   -­‐1.21-­‐4.11	  
Female	   -­‐2.99	   1.32	   0.024	   -­‐5.57-­‐	  -­‐0.40	  
Madeshi	   -­‐4.38	   2.47	   0.076	   -­‐9.21-­‐0.46	  
Mother	  literate	   2.66	   1.53	   0.083	   -­‐0.34-­‐5.66	  
Household	  has	  electricity	   1.70	   1.41	   0.228	   -­‐1.06-­‐4.45	  
Antenatal	  Care	  Visits
a	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   4.68	   1.66	   0.005	   1.42-­‐7.94	  
	  	  	  >=3	  ANC	  visits	   3.87	   1.71	   0.023	   0.53-­‐7.22	  




	   	   	   	  
	  	  	  1-­‐2	  hrs	   0.39	   1.50	   0.795	   -­‐2.54-­‐3.32	  
	  	  	  3-­‐4	  hrs	   -­‐1.54	   2.83	   0.588	   -­‐7.09-­‐4.02	  
	  	  	  >=5	  hrs	   5.89	   2.86	   0.039	   0.29-­‐11.49	  
Temperature	  (°C)	   -­‐1.24	   0.14	   <0.001	   -­‐1.50-­‐	  -­‐0.97	  
Relative	  humidity	  (%)
	  
0.36	   0.04	   <0.001	   0.28-­‐0.45	  
Infant’s	  age	  days	  0	  to	  3	   0.96	   0.46	   0.038	   0.05-­‐1.87	  
Infant’s	  age	  days	  4	  to	  28	   0.20	   0.05	   <0.001	   0.11-­‐0.29	  
a: Reference group, none; b: Reference group, <1 hour 
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Table 4-10: Skin pH and Infant Characteristics Bivariate Analyses 
Predictor	  Variable	  
Skin	  pH	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   0.017	   0.029	   0.552	   -­‐0.039-­‐0.074	  
Preterm	  (<37	  wks)	   0.010	   0.029	   0.724	   -­‐0.047-­‐0.068	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   0.0021	   0.031	   0.946	   -­‐0.058-­‐0.062	  
<32	  wks	   0.087	   0.063	   0.165	   -­‐0.036-­‐0.21	  
Gestational	  Age	  (cont.)	  (wks)	   -­‐0.0056	   0.0041	   0.170	   -­‐0.013-­‐0.0024	  
Low	  birthweight	  (<2500g)
	  
0.089	   0.030	   0.002	   0.032-­‐0.15	  
Birthweight	  (g)	  (cont.)	   -­‐0.00011	   0.000030	   <0.001	   -­‐0.00017-­‐	  -­‐0.000050	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   0.026	   0.038	   0.495	   -­‐0.049-­‐0.10	  
SGA	  3%	   0.055	   0.036	   0.119	   -­‐0.014-­‐0.13	  
Breastfed	  since	  birth	   -­‐0.076	   0.040	   0.060	   -­‐0.15-­‐0.0030	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   0.017	   0.036	   0.640	   -­‐0.053-­‐0.086	  
3-­‐4	  hrs	   0.031	   0.067	   0.647	   -­‐0.10-­‐0.16	  
>=5	  hrs	   0.087	   0.068	   0.203	   -­‐0.047-­‐0.22	  
Infant	  received	  colostrum	   0.036	   0.051	   0.483	   -­‐0.065-­‐0.14	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
0.011	   0.010	   0.296	   -­‐0.0096-­‐0.031	  




	   	   	   	  
30-­‐59	  min	   -­‐0.0091	   0.040	   0.822	   -­‐0.088-­‐0.070	  
60-­‐119	  min	   -­‐0.073	   0.038	   0.055	   -­‐0.15-­‐0.0016	  
120-­‐179	  min	   -­‐0.089	   0.044	   0.041	   -­‐0.18-­‐	  -­‐0.0037	  
>180	  min	   -­‐0.23	   0.037	   <0.001	   -­‐0.30-­‐	  -­‐0.16	  
Infant’s	  age	  days	  0	  to	  7	   -­‐0.14	   0.004	   <0.001	   -­‐0.14-­‐	  -­‐0.13	  
Infant’s	  age	  days	  8	  to	  28	   -­‐0.016	   0.001	   <0.001	   -­‐0.018-­‐	  -­‐0.014	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 minutes 
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Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   0.15	   0.057	   0.007	   0.043-­‐0.26	  
Mother	  literate	   -­‐0.080	   0.032	   0.013	   -­‐0.14-­‐	  -­‐0.017	  
Father	  literate	   -­‐0.082	   0.029	   0.005	   -­‐0.14-­‐	  -­‐0.025	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   -­‐0.10	   0.050	   0.047	   -­‐0.20-­‐	  -­‐0.0011	  
	  	  	  6-­‐10	  yrs	   -­‐0.063	   0.041	   0.126	   -­‐0.14-­‐0.018	  
	  	  	  >10	  yrs	   -­‐0.058	   0.072	   0.423	   -­‐0.20-­‐0.084	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   -­‐0.027	   0.042	   0.522	   -­‐0.11-­‐0.056	  
	  	  	  6-­‐10	  yrs	   -­‐0.11	   0.033	   0.001	   -­‐0.17-­‐	  -­‐0.045	  
	  	  	  >10	  yrs	   -­‐0.060	   0.062	   0.331	   -­‐0.18-­‐0.061	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.11	   0.059	   0.073	   -­‐0.22-­‐0.0098	  
	  	  	  6-­‐10	  assets	   -­‐0.14	   0.059	   0.016	   -­‐0.26-­‐	  -­‐0.026	  
	  	  	  >10	  assets	   -­‐0.28	   0.11	   0.010	   -­‐0.49-­‐	  -­‐0.066	  
Household	  has	  electricity	   -­‐0.077	   0.030	   0.010	   -­‐0.13-­‐	  -­‐0.019	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   -­‐0.077	   0.044	   0.080	   -­‐0.16-­‐0.0092	  
	  	  	  25-­‐29	  yrs	   -­‐0.061	   0.050	   0.224	   -­‐0.16-­‐0.037	  
	  	  	  30-­‐34	  yrs	   -­‐0.097	   0.072	   0.179	   -­‐0.24-­‐0.044	  
	  	  	  >=35	  yrs	   -­‐0.086	   0.093	   0.355	   -­‐0.27-­‐0.096	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   -­‐0.028	   0.035	   0.422	   -­‐0.098-­‐0.041	  
	  	  	  >=3	   0.0011	   0.039	   0.977	   -­‐0.076-­‐0.078	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   -­‐0.023	   0.035	   0.503	   -­‐0.092-­‐0.045	  
	  	  	  >=3	   0.0056	   0.038	   0.884	   -­‐0.069-­‐0.080	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   -­‐0.010	   0.036	   0.779	   -­‐0.081-­‐0.061	  
	  	  	  >=3	  ANC	  visits	   -­‐0.0016	   0.037	   0.966	   -­‐0.073-­‐0.070	  
Delivery	  at	  facility	   -­‐0.076	   0.032	   0.018	   -­‐0.14-­‐	  -­‐0.013	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   0.012	   0.031	   0.693	   -­‐0.048-­‐0.073	  
	  	  	  >=15	  hrs	   0.051	   0.048	   0.286	   -­‐0.043-­‐0.14	  
Complications	  during	  delivery	   -­‐0.021	   0.38	   0.572	   -­‐0.095-­‐0.052	  
Skiled	  assistant	  at	  delivery	   -­‐0.085	   0.031	   0.006	   -­‐0.15-­‐	  -­‐0.025	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
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Table 4-12: Skin pH and Environmental Characteristics Bivariate Analyses 
Predictor	  Variable	  
Skin	  pH	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   -­‐0.019	   0.0032	   <0.001	   -­‐0.025-­‐	  -­‐0.013	  
Relative	  humidity	  (cont.)	  (%)	   0.0078	   0.0011	   <0.001	   0.0056-­‐0.010	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   -­‐0.35	   0.14	   0.011	   -­‐0.61-­‐	  -­‐0.077	  
60-­‐79%	   -­‐0.36	   0.13	   0.006	   -­‐0.61-­‐	  -­‐0.10	  
>80%	   -­‐0.17	   0.13	   0.198	   -­‐0.42-­‐	  0.087	  
Heat	  index	  (°C)	   -­‐0.0050	   0.0015	   0.001	   -­‐0.0080-­‐	  -­‐0.0020	  
a: Reference group, <40% 
 
 
Table 4-13: Skin pH Multivariate Model 
Predictor	  Variable	  
Skin	  pH	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  wks)	   -­‐0.0072	   0.028	   0.800	   -­‐0.063-­‐0.049	  
Female	   0.037	   0.028	   0.183	   -­‐0.018-­‐0.092	  
Madeshi	   0.13	   0.056	   0.016	   0.025-­‐0.25	  
Low	  birthweight	  (<2500g)	   0.059	   0.029	   0.044	   0.0015-­‐0.12	  
Mother	  literate	   -­‐0.040	   0.035	   0.252	   -­‐0.11-­‐0.028	  
Father	  literate	   -­‐0.040	   0.033	   0.226	   -­‐0.10-­‐0.025	  
Household	  has	  electricity	   -­‐0.043	   0.031	   0.169	   -­‐0.10-­‐0.018	  
Household	  Assets
a,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.07	   0.056	   0.220	   -­‐0.18-­‐0.041	  
	  	  	  6-­‐10	  assets	   -­‐0.062	   0.061	   0.311	   -­‐0.18-­‐0.058	  
	  	  	  >10	  assets	   -­‐0.14	   0.11	   0.201	   -­‐0.35-­‐0.074	  
Skiled	  Attendant	  at	  delivery	   -­‐0.013	   0.031	   0.658	   -­‐0.074-­‐0.047	  
Time	  between	  folow-­‐up	  visit	  and	  
last	  massage
b	   	   	   	   	  
	  	  	  30-­‐59	  min	   0.015	   0.029	   0.596	   -­‐0.041-­‐0.072	  
	  	  	  60-­‐119	  min	   -­‐0.028	   0.028	   0.308	   -­‐0.082-­‐0.026	  
	  	  	  120-­‐179	  min	   -­‐0.0040	   0.032	   0.898	   -­‐0.066-­‐0.058	  
	  	  	  >180	  min	   -­‐0.050	   0.028	   0.067	   -­‐0.104-­‐0.0035	  
Temperature	  (°C)	   -­‐0.023	   0.0029	   <0.001	   -­‐0.029-­‐	  -­‐0.017	  
Relative	  humidity	  (%)
	  
0.0057	   0.00094	   <0.001	   0.0038-­‐0.0075	  
Infant’s	  age	  days	  0	  to	  7	   -­‐0.14	   0.0038	   <0.001	   -­‐0.15-­‐	  -­‐0.13	  
Infant’s	  age	  days	  8	  to	  28	   -­‐0.015	   0.0013	   <0.001	   -­‐0.017-­‐	  -­‐0.012	  
a: Reference group, 0 or 1 asset(s); b: Reference group, <30 min; §:
 
HH assets were based on having at 
least one of the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, 
TVs, phones, plot of farmable land, plot of other land, family member living & working out of home. 
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Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   0.39	   0.35	   0.266	   -­‐0.30-­‐1.08	  
Preterm	  (<37	  wks)	   0.48	   0.36	   0.180	   -­‐0.22-­‐1.17	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   0.44	   0.37	   0.241	   -­‐0.29-­‐1.16	  
<32	  wks	   0.96	   0.76	   0.205	   -­‐0.53-­‐2.45	  
Gestational	  Age	  (cont.)	  (wks)	   -­‐0.088	   0.049	   0.072	   -­‐0.18-­‐0.0079	  
Low	  birthweight	  (<2500g)
	  
0.57	   0.36	   0.112	   -­‐0.13-­‐1.28	  
Birthweight	  (g)	  (cont.)	   -­‐0.00036	   0.00037	   0.326	   -­‐0.0011-­‐0.00037	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   -­‐0.49	   0.46	   0.291	   -­‐1.40-­‐0.42	  
SGA	  3%	   -­‐0.37	   0.43	   0.387	   -­‐1.22-­‐0.47	  
Breastfed	  since	  birth	   -­‐0.29	   0.48	   0.551	   -­‐1.24-­‐0.66	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   0.20	   0.44	   0.644	   -­‐0.66-­‐1.07	  
3-­‐4	  hrs	   0.60	   0.83	   0.470	   -­‐1.02-­‐2.22	  
>=5	  hrs	   0.69	   0.82	   0.399	   -­‐0.91-­‐2.30	  
Infant	  received	  colostrum	   -­‐0.89	   0.65	   0.169	   -­‐2.16-­‐0.38	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
-­‐0.12	   0.13	   0.352	   -­‐0.37-­‐0.13	  




	   	   	   	  
	  30-­‐59	  min	   0.25	   0.51	   0.628	   -­‐0.75-­‐1.25	  
	  60-­‐119	  min	   1.47	   0.47	   0.002	   0.54-­‐2.40	  
120-­‐179	  min	   1.22	   0.55	   0.026	   0.15-­‐2.30	  
>180	  min	   1.78	   0.46	   <0.001	   0.88-­‐2.68	  
Infant’s	  age	  days	  0	  to	  7	   -­‐0.58	   0.06	   <0.001	   -­‐0.70-­‐	  -­‐0.46	  
Infant’s	  age	  days	  8	  to	  28	   0.06	   0.02	   0.003	   0.02-­‐0.10	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 min 
 
 
	    
	   142 
Table 4-15: Stratum Corneum Protein Concentration and Maternal, 





Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐0.67	   0.72	   0.351	   -­‐2.09-­‐0.74	  
Mother	  literate	   -­‐0.37	   0.39	   0.343	   -­‐1.14-­‐0.40	  
Father	  literate	   -­‐0.92	   0.35	   0.009	   -­‐1.60-­‐	  -­‐0.23	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   -­‐0.69	   0.60	   0.248	   -­‐1.86-­‐0.48	  
	  	  	  6-­‐10	  yrs	   -­‐0.35	   0.51	   0.493	   -­‐1.35-­‐0.65	  
	  	  	  >10	  yrs	   1.12	   0.91	   0.220	   -­‐0.67-­‐2.91	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   -­‐0.04	   0.51	   0.937	   -­‐1.04-­‐0.96	  
	  	  	  6-­‐10	  yrs	   -­‐1.08	   0.40	   0.007	   -­‐1.87-­‐	  -­‐0.29	  
	  	  	  >10	  yrs	   -­‐1.27	   0.78	   0.102	   -­‐2.79-­‐0.25	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.19	   0.71	   0.793	   -­‐1.16-­‐0.88	  
	  	  	  6-­‐10	  assets	   -­‐0.66	   0.71	   0.351	   -­‐2.05-­‐0.73	  
	  	  	  >10	  assets	   0.43	   1.27	   0.733	   -­‐2.05-­‐2.92	  
Household	  has	  electricity	   -­‐0.85	   0.36	   0.017	   -­‐1.55-­‐	  -­‐0.15	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   -­‐0.80	   0.54	   0.141	   -­‐1.87-­‐0.27	  
	  	  	  25-­‐29	  yrs	   -­‐1.15	   0.62	   0.063	   -­‐2.36-­‐0.063	  
	  	  	  30-­‐34	  yrs	   -­‐0.04	   0.87	   0.960	   -­‐1.75-­‐1.66	  
	  	  	  >=35	  yrs	   0.04	   1.05	   0.973	   -­‐2.03-­‐2.10	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   -­‐0.14	   0.43	   0.751	   -­‐0.98-­‐0.71	  
	  	  >=3	   0.23	   0.48	   0.635	   -­‐0.71-­‐1.16	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   -­‐0.23	   0.43	   0.598	   -­‐1.06-­‐0.61	  
	  	  	  >=3	   0.34	   0.46	   0.456	   -­‐0.56-­‐1.25	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   -­‐1.07	   0.44	   0.014	   -­‐1.93-­‐	  -­‐0.22	  
	  	  	  >=3	  ANC	  visits	   -­‐0.83	   0.45	   0.064	   -­‐1.71-­‐0.048	  
Delivery	  at	  facility	   -­‐0.54	   0.39	   0.170	   -­‐1.32-­‐0.23	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   -­‐0.89	   0.37	   0.017	   -­‐1.62-­‐	  -­‐0.16	  
	  	  	  >=15	  hrs	   -­‐0.43	   0.58	   0.541	   -­‐1.57-­‐0.70	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Table 4-15: Stratum Corneum Protein Concentration and Maternal, 






Coeficient	   SE	   p-­‐value	   95%	  CI	  
Complications	  during	  delivery	   0.48	   0.47	   0.301	   -­‐0.43-­‐1.40	  
Skiled	  assistant	  at	  delivery	   -­‐0.69	   0.38	   0.070	   -­‐1.44-­‐0.06	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
 
 
Table 4-16: Stratum Corneum Protein Concentration and Environmental 





Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   -­‐0.20	   0.04	   <0.001	   -­‐0.27-­‐	  -­‐0.13	  
Relative	  humidity	  (cont.)	  (%)	   -­‐0.06	   0.01	   <0.001	   -­‐0.09-­‐	  -­‐0.04	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   -­‐0.18	   1.60	   0.910	   -­‐3.32-­‐2.96	  
60-­‐79%	   -­‐1.51	   1.53	   0.325	   -­‐4.51-­‐1.49	  
>80%	   -­‐2.71	   1.53	   0.077	   -­‐5.72-­‐0.29	  
Heat	  index	  (°C)	   -­‐0.14	   0.02	   <0.001	   -­‐0.17-­‐	  -­‐0.10	  
a: Reference group, <40% 
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Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  wks)	   0.54	   0.33	   0.103	   -­‐0.11-­‐1.18	  
Female	   0.55	   0.33	   0.089	   -­‐0.084-­‐1.19	  
Madeshi	   -­‐0.092	   0.68	   0.893	   -­‐1.42-­‐1.24	  
Father	  literate	   -­‐0.96	   0.35	   0.005	   -­‐1.64-­‐	  -­‐0.28	  
Household	  has	  electricity	   -­‐0.62	   0.35	   0.075	   -­‐1.30-­‐0.062	  
Antenatal	  Care	  Visits
a	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   -­‐0.67	   0.41	   0.099	   -­‐1.46-­‐0.12	  
	  	  	  >=3	  ANC	  visits	   -­‐0.19	   0.42	   0.661	   -­‐1.02-­‐0.64	  
Length	  of	  Labor	   	   	   	   	  
	  	  	  5-­‐14	  hrs	   -­‐0.79	   0.34	   0.022	   -­‐1.46-­‐	  -­‐0.12	  
	  	  	  >=15	  hrs	   -­‐0.55	   0.53	   0.302	   -­‐1.60-­‐0.50	  
Time	  from	  visit	  to	  last	  massage
b
	   	   	   	   	  
	  	  	  30-­‐59	  min	   0.29	   0.49	   0.561	   -­‐0.68-­‐1.25	  
	  	  	  60-­‐119	  min	   1.55	   0.46	   0.001	   0.65-­‐2.44	  
	  	  	  120-­‐179	  min	   1.43	   0.53	   0.007	   0.39-­‐2.48	  
	  	  	  >180	  min	   1.34	   0.45	   <0.001	   1.46-­‐3.22	  
Temperature	  (°C)	   -­‐0.31	   0.037	   <0.001	   -­‐0.38-­‐	  -­‐0.24	  
Relative	  humidity	  (%)
	  
-­‐0.084	   0.013	   <0.001	   -­‐0.11-­‐	  -­‐0.058	  
Infant’s	  age	  days	  0	  to	  7	   -­‐0.57	   0.062	   <0.001	   -­‐0.69-­‐	  -­‐0.45	  
Infant’s	  age	  days	  8	  to	  28	   0.045	   0.020	   0.028	   0.0047-­‐0.085	  
a: Reference group, none; b: Reference group, <30 min 
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Table 4-18: Chest Erythema Score and Infant Characteristics Bivariate Analyses 
Predictor	  Variable	  
Chest	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   0.011	   0.032	   0.731	   -­‐0.052-­‐0.074	  
Preterm	  (<37	  wks)	   0.011	   0.033	   0.738	   -­‐0.053-­‐0.075	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   0.023	   0.034	   0.498	   -­‐0.044-­‐0.090	  
<32	  wks	   -­‐0.052	   0.070	   0.460	   -­‐0.19-­‐0.085	  
Gestational	  Age	  (cont.)	  (wks)	   -­‐0.0013	   0.0045	   0.767	   -­‐0.010-­‐0.0075	  
Low	  birthweight	  (<2500g)
	  
-­‐0.019	   0.033	   0.560	   -­‐0.084-­‐	  0.046	  
Birthweight	  (g)	  (cont.)	   0.000084	   0.000034	   0.014	   0.000017-­‐0.00015	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   0.025	   0.043	   0.551	   -­‐0.058-­‐0.11	  
SGA	  3%	   -­‐0.038	   0.040	   0.341	   -­‐0.12-­‐0.040	  
Breastfed	  since	  birth	   -­‐0.076	   0.045	   0.090	   -­‐0.16-­‐0.012	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   -­‐0.0012	   0.039	   0.976	   -­‐0.078-­‐0.075	  
3-­‐4	  hrs	   -­‐0.037	   0.074	   0.615	   -­‐0.18-­‐0.11	  
>=5	  hrs	   0.078	   0.075	   0.301	   -­‐0.069-­‐0.22	  
Infant	  received	  colostrum	   0.047	   0.057	   0.410	   -­‐0.065-­‐0.16	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
-­‐0.023	   0.012	   0.047	   -­‐0.046-­‐	  -­‐0.00035	  




	   	   	   	  
	  30-­‐59	  min	   -­‐0.041	   0.037	   0.268	   -­‐0.11-­‐0.032	  
	  60-­‐119	  min	   -­‐0.063	   0.035	   0.073	   -­‐0.13-­‐0.0060	  
120-­‐179	  min	   -­‐0.032	   0.041	   0.429	   -­‐0.11-­‐0.048	  
>180	  min	   -­‐0.026	   0.035	   0.460	   -­‐0.094-­‐0.043	  
Infant’s	  age	  days	  0	  to	  3	   0.14	   0.014	   <0.001	   0.11-­‐0.17	  
Infant’s	  age	  days	  4	  to	  14	   0.00037	   0.003	   0.904	   -­‐0.0056-­‐0.0063	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.021	   0.002	   <0.001	   -­‐0.025-­‐	  -­‐0.017	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 minutes 
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Table 4-19: Chest Rash Score and Infant Characteristics Bivariate Analyses 
Predictor	  Variable	  
Chest	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   0.0043	   0.034	   0.902	   -­‐0.063-­‐0.072	  
Preterm	  (<37	  wks)	   -­‐0.083	   0.035	   0.017	   -­‐0.15-­‐	  -­‐0.015	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   -­‐0.077	   0.036	   0.034	   -­‐0.15-­‐	  -­‐0.0058	  
<32	  wks	   -­‐0.13	   0.075	   0.088	   -­‐0.27-­‐0.019	  
Gestational	  Age	  (cont.)	  (wks)	   0.014	   0.0047	   0.005	   0.0041-­‐0.023	  
Low	  birthweight	  (<2500g)
	  
-­‐0.16	   0.035	   <0.001	   -­‐0.23-­‐	  -­‐0.092	  
Birthweight	  (g)	  (cont.)	   0.00024	   0.000035	   <0.001	   0.00017-­‐0.00031	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   0.041	   0.045	   0.364	   -­‐0.048-­‐0.13	  
SGA	  3%	   -­‐0.087	   0.042	   0.039	   -­‐0.17-­‐	  -­‐0.0046	  
Breastfed	  since	  birth	   -­‐0.018	   0.048	   0.704	   -­‐0.11-­‐0.076	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   -­‐0.00060	   0.043	   0.989	   -­‐0.084-­‐0.085	  
3-­‐4	  hrs	   -­‐0.11	   0.081	   0.165	   -­‐0.27-­‐0.046	  
>=5	  hrs	   -­‐0.010	   0.082	   0.903	   -­‐0.17-­‐0.15	  
Infant	  received	  colostrum	   0.074	   0.062	   0.234	   -­‐0.048-­‐0.20	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
-­‐0.042	   0.012	   0.001	   -­‐0.068-­‐	  -­‐0.019	  




	   	   	   	  
	  30-­‐59	  min	   0.024	   0.045	   0.591	   -­‐0.065-­‐0.11	  
	  60-­‐119	  min	   -­‐0.0082	   0.043	   0.848	   -­‐0.092-­‐0.075	  
120-­‐179	  min	   0.041	   0.049	   0.406	   -­‐0.056-­‐0.14	  
>180	  min	   0.097	   0.042	   0.021	   0.015-­‐0.18	  
Infant’s	  age	  days	  0	  to	  14	   0.058	   0.003	   <0.001	   0.052-­‐0.063	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.031	   0.003	   <0.001	   -­‐0.036-­‐	  -­‐0.025	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 minutes 
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Table 4-20: Chest Erythema Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses 
Predictor	  Variable	  
Chest	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐0.12	   0.063	   0.055	   -­‐0.24-­‐0.0023	  
Mother	  literate	   -­‐0.027	   0.036	   0.444	   -­‐0.097-­‐0.043	  
Father	  literate	   0.014	   0.032	   0.671	   -­‐0.050-­‐0.077	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   -­‐0.00091	   0.056	   0.987	   -­‐0.11-­‐0.11	  
	  	  	  6-­‐10	  yrs	   -­‐0.049	   0.046	   0.291	   -­‐0.14-­‐0.042	  
	  	  	  >10	  yrs	   -­‐0.0015	   0.080	   0.985	   -­‐0.16-­‐0.16	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.016	   0.048	   0.735	   -­‐0.077-­‐0.11	  
	  	  	  6-­‐10	  yrs	   0.010	   0.037	   0.784	   -­‐0.062-­‐0.083	  
	  	  	  >10	  yrs	   -­‐0.054	   0.069	   0.432	   -­‐0.19-­‐0.081	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.032	   0.066	   0.630	   -­‐0.16-­‐0.097	  
	  	  	  6-­‐10	  assets	   -­‐0.059	   0.066	   0.366	   -­‐0.19-­‐0.069	  
	  	  	  >10	  assets	   -­‐0.11	   0.12	   0.363	   -­‐0.35-­‐0.13	  
Household	  has	  electricity	   -­‐0.094	   0.033	   0.004	   -­‐0.16-­‐	  -­‐0.029	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.097	   0.049	   0.047	   0.0013-­‐0.19	  
	  	  	  25-­‐29	  yrs	   0.11	   0.056	   0.047	   0.0016-­‐0.22	  
	  	  	  30-­‐34	  yrs	   0.010	   0.080	   0.214	   -­‐0.058-­‐0.26	  
	  	  	  >=35	  yrs	   0.075	   0.10	   0.467	   -­‐0.13-­‐0.28	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.064	   0.039	   0.102	   -­‐0.013-­‐0.14	  
	  	  	  >=3	   0.053	   0.044	   0.230	   -­‐0.033-­‐0.14	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.052	   0.039	   0.179	   -­‐0.024-­‐0.13	  
	  	  	  >=3	   0.044	   0.042	   0.296	   -­‐0.039-­‐0.13	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   0.045	   0.043	   0.263	   -­‐0.034-­‐0.12	  
	  	  	  >=3	  ANC	  visits	   0.034	   0.045	   0.404	   -­‐0.046-­‐0.11	  
Delivery	  at	  facility	   -­‐0.13	   0.035	   <0.001	   -­‐0.20-­‐	  -­‐0.058	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   -­‐0.0021	   0.034	   0.952	   -­‐0.069-­‐0.065	  
	  	  >=15	  hrs	   -­‐0.016	   0.053	   0.766	   -­‐0.12-­‐0.089	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Table 4-20: Chest Erythema Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses (continued) 
 
Predictor	  Variable	  
Chest	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Complications	  during	  delivery	   -­‐0.058	   0.042	   0.166	   -­‐0.14-­‐0.024	  
Skiled	  assistant	  at	  delivery	   -­‐0.11	   0.034	   0.002	   -­‐0.17-­‐	  -­‐0.038	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
 
 
Table 4-21: Chest Rash Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses 
Predictor	  Variable	  
Chest	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐0.17	   0.067	   0.011	   -­‐0.30-­‐	  -­‐0.038	  
Mother	  literate	   0.0022	   0.038	   0.953	   -­‐0.073-­‐0.077	  
Father	  literate	   0.051	   0.035	   0.138	   -­‐0.016-­‐0.12	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   -­‐0.016	   0.060	   0.793	   -­‐0.13-­‐0.10	  
	  	  	  6-­‐10	  yrs	   -­‐0.022	   0.049	   0.649	   -­‐0.12-­‐0.074	  
	  	  	  >10	  yrs	   0.011	   0.086	   0.218	   -­‐0.063-­‐0.28	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.012	   0.051	   0.813	   -­‐0.088-­‐0.11	  
	  	  	  6-­‐10	  yrs	   0.049	   0.040	   0.215	   -­‐0.028-­‐0.13	  
	  	  	  >10	  yrs	   0.057	   0.074	   0.442	   -­‐0.088-­‐0.20	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   0.013	   0.070	   0.858	   -­‐0.13-­‐0.15	  
	  	  	  6-­‐10	  assets	   0.006	   0.070	   0.930	   -­‐0.13-­‐0.14	  
	  	  	  >10	  assets	   0.11	   0.13	   0.399	   -­‐0.14-­‐0.36	  
Household	  has	  electricity	   -­‐0.040	   0.035	   0.258	   -­‐0.11-­‐0.029	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.15	   0.052	   0.004	   0.050-­‐0.26	  
	  	  	  25-­‐29	  yrs	   0.18	   0.060	   0.003	   0.058-­‐0.29	  
	  	  	  30-­‐34	  yrs	   0.19	   0.086	   0.023	   0.027-­‐0.36	  
	  	  	  >=35	  yrs	   0.19	   0.11	   0.084	   -­‐0.025-­‐0.41	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.098	   0.042	   0.020	   0.016-­‐	  0.18	  
	  	  	  >=3	   0.14	   0.047	   0.003	   0.050-­‐0.23	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.090	   0.041	   0.030	   0.0085-­‐0.17	  
	  	  	  >=3	   0.15	   0.045	   0.001	   0.060-­‐0.27	  
	   149 
Table 4-21: Chest Rash Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses (continued) 
 
Predictor	  Variable	  
Chest	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   0.049	   0.043	   0.255	   -­‐0.035-­‐0.13	  
	  	  	  >=3	  ANC	  visits	   0.027	   0.043	   0.542	   -­‐0.059-­‐0.11	  
Delivery	  at	  facility	   -­‐0.028	   0.038	   0.468	   -­‐0.10-­‐0.047	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   0.027	   0.037	   0.471	   -­‐0.046-­‐0.099	  
	  	  >=15	  hrs	   -­‐0.087	   0.057	   0.126	   -­‐0.20-­‐0.024	  
Complications	  during	  delivery	   -­‐0.013	   0.045	   0.775	   -­‐0.10-­‐0.075	  
Skiled	  assistant	  at	  delivery	   -­‐0.029	   0.037	   0.428	   -­‐0.10-­‐0.043	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
 
Table 4-22: Chest Erythema Score and Environmental Characteristics Bivariate 
Analyses 
Predictor	  Variable	  
Chest	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   -­‐0.026	   0.0033	   <0.001	   -­‐0.032-­‐	  -­‐0.019	  
Relative	  humidity	  (cont.)	  (%)	   0.0022	   0.0011	   0.053	   -­‐0.000029-­‐0.0045	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   0.080	   0.13	   0.526	   -­‐0.17-­‐0.33	  
60-­‐79%	   0.13	   0.12	   0.284	   -­‐0.11-­‐0.37	  
>80%	   0.12	   0.12	   0.330	   -­‐0.12-­‐0.35	  
Heat	  index	  (°C)	   -­‐0.012	   0.0016	   <0.001	   -­‐0.015-­‐	  -­‐0.0085	  
a: Reference group, <40% 
 
Table 4-23: Chest Rash and Environmental Characteristics Bivariate Analyses 
Predictor	  Variable	  
Chest	  Rash	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   0.0065	   0.0038	   0.085	   -­‐0.0009-­‐0.014	  
Relative	  humidity	  (cont.)	  (%)	   0.0045	   0.0013	   0.001	   0.0019-­‐0.007	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   -­‐0.00091	   0.15	   0.995	   -­‐0.30-­‐0.30	  
60-­‐79%	   0.13	   0.12	   0.361	   -­‐0.15-­‐0.42	  
>80%	   0.12	   0.12	   0.259	   -­‐0.12-­‐0.45	  
Heat	  index	  (°C)	   0.0055	   0.0018	   0.002	   0.0020-­‐0.0090	  
a: Reference group, <40% 
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Table 4-24: Chest Erythema Score Multivariate Model 
Predictor	  Variable	  
Chest	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  wks)	   0.025	   0.032	   0.452	   -­‐0.039-­‐0.088	  
Female	   0.027	   0.032	   0.400	   -­‐0.036-­‐0.089	  
Madeshi	   -­‐0.14	   0.065	   0.026	   -­‐0.27-­‐	  -­‐0.017	  
Birthweight	  (g)	  (cont.)	   0.000073	   0.000036	   0.044	   0.000002-­‐0.00014	  
Avg	  #	  of	  massages	  per	  day	  during	  
first	  week	  of	  life	  
-­‐0.0024	   0.012	   0.843	   -­‐0.026-­‐0.021	  
Household	  has	  electricity	   -­‐0.088	   0.032	   0.006	   -­‐0.15-­‐	  -­‐0.025	  
Maternal	  Age
a	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.10	   0.048	   0.031	   0.0096-­‐0.20	  
	  	  	  25-­‐29	  yrs	   0.082	   0.056	   0.143	   -­‐0.028-­‐0.19	  
	  	  	  30-­‐34	  yrs	   0.062	   0.078	   0.430	   -­‐0.091-­‐0.22	  
	  	  	  >=35	  yrs	   0.026	   0.099	   0.797	   -­‐0.17-­‐0.22	  
Facility	  delivery	   -­‐0.11	   0.036	   0.002	   -­‐0.18-­‐	  -­‐0.039	  
Temperature	  (°C)	   -­‐0.025	   0.0034	   <0.001	   -­‐0.031-­‐	  -­‐0.018	  
Relative	  humidity	  (%)
	  
0.0010	   0.0011	   0.373	   -­‐0.0033-­‐0.0012	  
Infant’s	  age	  days	  0	  to	  3	   0.13	   0.014	   <0.001	   0.11-­‐0.16	  
Infant’s	  age	  days	  4	  to	  14	   0.0017	   0.0031	   0.592	   -­‐0.0044-­‐0.0078	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.022	   0.0024	   <0.001	   -­‐0.027-­‐	  -­‐0.017	  
a: Reference group, <18 years 
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Table 4-25: Chest Rash Score Multivariate Model 
Predictor	  Variable	  
Chest	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  wks)	   -­‐0.063	   0.035	   0.068	   -­‐0.13-­‐0.0046	  
Female	   0.013	   0.034	   0.688	   -­‐0.053-­‐0.080	  
Madeshi	   -­‐0.17	   0.072	   0.016	   -­‐0.31-­‐	  -­‐0.032	  
Low	  birthweight	  (<2500	  g)	   -­‐0.12	   0.036	   0.002	   -­‐0.19-­‐	  -­‐0.044	  
Avg	  #	  of	  massages	  per	  day	  during	  
first	  week	  of	  life	  
-­‐0.016	   0.013	   0.232	   -­‐0.045-­‐0.0065	  
Time	  from	  visit	  to	  last	  massage
a
	   	   	   	   	  
	  	  	  30-­‐59	  min	   0.0071	   0.043	   0.869	   -­‐0.078-­‐0.092	  
	  	  	  60-­‐119	  min	   -­‐0.044	   0.041	   0.288	   -­‐0.12-­‐0.037	  
	  	  	  120-­‐179	  min	   -­‐0.025	   0.047	   0.602	   -­‐0.12-­‐0.068	  
	  	  	  >180	  min	   -­‐0.012	   0.041	   0.768	   -­‐0.093-­‐0.069	  
Maternal	  Age
b	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.065	   0.057	   0.255	   -­‐0.047-­‐0.18	  
	  	  	  25-­‐29	  yrs	   0.033	   0.074	   0.660	   -­‐0.11-­‐0.18	  
	  	  	  30-­‐34	  yrs	   0.032	   0.095	   0.739	   -­‐0.16-­‐0.22	  
	  	  	  >=35	  yrs	   0.043	   0.119	   0.719	   -­‐0.19-­‐0.28	  
Parity
c	  
	   	   	   	  
	  	  	  1-­‐2	   0.050	   0.046	   0.276	   -­‐0.040-­‐0.14	  
	  	  	  >=3	   0.13	   0.060	   0.025	   0.017-­‐0.25	  
Temperature	  (°C)	   0.013	   0.0038	   <0.001	   0.0059-­‐0	  .021	  
Relative	  humidity	  (%)
	  
0.0053	   0.0013	   <0.001	   0.0028-­‐0.0079	  
Infant’s	  age	  days	  0	  to	  14	   0.059	   0.0029	   <0.001	   0.053-­‐0.064	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.030	   0.0029	   <0.001	   -­‐0.036-­‐	  -­‐0.025	  
a: Reference group, <30 min; b: Reference group, <18 years; c: Reference group, none 
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Table 4-26: Direction of Association of Select Infant and Environmental 
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N.S.: Not statisticaly significant 
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Chapter 5 Effect of Oil Group on Skin Integrity and Barrier 
Function 
Background 
Ninety-eight percent of the 3.1 milion neonatal deaths occurring each year occur in 
developing countries. (Black, Cousens et al. 2010; Lawn, Kerber et al. 2010; Liu, 
Johnson et al. 2012) The top three causes of death in these infants are complications 
from preterm birth (35%), infections (including sepsis, pneumonia, diarrhea, meningitis, 
and tetanus) (27%), and intrapartum related neonatal deaths, such as birth asphyxia 
(23%). (Liu, Johnson et al. 2012) In setings with high neonatal mortality (NMR), 
infections account for about 50% of deaths. (Lawn, Cousens et al. 2005; Blencowe and 
Cousens 2013) In Southeast Asia, 52% of child deaths occur during the neonatal period 
and in Nepal it is estimated, 58% of under-five deaths occurred during this period in 
2010. (Liu, Johnson et al. 2012) 
 
One intervention being explored to reduce neonatal mortality is the practice of neonatal 
oil massage using localy available vegetable oils, which is practiced almost universaly 
throughout Southeast Asia. Studies in Bangladesh and Nepal found that more than 96% 
and 99% of newborns, respectively received ful body oil massage, with mustard seed oil 
being the most commonly used oil in both setings. (Darmstadt and Saha 2002; Mulany, 
Darmstadt et al. 2005) Newborn oil massage is also commonly practiced in many 
communities in Africa. (Iweze 1983; Niang 2004; Darmstadt, Hussein et al. 2007; 
Mrisho, Schelenberg et al. 2008; Waiswa, Nyanzi et al. 2010; Dufy, Ferguson et al. 
2012). 
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Many studies show that massage with oil is more beneficial than massage alone. These 
studies show that infants massaged with oil displayed fewer stress behaviors, lower 
salivary cortisol levels, increased vagal activity, and greater mean weight gain when 
compared with infants massaged without oil. (Field, Schanberg et al. 1996; Arora, Kumar 
et al. 2005; Falah, Akhavan Karbasi et al. 2013; Kumar, Upadhyay et al. 2013) In 
addition, hospital-based studies show that the application of sunflower oil reduces rates 
of invasive infection and mortality. A study in Egypt of preterm infants <34 weeks 
showed a significant decrease in the incidence of nosocomial infections and an 
improvement in skin condition in infants receiving sunflower oil. (Darmstadt, Badrawi et 
al. 2004) Another study of preterm infants in Bangladesh comparing infants randomized 
to massage with sunflower oil, Aquaphor, or no emolient, found a 41% reduction in 
nosocomial infections (Darmstadt, Saha et al. 2005) and a 26% reduction in neonatal 
mortality rates in the sunflower oil group compared with controls. (Darmstadt, Saha et al. 
2008) 
 
Although studies have shown that topical application of vegetable oil may be beneficial 
to neonates, the choice of oil may be important. A study done using a mouse model 
showed accelerated skin barrier recovery in mice one hour after application of sunflower 
oil, with a sustained efect up to five hours. (Darmstadt, Mao-Qiang et al. 2002) 
Conversely, aplication of mustard, olive, or soybean oils showed delayed recovery of 
skin barrier function when compared to untreated or Aquaphor treated skin. The most 
detrimental efects were seen with mustard seed oil, with sustained delay of barrier 
recovery for up to seven days. (Darmstadt, Mao-Qiang et al. 2002) Another study 
showed topical application of olive oil on adult forearms for 4 weeks caused significant 
reduction in skin integrity and induced mild erythema, while sunflower oil preserved skin 
integrity and improved hydration. (Danby, AlEnezi et al. 2013) 
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Newborn skin is the first line of defense between the infant and its environment and 
serves many important functions. These include: moderating fluctuations in 
transepidermal water loss (TEWL) and maintaining electrolyte homeostasis, 
thermoregulation and minimizing caloric losses, antimicrobial defense, protection from 
environmental toxins, protection from ultraviolet (UV) radiation, and tactile stimulation. At 
birth, ful term infant skin is fuly functional with a thick epidermis and wel-formed 
stratum corneum layers. (Cunico, Maibach et al. 1977; Yosipovitch, Maayan-Metzger et 
al. 2000) Preterm infants however, show immature barrier function. (Evans and Ruter 
1986; Cartlidge 2000; Darmstadt and Dinulos 2000; Ruter 2000) In addition, neonatal 
skin is always adjusting to its extrauterine environment as it adapts to its new cooler, 
less humid surroundings. (Visscher, Chaterjee et al. 2000; Chiou and Blume-Peytavi 
2004; Fluhr, Darlenski et al. 2012; King, Balaji et al. 2013) 
 
Improving skin barrier integrity and function may be one way in which emolient therapy 
with vegetable oil may improve the health of newborns. Emolient therapy using 
sunflower or saflower oil may normalize transepidermal water loss, which is related to 
gestational age, as TEWL has been shown to decrease in infants treated with emolient 
therapy. (Darmstadt and Dinulos 2000; Hoath and Maibach 2003; Nangia, Paul et al. 
2008) It could also improve skin condition directly providing metabolic building blocks to 
the stratum corneum to form healthy layers and repair damaged layers (Elias, Brown et 
al. 1980; Mao-Qiang, Elias et al. 1993). Improved skin barrier integrity could also provide 
fewer portals of entry of invasive pathogens, leading to fewer invasive infections. 
(Nopper, Hori et al. 1996; Edwards, Connter et al. 2004; Darmstadt, Saha et al. 2005) 
 
The acidic pH of the skin is another mode of protection and is important in the formation 
and integrity of the stratum corneum, alowing the efective functioning of enzymes that 
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are involved in lipid metabolism, bilayer structure, ceramide synthesis, and 
desquamatization. (Rippke, Schreiner et al. 2002; Schmid-Wendtner and Korting 2006) 
After birth, skin pH is elevated in ful term and preterm neonates compared with adults 
and older children and decreases in the first few weeks, with the most significant 
reductions occurring during the first 4 days of life. (Green, Carol et al. 1968; Fluhr, 
Pfisterer et al. 2000; Visscher, Chaterjee et al. 2000; Hoeger and Enzmann 2002) 
However, skin pH remains higher for longer in very premature infants. (Fox, Nelson et al. 
1998) A study looking at skin care practices in a Neonatal Intensive Care Unit (NICU) 
found that using skin wipes with emolient cleansers resulted in significantly lower skin 
pH levels compared with using a cloth and water. (Visscher, Odio et al. 2009) 
 
Emolient therapy research to improve neonatal survival is a global priority. (Lawn, 
Zupan et al. 2006) Although milions of infants in South Asia are massaged with mustard 
oil each year, it is unknown whether substituting sunflower seed oil changes any 
biological mechanisms that may improve neonatal health. With massage of neonates 
with mustard seed oil being almost universaly practiced in many communities in 
Southeast Asia, neonates are routinely exposed to the efects of mustard oil massage, 
which may include increased risk of microfissures in the epidermal layer that may 
increase the likelihood of transcutaneous acquisition of invasive pathogens from the 
environment. (Darmstadt and Dinulos 2000; Darmstadt, Saha et al. 2003) We aimed to 
determine how and if certain biological mechanisms relating to skin barrier and integrity 
including skin condition (measured visualy as rash and erythema), skin pH, TEWL, and 
stratum corneum protein concentrations (measured instrumentaly) might difer between 




	   164 
Methods 
Settings and Population 
This was a cluster-randomized community-based trial conducted by the Nepal Nutrition 
Intervention Project, Sarlahi (NNIPS). In 2011, the NNIPS surveilance area consisted of 
26 Vilage Development Commitees (VDCs) each encompassing nine government 
defined geopolitical units (wards), which were further divided into sectors based on 
population. This trial was nested within a larger parent trial on the Impact of Sunflower 
Seed Oil Massage on Neonatal Morbidity and Mortality in Nepal (NOMS). The study 
population for the NOMS trial was al live born infants in households in 13 VDCs in 
Sarlahi District in rural Nepal. The Nepal Health Research Council and the Commitee 
on Human Research of the Johns Hopkins Bloomberg School of Public Health approved 
this study. 
 
Procedures and Design of the Parent Trial 
Previous sector level mortality estimates were known for 9 of the 13 VDCs from prior 
research in this community and were used to perform restricted randomization in order 
to ensure balance of prior neonatal mortality risk. In the other 4 VDCs, sectors (clusters) 
were randomized with a computerized quasi-random number generator, stratified on 
VDC using blocks of 4, ensuring a geographical balance of the types of oil across the 
study area. Newborn infants were randomized within clusters (sectors) to receive either 
promotion of ful body massage with sunflower seed oil or promotion of ful body 
massage with mustard seed oil. A cluster-randomized design was chosen in order to 
minimize the chance of crossover or contamination of the intervention by providing each 
field worker with only one type of oil to promote in her area. It was not possible to blind 
field workers and mothers to the type of intervention as mustard oil and sunflower oil 
have distinct colors and smels.  
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For both intervention and control groups, oil was purchased from Shiv Shakti in Jitpur, 
Nepal, approximately every 4-6 weeks and stored in sealed half-liter plastic packets at 
site headquarters at room temperature. The company was required to submit a sample 
for purity/quality to the Government of Nepal Food Inspection Laboratory in Hetauda, 
Makwanpur District, Nepal. A copy of this analysis was received from the Hetauda food 
lab for each distinct batch. Determination of the faty-acid composition of the oils was 
done at Geo-Chem Laboratories PVT LTD (Mulund, Mumbai, India). This faty-acid 
profile analysis was repeated twice per year. These analyses consistently estimated the 
linoleic acid levels between 58%-67% and 18%-22% in the sunflower and mustard oils, 
respectively.  
 
Community-specific lists of married women of reproductive age were created. In order to 
rapidly identify new pregnancies, localy-resident female workers monitored the status of 
these women every 5 weeks. A woman identified as pregnant was approached for 
recruitment and consent for the infant’s participation in the parent trial. Each woman 
participating in the study received a set of basic antenatal care interventions (e.g. 
tetanus toxoid, a clean delivery kit, iron-folate supplements, chlorhexidine cleaning 
solution for disinfecting the umbilical region, iron folate, and deworming) and basic 
educational messages on antenatal and essential newborn care. The worker visited the 
women in late pregnancy (~28-32 weeks) to promote the use of either the sunflower 
seed oil or mustard seed oil and provide the mother or other caretaker with a 100ml 
botle of oil at that time. The mother or other caretaker initiated ful body massage 
folowing the field worker’s guidelines using the provided oil daily throughout the 
newborn period. The local project worker visited the homes daily during the first week of 
life to promote the continued use of the oil. 
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Immediately upon notification of the pregnancy, the local resident worker notified the 
supervisory staf and a birth assessment was conducted using standardized data 
colection forms recording information relating to late pregnancy morbidity, labor and 
delivery characteristics, birth assistants and practices, length of labor, maternal 
temperature, date and time of birth, sex, length and weight of infants, and immediate 
newborn care practices (thermal care, cord practices, early bathing and massage, 
breastfeeding initiation, etc.). In addition to the individual data obtained, household level 
data were colected at the time of enrolment of the mothers. This included information 
on socioeconomic factors, such as ethnicity, caste, household assets, ownership of 
materials or livestock, water sources, and family members who may be working 
overseas. Data were also colected on parental literacy, education, and birth history. 
After the initial birth visit, the birth team member completed newborn folow-up visits 
(NFF) on days 3, 7, 10, 14, 21, and 28 (for a total of 7 visits), where signs of infant 
morbidity and newborn care practices since prior visit were recorded. A 500ml botle of 
oil was provided at the initial visit and on folow-up visits on days 10 and 21. The primary 
outcomes of NOMS are mortality within 28 days of birth, and possible severe infection in 
newborns. 
 
Design of the Biological Mechanisms Sub-Study 
This biological mechanisms sub-study included an extended set of measurements 
colected from a subset of infants participating in the main trial. The focus of data 
colection for this sub-study was on direct measurement of biological markers of infants 
built into a specific sub-study schedule (days 1, 3, 7, 14, and 28) of the parent trial visits. 
The biological measurements used to assess skin integrity included: visual assessment 
of skin condition (erythema, rash), measurement of transepidermal water loss (TEWL), 
measurement of skin pH, and colection of skin discs in order to measure the stratum 
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corneum cohesion and protein concentration via measurement of optical density. Al skin 
integrity measures were taken at each of the five visits, apart from the skin disc 
colection, which was colected at visits 1, 7, 14, and 28. Table 5-1 shows the timing of 
measurement colections. 
 
A subset of 7 VDCs of the 13 original VDCs in the NOMS trial was selected to participate 
in the mechanisms study, which began in July 2012. An 8th VDC was added after 5 
months and a 9th VDC was added in January 2013. The cluster-randomization of the 
parent trial was conserved for the mechanisms study. Among infants participating in the 
main study, determination of eligibility to additionaly participate in the sub-study was 
done during the initial birth assessment visit, and was based on estimates of gestational 
age at birth. For this study, preterm infants (<37 weeks gestational age) were 
oversampled, aiming for approximately 50% of the sample to be preterm. During the 
study period (July 2012 until September 2013), the gestational age was estimated 
directly by the field worker using the date of last menstrual period estimated by the 
woman at the time of initial enrolment. Each birth team member had a list of the date of 
the mother’s last menstrual period (LMP), which was used along with the date of birth to 
determine the gestational age of the infant. If the infant was born before week 37, one of 
the members of a specialy trained team of field workers focused on the implementation 
of the mechanisms sub-study was contacted directly by mobile phone. Infants born on or 
after week 37 were listed by VDC in consecutive order (i.e. by birth date) on a pre-
printed computer-generated blank form of 20 rows, 4 of which had been randomly 
selected for shading. Infants listed on a randomly shaded row were eligible for inclusion 
in the mechanisms study, thus selecting 4 out of every 20 (20%) of the ful term infants 
for participation. Al preterm (<37 weeks) infants and every 5th ful term infant born in the 
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mechanisms study area were eligible for enrolment in the sub-study. Infants were 
enroled if consent was provided and the infant was met alive within 48 hours after birth. 
 
Newborns enroled in the mechanisms study were visited in their homes 5 times, on 
days 1, 3, 7, 14, and 28. In addition to performing the skin integrity measurements at 
these visits, the workers asked questions relating to newborn care practices since the 




Four measures were taken to evaluate skin integrity: skin condition scores, TEWL, skin 
pH, and stratum corneum protein concentration (via optical density). Field worker 
evaluation of skin condition was measured using a modified version of a scoring method 
described by Visscher et al..(Visscher, Odio et al. 2009) This team has experience 
extending these scores for patients in the United States. This study used an extended 
version of more established scales for the measure of irritation of the skin based on 
levels of erythema and rash, rating erythema severity on a scale from 0 to 3 and area 
afected on a scale from 0 to 4. Severity of rash and area afected by rash were 
evaluated on scales from 0 to 4 and 0 to 6 respectively. Scores were based on the 
percent area of involvement and severity of skin compromised within the specified body 
region for each component. Each field worker was trained in the use of the scales. The 
severity of erythema and rash as wel as the area covered was recorded on 
standardized data colection instruments. Skin condition assessments were completed 
on the same 4cm by 4cm area of the chest, the entire left arm, and the entire right leg.  
Transepidermal water loss was measured in g/m2/hr using a VapoMeter (Delfin 
Technologies, Ltd, Finland), a closed-chamber device containing sensors for relative 
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humidity and temperature, using standardized procedures. (Rogeries and Group 2001; 
Nuutinen, Alanen et al. 2003; De Paepe, Houben et al. 2005) At each visit, 
transepidermal water loss measurements were taken three times at the mid-chest nipple 
line. The mean value of these measurements was used for analyses. The exact location 
where measurements were taken was similar in al infants through the measurement of 
anatomical markers. The location of the measurements was chosen because it was 
easily accessible, an area that was massaged, and provided a reasonably flat surface 
area for placing the VapoMeter. The three measurements along with the temperature 
and relative humidity obtained from the VapoMeter were recorded on standardized data 
colection forms. 
 
Measurements of skin pH were performed with a flat electrode (SkincheckTM, Hanna 
Instruments, UK) calibrated daily to pH 4 and 7. (Parra and Paye 2003) Measurements 
were taken in the same location at the mid-nipple as the TEWL measurements. The 
three measurements were recorded on standardized data colection forms and the mean 
skin pH of the three measurements was used for analyses. 
 
Using a technique described by Voeglei et al., protein content from the outermost 
stratum corneum was analyzed using samples colected using 380 mm2 D-Squame 
adhesive discs (CuDerm, TX) applied to the chest with constant pressure for 2 minutes. 
(Voegeli, Heiland et al. 2007) Diferent locations on the chest were used for the 
placement of the skin discs at each of the four visits in order to colect discs from skin 
that had not been previously exposed to adhesive. These locations were diferent from 
where the skin pH and TEWL were measured. After the discs were removed from the 
chest, they were placed in microtubes and transferred to field headquarters in cold 
boxes kept between 2° and 8°C. At field headquarters, optical absorption of the skin 
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discs was determined using a spectrophotometer SquameScanTM 850A (Heiland 
electronic, Wetzlar, Germany) specificaly designed for the application of D-Squame 
discs. Before the optical absorptions of the discs were read, the spectrophotometer was 
calibrated to 0% and 36.2% optical absorption. Optical absorption of the discs was 
recorded on standardized data colection forms. The folowing equation was used for 







The nested biological mechanisms study included a subset of the sample size of 29,620 
infants required for the parent trial. Given that we hypothesized that the outcome 
measures (and the moderating efect(s) of the diferent oils, if any) may be more 
important in preterm infants than ful term infants due to the immaturity of their skin, 
preterm infants were oversampled. A total sample size of 1000 infants was selected, 
equaly stratified by 500 preterm and 500 ful term infants. Al power calculations 
assumed a design efect of 1.5, a 5% loss to folow-up, and a 5% Type 1 error. A design 
efect of 1.5 was assumed without prior knowledge of the true extent of correlation of the 
diferent measurements within clusters. The chosen sample size of 1000 infants enabled 
detection of a diference in mean values of skin condition scores, skin pH, TEWL, and 
protein concentrations of 0.5 with between 71% and 100% power for standard deviations 
of 1.0 to 2.5. In addition, the sample size provided 80% power to detect a true hazard 
ratio of 20% in a Cox proportional hazards analysis of the time required for newborn skin 
to reach a beneficial pH level of 5.7. (Yosipovitch, Maayan-Metzger et al. 2000) The 
analyses presented here represent a preliminary analysis of the first 63.7% of the 
anticipated enroled infants. 
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Al analyses for these measurements were conducted using STATA v12 (Colege 
Station, TX). The comparability of the treatment groups in relation to their background 
characteristics was assessed to determine if there were any confounding variables. 
Possible confounders included: household demographics and SES, ethnic group, caste, 
maternal and paternal education levels, maternal age, reproductive history, labor and 
delivery characteristics (place of birth, length and type of labor, type and practice of birth 
assistants), newborn characteristics and newborn care practices (sex, birthweight, 
gestational age, smal-for-gestational age (SGA) status, breastfeeding), and intervention 
exposure and compliance. Outliers that were biologicaly impossible were removed from 
the analyses on the basis that they were likely due to an instrument malfunction or 
measurement of another biological process (e.g. measurement of perspiration rather 
than TEWL). Skin pH values greater than 8 and less than 3 (Marty Visscher, personal 
communication) were removed as wel as TEWL values greater than 100 g/m2/hr (Aki 
Immonen, personal communication). A total of 22 (<1%) skin pH measurements were 
removed, although due to using the mean of 3 measurements, this did not result in any 
lost observations. Thirty-nine (1.3%) TEWL observations were removed as a result of 
133 (4%) measurements being out of range. 
 
In order to analyze diferences in skin pH, the diferences in the time it took for infants in 
each group to reach a beneficial skin pH level (<5.7) was assessed using Cox 
regression models. (Yosipovitch, Maayan-Metzger et al. 2000) For this survival analysis, 
infants were censored at the earliest of: skin pH = 5.7 (event), death, loss to folow-up, 
and after 28 days. 
 
Skin condition scores for erythema and rash were added together separately for each 
body region assessed to get a total skin condition score for each region (chest, left arm, 
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and right leg). To examine whether there were diferences in skin condition, TEWL, skin 
pH, and stratum corneum protein concentration at diferent folow-up visit times between 
the diferent oil groups, regression analyses with random intercepts were performed. In 
al models, estimates of standard errors accounted for the clustered design. Regression 
models were also run for each of the skin condition score components (erythema and 
rash) to examine whether there was a diference between the two oil groups for either 
component score. In addition, mixed-efects, multi-level regression models with random 
intercepts accounting for the randomized clusters and repeated measures on each infant 
were performed for the ful neonatal period and stratified by early (<7 days) and late (≥7 
days) neonatal periods. Mixed-efects, multi-level models with an interaction between 
infant’s age and oil group were also used to explore whether the rate of change in skin 
pH, TEWL, or stratum corneum protein concentration difered between the two oil 
groups. Linear splines for infant‘s age at measurement were used where needed to 
account for nonlinearity, assessed through localy weighted regression smoothing. Sub-
group analyses were conducted for preterm infants for each measurement. Analyses 




Between July 23, 2012 and September 30, 2013, there were a total of 1,876 ful term 
and 409 preterm live born infants in the study area that were eligible for enrolment in the 
biological mechanisms study. Of these infants, 785 (376 ful term and 409 preterm) were 
selected for enrolment (Figure 5-1). Of those selected, 148 (18.9%) died or were not 
met by the mechanisms study field worker before 48 hours after birth and 5 (0.6%) 
mothers refused their infant’s participation in the study. A total of 632 newborns were 
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enroled in the mustard seed oil (N=324) and sunflower seed oil (N=308) clusters. In 
total, 271 (83.6%) and 262 (85.1%) newborns completed 28 days of folow-up in the 
mustard seed oil and the sunflower seed oil groups respectively. In the sunflower oil 
group, 7 (2%) infants died and 39 (13%) permanently moved, most likely returning to the 
mother’s maternal home or maiti, or were not met at their 28-day visit. In the mustard oil 
group, 6 (2%) infants died and 47 (14%) permanently moved or were not met at their 28-
day visit. 
 
Socioeconomic, household, and individual characteristics were wel balanced between 
groups (Table 5-2). In the sunflower seed oil group, a greater proportion of infants were 
born to families who were of Pahadi (originating from the hils) ethnicity than in the 
mustard oil group. Households in the sunflower seed oil group were less likely to have 
electricity and were more likely to have low birthweight (<2500g) infants. In the sunflower 
seed oil group, 40.3% of infants were low birthweight compared to 33.9% in the mustard 
seed oil group. Overal prevalence of low birthweight in this study population with 
oversampled preterm births was 36.7%. Both oil groups had similar proportions of 
infants that were smal-for-gestational age (SGA). The overal prevalence of infants born 
SGA was 42.7%. The mustard seed oil group had a slightly higher proportion of infants 
who were born prematurely with 45.4% of newborns in the mustard seed oil group and 
39.9% of newborns in the sunflower seed oil group born premature. Overal prevalence 
of prematurity in the study population was 42.7%. As these analyses were not completed 
on the total sample size, recruitment was stil ongoing. Premature infants were being 
enroled at a slower rate than ful term infants, as our estimated proportion of preterm 
infants in this study (20%) was based on data from older studies. The actual proportion 
of infants who were born preterm in the study area during this study period was closer to 
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16%, accounting for the prevalence of preterm infants in the population used for these 
analyses being less than 50%. 
 
The number of folow-up visits was similar for both treatment groups (see Table 5-3). 
Both groups had very high percentages of newborns that had been massaged since the 
previous visit (or since birth, if visit 1). The sunflower seed oil group had a larger 
proportion of infants who were not massaged with the study provided oil. Both groups 
had the lowest proportion of infants massaged with the study provided oil during their 
last massage prior to visit 1 (92.3% in the mustard oil group and 82.5% in the sunflower 
oil group), although greater than 99% of infants were massaged prior to the first visit. 
Both groups were massaged frequently during their first week of life, with infants in the 
mustard oil group massaged slightly more frequently, with a mean of 32.34 (±10.78) 
massages in the first week compared to 29.79 (±9.36) massages during the first week in 
the sunflower oil group, The average number of massages per day was 4.70 (±1.47) and 
4.31 (±1.27) in the mustard oil group and the sunflower oil group, respectively. The time 
between last massage and folow-up visits was similar in both treatment groups. 
 
Effect of Oil Group on TEWL  
 
In the complete data set TEWL of both oil groups showed an increasing trend over time, 
however this leveled of in the sunflower oil group after day 3. Both the mustard oil group 
and sunflower oil group show a trend of increasing mean TEWL over time in the ful term 
group, whereas preterm infants in the sunflower oil group had mean TEWL increasing 
quickly from visits 1 to 3 and decreasing after visit 3. Figures 5-2 and 5-3 show 
scaterplots of the mean TEWL at each visit with weighted linear least squares 
regression curves for each oil group for the complete data and the preterm group 
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respectively. (Ful term group figures for al measurements are shown in Appendix B.) In 
this population, neonates in the ful term groups had similar mean TEWL measures at 
most visits (Table 5-4).  However in the preterm group, the sunflower oil group had 
slightly higher mean TEWL at visit 1 (35.52 g/m2/hr (±24.19)) than the mustard oil group 
(31.60 g/m2/hr (±21.64)). At visit 3, the sunflower oil group’s TEWL in the preterm infants 
was higher compared with the mustard oil group (41.49 g/m2/hr (±25.89) compared with 
33.81 g/m2/hr (±23.85)). However, after visit 3 the sunflower oil group’s TEWL starts 
decreasing, whereas the mustard oil group’s TEWL continues to increase. Mean TEWL 
measures at visit 28 for the preterm groups were 38.09 g/m2/hr (±21.88) versus 43.63 
g/m2/hr (±24.19) for sunflower oil and mustard oil, respectively.  
 
Table 5-5 shows the results from the regression models, indicating that the sunflower oil 
group had a statisticaly significantly higher mean TEWL value at visit 3 for the preterm 
data set. It is estimated that the mean TEWL in the sunflower oil group was 7.27 g/m2/hr 
(95% CI: 0.65-13.89) higher when compared to the mustard oil group in preterm infants 
at visit 3. There were no other statisticaly significant diferences of the mean TEWL 
values at any of the other visits when comparing the sunflower oil group to the mustard 
seed oil group for the complete data set or when stratified by term status. The results 
indicate there was no efect of oil group on TEWL over the complete neonatal period or 
when stratified by early and late neonatal periods. 
 
A statisticaly significant diference was found in the rate of change in mean TEWL over 
time in the sunflower oil group when compared with the mustard oil group. The sunflower 
oil group’s mean TEWL decreased 0.16 g/m2/hr (95% CI: 0.016-0.30) per day faster over 
the 28-day period than the mustard oil group in the complete data set (i.e. without regard 
to preterm status). Investigating diferent time periods within the 28-day period showed 
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no statisticaly significant diference in the rate of change of mean TEWL from day 0 to 
day 3. However, from day 4 to day 28 the sunflower oil group’s TEWL decreased an 
estimated 0.23 g/m2/hr (95% CI: 0.06-0.39) per day more quickly than the mustard seed 
oil group’s TEWL in the complete data set. The preterm group showed a similar result, 
with the sunflower oil group’s mean TEWL decreasing at an estimated rate of 0.39 
g/m2/hr (95% CI: 0.18-0.61) faster than the mustard oil group for the complete 28-day 
period and 0.47 g/m2/hr (95% CI: 0.22-0.72) per day faster between days 4 and 28.  
 
Effect of Oil Group on Skin pH  
 
In this population, neonates in the sunflower oil group had a higher mean skin pH on visit 
1 for the complete set of neonates and when stratified by term status when compared to 
the mustard oil group (Table 5-6). The mustard oil group had means of 5.95 (±0.51), 
5.98 (±0.51), and 5.93 (±0.51) for the complete data, the ful term group, and the preterm 
group, respectively. The sunflower oil group had means of 6.12 (±0.53), 6.15 (±0.56), 
and 6.09 (±0.48) for the complete data, ful term group, and preterm group, respectively. 
During the subsequent visits the means were more similar between groups. Figures 5-4 
and 5-5 show how skin pH changes over the complete neonatal period for each oil group 
for the complete data set and preterm group, respectively. These graphs further ilustrate 
the diference in mean skin pH values for the sunflower and mustard oil groups at visit 1. 
The graphs also show a trend of decreasing mean skin pH values over time for both the 
sunflower oil group and the mustard seed oil group for the complete data and when 
stratified by term status. 
 
The regression models indicate that the sunflower oil group had a statisticaly significant 
higher mean skin pH value at visit one for the complete data set, the ful term group, and 
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the preterm group (Table 5-7). For the complete data, it is estimated that at visit 1 the 
mean skin pH in the sunflower oil group was 0.16 (95% CI: 0.07-0.25) higher when 
compared to the mustard oil group. When stratified by term status, it is estimated that 
the mean skin pH in the sunflower oil group was 0.17 (95% CI: 0.06-0.28) higher in the 
ful term group and 0.16 (95% CI: 0.03-0.28) higher in the preterm group when 
compared to the mustard oil group. There were no other statisticaly significant 
diferences in mean skin pH values at any of the subsequent visits when comparing the 
sunflower oil group to the mustard seed oil group. During the early neonatal period the 
mean skin pH in the sunflower oil group was estimated to be 0.12 (95% CI: 0.04-0.20) 
higher than the mustard seed oil group in the complete data set and 0.12 (95% CI: 0.02-
0.21) and 0.13 (95% CI: 0.03-0.23) higher in the ful term and preterm groups, 
respectively. There were no significant efects on mean skin pH when comparing the 
diferent oil groups for the complete or late neonatal periods. 
 
A statisticaly significant diference was found in the rate of change in skin pH over time 
in the sunflower oil group when compared with the mustard oil group. The sunflower oil 
group’s mean skin pH decreased 0.006 (95% CI: 0.003-0.01) per day more quickly than 
the mustard oil group over the 28-day period for the complete data set. The same trend 
was seen in the ful term group, with the sunflower oil group’s mean skin pH decreasing 
0.007 (95% CI: 0.002-0.03) per day more quickly when compared with the mustard oil 
group over the 28-day period. The preterm group showed no statisticaly significant 
diference in the rate of change of the mean skin pH over the 28-day time period when 
comparing the two oil groups, although it showed a trend of decreasing at a faster rate, 
which was similar to the ful term and complete data set groups. During the first week 
after birth, the faster rate of decrease was even more pronounced for the complete data 
set, with the sunflower oil group’s skin pH decreasing 0.018 (95% CI: 0.003-0.033) more 
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quickly than the mustard oil group’s skin pH. The ful term and preterm groups did not 
show any significant diferences in rates of decrease when stratified by early and late 
neonatal periods.  
 
Cox regression models (adjusted for first skin pH measure) were also fit for the data to 
investigate if there were diferences in the hazard of the mean skin pH reaching a value 
of 5.7 when comparing the sunflower oil group to the mustard oil group. At day 7, 235 
(73%) infants in the mustard oil group had reached a skin pH of 5.7 compared with 261 
(70%) infants in the sunflower oil group. However, by day 28 the proportion of infants in 
the sunflower oil group reaching a skin pH of 5.7 surpassed that in the mustard oil group 
with 298 (97%) infants in the sunflower oil group reaching a pH of 5.7 compared with 
305 (94%) in the mustard oil group. The models did not show statisticaly significant 
diferences in the hazards of reaching a skin pH of 5.7 in the complete data set or when 
stratified by term status (Table 5-8). Figures 5-6 and 5-7 show the Cox proportional 
hazards regression survival curves for the complete data set and the preterm group. 
 
Effect of Oil Group on Stratum Corneum Protein Concentration 
 
Overal, both groups showed a decrease in protein concentration from visit 1 to visit 7 
with a leveling of from visits 7 to 14 and then a slight increase between visits 14 and 28 
(Figures 5-8 and 5-9). Table 5-9 shows the means and standard deviations for each 
group by visit. The mustard oil group had means of 16.07 µg/cm2 (±8.14), 12.45 µg/cm2 
(±6.26), 12.89 µg/cm2 (±6.12), and 13.68 µg/cm2 (±6.26) and the sunflower oil group had 
means of 16.75 µg/cm2 (±7.61), 13.40 µg/cm2 (±6.52), 13.20 µg/cm2 (±6.52), and 14.36 
µg/cm2 (±5.86), for the complete data set on visits 1, 7, 14, and 28 respectively. When 
stratified by term status, the ful term and preterm groups showed similar results with 
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very similar means between the two oil groups, except on visit 7 in the ful term group 
where the sunflower oil group had a higher mean protein concentration of 13.54 µg/cm2 
(±6.40) compared with the mustard oil group’s mean of 11.70 µg/cm2 (±6.26). 
 
The regression models indicate that the only visit where mean protein concentration was 
statisticaly significantly diferent between oil groups was in the ful term group on visit 7 
(Table 5-10). Comparing sunflower oil to mustard oil in ful term infants on visit 7, the 
sunflower oil group is estimated to have 1.84 µg/cm2 (95% CI: 0.37-3.31) higher protein 
concentration than the mustard oil group. Regression models for the complete neonatal 
period indicated mean protein concentrations in the sunflower oil group for ful term 
infants to be 0.97 µg/cm2 (95% CI: 0.07-1.87) higher than the mustard oil group, 
however this was no longer significant when adjusted for whether the household had 
electricity. When stratified by early and late neonatal periods ful term infants in the 
sunflower oil group had protein concentrations 1.26 µg/cm2 (95% CI: 0.15-2.38) higher 
during the late neonatal period compared with the mustard oil group (these results did 
not change when controling for confounders). The rate of change of the protein 
concentrations comparing the two oil groups was not different in the complete data set or 
when stratified by term status for any time period over the first 28 days. 
 
Effect of Oil Group on Skin Condition  
 
Neonates in this population had similar chest skin condition scores for each oil group at 
al visits for both the complete group of neonates and when stratified by term status. This 
was observed for the total skin condition score and for erythema and rash individualy 
(results not shown). The total chest skin condition score showed an increasing trend until 
around day 17, folowed by a decreasing trend until day 28, observed in both the 
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complete data set and when stratified by term status (Figures 5-10 and 5-11). This trend 
was also observed for each component of the skin condition score for both the mustard 
seed oil and the sunflower seed oil groups (Figure 5-12). Table 5-11 shows the mean 
skin condition scores for each component, along with the mean total skin condition 
score. Both rash and erythema increased until visit 14 and then decreased between visit 
14 and visit 28 in the complete data set and when stratified by term status (Tables 5-11, 
5-12, and 5-13). 
 
The regression model indicates no statisticaly significant diferences between total chest 
skin condition scores between oil groups at any of the follow-up visits for the complete 
data set or when stratified by term status (Table 5-14). In addition, regression models for 
rash and erythema individualy showed no statisticaly significant diferences for any of 
the component scores for the complete data or when stratified by term status for any of 
the folow-up visits (data not shown). Infants in the sunflower oil group had a trend of 
lower skin condition scores during the neonatal period compared with the mustard oil 
group for the complete data set and when stratified by term status, although this was not 
statisticaly significant. Stratification of the regression models by early and late neonatal 
periods also suggested that the type of oil group had no efect on the total skin condition 
score of the chest, nor did it have an efect on any of the skin condition score 
components for either of the period stratifications. This was true for the complete data 
set and when stratified by term status. 
 
Scaterplots, descriptive characteristics, and regression results of skin conditions for the 
left arm and right leg are shown in Appendix B. These regions showed similar results to 
the chest region. There was an increasing trend in mean total skin condition and for 
erythema and rash individualy in the left arm and right leg region until around day 16 
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and then a decreasing trend until day 28, which was similar in both oil groups. The only 
visit showing a statisticaly significant diference in skin condition scores between oil 
groups was for the left arm at visit 1, which showed the sunflower oil group to have an 
estimated skin condition score 0.24 (95% CI: 0.03-0.45) lower than infants in the 
mustard oil group after adjusting for birthweight and whether the household had 
electricity (results not shown). Similarly to the chest region, infants in the sunflower oil 
group tended to have lower skin condition scores during the neonatal period for the 
complete data set and when stratified by term status for both the left arm and the right 
leg, although this was not statisticaly significant (Appendix B). 
 
Discussion 
These data provide some evidence that diferent types of oil may contribute to 
diferences in skin integrity measurements when infants are massaged regularly with 
sunflower seed oil compared with mustard seed oil. The mean skin pH in the sunflower 
oil group decreased at a faster rate in the complete data set (0.006 pH units per day) 
and in the ful term group (0.007 pH units per day) over the 28-day folow-up period. The 
skin pH of infants in the sunflower seed oil group was higher than in the mustard seed oil 
group at visit 1, resulting in the early neonatal period showing a statisticaly significant 
diference in the mean skin pH in the sunflower oil group. Due to the fact that the 
sunflower oil group started with a higher mean skin pH at visit 1 this diference is unlikely 
an efect of the diferent oils over the first week of life. This faster decrease in skin pH 
could indicate improved barrier function in the sunflower oil group caused by a more 
quickly forming acid mantle, which is important in order for the skin to maintain 
bacteriological, chemical, and mechanical resistance. (Schmid-Wendtner and Korting 
2006) 
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The values of mean TEWL in this population started much higher than in other 
populations where TEWL has been measured and increased during the first month of 
life. This is in contrast to other studies that have found TEWL measures in ful term 
infants to be lower than or equal to adults and to remain relatively stable during the first 
month of life, indicating a highly efective skin barrier. (Cunico, Maibach et al. 1977; 
Yosipovitch, Maayan-Metzger et al. 2000) TEWL measures in preterm infants have also 
been shown to decrease relatively quickly during the first few days and then level of 
during the first month of life. (Agren, Sjörs et al. 1998; Kalia, Nonato et al. 1998) These 
diferences in results could be explained by the diferences in study design between our 
study and previous studies that were conducted in more wel climate-
controled/consistent environments. TEWL in our study was measured in a community 
seting with consistently high humidity, therefore an infant’s skin may not be undergoing 
the changes one would normaly expect when adapting from a warm, humid environment 
in utero, to a cool, dry extrauterine environment. 
 
Although the values of mean TEWL were similar at al visits for both treatment groups 
(apart from visit 3 in the preterm group), mean TEWL decreased at a faster rate in the 
sunflower oil group than in the mustard oil group with the largest diference in rate in the 
complete data set occurring from days 4 to 28, with an estimated 0.23 g/m2/hr per day 
faster decrease in the sunflower oil group. In addition, the preterm group had an 
estimated 0.47 g/m2/hr per day faster decrease in TEWL per day in the sunflower oil 
group between days 4 and 28. This could indicate that although the values of TEWL in 
this population are high, the skin barrier may be improving more rapidly in the sunflower 
oil group in preterm infants. 
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There was litle evidence that skin condition scores were diferent between the two 
treatment groups. This is in contrast with a study done in Egypt, which resulted in a 
significant improvement in skin condition in a group of preterm infants massaged with 
sunflower oil. (Darmstadt, Badrawi et al. 2004) However, the Egypt study was conducted 
in a neonatal intensive care unit with a controled climate, while this study was 
conducted in a community seting. In addition, that study was comparing the use of 
topical sunflower oil application with the use of minimal or no topical emolients, whereas 
in this study al participants were massaged with oil. Al body regions in this study for 
both treatment groups showed increasing skin condition scores (worsening skin 
condition) until about two weeks of life folowed by decreasing skin condition scores 
(improving skin condition) until day 28. This is in contrast to data from other studies that 
found rash only in a diapered region due to fecal contact and did not find rash in the 
chest region. (Visscher, Odio et al. 2009) More research should be done as to whether 
this is an efect of the oil (regardless of type) or whether it is a condition of the hot and 
humid environment (possibly causing infants to develop miliaria as a result of retention 
of sweat). (Foster, Hey et al. 1969; Zuniga and Nguyen 2013) This possible increase in 
rash and erythema due to climate could have nulified any improvement in skin condition 
from the diferent emolients. 
 
Both treatment groups showed the same trend of decreasing stratum corneum protein 
concentration until around day 7, with a leveling of period, and then a slight increase 
from day 14 to 28, indicating that in both groups the skin barrier is improving (less 
stratum corneum protein is being removed and the barrier is more cohesive) during the 
first week of life, signifying the maturation of the stratum corneum. (Berthaud and 
Boncheva 2011; Myer and Maibach 2013) The slight increase in protein concentration 
during the second two weeks of life could indicate the stratum corneum is starting to 
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regenerate, causing old skin cels to shed and the stratum corneum to be less cohesive. 
(Chiou and Blume-Peytavi 2004) Ful term infants in the late neonatal period in the 
sunflower oil group were estimated to have stratum corneum protein concentrations 1.26 
µg/cm2 higher than in the mustard oil group. This may indicate a faster regeneration of 
the stratum corneum. 
 
Although this study had many strengths, including the cluster-randomized design and 
the large sample size with an oversampling of preterm infants, there were some 
limitations. This study population has strong cultural practices of universal oil massage 
during the newborn period, which were not changed for this study. (Mulany, Darmstadt 
et al. 2005) Therefore, this study did not include a control group who did not receive ful 
body oil massage or massage without oil and consequently was not able to compare the 
skin integrity measurements to infants who did not receive any emolient therapy or 
massage. In addition, the way in which newborn ful body massage is practiced in Nepal, 
which is traditionaly done in a very vigorous manner, was not changed and could 
potentialy be harmful to the skin barrier. Vigorous rubbing could damage the stratum 
corneum, negating any possible beneficial efects of the emolients. (Chiou and Blume-
Peytavi 2004) 
 
In addition, due to the fact that measurements were made at homes in this rural 
community it was sometimes dificult to folow the recommended measurement protocols 
for the instruments (VapoMeters and skin pH meters). For example, the standard TEWL 
measurement protocol normaly requires the skin to be bare and in a stil position for up 
to 30 minutes prior to measuring so that it acclimatizes to the environment. (Aki 
Immonen, personal communication) This was not possible in our study, which may have 
resulted in higher measurements as infants usualy had their skin covered before and 
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between measurements, possibly increasing sweating. In addition, it is recommended 
that TEWL measurements be taken in an environment that is less than 50% relative 
humidity and between 20-22°C, which never occurred during our study period. (Rogeries 
and Group 2001) A similar, temperature controled environment is recommended for skin 
pH measures. (Parra and Paye 2003) However, as infants from both oil groups were 
assessed in the same environment, this should not have impacted whether we could 
detect a diference between oil groups.  
 
A mother’s recaled date of last menstrual period (LMP) was relied on in order to 
determine gestational age, which may have resulted in inaccurate estimates of 
gestational age in our study. A study done in a tertiary-care hospital in Bangladesh found 
that LMP underestimated gestational age by one day compared with estimation from 
ultrasound. (Rosenberg, Ahmed et al. 2009) In addition, a study done at a hospital in 
Pakistan found that only 65% of estimated gestational age of reported LMP were within 
7 days and only 82% were within 14 days when compared to gestational age estimates 
using ultrasound. (Jehan, Zaidi et al. 2010) Despite the problems of the uncertainty of 
LMP date, in this community seting in rural Nepal, the low-cost and simple method of 
reported LMP is the best option for estimating gestational age. Also, LMPs from our 
study were colected as soon as a pregnancy was identified (folowing-up women every 
5 weeks), so recal bias would be minimized. In order to determine the accuracy of using 
recaled LMP to estimate gestational age in this population and to determine the 
direction of possible misclassification, research should be done on a smal number of 
women comparing LMP estimates to estimation from ultrasound. Analyses should also 
be performed limiting our preterm group to those <34 weeks in order to determine if 
there are efects of the oils on skin integrity in infants who are more premature. 
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Further research should be conducted in this population investigating whether massage 
with emolients has any efect on skin barrier function when compared to massage 
without emolients and to no massage. It is also important to assess if diferences exist in 
these skin integrity measurements in infants who are massaged diferently (i.e. vigorous 
versus gentle massage, or massage with moderate pressure). Both changing the way in 
which an infant is massaged and whether an infant is massaged would be very dificult in 
this community seting in rural Nepal, as neonatal oil massage is a nearly universal 
cultural practice. (Mulany, Darmstadt et al. 2005) However, a smaller group of neonates 
in an urban area may be more wiling to accept these behavioral change interventions. 
Another possibility in this rural community is to enrol older infants past the age when it is 
considered a cultural necessity to massage the infants, in order to get control groups of 
massage without oil or no massage. However, in this type of population, the maturation 
of the skin barrier could not be measured. 
 
Additional research should also be conducted on other possible biological mechanisms, 
which may be afected by neonatal ful body oil massage with mustard oil or sunflower 
oil. These include diferences of the efects of the diferent oils on bacterial colonization 
of the skin, diferences in immune status and function, and diferences in nutritional 
status. In addition, risk factors for skin integrity, bacterial colonization, immune function, 
and nutritional status should be examined in this population in order to beter target 
groups of infants who may be at higher risk of poor skin integrity and function, poor 
immune function, poor nutrition, or colonization of certain bacteria. In addition, whether 
there are any correlations between the diferent skin integrity measurements (TEWL, 
skin pH, stratum corneum protein concentration, and skin condition) should be explored 
as wel as any relationships between diferent biological mechanisms (skin integrity, 
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bacterial colonization, nutritional status, and immune function). Relationships between 
morbidity and skin integrity should also be examined. 
 
These results indicate a possible faster rate of decrease in skin pH and TEWL in infants 
when massaged with sunflower oil versus mustard seed oil, which could be indicative of 
improved skin barrier function in infants massaged with sunflower oil. If there are 
improved health outcomes in neonates massaged with sunflower oil, improved skin 
barrier function could be one of the reasons. These results may also be applicable to 
northern India, Pakistan, and northwestern Bangladesh, as wel as the Terai region in 
southern Nepal, as they share cultural, social, and economic characteristics. Benefits of 
topical emolient therapy should also be explored in other low-resource setings. It is 
important to have a beter of understanding of the underlying mechanisms of how and 
why emolient therapy can improve neonatal health outcomes in low-resource setings, 
because the optimization of health benefits of oils depends upon the understanding of 
which biological mechanisms are impacted by the use of diferent oils.  
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Chapter 5 Tables and Figures 




Visit	  1 Visit	  3 Visit	  7 Visit	  14 Visit	  28 
Skin	  Condition	  Score	   1000	   X	   X	   X	   X	   X	  
TEWL	   1000	   X	   X	   X	   X	   X	  
Skin	  pH	   1000	   X	   X	   X	   X	   X	  
Skin	  Discs	  to	  Measure	  Protein	  
Concentration	  
1000	   X	   	   X	   X	   X	  
 
	    
	   189 
Table 5-2: Baseline Maternal, Socioeconomic, Household, and Newborn Care 
Characteristics by Intervention Group 
	  
Oil	  Randomization	  Group	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   (%)	   N	   (%)	  
Number	  of	  Clusters	   56	   	   58	   	  
Total	  number	  of	  infants	   324	   	   308	   	  
Ethnic	  Group	  
	   	   	   	  
Pahadi	   15	   4.8	   29	   9.5	  
Madeshi	   300	   95.2	   277	   90.5	  
Maternal	  literacy	  
	   	   	   	  
Not	  literate	   229	   71.3	   220	   71.2	  
Literate	   92	   28.7	   89	   28.8	  
Paternal	  literacy	  
	   	   	   	  
Not	  literate	   153	   47.7	   141	   45.6	  
Literate	   168	   52.3	   168	   54.4	  
Maternal	  Education	  
	   	   	   	  
None	   229	   71.3	   221	   71.5	  
1-­‐5	  yrs	   30	   9.4	   29	   9.4	  
6-­‐10	  yrs	   47	   14.6	   47	   15.2	  
>10	  yrs	   15	   4.7	   12	   3.9	  
Paternal	  Education	  
	   	   	   	  
None	   147	   45.8	   142	   46.0	  
1-­‐5	  yrs	   48	   15.0	   48	   15.5	  
6-­‐10	  yrs	   100	   31.2	   105	   34.0	  
>10	  yrs	   26	   8.1	   14	   4.5	  
Household	  Assets
§	  
	   	   	   	  
0	  or	  1	  asset(s)	   22	   7.0	   22	   7.2	  
2-­‐5	  assets	   135	   42.9	   143	   46.7	  
6-­‐10	  assets	   150	   47.6	   133	   43.5	  
>10	  assets	   8	   2.5	   8	   2.6	  
Electricity	  
	   	   	   	  
No	   112	   35.6	   140	   45.8	  
Yes	   203	   64.4	   166	   54.3	  
Maternal	  Age	  
	   	   	   	  
<18	  yrs	   43	   13.4	   41	   13.3	  
18-­‐24	  yrs	   177	   55.1	   180	   58.3	  
25-­‐29	  yrs	   72	   22.4	   63	   20.4	  
30-­‐34	  yrs	   23	   7.2	   13	   4.2	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Table 5-2: Baseline Maternal, Socioeconomic, Household, and Newborn Care 
Characteristics by Intervention Group (continued) 
	  
	  
Oil	  Randomization	  Group	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   (%)	   N	   (%)	  
Gravidity	  
	   	   	   	  
None	   83	   25.9	   83	   26.9	  
1-­‐2	   143	   44.6	   152	   49.2	  
3-­‐4	   85	   26.5	   70	   22.7	  
>5	   10	   3.1	   4	   1.3	  
Parity	  
	   	   	   	  
None	   88	   27.4	   91	   29.5	  
1-­‐2	   135	   42.1	   136	   44.0	  
3-­‐4	   82	   25.6	   73	   23.6	  
>5	   16	   5.0	   9	   2.9	  
Antenatal	  Care	  Visits	  
	   	   	   	  
No	  ANC	   90	   28.0	   92	   29.8	  
1-­‐2	  ANC	  visits	   122	   38.0	   109	   35.3	  
3-­‐4	  ANC	  visits	   94	   29.3	   96	   31.1	  
>=5	  ANC	  visits	   15	   4.7	   12	   3.9	  
Location	  of	  Delivery	  
	   	   	   	  
Home	   163	   50.8	   160	   51.8	  
Maiti	   57	   17.8	   52	   16.8	  
HP/Clinic	   54	   16.8	   58	   18.8	  
Hospital	   36	   11.2	   32	   10.4	  
On	  way	  to	  facility	   11	   3.4	   7	   2.3	  
Length	  of	  Labor	  
	   	   	   	  
<5	  hrs	   147	   45.8	   149	   48.4	  
5-­‐14	  hrs	   144	   44.7	   118	   38.3	  
15-­‐19	  hrs	   11	   3.4	   16	   5.2	  
20-­‐24	  hrs	   10	   3.1	   14	   4.6	  
>24	  hrs	   9	   2.8	   11	   3.6	  
Complications	  during	  Delivery	  
	   	   	   	  
No	   267	   83.2	   246	   80.1	  
Yes	   54	   16.8	   61	   19.9	  
Delivery	  Assistant	   	   	   	   	  
No	  one/Family/Neighbors	   81	   25.3	   78	   25.2	  
TBA/Chamain	   57	   17.8	   61	   19.7	  
CHV/VHW/MCH	  Worker	   14	   4.4	   8	   2.6	  
ANM/HA/CMA/Staf	  Nurse	   84	   26.3	   86	   27.8	  
Local	  doctor	   79	   24.7	   73	   23.6	  
MBBS	  doctor	   5	   1.6	   3	   1.0	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Table 5-2:	  Baseline Maternal, Socioeconomic, Household, and Newborn Care 
Characteristics by Intervention Group (continued)	  
	  
	  
Oil	  Randomization	  Group	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   (%)	   N	   (%)	  
Sex	   	   	   	   	  
Male	   169	   51.8	   160	   51.4	  
Female	   157	   48.2	   151	   48.6	  
Gestational	  Age	   	   	   	   	  
<32	  wks	   20	   6.3	   17	   5.6	  
32-­‐36	  wks	   124	   39.1	   104	   34.3	  
37-­‐41	  wks	   148	   46.7	   157	   51.8	  
>=42	  wks	   25	   7.9	   25	   8.3	  
Birthweight	   	   	   	   	  
<1500g	   4	   1.3	   8	   2.6	  
1500-­‐2499g	   104	   32.6	   115	   37.7	  
>2500g	   211	   66.1	   182	   59.7	  
SGA	  Status	   	   	   	   	  
AGA	   185	   58.0	   172	   56.4	  
SGA	  3-­‐10%	   62	   19.4	   57	   18.7	  
SGA	  3%	   72	   22.6	   76	   25.0	  
Breastfed	  since	  birth	  at	  first	  
visit	  
	   	   	   	  
No	   54	   16.6	   42	   13.5	  
Yes	   272	   83.4	   269	   86.5	  
Hours	  before	  breastfeeding	  
initiation	  
	   	   	   	  
<1	  hr	   87	   32.3	   74	   27.8	  
1-­‐2	  hrs	   154	   57.2	   151	   56.8	  
3-­‐4	  hrs	   15	   5.6	   20	   7.5	  
>=5	  hrs	   13	   4.8	   21	   7.9	  
Infants	  received	  colostrum	   	   	   	   	  
No	   30	   11	   27	   10	  
Yes	   241	   88.6	   242	   90	  
Gestational	  Age	  (wks)	  	  
(mean,	  SD)	  
37.5	   (3.7)	   37.9	   (3.5)	  
Birthweight	  (g)	  
(mean,	  SD)	  
2639.4	   (465.6)	   2582.8	   (501.3)	  
§:
 
HH assets were based on having at least one of the folowing: electricity, servants, 2nd floor, catle, goats, 
bulock carts, bicycles, clocks, radios, TVs, phones, plot of farmable land, plot of other land, family member 
living & working out of home.	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Table 5-3: Intervention Coverage by Intervention Group 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   %	   N	   %	  
#	  of	  folow-­‐up	  visits
*
	  







#	  of	  times	  massaged	  in	  








Avg	  #	  of	  times	  massaged	  
per	  day	  in	  first	  week	  







Massaged	  since	  last	  visit
§	  
	   	   	   	  
Visit	  1	   323	   99.7	   308	   100	  
Visit	  3	   315	   100	   302	   99.7	  
Visit	  7	   311	   99.7	   301	   98.7	  
Visit	  14	   305	   98.7	   290	   97.0	  
Visit	  28	   269	   99.6	   259	   98.9	  
Massaged	  with	  NNIPS	  oil	  
during	  last	  massage	  
	   	   	   	  
Visit	  1	   298	   92.3	   254	   82.5	  
Visit	  3	   315	   100	   283	   93.7	  
Visit	  7	   299	   96.1	   272	   90.3	  
Visit	  14	   294	   96.4	   269	   92.8	  
Visit	  28	   260	   96.7	   229	   88.4	  
Time	  between	  visit	  and	  
last	  massage	  
	   	   	   	  
<30	  min	   302	   20.0	   313	   21.7	  
30-­‐59	  min	   267	   17.7	   237	   16.4	  
60-­‐119	  min	   355	   23.5	   326	   22.6	  
120-­‐179	  min	   205	   13.6	   192	   13.3	  
>180	  min	   382	   25.3	   375	   26.0	  
*Max number of household visits is 5; § At visit 1 this is massaged since birth 
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Table 5-4: Descriptive Characteristics of TEWL by Visit and Intervention Group 
Visit	  
Number	  
Mustard	  Oil	   Sunflower	  Oil	  


















Complete	  Data	  Set	  
1	   322	   56	   34.34	   22.47	   307	   57	   35.34	   23.34	  
3	   314	   56	   36.21	   24.25	   302	   57	   39.36	   24.45	  
7	   310	   56	   37.92	   22.96	   301	   57	   40.53	   24.95	  
14	   305	   56	   41.70	   24.69	   288	   57	   41.32	   23.85	  
28	   266	   56	   44.79	   23.88	   254	   57	   41.74	   22.50	  
Ful	  Term	  
1	   173	   51	   36.13	   22.38	   184	   52	   35.19	   22.92	  
3	   168	   51	   38.10	   24.46	   179	   52	   37.93	   23.45	  
7	   165	   51	   38.16	   23.37	   179	   51	   40.98	   24.65	  
14	   164	   51	   42.14	   24.68	   178	   52	   43.14	   23.94	  
28	   143	   50	   45.43	   23.25	   150	   51	   44.26	   22.78	  
Preterm	  
1	   143	   53	   31.60	   21.64	   120	   47	   35.52	   24.19	  
3	   141	   53	   33.81	   23.85	   120	   47	   41.49	   25.89	  
7	   138	   53	   37.36	   22.36	   119	   47	   40.36	   25.53	  
14	   136	   53	   40.11	   24.00	   108	   47	   38.27	   23.49	  
28	   119	   51	   43.63	   24.19	   102	   45	   38.09	   21.88	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table 5-5: Regression Results of Intervention Group on TEWL  













Complete	  Data	  Set	  
Visit	  1	   629	   113	   0.70	   2.06	   -­‐3.32-­‐4.72	  
Visit	  3	   615	   113	   3.29	   2.23	   -­‐1.07-­‐7.66	  
Visit	  7	   608	   113	   2.59	   2.10	   -­‐1.52-­‐6.71	  
Visit	  14	   592	   113	   -­‐0.35	   2.02	   -­‐4.31-­‐3.60	  
Visit	  28	   519	   113	   -­‐3.05	   2.03	   -­‐7.04-­‐0.94	  
Complete	  
Neonatal	  Period	  
631	   113	   0.99	   1.67	   -­‐2.26-­‐4.24	  
Early	  Neonatal	  
Period	  
631	   113	   1.48	   1.89	   -­‐2.23-­‐5.18	  
Late	  Neonatal	  
Period	  
610	   113	   0.64	   1.77	   -­‐2.83-­‐4.11	  
Ful	  Term	  
Visit	  1	   357	   103	   -­‐1.33	   2.56	   -­‐6.35-­‐3.69	  
Visit	  3	   347	   103	   -­‐0.10	   2.66	   -­‐5.32-­‐5.12	  
Visit	  7	   344	   102	   2.84	   2.66	   -­‐2.36-­‐8.04	  
Visit	  14	   342	   103	   1.00	   2.62	   -­‐4.14-­‐6.14	  
Visit	  28	   293	   101	   -­‐1.17	   2.68	   -­‐6.42-­‐4.08	  
Complete	  
Neonatal	  Period	  
358	   104	   0.61	   1.92	   -­‐3.14-­‐4.36	  
Early	  Neonatal	  
Period	  
358	   104	   -­‐0.65	   2.22	   -­‐4.99-­‐3.70	  
Late	  Neonatal	  
Period	  
347	   103	   2.19	   2.17	   -­‐2.07-­‐6.45	  
Preterm	  
Visit	  1	   264	   100	   2.80	   3.19	   -­‐3.45-­‐9.05	  
Visit	  3	   261	   100	   7.27*	   3.38	   0.65-­‐13.89	  
Visit	  7	   257	   100	   2.56	   3.15	   -­‐3.61-­‐8.73	  
Visit	  14	   244	   100	   -­‐1.84	   3.05	   -­‐7.82-­‐4.14	  
Visit	  28	   221	   96	   -­‐5.54	   3.11	   -­‐11.63-­‐0.56	  
Complete	  
Neonatal	  Period	  
265	   100	   1.35	   2.41	   -­‐3.39-­‐6.09	  
Early	  Neonatal	  
Period	  
265	   100	   3.38	   2.99	   -­‐2.48-­‐9.24	  
Late	  Neonatal	  
Period	  
256	   100	   -­‐1.07	   2.60	   -­‐6.16-­‐4.02	  
N=number of observations for visits and number of infants for neonatal periods, n=number of clusters, 
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Table 5-6: Descriptive Characteristics of Skin pH by Visit and Intervention Group 
Visit	  
Number	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Complete	  Data	  Set	  
1	   322	   56	   5.95	   0.51	   308	   57	   6.12	   0.53	  
3	   314	   56	   5.55	   0.50	   302	   57	   5.63	   0.48	  
7	   310	   56	   5.15	   0.55	   304	   57	   5.22	   0.53	  
14	   305	   56	   5.07	   0.56	   297	   57	   5.07	   0.55	  
28	   266	   56	   4.83	   0.60	   255	   57	   4.82	   0.53	  
Ful	  Term	  
1	   174	   52	   5.98	   0.51	   184	   52	   6.15	   0.56	  
3	   168	   51	   5.55	   0.50	   179	   52	   5.60	   0.49	  
7	   167	   51	   5.14	   0.56	   182	   52	   5.20	   0.54	  
14	   165	   51	   5.07	   0.57	   180	   52	   5.05	   0.58	  
28	   142	   49	   4.83	   0.58	   150	   52	   4.79	   0.52	  
Preterm	  
1	   143	   53	   5.93	   0.51	   121	   47	   6.09	   0.48	  
3	   142	   53	   5.56	   0.50	   120	   42	   5.67	   0.47	  
7	   139	   52	   5.17	   0.54	   119	   47	   5.24	   0.51	  
14	   136	   53	   5.08	   0.55	   115	   47	   5.11	   0.49	  
28	   121	   51	   4.82	   0.62	   103	   45	   4.86	   0.54	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table 5-7: Regression Results of Intervention Group on Skin pH 
	   N	   n	   Coeficient	   SE	   95%	  CI	  
Complete	  Data	  Set	  
Visit	  1	   630	   113	   0.16**	   0.05	   0.07-­‐0.25	  
Visit	  3	   616	   113	   0.07	   0.05	   -­‐0.02-­‐0.16	  
Visit	  7	   614	   113	   0.07	   0.05	   -­‐0.03-­‐0.17	  
Visit	  14	   602	   113	   0.01	   0.05	   -­‐0.09-­‐0.11	  
Visit	  28	   521	   113	   -­‐0.01	   0.05	   -­‐0.11-­‐0.08	  
Complete	  
Neonatal	  Period	  
632	   112	   0.06	   0.04	   -­‐0.02-­‐0.13	  
Early	  Neonatal	  
Period	  
632	   113	   0.12**	   0.04	   0.04-­‐0.20	  
Late	  Neonatal	  
Period	  
612	   113	   0.05	   0.05	   -­‐0.04-­‐0.14	  
Ful	  Term	  
Visit	  1	   358	   104	   0.17**	   0.06	   0.06-­‐0.28	  
Visit	  3	   347	   103	   0.05	   0.05	   -­‐0.06-­‐0.15	  
Visit	  7	   349	   103	   0.07	   0.06	   -­‐0.06-­‐0.19	  
Visit	  14	   345	   103	   -­‐0.02	   0.06	   -­‐0.14-­‐0.10	  
Visit	  28	   292	   100	   -­‐0.05	   0.07	   -­‐0.18-­‐0.08	  
Complete	  
Neonatal	  Period	  
359	   104	   0.04	   0.04	   -­‐0.04-­‐0.12	  
Early	  Neonatal	  
Period	  
359	   104	   0.12*	   0.05	   0.02-­‐0.21	  
Late	  Neonatal	  
Period	  
348	   103	   0.04	   0.05	   -­‐0.06-­‐0.14	  
Preterm	  
Visit	  1	   264	   100	   0.16*	   0.06	   0.03-­‐0.28	  
Visit	  3	   262	   100	   0.11	   0.07	   -­‐0.02-­‐0.24	  
Visit	  7	   258	   99	   0.08	   0.07	   -­‐0.06-­‐0.22	  
Visit	  14	   251	   100	   0.04	   0.07	   -­‐0.11-­‐0.18	  
Visit	  28	   224	   96	   0.04	   0.08	   -­‐0.11-­‐0.19	  
Complete	  
Neonatal	  Period	  
265	   100	   0.09	   0.05	   -­‐0.01-­‐0.18	  
Early	  Neonatal	  
Period	  
265	   100	   0.13*	   0.05	   0.03-­‐0.23	  
Late	  Neonatal	  
Period	  
257	   100	   0.07	   0.07	   -­‐0.06-­‐0.20	  
N=number of observations for visits and number of infants for neonatal periods, n=number of clusters, 
Coeficient=regression coeficient for sunflower group, SE=standard errors, 95% CI=95% confidence 
interval, *=p<0.05, **=p<0.01 
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Table 5-8: Cox Hazard Regression Results of Intervention Group on Skin pH 
Adjusted for Skin pH Measure at Visit 1 
	   N	   n	   Hazard	  Ratio	   SE	   95%	  CI	  
Complete	  Data	  Set	   629	   113	   1.13	   0.10	   0.95-­‐1.34	  
Ful	  Term	   357	   104	   1.04	   0.13	   0.82-­‐1.33	  
Preterm	   264	   100	   1.23	   0.17	   0.94-­‐1.62	  
N=number of observations, n=number of clusters, SE= standard errors, 95% CI=95% confidence interval 
 
 
Table 5-9: Descriptive Characteristics of Stratum Corneum Protein Concentration 
by Visit and Intervention Group 
Visit	  
Number	  
Mustard	  Oil	   Sunflower	  Oil	  


















Complete	  Data	  Set	  
1	   264	   54	   16.07	   8.14	   247	   55	   16.75	   7.61	  
7	   259	   54	   12.45	   6.26	   248	   56	   13.40	   6.52	  
14	   253	   54	   12.89	   6.12	   247	   56	   13.20	   6.52	  
28	   224	   55	   13.68	   6.26	   213	   55	   14.36	   5.86	  
Ful	  Term	  
1	   141	   49	   15.82	   8.47	   144	   49	   16.65	   8.12	  
7	   137	   47	   11.70	   6.26	   148	   51	   13.54	   6.40	  
14	   136	   46	   12.60	   6.26	   148	   52	   13.28	   6.55	  
28	   121	   45	   13.26	   6.00	   123	   49	   13.94	   5.92	  
Preterm	  
1	   119	   52	   16.26	   7.84	   100	   43	   16.90	   6.85	  
7	   118	   51	   13.17	   6.15	   98	   42	   13.27	   6.77	  
14	   114	   50	   13.13	   4.84	   97	   42	   13.21	   6.51	  
28	   101	   48	   14.25	   6.58	   88	   39	   14.93	   5.83	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table 5-10: Regression Results of Intervention Group on Protein Concentration 













Complete	  Data	  Set	  
Visit	  1	   511	   109	   0.64	   0.73	   -­‐0.79-­‐2.07	  
Visit	  3	   507	   110	   0.97	   0.65	   -­‐0.30-­‐2.25	  
Visit	  7	   500	   110	   0.31	   0.56	   -­‐0.79-­‐1.42	  
Visit	  14	   437	   110	   0.69	   0.59	   -­‐0.46-­‐1.83	  
Visit	  28	   511	   109	   0.64	   0.73	   -­‐0.79-­‐2.07	  
Complete	  
Neonatal	  Period	  
572	   111	   0.61	   0.37	   -­‐0.10-­‐1.33	  
Early	  Neonatal	  
Period	  
522	   110	   0.84	   0.59	   -­‐0.33-­‐2.00	  
Late	  Neonatal	  
Period	  
533	   110	   0.55	   0.43	   -­‐0.29-­‐1.40	  
Ful	  Term	  
Visit	  1	   285	   98	   0.75	   1.02	   -­‐1.25-­‐2.74	  
Visit	  3	   285	   98	   1.84*	   0.75	   0.37-­‐3.31	  
Visit	  7	   284	   98	   0.68	   0.76	   -­‐0.81-­‐2.17	  
Visit	  14	   244	   94	   0.68	   0.76	   -­‐0.81-­‐2.17	  
Visit	  28	   285	   98	   0.75	   1.02	   -­‐1.25-­‐2.74	  
Complete	  
Neonatal	  Period	  
321	   101	   0.97*	   0.46	   0.07-­‐1.87	  
Early	  Neonatal	  
Period	  
291	   99	   0.79	   0.83	   -­‐0.84-­‐2.42	  
Late	  Neonatal	  
Period	  
299	   99	   1.26*	   0.57	   0.15-­‐2.38	  
Preterm	  
Visit	  1	   219	   95	   0.63	   1.08	   -­‐1.48-­‐2.74	  
Visit	  3	   216	   93	   0.27	   1.03	   -­‐1.74-­‐2.29	  
Visit	  7	   211	   92	   0.08	   0.85	   -­‐1.58-­‐1.74	  
Visit	  14	   189	   87	   0.69	   0.91	   -­‐1.09-­‐2.46	  
Visit	  28	   219	   95	   0.63	   1.08	   -­‐1.48-­‐2.74	  
Complete	  
Neonatal	  Period	  
244	   98	   0.35	   0.54	   -­‐0.72-­‐1.42	  
Early	  Neonatal	  
Period	  
224	   96	   1.08	   0.82	   -­‐0.52-­‐2.68	  
Late	  Neonatal	  
Period	  
228	   94	   -­‐0.22	   0.67	   -­‐1.54-­‐1.10	  
N=number of observations for visits and number of infants for neonatal periods, n=number of clusters, 
Coeficient=regression coeficient for sunflower group, SE=standard errors, 95% CI=95% confidence 
interval, *=p<0.05 
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Table 5-11: Descriptive Characteristics of Chest Skin Condition Score by Visit and 
Intervention Group-Complete Data 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   324	   56	   0.51	   0.65	   308	   57	   0.55	   0.69	  
Rash	   324	   56	   0.14	   0.40	   308	   57	   0.16	   0.44	  
Total	   324	   56	   0.64	   0.85	   308	   57	   0.70	   0.93	  
Visit	  3	  
Erythema	   315	   56	   0.84	   0.65	   303	   57	   0.82	   0.66	  
Rash	   315	   56	   0.75	   0.76	   303	   57	   0.64	   0.77	  
Total	   315	   56	   1.59	   1.24	   303	   57	   1.47	   1.11	  
Visit	  7	  
Erythema	   312	   56	   0.78	   0.62	   305	   57	   0.83	   0.65	  
Rash	   312	   56	   0.79	   0.79	   305	   57	   0.81	   0.82	  
Total	   312	   56	   1.57	   1.22	   305	   57	   1.64	   1.30	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   309	   56	   0.83	   0.63	   299	   57	   0.83	   0.65	  
Rash	   309	   56	   1.04	   0.77	   299	   57	   0.99	   0.82	  
Total	   309	   56	   1.88	   1.28	   299	   57	   1.81	   1.35	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   270	   56	   0.55	   0.58	   262	   57	   0.52	   0.59	  
Rash	   270	   56	   0.70	   0.72	   262	   57	   0.66	   0.73	  
Total	   270	   56	   1.25	   1.17	   262	   57	   1.19	   1.22	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table 5-12: Descriptive Characteristics of Chest Skin Condition Score by Visit and 
Intervention Group-Ful Term 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   175	   52	   0.51	   0.63	   184	   52	   0.48	   0.63	  
Rash	   175	   52	   0.13	   0.40	   184	   52	   0.20	   0.49	  
Total	   175	   52	   0.64	   0.82	   184	   52	   0.68	   0.93	  
Visit	  3	  
Erythema	   169	   51	   0.84	   0.63	   180	   52	   0.81	   0.66	  
Rash	   169	   51	   0.72	   0.73	   180	   52	   0.64	   0.76	  
Total	   169	   51	   1.56	   1.19	   180	   52	   1.44	   1.20	  
Visit	  7	  
Erythema	   168	   51	   0.76	   0.60	   183	   52	   0.81	   0.65	  
Rash	   168	   51	   0.82	   0.80	   183	   52	   0.90	   0.82	  
Total	   168	   51	   1.58	   1.21	   183	   52	   1.71	   1.32	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   167	   51	   0.91	   0.62	   181	   52	   0.86	   0.65	  
Rash	   167	   51	   1.14	   0.79	   181	   52	   1.10	   0.80	  
Total	   167	   51	   2.05	   1.27	   181	   52	   1.96	   1.36	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   144	   50	   0.54	   0.58	   155	   51	   0.51	   0.58	  
Rash	   144	   50	   0.73	   0.72	   155	   51	   0.71	   0.73	  
Total	   144	   50	   1.27	   1.19	   155	   51	   1.22	   1.22	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table 5-13: Descriptive Characteristics of Chest Skin Condition Score by Visit and 
Intervention Group-Preterm 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   144	   53	   0.51	   0.67	   121	   47	   0.66	   0.78	  
Rash	   144	   53	   0.15	   0.41	   121	   47	   0.10	   0.35	  
Total	   144	   53	   0.65	   0.90	   121	   47	   0.76	   0.93	  
Visit	  3	  
Erythema	   142	   53	   0.84	   0.68	   120	   47	   0.85	   0.67	  
Rash	   142	   53	   0.80	   0.79	   120	   47	   0.66	   0.78	  
Total	   142	   53	   1.64	   1.30	   120	   47	   1.51	   1.28	  
Visit	  7	  
Erythema	   140	   53	   0.82	   0.64	   119	   47	   0.87	   0.65	  
Rash	   140	   53	   0.76	   0.80	   119	   47	   0.70	   0.81	  
Total	   140	   53	   1.58	   1.23	   119	   47	   1.58	   1.26	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   138	   53	   0.75	   0.63	   116	   47	   0.78	   0.64	  
Rash	   138	   53	   0.92	   0.75	   116	   47	   0.83	   0.83	  
Total	   138	   53	   1.68	   1.26	   116	   47	   1.61	   1.30	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   123	   51	   0.56	   0.57	   105	   45	   0.54	   0.61	  
Rash	   123	   51	   0.67	   0.72	   105	   45	   0.60	   0.72	  
Total	   123	   51	   1.24	   1.15	   105	   45	   1.14	   1.23	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table 5-14: Regression Results of Intervention Group on Chest Skin Condition 
Total Score 
	   N	   n	   Coeficient	   SE	   95%	  CI	  
Complete	  Data	  Set	  
Visit	  1	   632	   113	   0.06	   0.07	   -­‐0.08-­‐0.20	  
Visit	  3	   618	   113	   -­‐0.13	   0.10	   -­‐0.32-­‐0.07	  
Visit	  7	   617	   113	   0.07	   0.10	   -­‐0.14-­‐0.27	  
Visit	  14	   608	   113	   -­‐0.06	   0.11	   -­‐0.27-­‐0.14	  
Visit	  28	   532	   113	   -­‐0.07	   0.11	   -­‐0.29-­‐0.16	  
Complete	  
Neonatal	  Period	  
632	   113	   -­‐0.03	   0.06	   -­‐0.14-­‐0.10	  
Early	  Neonatal	  
Period	  
632	   113	   -­‐0.03	   0.07	   -­‐0.16-­‐0.11	  
Late	  Neonatal	  
Period	  
632	   113	   -­‐0.004	   0.09	   -­‐0.18-­‐0.17	  
Ful	  Term	  
Visit	  1	   359	   104	   0.03	   0.11	   -­‐0.17-­‐0.24	  
Visit	  3	   349	   103	   -­‐0.11	   0.13	   -­‐0.36-­‐0.13	  
Visit	  7	   351	   103	   0.13	   0.14	   -­‐0.13-­‐0.40	  
Visit	  14	   348	   103	   -­‐0.11	   0.15	   -­‐0.41-­‐0.19	  
Visit	  28	   299	   101	   -­‐0.05	   0.13	   -­‐0.33-­‐0.22	  
Complete	  
Neonatal	  Period	  
359	   104	   -­‐0.01	   0.08	   -­‐0.16-­‐0.15	  
Early	  Neonatal	  
Period	  
359	   104	   0.02	   0.09	   -­‐0.16-­‐0.20	  
Late	  Neonatal	  
Period	  
359	   104	   -­‐0.03	   0.12	   -­‐0.26-­‐0.21	  
Preterm	  
Visit	  1	   265	   100	   0.10	   0.11	   -­‐0.12-­‐0.32	  
Visit	  3	   262	   100	   -­‐0.13	   0.16	   -­‐0.45-­‐0.18	  
Visit	  7	   259	   100	   -­‐0.01	   0.16	   -­‐0.32-­‐0.30	  
Visit	  14	   254	   100	   -­‐0.07	   0.17	   -­‐0.39-­‐0.25	  
Visit	  28	   228	   96	   -­‐0.10	   0.17	   -­‐0.43-­‐0.23	  
Complete	  
Neonatal	  Period	  
265	   100	   -­‐0.04	   0.09	   -­‐0.23-­‐0.14	  
Early	  Neonatal	  
Period	  
265	   100	   -­‐0.06	   0.10	   -­‐0.26-­‐0.15	  
Late	  Neonatal	  
Period	  
257	   100	   0.002	   0.13	   -­‐0.26-­‐0.26	  
N=number of observations for visits and number of infants for neonatal periods, n=number of clusters, 
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Chapter 6 Effect of Oil Group on Nutritional Status 
Background 
Globaly, 3.1 milion neonatal (≤28 days) deaths occur each year, with 98% of these 
deaths occurring in developing countries. (Black, Cousens et al. 2010; Lawn, Kerber et 
al. 2010; Liu, Johnson et al. 2012) This accounts for >40% of al deaths in children 
under-five years, a proportion that has been increasing in recent years as gains in post-
natal survival outpace those in the neonatal period. (Lawn, Cousens et al. 2005; 
Oestergaard, Inoue et al. 2011; Liu, Johnson et al. 2012) The top three causes of death 
in these infants are complications from preterm birth (35%), infections (including sepsis, 
pneumonia, diarrhea, meningitis, and tetanus) (27%), and intrapartum related neonatal 
deaths, such as birth asphyxia (23%). (Liu, Johnson et al. 2012) Preterm complications 
also contribute to other causes of death, resulting in half of al neonatal deaths globaly. 
(Belizan, McClure et al. 2012) In Southeast Asia, 52% of child deaths occur during the 
neonatal period and in Nepal it is estimated that in 2010, 58% of under-five deaths 
occurred during this period. (Liu, Johnson et al. 2012) 
 
The practice of neonatal oil massage using localy available vegetable oils is one 
intervention being explored to reduce neonatal mortality, which is practiced almost 
universaly throughout Southeast Asia. (Darmstadt and Saha 2002; Mulany, Darmstadt 
et al. 2005) Although less widespread, oil massage is also practiced in many 
communities in Africa, and could be acceptable as an intervention to improve neonatal 
mortality and morbidity. (Iweze 1983; Niang 2004; Darmstadt, Hussein et al. 2007; 
Mrisho, Schelenberg et al. 2008; Waiswa, Nyanzi et al. 2010; Dufy, Ferguson et al. 
2012) 
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Studies have shown that massage with oil is more beneficial than massage alone. 
Compared with non-massaged infants, those massaged with Johnson and Johnson 
baby oil demonstrated fewer stress behaviors, lower salivary cortisol levels, and 
increased vagal activity. (Field, Schanberg et al. 1996) A study in Egypt of preterm 
infants <34 weeks comparing the application of sunflower oil to controls showed a 
significant decrease in the incidence of nosocomial infections and an improvement in 
skin condition in infants receiving sunflower oil. (Darmstadt, Badrawi et al. 2004) A 
larger, similarly designed study of preterm infants in Bangladesh comparing infants 
randomized to massage with sunflower oil, Aquaphor, or no emolient, found a 41% 
reduction in nosocomial infections (Darmstadt, Saha et al. 2005) and a 26% reduction in 
neonatal mortality rates in the sunflower oil group. (Darmstadt, Saha et al. 2008) Many 
families from this same cohort perceived topical therapy with sunflower or Aquaphor to 
be beter than mustard oil. (Ahmed, Saha et al. 2007) 
 
Although studies have shown that topical application of vegetable oil may be beneficial 
to neonates, the choice of oil may be important. A study done using a mouse model 
showed accelerated skin barrier recovery in mice one hour after application of sunflower 
oil, with a sustained efect up to five hours while applications of mustard, olive, or 
soybean oils resulted in delayed recovery of skin barrier function. (Darmstadt, Mao-
Qiang et al. 2002) Mustard seed oil showed the most detrimental efects, with sustained 
delay of barrier recovery for up to seven days. One possible reason for this delayed 
recovery is that mice treated with mustard seed oil showed structural changes in their 
epidermis, with flatened keratinocytes, apoptotic nuclei and nuclear envelope 
hypertrophy, and condensed heterochromatin. (Darmstadt, Mao-Qiang et al. 2002) 
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One way in which topical emolient application may be beneficial to neonates is by 
improved nutritional status. Nutritional deficiencies in infants can result from many 
sources such as inadequate diet, impaired absorption, high metabolic demands due to 
relatively large surface areas and rapid tissue growth, and defective metabolism of 
nutrients. Premature infants may be even more at risk because of a lack of nutrient 
stores. (Darmstadt 1998) Preterm neonates in Iran randomized to moderate pressure 
massage alone and the same massage using sunflower oil, showed improved weight 
gain in the group massaged with sunflower oil. (Falah, Akhavan Karbasi et al. 2013) 
Another hospital-based study in Iran found a significant diference in weight gain 
between neonates massaged with coconut oil and both the group massaged without oil 
and the no massage group, but no diference between the massage only and no 
massage group. (Saeedi, Gholam et al. 2011) In addition, studies of very low birthweight 
preterm neonates (<1500g, <37 weeks gestational age and <1800g, <35 weeks 
gestational age) in India found infants receiving oil massage to have greater weight gain 
than those who received massage without oil or no massage. (Arora, Kumar et al. 2005; 
Kumar, Upadhyay et al. 2013) 
 
Emolient therapy research to improve neonatal survival is a global priority. (Lawn, 
Zupan et al. 2006) Milions of infants in South Asia are exposed to the efects of mustard 
oil massage each year and it is unknown whether substituting sunflower seed oil 
changes any biological mechanisms that may improve neonatal health. We aimed to 
determine if and how certain biological mechanisms relating to nutritional status might 
difer between infants massaged with mustard seed oil and sunflower seed oil in rural 
Nepal. An examination of these possible mechanisms wil facilitate characterization of 
the modes through which sunflower oil massage may improve neonatal health. 
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Methods 
Settings and Population 
This was a cluster-randomized community-based trial conducted by the Nepal Nutrition 
Intervention Project, Sarlahi (NNIPS). In 2011, the NNIPS surveilance area consisted of 
26 Vilage Development Commitees (VDCs) each encompassing nine government 
defined geopolitical units (wards), which were further divided into sectors based on 
population. This trial was nested within a larger parent trial on the Impact of Sunflower 
Seed Oil Massage on Neonatal Morbidity and Mortality in Nepal (NOMS). The original 
study population for the NOMS trial was al live born infants in households in 13 VDCs in 
Sarlahi District in rural Nepal. The Nepal Health Research Council and the Commitee 
on Human Research of the Johns Hopkins Bloomberg School of Public Health approved 
this study. 
 
Procedures and Design of the Parent Trial 
Previous sector level mortality estimates were known for 9 of the 13 VDCs from prior 
research in this community and were used to perform restricted randomization in order 
to ensure balance of prior neonatal mortality risk. In the other 4 VDCs, sectors (clusters) 
were randomized with a computerized quasi-random number generator, stratified on 
VDC using blocks of 4, ensuring a geographical balance of the types of oil across the 
study area. Newborn infants were randomized within clusters (sectors) to receive either 
promotion of ful body massage with sunflower seed oil or promotion of ful body 
massage with mustard seed oil. A cluster-randomized design was chosen in order to 
minimize the chance of crossover or contamination of the intervention by providing each 
field worker with only one type of oil to promote in her area. It was not possible to blind 
field workers or mothers to the treatment, as mustard oil and sunflower oil have distinct 
colors and smels.  
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For both intervention and control groups, oil was purchased from Shiv Shakti in Jitpur, 
Nepal, approximately every 4-6 weeks and stored in sealed half-liter plastic packets at 
site headquarters at room temperature. The company was required to submit a sample 
for purity/quality to the Government of Nepal Food Inspection Laboratory in Hetauda, 
Makwanpur District, Nepal. A copy of this analysis was received from the Hetauda food 
lab for each distinct batch. Determination of the faty-acid composition of the oils was 
done at Geo-Chem Laboratories PVT LTD (Mulund, Mumbai, India). This faty-acid 
profile analysis was repeated twice per year. These analyses consistently estimated the 
linoleic acid levels between 58%-67% and 18%-22% in the sunflower and mustard oils, 
respectively.  
 
Community-specific lists of married women of reproductive age were created. In order to 
rapidly identify new pregnancies, localy-resident female workers monitored the status of 
these women every 5 weeks. A woman identified as pregnant was approached for 
recruitment and consent for her infant’s participation in the parent trial. Each woman 
participating in the study received a set of basic antenatal care interventions (e.g. 
tetanus toxoid, a clean delivery kit, iron-folate supplements, chlorhexidine cleaning 
solution for disinfecting the umbilical cord, iron folate, and deworming) and basic 
educational messages on antenatal and essential newborn care. The worker visited the 
women in late pregnancy (~28-32 weeks) to promote the use of either the sunflower 
seed oil or mustard seed oil, and provide the mother or other caretaker with a 100ml 
botle of oil at that time. The mother or other caretaker initiated ful body massage 
folowing the field worker’s guidelines using the provided oil daily throughout the 
newborn period. The local project worker visited the homes daily during the first week of 
life to promote the continued use of the oil. 
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Immediately upon notification of the pregnancy, the local resident worker notified the 
supervisory staf and a birth assessment was conducted using standardized data 
colection forms recording information relating to late pregnancy morbidity, labor and 
delivery characteristics, birth assistants and practices, length of labor, maternal 
temperature, date and time of birth, sex, length and weight of infants, and immediate 
newborn care practices (thermal care, cord practices, early bathing and massage, 
breastfeeding initiation, etc.). In addition to the individual data obtained, household level 
data were colected at the time of enrolment of the mothers. This included information 
on socioeconomic factors, such as ethnicity, caste, household assets, ownership of 
materials or livestock, water sources, and family members who may be working 
overseas. Data were also colected on parental literacy, education, and birth history. 
After the initial birth visit, the birth team member completed newborn folow-up visits 
(NFF) on days 3, 7, 10, 14, 21, and 28 (for a total of 7 visits), where signs of infant 
morbidity and newborn care practices since prior visit were recorded. A 500ml botle of 
oil was provided at the initial visit and on folow-up visits on days 10 and 21. The primary 
outcomes of NOMS are mortality within 28 days of birth, and possible severe infection in 
newborns. 
 
Design of the Biological Mechanisms Sub-Study 
This biological mechanisms sub-study included an extended set of measurements 
colected from a subset of infants participating in the main trial. The focus of data 
colection for this sub-study was on direct measurement of biological markers of infants 
built into the scheduled visits for the parent trial. Weight and length were used to assess 
nutritional status. Weight was taken at the initial birth assessment visit and at folow-up 
visits on days 3, 7, 10, 14, 21, and 28. Length was measured at the initial birth visit and 
at the 28-day folow-up visit. 
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A subset of 7 VDCs of the 13 original VDCs in the NOMS trial was selected to participate 
in the mechanisms study, which began in July 2012. An 8th VDC was added after 5 
months and a 9th VDC was added in January 2013. The cluster-randomization of the 
parent trial was conserved for the mechanisms study. Among infants participating in the 
main study, determination of eligibility to additionaly participate in the sub-study was 
done during the initial birth assessment visit, and was based on estimates of gestational 
age at birth. For this study, preterm infants (<37 weeks gestational age) were 
oversampled, aiming for approximately 50% of the sample to be preterm. During the 
study period (July 2012 until September 2013), the gestational age was estimated 
directly by the field worker using the date of last menstrual period estimated by the 
woman at the time of initial enrolment. Each birth team member had a list of the date of 
the mother’s last menstrual period (LMP), which was used along with the date of birth to 
determine the gestational age of the infant. If the infant was born before week 37, one of 
the members of a specialy trained team of field workers focused on the implementation 
of the mechanisms sub-study was contacted directly by mobile phone. Infants born on or 
after week 37 were listed by VDC in consecutive order (i.e. by birth date) on a pre-
printed computer-generated blank form of 20 rows, 4 of which had been randomly 
selected for shading. Infants listed on a randomly shaded row were eligible for inclusion 
in the mechanisms study, thus selecting 4 out of every 20 (20%) of the ful term infants 
for participation. Al preterm (<37 weeks) infants and every 5th ful term infant born in the 
mechanisms study area were eligible for enrolment in the sub-study. Infants were 
enroled if consent was provided and the infant was met alive within 48 hours after birth. 
Newborns enroled in the mechanisms study were visited in their homes 7 times by the 
birth assessment team, on days 1, 3, 7, 10, 14, 21 and 28 in order to colect weight and 
length (days 1 and 28 only) data. At these visits, the workers also asked questions 
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relating to newborn care practices since the prior visit, including breastfeeding and other 
feding practices and massage practices.  
 
Measurement Methods 
Newborns’ weight measurements were taken without clothes using a Tanita portable 
digital infant scale (Tanita BD-585, Tokyo, Japan), with accuracy to ±10g. Length 




The nested biological mechanisms study included a subset of the sample size of 29,620 
infants required for the parent trial. Given that we hypothesized that the outcome 
measures (and the moderating efect(s) of the diferent oils, if any) may be more 
important in preterm infants than ful term infants due to the immaturity of their skin, 
preterm infants were oversampled. A total sample size of 1000 infants was selected, 
equaly stratified by 500 preterm and 500 ful term infants. Al power calculations 
assumed a design efect of 1.5, a 5% loss to folow-up, and a 5% Type 1 error. A design 
efect of 1.5 was assumed without prior knowledge of the true extent of correlation of the 
diferent measurements within clusters. The chosen sample size of 1000 infants enabled 
detection of a diference in mean values of weight and length of 0.5g or 0.5cm 
respectively, with between 71% and 100% power for standard deviations of 1.0 to 2.5. In 
addition, this sample size enabled us to detect a diference of 0.1 in the proportion of 
infants massaged with mustard seed oil versus sunflower oil with 2 SD or more below 
the normal mean weight-for-age or height-for-age with a power of 88-99% if the 
proportion of infants below -2 SD was between 0.5 and 0.1. The analyses presented 
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here represent a preliminary analysis of the first 63.7% of the anticipated enroled 
infants. 
 
Al analyses for these measurements were conducted using STATA v12 (Colege 
Station, TX). The comparability of the treatment groups in relation to their background 
characteristics was assessed to determine if there were any confounding variables. 
Possible confounders included: household demographics and socioeconomic status 
(SES), ethnic group, caste, maternal and paternal education levels, maternal age, 
reproductive history, labor and delivery characteristics (place of birth, length and type of 
labor, type and practice of birth assistants), newborn characteristics and newborn care 
practices (sex, birthweight, gestational age, smal-for-gestational age (SGA) status, 
breastfeeding), and intervention exposure and compliance.  
 
To examine whether there was an efect on weight, length, and z-scores for weight-for-
age and height-for-age at diferent folow-up visit times due to the diferent oil groups, 
mixed-efects regression models with random intercepts were performed. Z-scores were 
calculated using WHO Anthro (version 3.2.2, January 2011). (WHO 2011) In al models, 
estimates of standard errors accounted for the clustered design. These models were 
also run to investigate diferences between intervention groups in the change in weight 
between visits with 1, 2, and 3 visit increments (e.g. diference between weight at the 
birth visit and folow-up visit on day 3, the birth visit and the folow-up visit on day 7, etc.) 
and diferences in the mean change in length between the birth visit and the folow-up 
visit on day 28 between the two oil groups. In addition, multi-level mixed-efects 
regression models with random intercepts, accounting for the clustered design and the 
repeated measures in the standard error estimates, were performed for the entire 
neonatal period and stratified by early (<7 days) and late (≥7 days) neonatal periods. 
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Multi-level models with an interaction between infant’s age and oil group were also used 
to explore whether the rate of change in weight or length was diferent in the sunflower 
seed oil group. Mixed-efects logistic regression models with random-intercepts 
accounting for the clustered design in the standard error estimates were run to 
determine if there were diferences in the proportion of infants who were stunted or 
underweight (<-2 z-scores below normal) at 28 days of age. Linear splines for infant’s 
age at measurement were used where needed to account for nonlinearity, assessed 
through localy weighted regression smoothing. Sub-group analyses were conducted for 
preterm infants and smal-for-gestational age (SGA) status for each measurement. 
Analyses folowed an intention-to-treat approach for participating infants, regardless of 
the actual treatment provided. 
 
Results 
Between July 23, 2012 and September 30, 2013, there were a total of 1,876 ful term 
and 409 preterm live born infants in the study area that were eligible for enrolment in the 
biological mechanisms study. Of these infants, 785 (376 ful term and 409 preterm) were 
selected for enrolment (Figure 6-1). Of those selected, 148 (18.9%) died or were not 
met by the mechanisms study field worker before 48 hours after birth and 5 (0.6%) 
mothers refused their infant’s participation in the study. A total of 632 newborns were 
enroled in the mustard seed oil (N=324) and sunflower seed oil (N=308) clusters. In 
total, 271 (83.6%) and 262 (85.1%) of enroled newborns completed 28 days of folow-up 
in the mustard seed oil and the sunflower seed oil groups respectively. In the sunflower 
oil group, 7 (2%) infants died and 39 (13%) permanently moved, most likely returning to 
the mother’s maternal home or maiti, or were not met at their 28-day visit. In the mustard 
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oil group, 6 (2%) infants died and 47 (14%) permanently moved or were not met at their 
28-day visit. 
 
Socioeconomic, household, and individual characteristics were wel balanced between 
groups (Table 6-1), although infants in the sunflower oil group were more likely to be 
less than 2500 grams at first measurement at the initial birth assessment. In the 
sunflower seed oil group, 40.3% of infants were low birthweight compared to 33.9% in 
the mustard seed oil group. Overal prevalence of low birthweight was 36.7%, although 
this was not representative of the general population as preterm infants were 
oversampled. In the sunflower seed oil group, a greater proportion of infants were born 
to families who were of Pahadi (originating from the hils) ethnicity than in the mustard oil 
group and households in the sunflower seed oil group were less likely to have electricity. 
Both oil groups had similar proportions of infants that were smal-for-gestational age 
(SGA). The overal prevalence of infants born SGA was 42.7%. The mustard seed oil 
group had a slightly higher proportion of infants who were born prematurely with 45.4% 
of newborns in the mustard seed oil group and 39.9% of newborns in the sunflower seed 
oil group born premature. Overal prevalence of prematurity in the study population was 
42.7%. As these analyses were not completed on the total sample size, recruitment was 
stil ongoing. Premature infants were being enroled at a slower rate than ful term 
infants, as our estimated proportion of preterm infants in this population (20%) was 
based on data from older studies. The actual proportion of infants who were born 
preterm in the study area during this study period was closer to 16%, accounting for the 
prevalence of preterm infants in the population used for these analyses being less than 
50%. 
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The number of folow-up visits was similar for both treatment groups (Table 6-2). Both 
groups had very high percentages of newborns that had been massaged since the 
previous visit (or since birth, if visit 1). Reductions from ful compliance (i.e. <100%) were 
more common in the sunflower seed oil group, especialy on the first day of life (88.1% 
and 78.8% compliance in the mustard and sunflower oil groups, respectively), although 
greater than 98% of infants were massaged with oil in both groups prior to the first visit. 
Massage was frequent during the first week of life, and slightly more frequent in the 
mustard oil group: respondents reported means of 32.3 (±10.8) and 29.8 (±9.4) 
massages during the first week of life in the mustard and sunflower oil groups, 
respectively. In addition, the time from birth until the first weight measurement was 
nearly identical between oil groups (13.0 hours (±8.3) and 12.9 hours (±8.5) in the 
mustard and sunflower oil groups, respectively). The time between birth and first weight 
measurement were also similar between groups when stratified by term status. 
 
Effect of Oil Group on Weight 
	  
Descriptive characteristics of weight by visit for each oil group stratified by term status 
are shown in Table 6-3. Infants in the sunflower oil group tended to have lower weight at 
each visit compared with those in the mustard oil group. This was most pronounced in 
the preterm infants where the mean birthweight (measured at the initial birth assessment 
visit) was 2562.6g (±473.1) and 2414.3g (±545.9) in the mustard oil and sunflower oil 
groups respectively. By visit 3 the mean weight of both groups had decreased, with a 
mean weight in the mustard oil group of 2530.1g (±506.8) and a mean weight in the 
sunflower oil group of 2391.6g (±534.8). Figures 6-2 through 6-7 show scater plots of 
infants’ weight by age with a localy weighted least squared regression (LOWESS) curve 
for each oil group and graphs with only the LOWESS curves, for the complete data set 
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and stratified by term status. The curves of weight by age are very similar by oil group 
for the ful term infants, while for preterm infants in the sunflower oil group, weight starts 
lower at the initial birth assessment visit and continues to remain lower throughout the 
neonatal period. The shapes of the curves are similar for al groups with a decrease in 
weight from day 0 to day 3 (-27.6g (±199.8) in the mustard oil group and -29.3g (±164.6) 
in the sunflower oil group) (results not shown) and increasing weight after day 3. Preterm 
infants in the mustard oil group had a diference in weight of -36.2g (±165.2) between 
their initial birthweight and weight at visit 3 and preterm infants in the sunflower group 
had a diference of -29.7g (±157.7) between these visits. 
 
Table 6-4 displays regression results of the diferences in oil groups on weight for 
diferent visits. The sunflower oil group tended to have lower weights for each visit when 
compared with the mustard oil group, however these were not statisticaly significant for 
any visits for either the complete data or for the ful term group. In the preterm group, the 
sunflower oil group had significantly lower weights at the initial birth assessment visit and 
at folow-up visits on days 3 and 28 when compared to the mustard oil group. The 
sunflower oil group was estimated to have weights 148.3g (95% CI: 26.0-270.5), 138.5g 
(95% CI: 10.0-277.0), and 177.6g (95% CI: 7.1-348.1) lower compared to the mustard oil 
group at the initial birth visit and at folow-up visits on days 3 and 28 respectively. 
However, after controling for the birthweight measurement, diferences at visits 3 and 28 
were no longer significant. Results from regression models investigating diferences in 
weight change between visits by oil group are shown in Table 6-5. These results indicate 
no statisticaly significant diferences in weight change between oil groups for any of the 
visits for the complete data and when stratified by term status, both when controling for 
and not controling for birthweight. There were also no statisticaly significant efects of 
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oil group on weight change at 2 and 3 visit intervals. Oil group had no efect on weight by 
visit or change in weight between visits when stratified by SGA status. 
 
Regression models showed no statisticaly significant diferences in weight comparing 
the mustard oil and sunflower oil groups for the complete data or for the ful term group 
for the complete neonatal period or when stratified by early and late neonatal periods. 
For the preterm group, the sunflower group’s weight was estimated to be 147.4g (95% 
CI: 8.2-286.5) and 144.0g (95% CI: 17.8-270.2) lower than the mustard oil group’s over 
the complete period and early neonatal period respectively, however after controling for 
birthweight this efect was no longer statisticaly significant. Oil group had no efect on 
infants’ weight in the late neonatal period for the preterm group. There was no efect of 
oil group on weight for any of the neonatal periods when stratified by SGA status. 
 
The estimated average rate of change in weight per day over the neonatal period in the 
sunflower group compared to the mustard oil group was not statisticaly significantly 
diferent in the complete or ful term group. However, after adjusting for birthweight, the 
rate at which weight increased in the preterm infants in the sunflower oil group was 
slower than that in the mustard oil group from day 4 to day 28. Between days 0 and 3, 
the rate at which preterm infants in the sunflower oil group lost weight was not 
statisticaly significant (15.1 g/day (95% CI: -32.6-2.3)). Between days 4 and 28, infants 
in the sunflower oil group were estimated to gain 28.4 g/day (95% CI: 26.8-30.1). 
Preterm infants in the mustard oil group were estimated to lose 18.7 g/day (95% CI: 3.9-
33.5) between days 0 and 3 and gain 30.9 g/day (95% CI: 29.5-32.4) between days 4 
and 28. While preterm infants in the sunflower oil group showed a trend of losing weight 
at a slower rate than infants in the mustard oil group between days 0 and 3, this was not 
statisticaly significant. However, between days 4 and 28 weight of preterm infants in the 
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sunflower oil group was estimated to increase 2.6g (95% CI: 0.4-4.7) per day more 
slowly than preterm infants in the mustard oil group. 
 
Estimated average rate of change in weight per day over diferent time periods in the 
neonatal period showed a significant diference in the estimated weight gain per day 
between days 14 and 28 for the complete group of 2.77g/day (95% CI: 0.12-5.4) less in 
the sunflower oil group when compared with the mustard oil group. In the preterm group 
between days 14 and 28, infants’ weight in the sunflower oil group showed an estimated 
weight gain of 5.22g (95% CI: 1.11-9.33) less per day than the mustard oil group. After 
adjusting for birthweight the sunflower oil group had an estimated average weight gain of 
2.85g (95% CI: 0.21-5.49) and 5.22g (95% CI: 1.11-9.33) less per day in the complete 
group and the preterm group respectively when compared with the mustard oil group. 
There were no statisticaly significant diferences in average rate of change in weight per 
day when stratified by SGA status.  
 
Effect of Oil Group on Length 
	  
Descriptive characteristics of infants’ length at the initial birth visit and day 28 folow-up 
visit are shown in Table 6-6. Mean lengths at both the initial visit and day 28 visit were 
very similar between oil groups. In the preterm group, infants in the sunflower oil group 
had estimated mean lengths of 46.3cm (±3.0) and 50.8cm (±3.0) at the initial birth visit 
and at folow-up visit on day 28, respectively, while preterm infants in the mustard oil 
group had mean lengths of 46.8cm (±2.9) and 51.2cm (±3.0) at the initial birth visit and 
at visit 28, respectively. Figures 6-8 to 6-10 show distributions of infants’ length by visit 
for each oil group for the complete data and stratified by term status, showing similar 
distributions for both oil groups. 
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Regression models showed no statisticaly significant efect of oil group on infants’ 
length at the initial or day 28 visit for the complete group or when stratified by term status 
(Table 6-7), although infants in the sunflower group tended to be smaler at both visits. 
There was also no statisticaly significant efect of oil group on the diference in length 
gain between the two visits, or on the average change in length per day. This was also 
true when stratified by SGA status and when controling for birthweight. 
 
Effect of Oil Group on Z-score 
	  
The proportion of infants in this population who were underweight or stunted at visit 28 is 
shown in Table 6-8. The sunflower oil group had greater proportions of infants who were 
underweight and stunted for the complete data set and for both ful term and preterm 
groups, although the ful term groups were very similar. The proportion of preterm infants 
in the sunflower oil group who were underweight or stunted was 47.7% and 32.7%, 
respectively compared with 35.5% and 27.4% who were underweight or stunted in the 
mustard oil group. However, logistic regression models indicated that oil group had no 
efect on the odds of being underweight or stunted at 28 days for any of the term 
stratification groups (results not shown). This was also true when the data was stratified 
by SGA status. 
 
Descriptive characteristics for the average z-scores for weight-for-age and height-for-age 
at folow-up visit 28 are shown in Table 6-9. Both oil groups have lower mean z-scores 
for weight-for-age than for height-for-age. The sunflower oil group had lower mean z-
scores for both weight-for-age and height-for-age for the complete data set and also for 
both ful term and preterm groups. Regression analyses indicated preterm infants in the 
sunflower oil group had mean weight-for-age z-scores 0.37 (95% CI: 0.0084-0.74) lower 
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when compared with the mustard oil group at visit 28 (results not shown). This was 
however no longer statisticaly significant after adjusting for birthweight. Other 
diferences in z-scores were not statisticaly significant nor were diferences when 
stratified by SGA groups. 
 
Discussion 
These data do not provide evidence that ful body oil massage with sunflower oil 
improves neonates’ nutritional status when compared to ful body oil massage with 
mustard oil in this population of neonates in rural Nepal. This is in contrast to other 
studies, which have found improved weight and/or length gain in infants massaged with 
oils high in linoleic acid. (Arora, Kumar et al. 2005; Vaivre-Douret, Oriot et al. 2009; 
Falah, Akhavan Karbasi et al. 2013; Kumar, Upadhyay et al. 2013) However, these 
studies difered from our study in several important ways. These were al hospital-based 
studies with neonates who were generaly more vulnerable and who were less than 35 
weeks of age or of very low birthweight. In addition, these studies al used a 
standardized massage technique, using moderate pressure for a prescribed amount of 
time. In contrast, our study was done in a community seting, where most women in this 
population give birth in the home and the caretakers performed massage in a traditional 
(i.e. quite vigorous) way. These diferences in study design may have led to diferences 
in outcomes. For example, ful body oil massage with an oil high in linoleic acid may only 
improve nutritional status in infants who are either very premature or of very low 
birthweight, both of whom are unlikely to survive in a rural low-resource community 
seting. Fewer than 40 infants in our study population were less than 32 weeks 
gestational age, which may have made a diference in oil groups unable to be detected. 
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In addition, very preterm infants have a more permeable skin barrier, which may alow 
more transcutaneous absorption of the oils. (Cartlidge 2000) 
 
Type of massage may also afect a neonate’s nutritional status. Studies of infant 
massage using moderate pressure have shown a decrease in stress behavior and 
cortisol levels and an increase in weight gain compared with infants who are not 
massaged. (Field, Diego et al. 2010) However, infant massage in this population is quite 
vigorous, leaving infants stressed and agitated. This could lead to an increase in cortisol 
levels, which may influence weight gain. (Field, Diego et al. 2010)  
 
This study found that preterm infants massaged with sunflower oil had slower weight 
gain after day 3 than infants massaged with mustard seed oil. We are uncertain as to 
why this may have occurred, however it could be due to unmeasured confounders in this 
population. Although it is unclear why there may be slower weight gain in preterm infants 
in the sunflower oil group, this smal diference in weight gain (about 3 grams per day 
less than the mustard oil group) is unlikely to be clinicaly significant. 
 
This study only compared the diferences in nutritional status between infants massaged 
with an improved oil (sunflower oil) and the traditional oil (mustard oil). One of the 
limitations of this study was that there were no control groups for infants massaged 
without oil or infants who did not receive massage. Therefore, the beneficial nutritional 
efects of oil massage found in other studies, could be due to massage alone, or 
massage with any type of oil and not due to the type of oil used. A study by Ang et al. 
showed infants 28-33 weeks who were massaged had an increase in mean final weight 
and daily weight gain compared with infants who were not massaged. (Ang, Lua et al. 
2012) In addition, a meta-analysis showed massage improved daily weight gain by 
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5.32g. (Wang, He et al. 2013) Another study of one-month old infants reported less 
stress behaviors, lower salivary cortisol levels, and increased vagal activity in infants 
who were massaged with oil compared with those who were massaged without oil. 
(Field, Schanberg et al. 1996) Increased vagal activity, which increases gastric motility, 
may lead to an increase in food absorption hormones such as insulin and may be one of 
the underlying mechanisms for greater weight gain in massaged infants. (Field, Diego et 
al. 2011) An increase in IGF-1 through an independent pathway that is not related to 
vagal activity was also related to weight gain perhaps because of fomenting muscle and 
bone development. (Field, Diego et al. 2011) 
 
Although the cluster-randomized design and the large sample size with an oversampling 
of preterm infants was a strength of this study, unfortunately balance was not achieved 
between the birthweights of premature infants in the mustard oil and sunflower oil 
groups. On average, the premature infants in the sunflower oil group were of lower 
birthweight than the premature infants in the mustard oil group. This should not have 
influenced our results however, as we were able to adjust for birthweight during 
analyses. 
 
In addition, using recaled date of last menstrual period (LMP) in order to determine 
gestational age may have resulted in misclassification of infants as either preterm or ful 
term. This method has been shown to be less accurate than methods using ultrasound. 
A study done in a tertiary-care hospital in Bangladesh found that LMP underestimated 
gestational age by one day compared with estimation from ultrasound. (Rosenberg, 
Ahmed et al. 2009) In addition, a study done at a hospital in Pakistan found that only 
65% of estimated gestational age of reported LMP were within 7 days and only 82% 
were within 14 days when compared to gestational age estimates using ultrasound. 
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(Jehan, Zaidi et al. 2010) Despite the problems of the uncertainty of LMP date, in this 
community seting in rural Nepal, the low-cost and simple method of reported LMP is the 
best option for estimating gestational age. Also, LMPs from our study were colected as 
soon as a pregnancy was identified (folowing-up women every 5 weeks), so recal bias 
would be minimized. In order to determine the accuracy of using recaled LMP to 
estimate gestational age in this population and to determine the direction of possible 
misclassification, research should be done on a smal number of women comparing LMP 
estimates to estimation from ultrasound. Analyses should also be performed limiting our 
preterm group to those <34 weeks in order to reduce some of the possible 
misclassification problems and to determine if there are efects of the oils on nutritional 
status in infants who are more premature. 
 
Further research should be conducted in this population investigating whether massage 
with emolients has any efect on nutritional status when compared to massage without 
emolients and to no massage. It should also be investigated whether changing the way 
in which an infant is massaged (e.g. vigorous versus gentle massage) has any impact on 
nutritional status. Both changing the way in which an infant is massaged and whether an 
infant is massaged would be very dificult in this community seting in rural Nepal, as 
neonatal oil massage is a nearly universal cultural practice. (Mulany, Darmstadt et al. 
2005) However, a smaler group of neonates in an urban area may be more wiling to 
accept these behavioral change interventions. Another possibility in this rural community 
is to enrol older infants past the age when it is considered a cultural necessity to 
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It is important to have a beter of understanding of the underlying mechanisms of how 
and why emolient therapy can improve neonatal health outcomes in low-resource 
setings, because the optimization of health benefits of oils depends upon the 
understanding of which biological mechanisms are impacted by the use of diferent oils. 
Further research on possible diferences in immune function, skin integrity, and bacterial 
colonization in infants massaged with sunflower oil compared to those massaged with 
mustard seed oil should also be considered.  
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Chapter 6 Tables and Figures 
Table 6-1: Baseline Maternal, Socioeconomic, Household, and Newborn Care 
Characteristics by Intervention Group 
	  
Oil	  Randomization	  Group	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   (%)	   N	   (%)	  
Number	  of	  Clusters	   56	   	   58	   	  
Total	  number	  of	  infants	   324	   	   308	   	  
Ethnic	  Group	  
	   	   	   	  
Pahadi	   15	   4.8	   29	   9.5	  
Madeshi	   300	   95.2	   277	   90.5	  
Maternal	  literacy	  
	   	   	   	  
Not	  literate	   229	   71.3	   220	   71.2	  
Literate	   92	   28.7	   89	   28.8	  
Paternal	  literacy	  
	   	   	   	  
Not	  literate	   153	   47.7	   141	   45.6	  
Literate	   168	   52.3	   168	   54.4	  
Maternal	  Education	  
	   	   	   	  
None	   229	   71.3	   221	   71.5	  
1-­‐5	  yrs	   30	   9.4	   29	   9.4	  
6-­‐10	  yrs	   47	   14.6	   47	   15.2	  
>10	  yrs	   15	   4.7	   12	   3.9	  
Paternal	  Education	  
	   	   	   	  
None	   147	   45.8	   142	   46.0	  
1-­‐5	  yrs	   48	   15.0	   48	   15.5	  
6-­‐10	  yrs	   100	   31.2	   105	   34.0	  




	   	   	   	  
0	  or	  1	  asset(s)	   22	   7.0	   22	   7.2	  
2-­‐5	  assets	   135	   42.9	   143	   46.7	  
6-­‐10	  assets	   150	   47.6	   133	   43.5	  
>10	  assets	   8	   2.5	   8	   2.6	  
Electricity	  
	   	   	   	  
No	   112	   35.6	   140	   45.8	  
Yes	   203	   64.4	   166	   54.3	  
Maternal	  Age	  
	   	   	   	  
<18	  yrs	   43	   13.4	   41	   13.3	  
18-­‐24	  yrs	   177	   55.1	   180	   58.3	  
25-­‐29	  yrs	   72	   22.4	   63	   20.4	  
30-­‐34	  yrs	   23	   7.2	   13	   4.2	  
>=35	  yrs	   6	   1.9	   12	   3.9	  
	   237 
Table 6-1: Baseline Maternal, Socioeconomic, Household, and Newborn Care 
Characteristics by Intervention Group (continued) 
 
	  
Oil	  Randomization	  Group	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   (%)	   N	   (%)	  
Gravidity	  
	   	   	   	  
None	   83	   25.9	   83	   26.9	  
1-­‐2	   143	   44.6	   152	   49.2	  
3-­‐4	   85	   26.5	   70	   22.7	  
>5	   10	   3.1	   4	   1.3	  
Parity	  
	   	   	   	  
None	   88	   27.4	   91	   29.5	  
1-­‐2	   135	   42.1	   136	   44.0	  
3-­‐4	   82	   25.6	   73	   23.6	  
>5	   16	   5.0	   9	   2.9	  
Antenatal	  Care	  Visits	  
	   	   	   	  
No	  ANC	   90	   28.0	   92	   29.8	  
1-­‐2	  ANC	  visits	   122	   38.0	   109	   35.3	  
3-­‐4	  ANC	  visits	   94	   29.3	   96	   31.1	  
>=5	  ANC	  visits	   15	   4.7	   12	   3.9	  
Location	  of	  delivery	  
	   	   	   	  
Home	   163	   50.8	   160	   51.8	  
Maiti	   57	   17.8	   52	   16.8	  
HP/Clinic	   54	   16.8	   58	   18.8	  
Hospital	   36	   11.2	   32	   10.4	  
On	  way	  to	  facility	   11	   3.4	   7	   2.3	  
Length	  of	  labor	  
	   	   	   	  
<5	  hrs	   147	   45.8	   149	   48.4	  
5-­‐14	  hrs	   144	   44.7	   118	   38.3	  
15-­‐19	  hrs	   11	   3.4	   16	   5.2	  
20-­‐24	  hrs	   10	   3.1	   14	   4.6	  
>24	  hrs	   9	   2.8	   11	   3.6	  
Complications	  during	  delivery	  
	   	   	   	  
No	   267	   83.2	   246	   80.1	  
Yes	   54	   16.8	   61	   19.9	  
Delivery	  Assistant	  
	   	   	   	  
No	  one/Family/Neighbors	   81	   25.3	   78	   25.2	  
TBA/Chamain	   57	   17.8	   61	   19.7	  
CHV/VHW/MCH	  Worker	   14	   4.4	   8	   2.6	  
ANM/HA/CMA/Staf	  Nurse	   84	   26.3	   86	   27.8	  
Local	  doctor	   79	   24.7	   73	   23.6	  
MBBS	  doctor	   5	   1.6	   3	   1.0	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Table 6-1: Baseline Maternal, Socioeconomic, Household, and Newborn Care 
Characteristics by Intervention Group (continued) 
 
	  
Oil	  Randomization	  Group	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   (%)	   N	   (%)	  
Sex	   	   	   	   	  
Male	   169	   51.8	   160	   51.4	  
Female	   157	   48.2	   151	   48.6	  
Gestational	  Age	   	   	   	   	  
<32	  wks	   20	   6.3	   17	   5.6	  
32-­‐36	  wks	   124	   39.1	   104	   34.3	  
37-­‐41	  wks	   148	   46.7	   157	   51.8	  
>=42	  wks	   25	   7.9	   25	   8.3	  
Birthweight	   	   	   	   	  
<1500g	   4	   1.3	   8	   2.6	  
1500-­‐2499g	   104	   32.6	   115	   37.7	  
>2500g	   211	   66.1	   182	   59.7	  
SGA	  Status	   	   	   	   	  
AGA	   185	   58.0	   172	   56.4	  
SGA	  3-­‐10%	   62	   19.4	   57	   18.7	  
SGA	  3%	   72	   22.6	   76	   25.0	  
Breastfed	  since	  birth	  at	  first	  
visit	  
	   	   	   	  
No	   54	   16.6	   42	   13.5	  
Yes	   272	   83.4	   269	   86.5	  
Hours	  before	  breastfeeding	  
initiation	  
	   	   	   	  
<1	  hr	   87	   32.3	   74	   27.8	  
1-­‐2	  hrs	   154	   57.2	   151	   56.8	  
3-­‐4	  hrs	   15	   5.6	   20	   7.5	  
>=5	  hrs	   13	   4.8	   21	   7.9	  
Infant	  received	  colostrum	   	   	   	   	  
No	   30	   11	   27	   10	  
Yes	   241	   88.6	   242	   90	  
Gestational	  Age	  (wks)	  	  
(mean,	  SD)	  
37.5	   (3.7)	   37.9	   (3.5)	  
Birthweight	  (g)	  
(mean,	  SD)	  
2639.4	   (465.6)	   2582.8	   (501.3)	  
§:
 
HH assets were based on having at least one of the folowing: electricity, servants, 2nd floor, catle, goats, 
bulock carts, bicycles, clocks, radios, TVs, phones, plot of farmable land, plot of other land, family member 
living & working out of home	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Table 6-2: Intervention Coverage by Intervention Group 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   %	   N	   %	  
#	  of	  folow-­‐up	  visits
*
	  







Hours	  from	  birth	  until	  
initial	  weight	  measure	  







#	  of	  times	  massaged	  in	  








Avg	  #	  of	  times	  massaged	  
per	  day	  in	  first	  week	  







Massaged	  since	  last	  visit
§	  
	   	   	   	  
Visit	  1	   320	   98.8	   307	   99.7	  
Visit	  3	   313	   100	   296	   99.7	  
Visit	  7	   307	   99.0	   287	   98.6	  
Visit	  10	   295	   98.0	   281	   96.9	  
Visit	  14	   299	   98.7	   284	   97.6	  
Visit	  21	   291	   99.3	   276	   97.5	  
Visit	  28	   273	   99.6	   260	   99.2	  
Massaged	  with	  NNIPS	  oil	  
during	  last	  massage	  
	   	   	   	  
Visit	  1	   282	   88.1	   242	   78.8	  
Visit	  3	   311	   99.3	   283	   95.6	  
Visit	  7	   299	   97.4	   261	   90.9	  
Visit	  10	   290	   98.3	   263	   93.6	  
Visit	  14	   287	   96.0	   261	   91.9	  
Visit	  21	   282	   96.6	   256	   92.8	  
Visit	  28	   263	   96.7	   232	   89.2	  
*Max number of household visits is 7; § At visit 1 this is massaged since birth 
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Table 6-3: Descriptive Characteristics of Weight by Visit and Intervention Group 
Visit	  
Number	  
Mustard	  Oil	   Sunflower	  Oil	  










Complete	  Data	  Set	  
1	   324	   56	   2633.6	   455.4	   308	   57	   2578.3	   501.1	  
3	   312	   56	   2606.4	   484.8	   295	   57	   2555.9	   501.0	  
7	   308	   56	   2762.8	   493.3	   290	   57	   2717.0	   527.8	  
10	   300	   56	   2851.3	   506.4	   289	   57	   2796.0	   549.1	  
14	   302	   56	   2972.3	   530.4	   289	   57	   2936.2	   569.6	  
21	   292	   56	   3196.7	   569.4	   283	   57	   3164.1	   595.4	  
28	   273	   56	   3446.1	   594.5	   262	   57	   3359.7	   632.6	  
Ful	  Term	  
1	   175	   52	   2712.8	   416.5	   184	   52	   2703.5	   416.5	  
3	   166	   51	   2696.4	   435.3	   177	   52	   2681.6	   415.2	  
7	   168	   51	   2850.0	   434.3	   176	   52	   2843.4	   432.4	  
10	   162	   51	   2968.8	   432.5	   173	   51	   2940.1	   456.3	  
14	   164	   50	   3089.2	   450.7	   176	   51	   3069.5	   476.7	  
21	   159	   50	   3324.0	   490.0	   171	   52	   3316.3	   507.8	  
28	   146	   49	   3582.5	   488.8	   153	   51	   3539.2	   531.3	  
Preterm	  
1	   144	   53	   2562.6	   473.1	   121	   47	   2414.3	   545.9	  
3	   141	   53	   2530.1	   506.8	   115	   47	   2391.6	   534.8	  
7	   137	   53	   2672.6	   535.5	   111	   47	   2552.7	   575.3	  
10	   134	   53	   2734.9	   543.0	   114	   47	   2599.4	   591.7	  
14	   134	   53	   2854.9	   576.2	   111	   47	   2754.3	   614.0	  
21	   130	   52	   3062.5	   613.9	   110	   46	   2952.5	   628.6	  
28	   124	   52	   3305.9	   661.2	   107	   45	   3128.3	   663.1	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table 6-4: Regression Results of Intervention Group on Weight by Visit Number 







Complete	  Data	  Set	  
1	   632	   113	   -­‐58.0	   39.6	   -­‐135.6-­‐19.6	  
3	   607	   113	   -­‐50.5	   39.9	   -­‐128.8-­‐27.8	  
7	   598	   113	   -­‐45.7	   41.7	   -­‐127.4-­‐36.0	  
10	   589	   113	   -­‐67.0	   48.4	   -­‐161.9-­‐27.9	  
14	   591	   113	   -­‐43.0	   47.7	   -­‐136.6-­‐50.5	  
21	   575	   113	   -­‐41.8	   53.3	   -­‐146.4-­‐62.8	  
28	   535	   113	   -­‐90.3	   55.7	   -­‐199.4-­‐18.8	  
Ful	  Term	  
1	   359	   104	   -­‐9.3	   43.9	   -­‐95.3-­‐76.6	  
3	   343	   103	   -­‐14.9	   45.8	   -­‐104.6-­‐74.9	  
7	   344	   103	   -­‐6.6	   46.6	   -­‐97.9-­‐64.7	  
10	   335	   102	   -­‐28.7	   48.5	   -­‐123.7-­‐66.4	  
14	   340	   102	   -­‐19.7	   50.5	   -­‐119.8-­‐80.5	  
21	   330	   102	   -­‐19.9	   58.6	   -­‐134.7-­‐94.8	  
28	   299	   100	   -­‐44.9	   59.9	   -­‐162.2-­‐72.4	  
Preterm	  
1	   265	   100	   -­‐148.3*	   62.4	   -­‐270.5-­‐	  -­‐26.0	  
3	   256	   100	   -­‐138.5*	   65.5	   -­‐277.0-­‐	  -­‐10.0	  
7	   248	   100	   -­‐119.9	   70.4	   -­‐257.9-­‐18.2	  
10	   248	   100	   -­‐135.5	   71.8	   -­‐276.2-­‐5.3	  
14	   245	   100	   -­‐100.5	   75.9	   -­‐249.2-­‐48.2	  
21	   240	   98	   -­‐110.0	   80.1	   -­‐266.9-­‐46.9	  
28	   231	   97	   -­‐177.6*	   87.0	   -­‐348.1-­‐	  -­‐7.1	  
Preterm	  adjusted	  for	  birthweight	  
3	   256	   100	   9.4	   20.6	   -­‐30.9-­‐49.7	  
7	   248	   100	   22.7	   49.0	   -­‐20.0-­‐65.3	  
10	   248	   100	   22.3	   26.5	   -­‐29.5-­‐74.2	  
14	   245	   100	   16.6	   29.9	   -­‐42.0-­‐75.3	  
21	   240	   98	   -­‐1.1	   33.4	   -­‐66.6-­‐64.4	  
28	   231	   97	   -­‐40.9	   41.3	   -­‐121.9-­‐40.1	  
N=number of observations, n=number of clusters, Coeficient=regression coeficient for sunflower group, 
SE= standard errors, 95% CI=95% confidence interval, *=p<0.05 
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Table 6-5: Regression Results of Change in Weight Between Visits by Intervention 
Group and Visit Number 







Complete	  Data	  Set	  
1-­‐3	   607	   113	   -­‐1.7	   14.9	   -­‐30.9-­‐27.5	  
3-­‐7	   589	   113	   12.2	   12.9	   -­‐13.1-­‐37.5	  
7-­‐10	   577	   113	   -­‐5.7	   9.9	   -­‐25.1-­‐13.8	  
10-­‐14	   570	   113	   -­‐1.6	   10.6	   -­‐22.0-­‐19.5	  
14-­‐21	   555	   113	   7.7	   13.5	   -­‐18.8-­‐34.2	  
21-­‐28	   522	   113	   -­‐16.2	   12.8	   -­‐41.2-­‐8.9	  
Ful	  Term	  
1-­‐3	   343	   103	   -­‐11.3	   21.3	   -­‐53.0-­‐30.4	  
3-­‐7	   338	   103	   21.2	   17.6	   -­‐13.3-­‐55.8	  
7-­‐10	   332	   102	   -­‐6.8	   13.3	   -­‐32.9-­‐19.2	  
10-­‐14	   328	   102	   4.6	   11.2	   -­‐17.3-­‐26.5	  
14-­‐21	   320	   101	   18.7	   15.2	   -­‐11.1-­‐48.4	  
21-­‐28	   291	   100	   -­‐7.6	   17.1	   -­‐41.1-­‐25.8	  
Preterm	  
1-­‐3	   256	   100	   6.5	   20.4	   -­‐33.4-­‐46.5	  
3-­‐7	   245	   100	   -­‐1.9	   18.8	   -­‐38.7-­‐34.9	  
7-­‐10	   240	   100	   -­‐7.7	   15.0	   -­‐37.1-­‐21.7	  
10-­‐14	   236	   100	   -­‐5.3	   18.6	   -­‐41.8-­‐31.2	  
14-­‐21	   230	   98	   -­‐21.1	   20.2	   -­‐59.8-­‐19.6	  
21-­‐28	   226	   97	   -­‐28.3	   19.6	   -­‐66.7-­‐10.2	  
Preterm	  adjusted	  for	  birthweight	  
1-­‐3	   256	   100	   9.4	   20.6	   -­‐30.9-­‐49.7	  
3-­‐7	   245	   100	   6.5	   18.9	   -­‐30.6-­‐43.5	  
7-­‐10	   240	   100	   -­‐9.1	   15.1	   -­‐38.8-­‐20.5	  
10-­‐14	   236	   100	   2.0	   18.1	   -­‐33.5-­‐37.4	  
14-­‐21	   230	   98	   -­‐16.4	   20.1	   -­‐55.9-­‐23.1	  
21-­‐28	   226	   97	   -­‐24.8	   19.6	   -­‐63.2-­‐13.6	  
N=number of observations, n=number of clusters, Coeficient=regression coeficient for sunflower group, 
SE= standard errors, 95% CI=95% confidence interval 
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Table 6-6: Descriptive Characteristics of Length by Visit and Intervention Group 
Visit	  
Number	  
Mustard	  Oil	   Sunflower	  Oil	  










Complete	  Data	  Set	  
1	   324	   56	   47.5	   2.7	   308	   57	   47.2	   2.7	  
28	   272	   56	   52.0	   2.7	   261	   57	   51.6	   2.9	  
Ful	  Term	  
1	   175	   52	   48.2	   2.0	   184	   52	   47.9	   2.1	  
28	   145	   49	   52.7	   2.2	   153	   51	   52.3	   2.5	  
Preterm	  
1	   144	   53	   46.8	   2.9	   121	   47	   46.3	   3.0	  
28	   124	   52	   51.2	   3.0	   106	   44	   50.8	   3.0	  
N=number of observations, n=number of clusters, SD=standard deviation 
 
 
Table 6-7: Regression Results of Intervention Group on Length by Visit Number 







Complete	  Data	  Set	  
1	   632	   113	   -­‐0.3	   0.3	   -­‐0.8-­‐0.2	  
28	   533	   113	   -­‐0.4	   0.3	   -­‐0.9-­‐0.1	  
Ful	  Term	  
1	   359	   104	   -­‐0.3	   0.2	   -­‐0.7-­‐0.2	  
28	   298	   100	   -­‐0.5	   0.3	   -­‐1.1-­‐0.2	  
Preterm	  
1	   265	   100	   -­‐0.6	   0.4	   -­‐1.3-­‐0.2	  
28	   230	   96	   -­‐0.4	   0.4	   -­‐1.2-­‐0.3	  
N=number of observations, n=number of clusters, Coeficient=regression coeficient for sunflower group, 
SE= standard errors, 95% CI=95% confidence interval 
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Table 6-8: Stunting and Underweight on Visit 28 by Intervention Group 
	  
Oil	  Randomization	  Group	  
Mustard	  Oil	   Sunflower	  Oil	  
N	   (%)	   N	   (%)	  
Complete	  Data	  Set	   	  	   	  	   	  	   	  	  
Underweight	   77	   28.2	   85	   32.4	  
Stunted	   54	   19.8	   59	   22.5	  
Full	  Term	   	  	   	  	   	  	   	  	  
Underweight	   30	   20.5	   32	   20.9	  
Stunted	   18	   12.3	   23	   15.0	  
Preterm	   	  	   	  	   	  	   	  	  
Underweight	   44	   35.5	   51	   47.7	  
Stunted	   34	   27.4	   35	   32.7	  
 
 
Table 6-9: Descriptive Characteristics of Z-scores on Visit 28 by Intervention 
Group 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	  
Mean	  
Z-­‐score	  




Complete	  Data	  Set	  
Weight-­‐for-­‐Age	   273	   56	   -­‐1.5	   1.2	   262	   57	   -­‐1.7	   1.3	  
Height-­‐for-­‐Age	   273	   56	   -­‐2.0	   1.3	   262	   57	   -­‐1.2	   2.1	  
Ful	  Term	  
Weight-­‐for-­‐Age	   146	   49	   -­‐1.2	   0.9	   153	   51	   -­‐1.3	   1.0	  
Height-­‐for-­‐Age	   146	   49	   -­‐0.6	   1.1	   153	   51	   -­‐0.8	   1.3	  
Preterm	  
Weight-­‐for-­‐Age	   124	   52	   -­‐1.8	   1.4	   107	   45	   -­‐2.2	   1.4	  
Height-­‐for-­‐Age	   124	   52	   -­‐1.3	   1.5	   107	   45	   -­‐1.8	   2.7	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Chapter 7 Discussion and Recommendations for Further 
Research 
Risk Factors Associated with Skin Integrity and Barrier Function 
This research examined risk factors associated with skin integrity and barrier function 
and how these measurements change over the neonatal period in a community where 
mothers typicaly perform ful body neonatal oil massage.  
 
In this population, transepidermal water loss (TEWL) measures were much higher at 
birth than TEWL measures from other studies. (Visscher, Odio et al. 2009; Keleher, 
O'Carrol et al. 2013) In addition, TEWL values in this population increased over the 
entire neonatal period, with the greatest rate of increase occurring over the first 3 days. 
This is in contrast to other studies that have shown ful term infants’ TEWL values to be 
similar to or lower than adult values and then remain stable over the first month of life, 
while values in preterm infants start higher, but decrease relatively quickly during the first 
few days. (Agren, Sjörs et al. 1998; Kalia, Nonato et al. 1998) However, these studies 
were done in climate-controled hospital setings, which could explain some of the 
diferences when comparing our results. Our study was conducted in women’s homes in 
an environment of consistently very high relative humidity, with average daily humidity 
over 75%. Not surprisingly, increases in relative humidity were also asociated with 
increases in TEWL, most likely due to sweat being unable to evaporate at high humidity. 
(Foster, Hey et al. 1969) However, increases in temperature were associated with 
decreases in TEWL. The reason for this could be that increases in temperature causes 
increased blood flow to the skin, which is needed for maturation and repair of the skin 
barrier. Therefore higher temperatures could lead to decreased TEWL, indicating 
improved barrier function. 
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In contrast to other studies, this study did not find any association between TEWL and 
gestational age. However, most diferences in TEWL between ful term and preterm 
infants in these studies were found in infants with gestational age less than 32 weeks, of 
which there were fewer than 40 in our study. As such, we may have been unable to 
detect an association. Other risk factors associated with TEWL were socioeconomic 
(SES) factors (higher levels of SES were associated with higher values of TEWL) and 
sex (being female was associated with lower values of TEWL). One reason why infants 
of higher SES families might have higher TEWL values is perhaps those infants were 
wearing more clothes or wrapped in more blankets before the measurements were taken 
than infants who were of lower SES status. This could cause increased sweating, 
leading to higher TEWL measurements. 
 
Infants’ skin pH in this population decreased throughout the neonatal period, with the 
greatest decrease occurring during the first week. This supports findings from other 
studies. (Visscher, Chaterjee et al. 2000; Yosipovitch, Maayan-Metzger et al. 2000) 
Other risk factors statisticaly significantly associated with skin pH in this population were 
being low birthweight (associated with higher values of skin pH), temperature (increasing 
temperature associated with decreases in skin pH), and humidity (increasing humidity 
associated with increases in skin pH). The association we found between skin pH and 
birthweight is in contrast to the previous findings by Green et al. which found no 
association (Green, Carol et al. 1968) Diferences in study design could account for the 
diferences in results however, as al infants in the study by Green et al. were in 
incubators from birth and were not removed for the purposes of the skin pH 
measurements. The difering directions of associations between skin pH and 
temperature and humidity are interesting. Perhaps humidity plays a larger role in sweat 
response in infants in this seting and the increase in skin pH with increasing humidity 
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could be a result of measuring the pH of sweat on the skin which can result in higher 
skin pH measurements. (Herrmann and Mandol 1955; Parra and Paye 2003) Decreasing 
skin pH, indicating improved barrier function, with increases in temperature could be due 
to the same mechanism as discussed previously for the relationship between TEWL and 
temperature, increasing blood flow to the skin leading to improved maturation and repair 
of the skin barrier.  
 
This study also evaluated how stratum corneum protein concentrations removed using 
skin discs change throughout the first month of life. We found protein concentrations 
decreased over the first week, folowed by a slight increase over the rest of the neonatal 
period. This decrease in protein concentration indicates the maturation of the stratum 
corneum over the first week of life. (Berthaud and Boncheva 2011; Myer and Maibach 
2013) The slight increase after the first week could be indicative of the regeneration of 
the stratum corneum. (Chiou and Blume-Peytavi 2004) Other risk factors statisticaly 
significantly associated with stratum corneum protein concentrations were: time between 
measurement and last massage (with greater time since last massage associated with 
higher levels of protein), SES status (higher SES status associated with lower protein 
concentrations), and temperature and humidity (increases associated with decreases in 
protein concentration). Greater time since last massage could result in increases in 
protein concentration, because the massage may remove the layer of protein that would 
normaly be removed using the skin discs. In addition, the oil may afect whether protein 
can be removed, as the skin may be more moisturized after recent oil massage. 
Temperature and humidity may also afect the amount of moisture on the skin creating a 
barrier between the skin and the disc, which could be the reason for decreases in protein 
concentration removed by the skin discs with increasing temperature. 
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Erythema and rash are measures of skin irritation. In this population, erythema scores 
worsened (increased) over the first 3 days of life, leveled of until about day 14, and then 
improved (decreased) over the final two weeks. Rash scores worsened over the first two 
weeks, then improved over the second two weeks. This is in contrast to data from other 
studies that only found rash in a diapered region due to fecal contact and did not find 
rash in the chest region. (Visscher, Odio et al. 2009) Smaler infants (those who were of 
low birthweight or preterm) were associated with lower erythema and rash scores than 
larger infants. This may be due to the fact that preterm infants have less developed 
eccrine involvement, resulting in lower prevalence of miliaria, a common rash in 
newborns caused by retention of sweat. (Foster, Hey et al. 1969; Zuniga and Nguyen 
2013) The increase in miliaria was also likely the reason temperature and humidity were 
associated with increases in rash scores.  
 
Efect of Oil Group on Skin Integrity and Barrier Function 
Studies in mice models have shown there might be diferences in skin integrity after 
application of various oils and there have been several studies that have examined the 
efects of emolients on skin integrity measures comparing emolient treated skin with no 
emolient treatment. (Darmstadt, Mao-Qiang et al. 2002; Darmstadt, Badrawi et al. 2004; 
Visscher, Odio et al. 2009) We extend these observations by directly examining, in a 
community seting, efects on skin integrity measurements when comparing neonates 
massaged with mustard seed oil to neonates massaged with sunflower seed oil. These 
data provide some evidence that diferent types of oil may efect skin integrity 
measurements when infants are massaged regularly with sunflower oil compared with 
mustard seed oil. Skin pH measures in the sunflower oil group decreased at a faster rate 
than in the mustard oil group, indicating a more quickly forming acid mantle, which is 
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important in order for the skin to maintain bacteriological, chemical and mechanical 
resistance. (Schmid-Wendtner and Korting 2006) In addition, although TEWL measures 
increased throughout the neonatal period, they increased at a slower rate in the 
sunflower oil group than in the mustard oil group, which was more pronounced in 
preterm infants. This could be another indication of a more rapidly improving skin barrier 
in the sunflower oil group, although both groups in this population had higher TEWL 
measures than those in other studies. (Visscher, Odio et al. 2009; Keleher, O'Carrol et 
al. 2013) There was litle evidence that skin condition scores or stratum corneum protein 
concentrations were diferent between the two intervention groups.  
 
Efect of Oil Group on Nutritional Status 
These data do not provide evidence that ful body oil massage with sunflower oil 
improves neonates’ nutritional status when compared with ful body oil massage with 
mustard seed oil. This study found that preterm infants in the sunflower oil group had 
statisticaly significantly slower weight gain after day 3 than preterm infants in the 
mustard oil group. These results difer from those of other studies, which have found 
improved weight and/or length gain in infants massaged with oils high in linoleic acid. 
(Arora, Kumar et al. 2005; Vaivre-Douret, Oriot et al. 2009; Falah, Akhavan Karbasi et 
al. 2013; Kumar, Upadhyay et al. 2013) However, there were significant diferences 
between the study designs for those studies and our study. Those were al hospital-
based studies with study populations who were less than 35 weeks of age or of very low 
birthweight and as such were generaly more vulnerable than our study population. 
There also may have been diferences in the way in which the infants were being fed, as 
infants in our study population are almost exclusively breastfed. In addition, those 
studies al used a standardized massage technique using moderate pressure for a 
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prescribed amount of time (usualy around 10 minutes two or three times a day). In 
contrast, our study was community-based with massages performed by mothers or 
caretakers and done in the traditional (i.e. vigorous) way. These diferences in study 
design could have led to diferences in outcomes as improvements in nutritional status in 
neonates massaged with oils high in linoleic acid may only occur in either very low 
birthweight or very premature infants, who were unlikely to survive in our seting in rural 
Nepal. It is uncertain as to what may have led to the slower weight gain in preterm 
infants in the sunflower oil group, however this smal diference in rate of weight gain 
(about 3 grams less per day) is unlikely to be clinicaly significant.  
 
This study only compared the diferences in nutritional status between infants massaged 
with an improved oil (sunflower oil) and the traditional oil (mustard oil), therefore, the 
beneficial nutritional efects of oil massage found in other studies, could be due to 
massage alone, or massage with any type of oil, and not to the type of oil used. Several 
studies have shown increased weight gain, less stress behaviors, lower salivary cortisol 
levels, and increased vagal activity in infants who were massaged without oil when 
compared with infants who were not massaged. (Field, Schanberg et al. 1996; Ang, Lua 
et al. 2012; Wang, He et al. 2013) Increased vagal activity, which increases gastric 
motility, may lead to an increase in food absorption hormones such as insulin and may 
be one of the underlying mechanisms for greater weight gain in massaged infants. 
(Field, Diego et al. 2011) An increase in insulin-like growth factor-1 (IGF-1) through an 
independent pathway unrelated to vagal activity was also related to weight gain perhaps 
because of fomenting muscle and bone development. (Field, Diego et al. 2011) Also, the 
type of massage may afect a neonates’ nutritional status. Although moderate pressure 
massage has shown to decrease stress behavior and cortisol levels and increase weight 
gain compared to no massage, the mode in which massage of infants is conducted in 
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this population is quite vigorous, many times leaving infants stressed and agitated, 
possibly leading to an increase in cortisol levels, which may influence weight gain. (Field, 
Diego et al. 2010) 
 
Strengths and Limitations 
This study had several strengths. This is the largest study that has investigated skin 
barrier integrity in infants over the first month of life using a composite measure of visual 
scoring and more traditional methods (TEWL, skin pH), an approach recommended at a 
recent expert meeting on emolients. (Expert Emolients Meeting, Bil and Melinda Gates 
Foundation, December 14, 2012) In addition, although other studies have compared the 
efect on skin barrier of diferent oils using a mouse model (Darmstadt, Mao-Qiang et al. 
2002), our study expanded on this work, investigating the efects on skin barrier function 
when comparing mustard and sunflower seed oil in humans. At the same expert 
meeting, there was a consensus that mouse model work could not be extrapolated to 
humans and that future work was needed in this area. (Expert Emolients Meeting, Bil 
and Melinda Gates Foundation, December 14, 2012) 
 
Another strength was our large sample size with an oversampling of preterm infants, 
which enabled us to detect even smal diferences between oil groups even when 
stratified by term status. This study was also conducted in a community “real world” 
seting where women routinely perform neonatal oil massage using localy available 
vegetable oils, instead of in a hospital where many other studies examining these 
relationships have been conducted. In addition, the cluster-randomized design 
minimized crossover contamination between the two oil groups and helped to avoid 
selection bias and improve comparability between groups. 
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This study however, did have some limitations. This study did not include a control group 
of infants who did not receive massage or infants who received massage without oil. 
Therefore we were only able to compare the efects of oil massage with the traditional 
(mustard) and improved (sunflower) oils. We could not make any conclusions on 
whether the massage itself had any impact on skin integrity or nutritional status in this 
community. Also, because the measurements were made at home in this rural 
community, it was sometimes dificult to folow the recommended measurement 
protocols for the instruments. For example, TEWL and skin pH measures could not be 
taken in the recommended climate controled environment (20-22°C and <50% relative 
humidity). (Rogeries and Group 2001; Parra and Paye 2003) For TEWL measures 
however, we did folow guidance in taking measurements in non-clinical setings. (du 
Plessis, Stefaniak et al. 2013) Estimations of gestational age may also have been 
inaccurate as we used recaled date of last menstrual period (LMP) in order to determine 
gestational age. This method has been shown to be less accurate than methods using 
ultrasound. (Rosenberg, Ahmed et al. 2009; Jehan, Zaidi et al. 2010) This inaccuracy 
may have resulted in misclassification of whether an infant was preterm or ful term. 
However, this misclassification was likely minimal in our study, as LMPs were colected 
as soon as a pregnancy was identified (folowing-up women every 5 weeks), so recal 
bias was likely minimal.  
 
Further Research and Conclusion 
Future research using data colected during this study wil be conducted on other 
possible biological mechanisms, which may be afected by neonatal ful body oil 
massage with mustard oil or sunflower oil. These include diferences in the efects of the 
diferent oils on bacterial colonization of the skin and whether there are diferences in 
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immune status and function. In addition, risk factors for bacterial colonization and 
immune function wil be examined in this population in order to beter target groups of 
infants who may be at higher risk of poor immune function or colonization of certain 
bacteria. Whether the diferent oil groups have any efect on infants’ nutritional status 
after 6 months wil also be explored.  
 
Other future analyses that wil be completed using these data are to analyze whether 
there are any correlations between the diferent skin integrity measurements (TEWL, 
skin pH, stratum corneum protein concentration, and skin condition). In addition, the 
relationships between al of the biological mechanisms studied (skin integrity, bacterial 
colonization, nutritional status, and immune function) wil be examined to determine how 
they might influence each other. Also, any relationships between morbidity (using data 
from the NOMS parent trial) and the biological mechanisms wil be investigated. 
Analyses wil also be performed limiting our preterm group to those <34 weeks in order 
to determine if there are efects of the oils on nutritional status and skin integrity on 
infants who are more premature. 
 
In addition to research on whether there are diferences in biological mechanisms 
between infants massaged with mustard and sunflower oils, research should be 
conducted on whether there are any diferences in biological mechanisms in infants who 
receive emolient massage, those who receive massage without emolients, and those 
who receive no massage. It is also important to assess if diferences exist in these 
biological mechanisms in infants who are massaged diferently (i.e. vigorous versus 
gentle massage, or massage with moderate pressure). Although these studies would be 
dificult to conduct in this population due to the universal cultural practice of neonatal oil 
massage, these types of studies could possibly be conducted in a smaler group of 
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infants in an urban area where mothers may be more wiling to accept behavioral 
change interventions. (Mulany, Darmstadt et al. 2005) Another possibility is to conduct 
this type of study in a population of older infants in this rural community, although such 
an approach would preclude examining diferences in skin maturation between diferent 
massage approaches. 
 
Since time from last massage was significantly associated with changes in stratum 
corneum protein concentration, it is also important to perform some controled 
experiments in order to further examine the efect that oil massage may have on skin 
barrier. These experiments should examine variables related to massage, such as the 
efects of time of oil exposure on protein concentrations, the amount the oil is rubbed in, 
the pressure used when rubbing in the oil, rubbing with or without oil, etc. These types of 
experiments could be done on the adult forearm model. (Marty Visscher, personal 
communication) 
 
Emolient therapy research to improve neonatal survival is a global priority. (Lawn, 
Zupan et al. 2006) Although milions of babies in South Asia are massaged with mustard 
oil each year, it is unknown whether substituting sunflower seed oil changes any 
biological mechanisms that may improve neonatal health. The nearly universal practice 
of neonatal oil massage in South Asia routinely exposes neonates to the efects of 
mustard oil massage. Determining how and if certain biological mechanisms are diferent 
in infants massaged with sunflower oil wil help in the characterization of the modes 
through which sunflower oil massage may improve neonatal health, and alow for direct 
comparison of functional indicators across public health outcomes including neonatal 
skin infection, clinical signs of sepsis, and mortality. These data indicate there may be 
diferences in skin integrity measures in infants massaged with sunflower oil compared 
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with those massaged with mustard seed oil and also discussed some possible risk 
factors associated with skin integrity in this population in rural southern Nepal. In 
addition, these data indicated that sunflower oil massage did not improve nutritional 
status in neonates when compared with mustard oil massage. These results could be 
applicable to similar populations in northern India, Pakistan, and northwestern 
Bangladesh, as wel as the Terai region in southern Nepal, as they share cultural, social, 
and economic characteristics. It is important to have a beter understanding of the 
underlying mechanisms of how and why emolient therapy can improve neonatal health 
outcomes in low-resource setings in order to optimize any health benefits of the oils. 
Such data are necessary to refine the timing, frequency, and mode of administration in 
future scaled up programmatic promotion of sunflower oil, a low cost intervention with 
the potential to substantialy improve survival of newborns across South Asia. 
  
	   265 
Chapter 7 References 
Agren, J., G. Sjörs, et al. (1998). "Transepidermal water loss in infants born at 24 and 25 
weeks of gestation." Acta Paediatr 87(11): 1185-1190. 
 
Ang, J. Y., J. L. Lua, et al. (2012). "A randomized placebo-controled trial of massage 
therapy on the immune system of preterm infants." Pediatrics 130(6): e1549-
1558. 
 
Arora, J., A. Kumar, et al. (2005). "Efect of oil massage on growth and neurobehavior in 
very low birth weight preterm neonates." Indian Pediatr 42(11): 1092-1100. 
 
Berthaud, F. and M. Boncheva (2011). "Correlation between the properties of the lipid 
matrix and the degrees of integrity and cohesion in healthy human stratum 
corneum." Exp Dermatol 20(3): 255-262. 
 
Chiou, Y. B. and U. Blume-Peytavi (2004). "Stratum corneum maturation. A review of 
neonatal skin function." Skin Pharmacol Physiol 17(2): 57-66. 
 
Darmstadt, G. L., N. Badrawi, et al. (2004). "Topicaly applied sunflower seed oil 
prevents invasive bacterial infections in preterm infants in Egypt." Pediatr Infect 
Dis J	  23(8): 719-725. 
 
Darmstadt, G. L., M. Mao-Qiang, et al. (2002). "Impact of topical oils on the skin barrier: 
possible implications for neonatal health in developing countries." Acta Pediatr 
91: 546-554. 
 
du Plessis, J., A. Stefaniak, et al. (2013). "International guidelines for the in vivo 
assessment of skin properties in non-clinical setings: Part 2. transepidermal 
water loss and skin hydration." Skin Res Technol 19(3): 265-278. 
 
Falah, R., S. Akhavan Karbasi, et al. (2013). "Sunflower oil versus no oil moderate 
pressure massage leads to greater increases in weight in preterm neonates who 
are low birth weight." Early Hum Dev 89(9): 769-772. 
 
Field, T., M. Diego, et al. (2010). "Preterm infant massage therapy research: a review." 
Infant Behav Dev 33(2): 115-124. 
 
Field, T., M. Diego, et al. (2011). "Potential underlying mechanisms for greater weight 
gain in massaged preterm infants." Infant Behav Dev 34(3): 383-389. 
 
Field, T. T., S. Schanberg, et al. (1996). "Massage with oil has more positive efects on 
normal infants." Pre and Peri-natal Psychology Journal 11(2): 75-80. 
 
Foster, K. G., E. N. Hey, et al. (1969). "The response of the sweat glands of the newborn 
baby to thermal stimuli and to intradermal acetylcholine." J Physiol 203(1): 13-29. 
 
Green, M., B. Carol, et al. (1968). "Physiologic skin pH paterns in infants of low birth 
weight. The onset of surface acidification." Am J Dis Child 115(1): 9-16. 
 
	   266 
Herrmann, F. and L. Mandol (1955). "Studies of pH of sweat produced by diferent forms 
of stimulation." J Invest Dermatol 24(3): 225-246. 
 
Jehan, I., S. Zaidi, et al. (2010). "Dating gestational age by last menstrual period, 
symphysis-fundal height, and ultrasound in urban Pakistan." Int J Gynaecol 
Obstet 110(3): 231-234. 
 
Kalia, Y. N., L. B. Nonato, et al. (1998). "Development of skin barrier function in 
premature infants." J Invest Dermatol 111(2): 320-326. 
 
Keleher, M. M., M. O'Carrol, et al. (2013). "Newborn transepidermal water loss values: 
a reference dataset." Pediatr Dermatol 30(6): 712-6. 
 
Kumar, J., A. Upadhyay, et al. (2013). "Efect of oil massage on growth in preterm 
neonates less than 1800g: a randomized control trial." Indian J Pediatr 80(6): 
465-469. 
 
Lawn, J. E., J. Zupan, et al. (2006). Newborn survival. Disease Control Priorities in 
Developing Countries, 2nd ed. D. Jamison, J. Breman, A. Beashamet al. 
Washington, DC, The World Bank and Oxford University Press: 531-549. 
 
Mulany, L. C., G. L. Darmstadt, et al. (2005). "Traditional massage of newborns in 
Nepal: implications for trials of improved practice." J Trop Pediatr 51(2): 82-86. 
 
Myer, K. and H. Maibach (2013). "Stratum corneum evaluation methods: overview." Skin 
Res Technol 19(3): 213-219. 
 
Parra, J. L. and M. Paye (2003). "EEMCO guidance for the in vivo assessment of skin 
surface pH." Skin Pharmacol Appl Skin Physiol 16(3): 188-202. 
 
Rogeries, V. and E. Group (2001). "EEMCO guidance for the assessment of 
transepidermal water loss in cosmetic sciences." Skin Pharmacol Appl Skin 
Physiol 14: 117-128. 
 
Rosenberg, R. E., A. S. M. Ahmed, et al. (2009). "Determining gestational age in a low-
resource seting: validity of last menstrual period." J Health Popul Nutr 27(3): 
332-338. 
 
Schmid-Wendtner, M. H. and H. C. Korting (2006). "The pH of the skin surface and its 
impact on the barrier function." Skin Pharmacol Physiol 19(6): 296-302. 
 
Vaivre-Douret, L., D. Oriot, et al. (2009). "The efect of multimodal stimulation and 
cutaneous application of vegetable oils on neonatal development in preterm 
infants: a randomized controled trial." Child Care Health Dev	  35(1): 96-105. 
 
Visscher, M., M. Odio, et al. (2009). "Skin care in the NICU patient: efects of wipes 
versus cloth and water on stratum corneum integrity." Neonatology 96(4): 226-
234. 
 
Visscher, M. O., R. Chaterjee, et al. (2000). "Changes in diapered and nondiapered 
infant skin over the first month of life." Pediatr Dermatol	  17(1): 45-51. 
	   267 
Wang, L., J. L. He, et al. (2013). "The eficacy of massage on preterm infants: a meta-
analysis." Am J Perinatol 30(9): 731-738. 
 
Yosipovitch, G., A. Maayan-Metzger, et al. (2000). "Skin barrier properties in diferent 
body areas in neonates." Pediatrics 106(1): 105-108. 
 
Zuniga, R. and T. Nguyen (2013). "Skin conditions: common skin rashes in infants." FP 
Essent 407: 31-41.
	   268 
Appendix A Epidemiology and Risk Factors Associated with Left 
Arm and Right Leg Skin Condition 












Right	  Leg	  Rash	  
Score	  
1	   0.67	  (0.70)	   0.17	  (0.46)	   0.70	  (0.72)	   0.15	  (0.42)	  
3	   0.90	  (0.62)	   0.69	  (0.78)	   0.89	  (0.67)	   0.54	  (0.71)	  
7	   0.96	  (0.59)	   1.02	  (0.87)	   0.93	  (0.64)	   0.76	  (0.80)	  
14	   1.01	  (0.61)	   1.27	  (0.88)	   0.94	  (0.62)	   1.06	  (0.80)	  
28	   0.67	  (0.57)	   0.78	  (0.74)	   0.70	  (0.64)	   0.77	  (0.76)	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Table A-2: Left Arm Erythema Score and Infant Characteristics Bivariate Analyses 
Predictor	  Variable	  
Left	  Arm	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   0.0046	   0.033	   0.888	   -­‐0.059-­‐0.069	  
Preterm	  (<37	  wks)	   -­‐0.023	   0.033	   0.486	   -­‐0.088-­‐0.042	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   -­‐0.0027	   0.035	   0.939	   -­‐0.070-­‐0.065	  
<32	  wks	   -­‐0.15	   0.071	   0.036	   -­‐0.29-­‐	  -­‐0.0096	  
Gestational	  Age	  (cont.)	  (wks)	   0.0025	   0.0046	   0.588	   -­‐0.0065-­‐0.011	  
Low	  birthweight	  (<2500g)
	  
-­‐0.079	   0.034	   0.019	   -­‐0.14-­‐	  -­‐0.013	  
Birthweight	  (g)	  (cont.)	   0.00015	   0.000034	   <0.001	   0.000086-­‐0.00022	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   0.017	   0.043	   0.694	   -­‐0.067-­‐0.10	  
SGA	  3%	   -­‐0.11	   0.040	   0.005	   -­‐0.19-­‐	  -­‐0.035	  
Breastfed	  since	  birth	   -­‐0.013	   0.046	   0.775	   -­‐0.10-­‐0.077	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   0.013	   0.040	   0.748	   -­‐0.066-­‐0.092	  
3-­‐4	  hrs	   -­‐0.022	   0.077	   0.769	   -­‐0.17-­‐0.13	  
>=5	  hrs	   0.054	   0.077	   0.488	   -­‐0.098-­‐0.21	  
Infant	  received	  colostrum	   0.045	   0.059	   0.439	   -­‐0.069-­‐0.16	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
-­‐0.019	   0.012	   0.111	   -­‐0.042-­‐0.0044	  




	   	   	   	  
30-­‐59	  min	   -­‐0.042	   0.036	   0.234	   -­‐0.11-­‐0.027	  
60-­‐119	  min	   -­‐0.046	   0.034	   0.172	   -­‐0.11-­‐0.020	  
120-­‐179	  min	   0.0022	   0.039	   0.954	   -­‐0.074-­‐0.078	  
>180	  min	   0.013	   0.033	   0.703	   -­‐0.05-­‐0.078	  
Infant’s	  age	  days	  0	  to	  3	   0.111	   0.013	   <0.001	   0.085-­‐0.14	  
Infant’s	  age	  days	  4	  to	  14	   0.010	   0.003	   <0.001	   0.0048-­‐0.016	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.025	   0.002	   <0.001	   -­‐0.30-­‐	  -­‐0.021	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 minutes 
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Table A-3: Left Arm Erythema Score and Maternal, Socioeconomic, and 
Household Characteristics Bivariate Analyses 
Predictor	  Variable	  
Left	  Arm	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐0.13	   0.064	   0.042	   -­‐0.26-­‐	  -­‐0.0046	  
Mother	  literate	   -­‐0.023	   0.036	   0.528	   -­‐0.094-­‐0.048	  
Father	  literate	   0.012	   0.033	   0.715	   -­‐0.052-­‐0.076	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.030	   0.057	   0.606	   -­‐0.083-­‐0.14	  
	  	  	  6-­‐10	  yrs	   -­‐0.046	   0.047	   0.323	   -­‐0.14-­‐0.046	  
	  	  	  >10	  yrs	   -­‐0.069	   0.082	   0.394	   -­‐0.23-­‐0.090	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.047	   0.049	   0.334	   -­‐0.048-­‐0.14	  
	  	  	  6-­‐10	  yrs	   0.010	   0.038	   0.785	   -­‐0.063-­‐0.084	  
	  	  	  >10	  yrs	   -­‐0.073	   0.070	   0.293	   -­‐0.21-­‐0.064	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.0035	   0.067	   0.959	   -­‐0.13-­‐0.13	  
	  	  	  6-­‐10	  assets	   -­‐0.031	   0.067	   0.646	   -­‐0.16-­‐0.10	  
	  	  	  >10	  assets	   -­‐0.04	   0.12	   0.731	   -­‐0.20-­‐0.28	  
Household	  has	  electricity	   -­‐0.099	   0.033	   0.003	   -­‐0.16-­‐	  -­‐0.033	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.13	   0.050	   0.008	   0.035-­‐0.23	  
	  	  	  25-­‐29	  yrs	   0.14	   0.057	   0.011	   0.034-­‐0.26	  
	  	  	  30-­‐34	  yrs	   0.12	   0.082	   0.147	   -­‐0.041-­‐0.28	  
	  	  	  >=35	  yrs	   0.057	   0.10	   0.588	   -­‐0.15-­‐0.26	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.069	   0.040	   0.082	   -­‐0.0088-­‐0.15	  
	  	  	  >=3	   -­‐0.064	   0.045	   0.152	   -­‐0.024-­‐0.15	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.045	   0.040	   0.257	   -­‐0.033-­‐0.12	  
	  	  	  >=3	   0.048	   0.043	   0.265	   -­‐0.036-­‐0.13	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   0.074	   0.041	   0.068	   -­‐0.0055-­‐0.15	  
	  	  	  >=3	  ANC	  visits	   0.080	   0.041	   0.051	   -­‐0.00019-­‐0.16	  
Delivery	  at	  facility	   -­‐0.096	   0.036	   0.008	   -­‐0.17-­‐	  -­‐0.025	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   -­‐0.021	   0.035	   0.548	   -­‐0.089-­‐0.047	  
	  	  	  >=15	  hrs	   -­‐0.090	   0.054	   0.097	   -­‐0.20-­‐0.016	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Table A-3: Left Arm Erythema Score and Maternal, Socioeconomic, and 
Household Characteristics Bivariate Analyses (continued) 
 
Predictor	  Variable	  
Left	  Arm	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Complications	  during	  delivery	   -­‐0.040	   0.043	   0.350	   -­‐0.12-­‐0.044	  
Skiled	  assistant	  at	  delivery	   -­‐0.10	   0.035	   0.005	   -­‐0.17-­‐	  -­‐0.031	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
 
 
Table A-4: Left Arm Erythema Score and Environmental Characteristics Bivariate 
Analyses 
Predictor	  Variable	  
Left	  Arm	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   -­‐0.012	   0.0033	   <0.001	   -­‐0.018-­‐	  -­‐0.0054	  
Relative	  humidity	  (cont.)	  (%)	   0.0020	   0.0011	   0.071	   -­‐0.00017-­‐0.0041	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   -­‐0.084	   0.12	   0.485	   -­‐0.32-­‐0.15	  
60-­‐79%	   -­‐0.0017	   0.12	   0.988	   -­‐0.23-­‐0.22	  
>80%	   -­‐0.018	   0.11	   0.874	   -­‐0.24-­‐0.21	  
Heat	  index	  (°C)	   -­‐0.0054	   0.0016	   0.001	   -­‐0.0085-­‐	  -­‐0.0022	  
a: Reference group, <40% 
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Table A-5: Left Arm Erythema Score Multivariate Model 
Predictor	  Variable	  
Left	  Arm	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Gestational	  age
a	  
	   	   	   	  
	  	  	  32-­‐36	  wks	   0.025	   0.034	   0.465	   -­‐0.043-­‐0.093	  
	  	  	  <32	  wks	   -­‐0.078	   0.071	   0.289	   -­‐0.22-­‐0.064	  
Female	   0.017	   0.033	   0.603	   -­‐0.047-­‐0.081	  
Madeshi	   -­‐0.14	   0.062	   0.023	   -­‐0.27-­‐	  -­‐0.019	  
Birthweight	  (g)	  (cont.)	   0.00014	   0.000037	   <0.001	   0.000067-­‐0.00021	  
Household	  has	  electricity	   -­‐0.098	   0.033	   0.003	   -­‐0.16-­‐	  -­‐0.033	  
Maternal	  Age
b	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.11	   0.049	   0.029	   0.011-­‐0.20	  
	  	  	  25-­‐29	  yrs	   0.071	   0.057	   0.213	   -­‐0.041-­‐0.18	  
	  	  	  30-­‐34	  yrs	   0.065	   0.081	   0.425	   -­‐0.094-­‐0.22	  
	  	  	  >=	  35	  yrs	   0.0092	   0.10	   0.928	   -­‐0.19-­‐0.21	  
Facility	  delivery	   -­‐0.083	   0.036	   0.022	   -­‐0.15-­‐	  -­‐0.0046	  
Temperature	  (°C)	   -­‐0.010	   0.0034	   0.003	   -­‐0.017-­‐	  -­‐0.0036	  
Relative	  humidity	  (%)
	  
0.00018	   0.0011	   0.874	   -­‐0.0020-­‐0.0023	  
Infant’s	  age	  days	  0	  to	  3	   0.11	   0.013	   <0.001	   0.080-­‐0.13	  
Infant’s	  age	  days	  4	  to	  14	   0.011	   0.0029	   <0.001	   0.0055-­‐0.017	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.026	   0.0023	   <0.001	   -­‐0.031-­‐	  -­‐0.022	  
a: Reference group, ≤37 wks; b: Reference group, <18 years 
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Table A-6: Left Arm Rash Score and Infant Characteristics Bivariate Analyses 
Predictor	  Variable	  
Left	  Arm	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   -­‐0.0020	   0.038	   0.959	   -­‐0.077-­‐0.073	  
Preterm	  (<37	  wks)	   -­‐0.11	   0.039	   0.003	   -­‐0.19-­‐	  -­‐0.038	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   -­‐0.098	   0.040	   0.015	   -­‐0.18-­‐	  -­‐0.019	  
<32	  wks	   -­‐0.22	   0.083	   0.009	   -­‐0.38-­‐	  -­‐0.053	  
Gestational	  Age	  (cont.)	  (wks)	   0.017	   0.0053	   0.001	   0.0070-­‐0.028	  
Low	  birthweight	  (<2500g)
	  
-­‐0.23	   0.039	   <0.001	   -­‐0.31-­‐	  -­‐0.16	  
Birthweight	  (g)	  (cont.)	   0.00032	   0.000039	   <0.001	   0.00024-­‐0.00040	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   0.022	   0.059	   0.661	   -­‐0.076-­‐0.12	  
SGA	  3%	   -­‐0.16	   0.047	   0.001	   -­‐0.25-­‐	  -­‐0.069	  
Breastfed	  since	  birth	   0.0061	   0.054	   0.909	   -­‐0.090-­‐0.11	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   0.0051	   0.048	   0.915	   -­‐0.088-­‐0.098	  
3-­‐4	  hrs	   -­‐0.093	   0.090	   0.299	   -­‐0.27-­‐0.083	  
>=5	  hrs	   -­‐0.041	   0.091	   0.649	   -­‐0.22-­‐0.14	  
Infant	  received	  colostrum	   0.052	   0.069	   0.452	   -­‐0.084-­‐0.19	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
-­‐0.041	   0.014	   0.003	   -­‐0.068-­‐	  -­‐0.014	  




	   	   	   	  
30-­‐59	  min	   -­‐0.000063	   0.049	   0.999	   -­‐0.097-­‐0.097	  
60-­‐119	  min	   0.0094	   0.047	   0.839	   -­‐0.082-­‐0.10	  
120-­‐179	  min	   0.076	   0.054	   0.156	   -­‐0.029-­‐0.18	  
>180	  min	   0.12	   0.046	   0.007	   0.033-­‐0.21	  
Infant’s	  age	  days	  0	  to	  14	   0.080	   0.003	   <0.001	   0.074-­‐0.085	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.045	   0.003	   <0.001	   -­‐0.051-­‐	  -­‐0.039	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 minutes 
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Table A-7: Left Arm Rash Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses 
Predictor	  Variable	  
Left	  Arm	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐0.20	   0.074	   0.007	   -­‐0.34-­‐	  -­‐0.053	  
Mother	  literate	   0.015	   0.043	   0.716	   -­‐0.068-­‐0.099	  
Father	  literate	   0.054	   0.038	   0.164	   -­‐0.022-­‐0.13	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.040	   0.067	   0.549	   -­‐0.091-­‐0.17	  
	  	  	  6-­‐10	  yrs	   -­‐0.0014	   0.055	   0.980	   -­‐0.11-­‐0.11	  
	  	  	  >10	  yrs	   -­‐0.0092	   0.096	   0.923	   -­‐0.20-­‐0.18	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.012	   0.051	   0.813	   -­‐0.088-­‐0.11	  
	  	  	  6-­‐10	  yrs	   0.049	   0.040	   0.215	   -­‐0.028-­‐0.13	  
	  	  	  >10	  yrs	   0.057	   0.074	   0.442	   -­‐0.088-­‐0.20	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   0.023	   0.078	   0.766	   -­‐0.13-­‐0.18	  
	  	  	  6-­‐10	  assets	   0.044	   0.078	   0.572	   -­‐0.11-­‐0.20	  
	  	  	  >10	  assets	   0.25	   0.14	   0.082	   -­‐0.032-­‐0.53	  
Household	  has	  electricity	   0.0021	   0.039	   0.957	   -­‐0.075-­‐0.079	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.21	   0.058	   <0.001	   0.094-­‐0.32	  
	  	  	  25-­‐29	  yrs	   0.23	   0.066	   0.001	   0.097-­‐0.36	  
	  	  	  30-­‐34	  yrs	   0.18	   0.095	   0.060	   -­‐0.0076-­‐0.36	  
	  	  	  >=35	  yrs	   0.12	   0.12	   0.327	   -­‐0.12-­‐0.36	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.15	   0.046	   0.001	   0.061-­‐0.24	  
	  	  	  >=3	   0.16	   0.052	   0.001	   0.063-­‐0.27	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.14	   0.046	   0.003	   0.045-­‐0.23	  
	  	  	  >=3	   0.18	   0.050	   <0.001	   0.078-­‐0.27	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   0.062	   0.048	   0.191	   -­‐0.031-­‐0.16	  
	  	  	  >=3	  ANC	  visits	   0.095	   0.048	   0.050	   0.000030-­‐0.19	  
Delivery	  at	  facility	   0.042	   0.042	   0.322	   -­‐0.041-­‐0.13	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   0.017	   0.041	   0.685	   -­‐0.064-­‐0.097	  
	  	  	  >=15	  hrs	   -­‐0.12	   0.095	   0.069	   -­‐0.24-­‐0.0091	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Table A-7: Left Arm Rash Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses (continued) 
 
Predictor	  Variable	  
Left	  Arm	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Complications	  during	  delivery	   -­‐0.018	   0.050	   0.714	   -­‐0.12-­‐0.079	  
Skiled	  assistant	  at	  delivery	   0.036	   0.041	   0.381	   -­‐0.044-­‐0.12	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
 
 
Table A-8: Left Arm Rash Score and Environmental Characteristics Bivariate 
Analyses 
Predictor	  Variable	  
Left	  Arm	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   0.023	   0.0041	   <0.001	   0.015-­‐0.031	  
Relative	  humidity	  (cont.)	  (%)	   0.0057	   0.0014	   <0.001	   0.0029-­‐0.0084	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   -­‐0.024	   0.17	   0.888	   -­‐0.35-­‐0.31	  
60-­‐79%	   0.22	   0.16	   0.160	   -­‐0.089-­‐0.54	  
>80%	   0.27	   0.16	   0.092	   -­‐0.044-­‐0.58	  
Heat	  index	  (°C)	   0.013	   0.0019	   <0.001	   0.0094-­‐0.017	  
a: Reference group, <40% 
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Table A-9: Left Arm Rash Score Multivariate Model 
Predictor	  Variable	  
Left	  Arm	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  wks)	   -­‐0.10	   0.036	   0.004	   -­‐0.17-­‐	  -­‐0.032	  
Female	   0.012	   0.035	   0.717	   -­‐0.056-­‐0.082	  
Madeshi	   -­‐0.21	   0.073	   0.004	   -­‐0.35-­‐	  -­‐0.067	  
Low	  birthweight	  (<2500	  g)	   -­‐0.16	   0.038	   <0.001	   -­‐0.23-­‐	  -­‐0.082	  
Avg	  #	  of	  massages	  per	  day	  during	  
first	  week	  of	  life	  
-­‐0.0072	   0.014	   0.596	   -­‐0.034-­‐0.019	  
Maternal	  Age
a	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.070	   0.059	   0.240	   -­‐0.046-­‐0.19	  
	  	  	  25-­‐29	  yrs	   0.027	   0.077	   0.728	   -­‐0.12-­‐0.18	  
	  	  	  30-­‐34	  yrs	   -­‐0.025	   0.099	   0.805	   -­‐0.22-­‐0.17	  
	  	  	  >=	  35	  yrs	   -­‐0.055	   0.122	   0.654	   -­‐0.29-­‐0.18	  
Parity
b	  
	   	   	   	  
	  	  	  1-­‐2	   0.090	   0.048	   0.060	   -­‐0.0036-­‐0.18	  
	  	  	  >=3	   0.18	   0.062	   0.004	   0.055-­‐0.30	  
Antenatal	  Care	  Visits
b
	   	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   0.050	   0.043	   0.245	   -­‐0.35-­‐0.13	  
	  	  	  >=3	  ANC	  visits	   0.064	   0.044	   0.151	   -­‐0.023-­‐0.15	  
Temperature	  (°C)	   0.031	   0.0039	   <0.001	   0.023-­‐0.038	  
Relative	  humidity	  (%)
	  
0.0074	   0.0013	   <0.001	   0.0048-­‐0.010	  
Infant’s	  age	  days	  0	  to	  14	   0.081	   0.0029	   <0.001	   0.075-­‐0.087	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.044	   0.0029	   <0.001	   -­‐0.050-­‐	  -­‐0.039	  
a: Reference group, <18 years; b: Reference group, none 
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Table A-10: Right Leg Erythema Score and Infant Characteristics Bivariate 
Analyses 
Predictor	  Variable	  
Right	  Leg	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   0.042	   0.035	   0.224	   -­‐0.026-­‐0.11	  
Preterm	  (<37	  wks)	   0.0058	   0.035	   0.870	   -­‐0.064-­‐0.075	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   0.017	   0.037	   0.640	   -­‐0.055-­‐0.090	  
<32	  wks	   -­‐0.058	   0.076	   0.439	   -­‐0.21-­‐0.090	  
Gestational	  Age	  (cont.)	  (wks)	   -­‐0.0024	   0.0049	   0.622	   -­‐0.012-­‐0.0071	  
Low	  birthweight	  (<2500g)
	  
-­‐0.058	   0.036	   0.105	   -­‐0.13-­‐0.012	  
Birthweight	  (g)	  (cont.)	   0.00014	   0.000037	   <0.001	   0.000069-­‐0.00021	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   0.011	   0.046	   0.803	   -­‐0.078-­‐0.10	  
SGA	  3%	   -­‐0.12	   0.043	   0.007	   -­‐0.20-­‐	  -­‐0.032	  
Breastfed	  since	  birth	   -­‐0.055	   0.049	   0.261	   -­‐0.15-­‐0.041	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   0.051	   0.040	   0.225	   -­‐0.032-­‐0.13	  
3-­‐4	  hrs	   0.019	   0.077	   0.808	   -­‐0.14-­‐0.18	  
>=5	  hrs	   0.11	   0.077	   0.159	   -­‐0.045-­‐0.27	  
Infant	  received	  colostrum	   0.040	   0.061	   0.519	   -­‐0.081-­‐0.16	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
-­‐0.018	   0.013	   0.151	   -­‐0.043-­‐0.0066	  




	   	   	   	  
30-­‐59	  min	   -­‐0.043	   0.037	   0.242	   -­‐0.12-­‐0.029	  
60-­‐119	  min	   -­‐0.059	   0.035	   0.090	   -­‐0.13-­‐0.0092	  
120-­‐179	  min	   0.036	   0.040	   0.367	   -­‐0.12-­‐0.043	  
>180	  min	   0.018	   0.034	   0.603	   -­‐0.086-­‐0.050	  
Infant’s	  age	  days	  0	  to	  3	   0.096	   0.014	   <0.001	   0.069-­‐0.12	  
Infant’s	  age	  days	  4	  to	  14	   0.0042	   0.003	   0.160	   -­‐0.0017-­‐0.010	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.018	   0.002	   <0.001	   -­‐0.023-­‐	  -­‐0.013	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 minutes 
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Table A-11: Right Leg Erythema Score and Maternal, Socioeconomic, and 
Household Characteristics Bivariate Analyses 
Predictor	  Variable	  
Right	  Leg	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐0.11	   0.068	   0.105	   -­‐0.24-­‐0.023	  
Mother	  literate	   -­‐0.029	   0.039	   0.454	   -­‐0.10-­‐0.047	  
Father	  literate	   0.0056	   0.035	   0.874	   -­‐0.063-­‐0.074	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.020	   0.061	   0.747	   -­‐0.010-­‐0.14	  
	  	  	  6-­‐10	  yrs	   -­‐0.046	   0.050	   0.360	   -­‐0.14-­‐0.052	  
	  	  	  >10	  yrs	   -­‐0.094	   0.086	   0.278	   -­‐0.26-­‐0.076	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.038	   0.052	   0.461	   -­‐0.063-­‐0.14	  
	  	  	  6-­‐10	  yrs	   0.012	   0.040	   0.764	   -­‐0.066-­‐0.090	  
	  	  	  >10	  yrs	   -­‐0.12	   0.074	   0.110	   -­‐0.26-­‐0.027	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.032	   0.071	   0.654	   -­‐0.17-­‐0.11	  
	  	  	  6-­‐10	  assets	   -­‐0.056	   0.071	   0.431	   -­‐0.20-­‐0.083	  
	  	  	  >10	  assets	   0.018	   0.13	   0.888	   -­‐0.24-­‐0.27	  
Household	  has	  electricity	   -­‐0.11	   0.036	   0.002	   -­‐0.18-­‐	  -­‐0.040	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.15	   0.053	   0.006	   0.041-­‐0.25	  
	  	  	  25-­‐29	  yrs	   0.16	   0.060	   0.009	   0.039-­‐0.28	  
	  	  	  30-­‐34	  yrs	   0.13	   0.087	   0.122	   -­‐0.036-­‐0.30	  
	  	  	  >=35	  yrs	   0.15	   0.11	   0.175	   -­‐0.067-­‐0.37	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.058	   0.042	   0.172	   -­‐0.025-­‐0.14	  
	  	  	  >=3	   -­‐0.091	   0.047	   0.055	   -­‐0.0019-­‐0.18	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.034	   0.042	   0.427	   -­‐0.049-­‐0.12	  
	  	  	  >=3	   0.066	   0.066	   0.151	   -­‐0.024-­‐0.16	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   0.065	   0.043	   0.133	   -­‐0.020-­‐0.15	  
	  	  	  >=3	  ANC	  visits	   0.041	   0.044	   0.352	   -­‐0.045-­‐0.13	  
Delivery	  at	  facility	   -­‐0.16	   0.038	   <0.001	   -­‐0.24-­‐	  -­‐0.086	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   -­‐0.052	   0.037	   0.163	   -­‐0.12-­‐0.021	  
	  	  	  >=15	  hrs	   -­‐0.107	   0.058	   0.063	   -­‐0.22-­‐0.0058	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Table A-11: Right Leg Erythema Score and Maternal, Socioeconomic, and 
Household Characteristics Bivariate Analyses (continued) 
 
Predictor	  Variable	  
Right	  Leg	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Complications	  during	  delivery	   -­‐0.056	   0.045	   0.214	   -­‐0.15-­‐0.032	  
Skiled	  assistant	  at	  delivery	   -­‐0.15	   0.037	   <0.001	   -­‐0.22-­‐	  -­‐0.081	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
 
 
Table A-12: Right Leg Erythema Score and Environmental Characteristics 
Bivariate Analyses 
Predictor	  Variable	  
Right	  Leg	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   -­‐0.014	   0.0035	   <0.001	   -­‐0.021-­‐	  -­‐0.0071	  
Relative	  humidity	  (cont.)	  (%)	   0.00093	   0.0011	   0.414	   -­‐0.0013-­‐0.0032	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   0.14	   0.13	   0.260	   -­‐0.10-­‐0.39	  
60-­‐79%	   0.13	   0.12	   0.278	   -­‐0.10-­‐0.36	  
>80%	   0.13	   0.12	   0.264	   -­‐0.10-­‐0.37	  
Heat	  index	  (°C)	   -­‐0.0064	   0.0017	   <0.001	   -­‐0.0097-­‐	  -­‐0.0031	  
a: Reference group, <40% 
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Table A-13: Right Leg Erythema Score Multivariate Model 
Predictor	  Variable	  
Right	  Leg	  Erythema	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  weeks)
	  
0.028	   0.035	   0.430	   -­‐0.041-­‐0.096	  
Female	   0.060	   0.034	   0.080	   -­‐0.0071-­‐0.13	  
Madeshi	   -­‐0.14	   0.066	   0.038	   -­‐0.27-­‐	  -­‐0.0078	  
Birthweight	  (g)	  (cont.)	   0.00014	   0.000038	   <0.001	   0.00006-­‐0.00021	  
Household	  has	  electricity	   -­‐0.10	   0.035	   0.004	   -­‐0.17-­‐	  -­‐0.033	  
Maternal	  Age
a	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.13	   0.052	   0.012	   0.029-­‐0.23	  
	  	  	  25-­‐29	  yrs	   0.092	   0.060	   0.129	   -­‐0.027-­‐0.21	  
	  	  	  30-­‐34	  yrs	   0.085	   0.085	   0.320	   -­‐0.082-­‐0.25	  
	  	  	  >=	  35	  yrs	   0087	   0.11	   0.422	   -­‐0.12-­‐0.30	  
Facility	  delivery	   -­‐0.15	   0.038	   <0.001	   -­‐0.22-­‐	  -­‐0.073	  
Temperature	  (°C)	   -­‐0.014	   0.0036	   <0.001	   -­‐0.021-­‐	  -­‐0.0072	  
Relative	  humidity	  (%)
	  
-­‐0.0011	   0.0012	   0.363	   -­‐0.0034-­‐0.0012	  
Infant’s	  age	  days	  0	  to	  3	   0.089	   0.014	   <0.001	   0.062-­‐0.12	  
Infant’s	  age	  days	  4	  to	  14	   0.0050	   0.0031	   0.108	   -­‐0.0023-­‐0.014	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.019	   0.0024	   <0.001	   -­‐0.023-­‐	  -­‐0.014	  
a: Reference group, <18 years 
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Table A-14: Right Leg Rash Score and Infant Characteristics Bivariate Analyses 
Predictor	  Variable	  
Right	  Leg	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Female	   -­‐0.0042	   0.034	   0.903	   -­‐0.071-­‐0.063	  
Preterm	  (<37	  wks)	   -­‐0.095	   0.035	   0.006	   -­‐0.16-­‐	  -­‐0.028	  
Gestational	  Age
a	  
	   	   	   	  
32-­‐36	  wks	   -­‐0.10	   0.036	   0.005	   -­‐0.17-­‐	  -­‐0.031	  
<32	  wks	   -­‐0.061	   0.074	   0.407	   -­‐0.21-­‐0.083	  
Gestational	  Age	  (cont.)	  (wks)	   0.010	   0.0048	   0.034	   0.0075-­‐0.019	  
Low	  birthweight	  (<2500g)
	  
-­‐0.20	   0.034	   <0.001	   -­‐0.27-­‐	  -­‐0.13	  
Birthweight	  (g)	  (cont.)	   0.00027	   0.000035	   <0.001	   0.00020-­‐0.00034	  
SGA	  status
b	  
	   	   	   	  
SGA	  3-­‐10%	   0.021	   0.045	   0.633	   -­‐0.066-­‐0.11	  
SGA	  3%	   -­‐0.16	   0.041	   <0.001	   -­‐0.24-­‐	  -­‐0.081	  
Breastfed	  since	  birth	   -­‐0.0083	   0.048	   0.862	   -­‐0.10-­‐0.085	  
Hours	  before	  breastfeeding	  
initiation
c	   	   	   	   	  
1-­‐2	  hrs	   0.014	   0.042	   0.749	   -­‐0.069-­‐0.096	  
3-­‐4	  hrs	   -­‐0.018	   0.080	   0.822	   -­‐0.17-­‐0.14	  
>=5	  hrs	   -­‐0.0090	   0.081	   0.911	   -­‐0.17-­‐0.15	  
Infant	  received	  colostrum	   0.014	   0.061	   0.825	   -­‐0.11-­‐0.13	  
Avg	  #	  of	  massages	  per	  day	  
during	  first	  week	  of	  life	  
-­‐0.032	   0.012	   0.010	   -­‐0.056-­‐	  -­‐0.0077	  




	   	   	   	  
30-­‐59	  min	   -­‐0.055	   0.045	   0.224	   -­‐0.14-­‐0.034	  
60-­‐119	  min	   0.032	   0.043	   0.441	   -­‐0.12-­‐0.051	  
120-­‐179	  min	   0.040	   0.049	   0.412	   -­‐0.056-­‐0.14	  
>180	  min	   0.11	   0.042	   0.008	   0.029-­‐0.19	  
Infant’s	  age	  days	  0	  to	  14	   0.066	   0.003	   <0.001	   0.060-­‐0.071	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.027	   0.003	   <0.001	   -­‐0.0323-­‐	  -­‐0.022	  
a: Reference group, ≥37 weeks; b: Reference group, AGA; c: Reference group, <1 hour; d: Reference 
group, <30 minutes 
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Table A-15: Right Leg Rash Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses 
Predictor	  Variable	  
Right	  Leg	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Madeshi	   -­‐0.13	   0.066	   0.056	   -­‐0.26-­‐0.0031	  
Mother	  literate	   0.0029	   0.038	   0.939	   -­‐0.071-­‐0.077	  
Father	  literate	   0.011	   0.034	   0.753	   -­‐0.056-­‐0.078	  
Maternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   0.029	   0.060	   0.630	   -­‐0.088-­‐0.15	  
	  	  	  6-­‐10	  yrs	   -­‐0.031	   0.049	   0.524	   -­‐0.13-­‐0.065	  
	  	  	  >10	  yrs	   0.071	   0.085	   0.404	   -­‐0.096-­‐0.24	  
Paternal	  Education
a	  
	   	   	   	  
	  	  	  1-­‐5	  yrs	   -­‐0.050	   0.051	   0.324	   -­‐0.15-­‐0.049	  
	  	  	  6-­‐10	  yrs	   0.017	   0.039	   0.653	   -­‐0.059-­‐0.094	  
	  	  	  >10	  yrs	   0.0086	   0.073	   0.906	   -­‐0.13-­‐0.15	  
Household	  Assets
b,	  §	  
	   	   	   	  
	  	  	  2-­‐5	  assets	   -­‐0.036	   0.069	   0.610	   -­‐0.17-­‐0.10	  
	  	  	  6-­‐10	  assets	   -­‐0.0045	   0.069	   0.948	   -­‐0.14-­‐0.13	  
	  	  	  >10	  assets	   0.20	   0.13	   0.110	   -­‐0.046-­‐0.45	  
Household	  has	  electricity	   0.039	   0.035	   0.260	   -­‐0.029-­‐0.11	  
Maternal	  Age
c	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.14	   0.058	   0.005	   0.043-­‐0.25	  
	  	  	  25-­‐29	  yrs	   0.15	   0.066	   0.021	   0.034-­‐0.27	  
	  	  	  30-­‐34	  yrs	   0.18	   0.095	   0.037	   0.011-­‐0.34	  
	  	  	  >=35	  yrs	   0.17	   0.12	   0.227	   -­‐0.043-­‐0.38	  
Gravidity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.010	   0.041	   0.016	   0.019-­‐0.18	  
	  	  	  >=3	   0.15	   0.046	   0.001	   0.061-­‐0.24	  
Parity
d	  
	   	   	   	  
	  	  	  1-­‐2	   0.093	   0.041	   0.023	   0.013-­‐0.17	  
	  	  	  >=3	   0.17	   0.045	   <0.001	   0.079-­‐0.25	  
Antenatal	  Care	  Visits
d	  
	   	   	   	  
	  	  	  1-­‐2	  ANC	  visits	   0.046	   0.042	   0.281	   -­‐0.037-­‐0.13	  
	  	  	  >=3	  ANC	  visits	   0.045	   0.043	   0.291	   -­‐0.039-­‐0.13	  
Delivery	  at	  facility	   0.022	   0.038	   0.562	   -­‐0.052-­‐0.096	  
Length	  of	  labor
e	  
	   	   	   	  
	  	  	  5-­‐14	  hrs	   0.038	   0.036	   0.295	   -­‐0.033-­‐0.11	  
	  	  	  >=15	  hrs	   -­‐0.057	   0.057	   0.312	   -­‐0.17-­‐0.054	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Table A-15: Right Leg Rash Score and Maternal, Socioeconomic, and Household 
Characteristics Bivariate Analyses (continued) 
 
Predictor	  Variable	  
Right	  Leg	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Complications	  during	  delivery	   -­‐0.018	   0.044	   0.693	   -­‐0.070-­‐0.10	  
Skiled	  assistant	  at	  delivery	   0.020	   0.046	   0.574	   -­‐0.051-­‐0.092	  
a: Reference group, no education; b: Reference group, 0 or 1 asset(s); c: Reference group, <18 years; d: 
Reference group, none; e: Reference group, <5 hours; §:
 
HH assets were based on having at least one of 
the folowing: electricity, servants, 2nd floor, catle, goats, bulock carts, bicycles, clocks, radios, TVs, 
phones, plot of farmable land, plot of other land, family member living & working out of home. 
 
 
Table A-16: Right Leg Rash Score and Environmental Characteristics Bivariate 
Analyses 
Predictor	  Variable	  
Right	  Leg	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Temperature	  (°C)	   0.016	   0.0037	   <0.001	   0.0092-­‐0.024	  
Relative	  humidity	  (cont.)	  (%)	   0.0045	   0.0013	   <0.001	   0.0020-­‐0.0070	  
Relative	  humidity	  (%)
a	  
	   	   	   	  
40-­‐59%	   0.16	   0.15	   0.304	   -­‐0.14-­‐0.46	  
60-­‐79%	   0.30	   0.15	   0.039	   0.016-­‐0.59	  
>80%	   0.36	   0.15	   0.015	   0.070-­‐0.65	  
Heat	  index	  (°C)	   0.010	   0.0017	   <0.001	   0.0068-­‐0.014	  
a: Reference group, <40% 
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Table A-17: Right Leg Rash Score Multivariate Model 
Predictor	  Variable	  
Right	  Leg	  Rash	  Score	  
Coeficient	   SE	   p-­‐value	   95%	  CI	  
Preterm	  (<37	  wks)	   -­‐0.085	   0.033	   0.010	   -­‐0.15-­‐	  -­‐0.020	  
Female	   0.0028	   0.033	   0.813	   -­‐0.062-­‐0.067	  
Madeshi	   -­‐0.17	   0.069	   0.028	   -­‐0.30-­‐	  -­‐0.032	  
Low	  birthweight	  (<2500	  g)	   -­‐0.15	   0.035	   <0.001	   -­‐0.22-­‐	  -­‐0.085	  
Avg	  #	  of	  massages	  per	  day	  during	  
first	  week	  of	  life	  
-­‐0.0032	   0.013	   0.798	   -­‐0.028-­‐0.022	  
Time	  from	  visit	  to	  last	  massage
a
	   	   	   	   	  
	  	  	  30-­‐59	  min	   -­‐0.084	   0.042	   0.046	   -­‐0.17-­‐	  -­‐0.0015	  
	  	  	  60-­‐119	  min	   -­‐0.093	   0.040	   0.019	   -­‐0.17-­‐	  -­‐0.015	  
	  	  	  120-­‐179	  min	   -­‐0.053	   0.046	   0.246	   -­‐0.14-­‐0.036	  
	  	  	  >180	  min	   -­‐0.035	   0.040	   0.376	   -­‐0.11-­‐0.043	  
Maternal	  Age
b	  
	   	   	   	  
	  	  	  18-­‐24	  yrs	   0.028	   0.054	   0.611	   -­‐0.080-­‐0.14	  
	  	  	  25-­‐29	  yrs	   -­‐0.059	   0.071	   0.405	   -­‐0.20-­‐0.080	  
	  	  	  30-­‐34	  yrs	   -­‐0.042	   0.091	   0.651	   -­‐0.22-­‐0.14	  
	  	  	  >=	  35	  yrs	   -­‐0.029	   0.11	   0.798	   -­‐0.25-­‐0.19	  
Parity
c	  
	   	   	   	  
	  	  	  1-­‐2	   0.054	   0.044	   0.219	   -­‐0.032-­‐0.14	  
	  	  	  >=3	   0.19	   0.057	   0.001	   0.076-­‐0.30	  
Temperature	  (°C)	   0.022	   0.0036	   <0.001	   0.015-­‐0.029	  
Relative	  humidity	  (%)
	  
0.0059	   0.0013	   <0.001	   0.0034-­‐0.0083	  
Infant’s	  age	  days	  0	  to	  14	   0.067	   0.0028	   <0.001	   0.061-­‐0.072	  
Infant’s	  age	  days	  15	  to	  28	   -­‐0.026	   0.0028	   <0.001	   -­‐0.032-­‐	  -­‐0.021	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Appendix B Effect of Oil Group on Skin Integrity and Barrier 
Function (Left Arm and Right Leg Skin Condition and Ful Term 
Group for Al Measurements) 
Table B-1: Left Arm Skin Condition Score by Visit and Intervention Group-
Complete Data 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   324	   56	   0.68	   0.70	   308	   57	   0.67	   0.70	  
Rash	   324	   56	   0.21	   0.51	   308	   57	   0.14	   0.41	  
Total	   324	   56	   0.89	   0.98	   308	   57	   0.81	   0.89	  
Visit	  3	  
Erythema	   315	   56	   0.92	   0.63	   303	   57	   0.89	   0.61	  
Rash	   315	   56	   0.72	   0.77	   303	   57	   0.66	   0.78	  
Total	   315	   56	   1.64	   1.20	   303	   57	   1.55	   1.16	  
Visit	  7	  
Erythema	   312	   56	   0.92	   0.57	   305	   57	   1.00	   0.61	  
Rash	   312	   56	   1.04	   0.85	   305	   57	   1.00	   0.90	  
Total	   312	   56	   1.96	   1.24	   305	   57	   2.00	   1.31	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   309	   56	   1.01	   0.62	   299	   57	   1.02	   0.60	  
Rash	   309	   56	   1.29	   0.86	   299	   57	   1.26	   0.89	  
Total	   309	   56	   2.30	   1.36	   299	   57	   2.27	   1.36	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   270	   56	   0.69	   0.55	   262	   57	   0.66	   0.59	  
Rash	   270	   56	   0.78	   0.74	   262	   57	   0.78	   0.74	  
Total	   270	   56	   1.47	   1.15	   262	   57	   1.44	   1.22	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table B-2: Descriptive Characteristics of Left Arm Skin Condition Score by Visit 
and Intervention Group-Ful Term 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   175	   52	   0.71	   0.70	   184	   52	   0.62	   0.66	  
Rash	   175	   52	   0.27	   0.57	   184	   52	   0.17	   0.44	  
Total	   175	   52	   0.98	   1.02	   184	   52	   0.78	   0.90	  
Visit	  3	  
Erythema	   169	   51	   0.94	   0.62	   180	   52	   0.89	   0.60	  
Rash	   169	   51	   0.72	   0.75	   180	   52	   0.68	   0.80	  
Total	   169	   51	   1.67	   1.19	   180	   52	   1.57	   1.17	  
Visit	  7	  
Erythema	   168	   51	   0.90	   0.58	   183	   52	   1.02	   0.60	  
Rash	   168	   51	   1.05	   0.87	   183	   52	   1.08	   0.88	  
Total	   168	   51	   1.96	   1.28	   183	   52	   2.11	   1.29	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   167	   51	   1.08	   0.64	   181	   52	   1.04	   0.59	  
Rash	   167	   51	   1.43	   0.85	   181	   52	   1.35	   0.86	  
Total	   167	   51	   2.51	   1.37	   181	   52	   2.39	   1.34	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   144	   50	   0.73	   0.55	   155	   51	   0.65	   0.57	  
Rash	   144	   50	   0.83	   0.73	   155	   51	   0.85	   0.73	  
Total	   144	   50	   1.56	   1.15	   155	   51	   1.49	   1.21	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table B-3: Descriptive Characteristics of Left Arm Skin Condition Score by Visit 
and Intervention Group-Preterm 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   144	   53	   0.65	   0.71	   121	   47	   0.76	   0.75	  
Rash	   144	   53	   0.15	   0.42	   121	   47	   0.10	   0.36	  
Total	   144	   53	   0.80	   0.94	   121	   47	   0.85	   0.89	  
Visit	  3	  
Erythema	   142	   53	   0.89	   0.64	   120	   47	   0.90	   0.63	  
Rash	   142	   53	   0.74	   0.80	   120	   47	   0.62	   0.75	  
Total	   142	   53	   1.63	   1.23	   120	   47	   1.52	   1.16	  
Visit	  7	  
Erythema	   140	   53	   0.96	   0.56	   119	   47	   0.98	   0.60	  
Rash	   140	   53	   1.04	   0.82	   119	   47	   0.90	   0.93	  
Total	   140	   53	   1.99	   1.19	   119	   47	   1.88	   1.30	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   138	   53	   0.95	   0.59	   116	   47	   0.99	   0.61	  
Rash	   138	   53	   1.14	   0.84	   116	   47	   1.13	   0.93	  
Total	   138	   53	   2.09	   1.30	   116	   47	   2.12	   1.36	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   123	   51	   0.64	   0.55	   105	   45	   0.67	   0.61	  
Rash	   123	   51	   0.74	   0.74	   105	   45	   0.70	   0.75	  
Total	   123	   51	   1.38	   1.15	   105	   45	   1.38	   1.24	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table B-4: Regression Results of Intervention Group On Left Arm Skin Condition 
Total Score 
	   N	   n	   Coeficient	   SE	   95%	  CI	  
Complete	  Data	  Set	  
Visit	  1	   632	   113	   -­‐0.08	   0.08	   -­‐0.23-­‐0.07	  
Visit	  3	   618	   113	   -­‐0.09	   0.10	   -­‐0.28-­‐0.09	  
Visit	  7	   617	   113	   0.03	   0.10	   -­‐0.17-­‐0.23	  
Visit	  14	   608	   113	   -­‐0.03	   0.11	   -­‐0.25-­‐0.19	  
Visit	  28	   532	   113	   -­‐0.02	   0.11	   -­‐0.23-­‐0.20	  
Complete	  
Neonatal	  Period	  
632	   113	   -­‐0.03	   0.07	   -­‐0.16-­‐0.10	  
Early	  Neonatal	  
Period	  
632	   113	   -­‐0.09	   0.07	   -­‐0.23-­‐0.05	  
Late	  Neonatal	  
Period	  
614	   113	   0.02	   0.09	   -­‐0.16-­‐0.20	  
Ful	  Term	  
Visit	  1	   359	   104	   -­‐0.20	   0.10	   -­‐0.40-­‐0.01	  
Visit	  3	   349	   103	   -­‐0.09	   0.13	   -­‐0.34-­‐0.16	  
Visit	  7	   351	   103	   0.15	   0.14	   -­‐0.12-­‐0.43	  
Visit	  14	   348	   103	   -­‐0.12	   0.15	   -­‐0.40-­‐0.17	  
Visit	  28	   299	   101	   -­‐0.07	   0.13	   -­‐0.34-­‐0.20	  
Complete	  
Neonatal	  Period	  
359	   104	   -­‐0.05	   0.08	   -­‐0.21-­‐0.11	  
Early	  Neonatal	  
Period	  
359	   104	   -­‐0.08	   0.09	   -­‐0.27-­‐0.10	  
Late	  Neonatal	  
Period	  
350	   103	   -­‐0.03	   0.12	   -­‐0.26-­‐0.20	  
Preterm	  
Visit	  1	   265	   100	   0.06	   0.11	   -­‐0.16-­‐0.28	  
Visit	  3	   262	   100	   -­‐0.11	   0.15	   -­‐0.40-­‐0.18	  
Visit	  7	   259	   100	   -­‐0.12	   0.15	   -­‐0.42-­‐0.19	  
Visit	  14	   254	   100	   0.02	   0.18	   -­‐0.33-­‐0.38	  
Visit	  28	   228	   96	   -­‐0.003	   0.17	   -­‐0.33-­‐0.32	  
Complete	  
Neonatal	  Period	  	  
265	   100	   -­‐0.04	   0.09	   -­‐0.22-­‐0.15	  
Early	  Neonatal	  
Period	  
265	   100	   -­‐0.10	   0.11	   -­‐0.31-­‐0.11	  
Late	  Neonatal	  
Period	  
257	   100	   0.04	   0.14	   -­‐0.24-­‐0.32	  
N=number of observations for visits and number of infants for neonatal periods, n=number of clusters, 
Coeficient=regression coeficient for sunflower group, SE=standard errors, 95% CI=95% confidence interval 
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Table B-5: Descriptive Characteristics of Right Leg Skin Condition Score by Visit 
and Intervention Group-Complete Data 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   324	   56	   0.70	   0.72	   308	   57	   0.69	   0.72	  
Rash	   324	   56	   0.18	   0.48	   308	   57	   0.12	   0.34	  
Total	   324	   56	   0.89	   0.97	   308	   57	   0.81	   0.87	  
Visit	  3	  
Erythema	   315	   56	   0.89	   0.67	   303	   57	   0.89	   0.67	  
Rash	   315	   56	   0.57	   0.72	   303	   57	   0.51	   0.70	  
Total	   315	   56	   1.46	   1.18	   303	   57	   1.40	   1.13	  
Visit	  7	  
Erythema	   312	   56	   0.89	   0.62	   305	   57	   0.97	   0.66	  
Rash	   312	   56	   0.78	   0.81	   305	   57	   0.75	   0.79	  
Total	   312	   56	   1.67	   1.20	   305	   57	   1.72	   1.19	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   309	   56	   0.92	   0.63	   299	   57	   0.96	   0.61	  
Rash	   309	   56	   1.05	   0.75	   299	   57	   1.07	   0.84	  
Total	   309	   56	   1.96	   1.23	   299	   57	   2.03	   1.28	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   270	   56	   0.72	   0.62	   262	   57	   0.68	   0.65	  
Rash	   270	   56	   0.79	   0.76	   262	   57	   0.74	   0.75	  
Total	   270	   56	   1.51	   1.25	   262	   57	   1.42	   1.27	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table B-6: Descriptive Characteristics of Right Leg Skin Condition Score by Visit 
and Intervention Group-Ful Term 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   175	   52	   0.73	   0.72	   184	   52	   0.62	   0.67	  
Rash	   175	   52	   0.23	   0.55	   184	   52	   0.14	   0.38	  
Total	   175	   52	   0.96	   1.00	   184	   52	   0.77	   0.85	  
Visit	  3	  
Erythema	   169	   51	   0.88	   0.66	   180	   52	   0.88	   0.67	  
Rash	   169	   51	   0.54	   0.74	   180	   52	   0.50	   0.70	  
Total	   169	   51	   1.42	   1.20	   180	   52	   1.38	   1.15	  
Visit	  7	  
Erythema	   168	   51	   0.86	   0.62	   183	   52	   0.97	   0.65	  
Rash	   168	   51	   0.78	   0.79	   183	   52	   0.85	   0.80	  
Total	   168	   51	   1.64	   1.20	   183	   52	   1.82	   1.21	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   167	   51	   0.94	   0.62	   181	   52	   1.00	   0.61	  
Rash	   167	   51	   1.13	   0.76	   181	   52	   1.14	   0.83	  
Total	   167	   51	   2.06	   1.23	   181	   52	   2.15	   1.29	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   144	   50	   0.76	   0.63	   155	   51	   0.67	   0.62	  
Rash	   144	   50	   0.89	   0.78	   155	   51	   0.84	   0.77	  
Total	   144	   50	   1.65	   1.29	   155	   51	   1.51	   1.28	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table B-7: Descriptive Characteristics of Right Leg Skin Condition Score by Visit 
and Intervention Group-Preterm 
	   Mustard	  Oil	   Sunflower	  Oil	  
N	   n	   Mean	   SD	   N	   n	   Mean	   SD	  
Visit	  1	  
Erythema	   144	   53	   0.68	   0.73	   121	   47	   0.80	   0.79	  
Rash	   144	   53	   0.14	   0.38	   121	   47	   0.08	   0.29	  
Total	   144	   53	   0.82	   0.92	   121	   47	   0.88	   0.90	  
Visit	  3	  
Erythema	   142	   53	   0.90	   0.67	   120	   47	   0.93	   0.66	  
Rash	   142	   53	   0.62	   0.71	   120	   47	   0.53	   0.71	  
Total	   142	   53	   1.53	   1.16	   120	   47	   1.45	   1.12	  
Visit	  7	  
Erythema	   140	   53	   0.93	   0.62	   119	   47	   0.98	   0.66	  
Rash	   140	   53	   0.79	   0.84	   119	   47	   0.61	   0.77	  
Total	   140	   53	   1.71	   1.19	   119	   47	   1.59	   1.13	  
Visit	  14	   	   	   	   	   	   	   	   	  
Erythema	   138	   53	   0.91	   0.64	   116	   47	   0.92	   0.60	  
Rash	   138	   53	   0.96	   0.73	   116	   47	   0.97	   0.85	  
Total	   138	   53	   1.87	   1.21	   116	   47	   1.89	   1.23	  
Visit	  28	   	   	   	   	   	   	   	   	  
Erythema	   123	   51	   0.67	   0.62	   105	   45	   0.70	   0.68	  
Rash	   123	   51	   0.69	   0.73	   105	   45	   0.61	   0.71	  
Total	   123	   51	   1.36	   1.21	   105	   45	   1.31	   1.26	  
N=number of observations, n=number of clusters, SD=standard deviation 
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Table B-8: Regression Results of Intervention Group on Right Leg Skin Condition 
Total Score 
	   N	   n	   Coeficient	   SE	   95%	  CI	  
Complete	  Data	  Set	  
Visit	  1	   632	   113	   -­‐0.08	   0.07	   -­‐0.22-­‐0.06	  
Visit	  3	   618	   113	   -­‐0.06	   0.09	   -­‐0.24-­‐0.12	  
Visit	  7	   617	   113	   0.05	   0.10	   -­‐0.14-­‐0.23	  
Visit	  14	   608	   113	   0.07	   0.10	   -­‐0.13-­‐0.27	  
Visit	  28	   532	   113	   -­‐0.08	   0.11	   -­‐0.30-­‐0.13	  
Complete	  
Neonatal	  Period	  
632	   113	   -­‐0.02	   0.06	   -­‐0.13-­‐0.10	  
Early	  Neonatal	  
Period	  	  
632	   113	   -­‐0.06	   0.07	   -­‐0.19-­‐0.07	  
Late	  Neonatal	  
Period	  
614	   113	   0.03	   0.08	   -­‐0.13-­‐0.19	  
Ful	  Term	  
Visit	  1	   359	   104	   -­‐0.19	   0.10	   -­‐0.38-­‐0.004	  
Visit	  3	   349	   103	   -­‐0.05	   0.13	   -­‐0.30-­‐0.20	  
Visit	  7	   351	   103	   0.19	   0.13	   -­‐0.07-­‐0.44	  
Visit	  14	   348	   103	   0.08	   0.14	   -­‐0.18-­‐0.35	  
Visit	  28	   299	   101	   -­‐0.14	   0.15	   -­‐0.43-­‐0.15	  
Complete	  
Neonatal	  Period	  
359	   104	   -­‐0.01	   0.08	   -­‐0.16-­‐0.14	  
Early	  Neonatal	  
Period	  	  
359	   104	   -­‐0.08	   0.09	   -­‐0.26-­‐0.11	  
Late	  Neonatal	  
Period	  	  
350	   103	   0.07	   0.11	   -­‐0.14-­‐0.28	  
Preterm	  
Visit	  1	   265	   100	   0.06	   0.11	   -­‐0.16-­‐0.28	  
Visit	  3	   262	   100	   -­‐0.07	   0.14	   -­‐0.35-­‐0.20	  
Visit	  7	   259	   100	   -­‐0.12	   0.14	   -­‐0.40-­‐0.17	  
Visit	  14	   254	   100	   0.02	   0.15	   -­‐0.28-­‐0.32	  
Visit	  28	   228	   96	   -­‐0.05	   0.17	   -­‐0.38-­‐0.27	  
Complete	  
Neonatal	  Period	  
265	   100	   -­‐0.04	   0.09	   -­‐0.21-­‐0.14	  
Early	  Neonatal	  
Period	  
265	   100	   -­‐0.04	   0.10	   -­‐0.24-­‐0.16	  
Late	  Neonatal	  
Period	  	  
257	   100	   -­‐0.05	   0.13	   -­‐0.30-­‐0.20	  
N=number of observations for visits and number of infants for neonatal periods, n=number of clusters, 
Coeficient=regression coeficient for sunflower group, SE=standard errors, 95% CI=95% confidence interval 
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